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ABSTRACT 
CHAPTER I: 
STUDIES TOWARD THE TOTAL SYNTHESIS OF SALIMABROMIDE 
In 2013, one of the first examples of a secondary metabolite from an obligate marine 
myxobacterium was reported. The halogenated polyketide salimabromide was isolated from 
Enhygromyxa salina and consists of an unprecedented tetracyclic core structure featuring a 
dibrominated benzene ring. It contains four consecutive stereogenic centers, one of which is an 
all carbon quaternary center. Moreover, this chiral quaternary center resides adjacent to an 
additional all carbon quaternary carbon. 
The first part of this thesis describes synthetic efforts toward the synthesis of salimabromide. 
Both the tetraline core and the quaternary centers were successfully installed in a single step 
using an intramolecular Friedel-Crafts alkylation (I → II). The amide precursor III for the key 
step – a keteniminium [2+2] cycloaddtion developed by Ghosez – was synthesized in two 
further steps. Successful application of the Ghosez method in our synthesis allowed the creation 
of three additional stereocenters in a single process and in a stereodefined manner. Therefore, 
the single stereocenter of the tetralin core of II could be used to stereoselectively install all the 
others present in salimabromide. The highly congested tetracyclic intermediate IV was then 
converted in three subsequent steps to tricyclic aldehyde V, the precursor for the Aldol 
condensation to close the cycloheptenone portion of the natural product.  
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CHAPTER II: 
CATALYTIC ASYMMETRIC DEAROMATIZATION (CADA) REACTIONS 
The asymmetric synthesis of all carbon quaternary centers is a challenging problem for synthetic 
chemists. In the second part of this thesis, the development of an intramolecular CADA 
reaction of 2-substituted 1-naphthols is described. We were able to overcome the challenge of 
rearomatization via subsequent Cope rearrangement by developing mild and neutral conditions. 
Diallylation caused by ion diffusion was avoided by the use of more elaborated chiral ligands. In 
general, two types of substrates were found to be suitable for this CADA reaction of 
1-naphthols: allyl carbonates I and allyl ethers III. Heating the substrates in benzene to 45 °C in 
the presence of 5 mol% Pd2dba3 and 11 mol% of a chiral ligand afforded 3,4-dehydro-1-
tetralone II in up to 84% yield. Amongst several chiral ligands screened, the (S,S)-DACH-
phenyl Trost ligand appeared to give the highest yields and ee values of around 59%. Higher ee 
values could be obtained with the (S,S)-DACH-naphthyl Trost ligand, which gave constantly 
values around 70%, although the yields were moderate. Several substrates with different 
substituents were treated with these conditions to afford the corresponding ketones in very 
good yields.  
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CHAPTER III: 
CLAISEN REARRANGEMENT OF ALLYL CHLOROVINYL ETHERS 
The third chapter of this thesis presents the development of a synthetic methodology to afford 
Ư-chlorinated acids II and 2,4-dienoic acids III from allylic alcohols I. For the synthesis of 
Ư-chlorinated acids II commercially available allylic alcohols were treated with KH and 
trichloroethene (TCE) at low temperatures to undergo an elimination-addition reaction and 
form 1,2-dichlorovinyl ether at around −30 °C. Upon warming to −10 °C, the ethers undergo in 
situ Claisen rearrangement to generate Ư-chlorinated acid chlorides which are hydrolyzed upon 
work-up. The obtained products were heated under basic conditions to 85 °C to formally 
eliminate HCl and obtain the corresponding dienoic acids III. A one-pot protocol for this 
reaction sequence was established as well. However, the sensitivity of both types of products II 
and III toward a variety of purification methods made their isolation and identification very 
difficult. Furthermore, the generation of the Ư-chlorinated acids was problematic and often 
resulted in low yields.  
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CHAPTER I 
 
 
 
STUDIES TOWARD THE TOTAL SYNTHESIS OF 
SALIMABROMIDE 
 
 
2  INTRODUCTION 
 
1 Introduction 
1.1 Myxobacteria and their Secondary Metabolites 
Myxobacteria, first discovered in 1892 by R. Thaxter,1 belong to the Ʋ-group of gram-negative 
proteobacteria and are a very rich source for secondary metabolites with diverse types of 
structures and fascinating biological activities. However, myxobacteria are not typical bacteria, 
since they are one of the bacterial groups that successfully achieved the transition from a single 
cell to multicellular life. They move by gliding or creeping on surfaces and are able to form 
complex fruit bodies. Those fruit bodies are build in times when nutrients are limited by 
migrating swarm colonies, which then develop macroscopic clusters and exchange extracellular 
chemical signals and physical contact signals (Figure 1). Within those fruit bodies, vegetative 
cells differentiate into myxospores. Both multicellular processes, the cooperative predation by 
swarm colonies and the multicellular development, are mediated by the coordinated movement 
of the cells and illustrate the social nature of myxobacteria. However, since they can switch 
between those two processes, their multicellularity is transitory and not obligatory in contrast to 
organisms which have no other choice than multicellularity.2,3,4,5 Another characteristic of 
myxobacteria is their exceedingly large genome in contrast to other prokaryotes. The largest 
sequenced genome contains 14,782,125 base pairs and was isolated from the So0157-2 strain of 
Sorangium cellulosum.6  
 
 
Figure 1 Fruitbodies: a)7 and b); 8 Swarm colony: c)3 and d).9  
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Noticeable is in particular that the metabolites of myxobacteria show modes of action, which are 
scarcely exhibited by other microbial natural products and are therefore very interesting as novel 
drug leads. Especially polyketides are often isolated of which several possess very high 
bioactivities, such as antiproliferative, antibiotic, antifungal and antiplasmodial activities. A 
representative for such a bioactive polyketide is chlorotonil A (I.1) (Figure 2).2 It was isolated 
from the soil-dwelling myxobacterium Sorangium cellulosum So ce15254 and has already been 
asymmetrically synthesized by Kalesse in 2008.10 It shows remarkable antibacterial and 
antimalarial activities, as it is active against all blood stages of P. falciparum and also against 
gametocytes. It proved also to be effective in vivo after oral administration, however, its poor 
solubility prevents at the moment clinical development.4  
 
 
Figure 2 Structure of chlorotonil A (I.1). 
 
Another important class of myxobacteria derived polyketides is the epothilone family, produced 
by Sorangium cellulosum, strain So ce90, and isolated first in 1985 by H. Reichenbach (Figure 3). 
Several representatives of this class are highly bioactive, since they act as microtubule-stabilizing 
agents, similar to taxol.11 Epothilon D (I.2) for example was identified as selective inhibitor of 
early steps of HIV infection (EC50 0.5 nM; selectivity index SI 24.4)4 and was also tested in 
clinical trials due to its potent antitumor activity (phase II, abandoned).11 Epothilone B (I.3) 
reached phase III trials for patients with advanced ovarian cancer, but failed unfortunately in the 
end.12 The most successful member of the epothilones is the semisynthetic derivative 
ixabepilone (I.4). In 2007 it granted FDA approval for “treatment of metastatic or advanced 
breast cancer, either as single agent or in combination with capecitabine, and will be marketed in 
the US by Bristol-Myers Squibb (BMS) under the trade name Ixempra®”.11  
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Figure 3 Structures of epothilone D (I.2), epothilone B (I.3) and ixabepilone (I.4). 
 
Due to their importance as drug candidates, several total syntheses were reported by 
Danishefsky13,14,15, Nicolaou16,17,18, Schinzer19, Sinha20, Carreira21 and Shibasaki22 amongst others. 
Ixabepilone (I.4) was prepared by a semisynthetic approach from epothilone B (I.3) in a three 
step, one-pot sequence.23 
Although it was believed for a long time that there are only terrestrial myxobacteria, marine 
myxobacteria were discovered in recent years and they are phylogenetically quite distinct. Since 
their cultivation and isolation is very difficult and often not possible at all, only a few obligate 
genera (Enhygromyxa, Haliangium and Plesiocycstis) are known. They are strictly halophilic and need 
sea-like salinity conditions to grow. The first isolated secondary metabolite that occurs from 
strict marine myxobacterial origin is haliangicin (I.5) from Haliangium ochraceum, which shows 
antifungal bioactivity against Aspergillus niger (AJ117374, MIC: 12.5 μg mL−1) and Fusarium sp. 
(AJ177167, MIC: 6.3 μg mL−1) (Figure 4). Interestingly, the production of haliangicin (I.5) is 
dependent of the NaCl-concentration and is optimal at 2–3% NaCl (w/v). This is also the best 
concentration for optimal growth.24,25  
 
 
Figure 4 Structure of haliangicin (I.5). 
 
Another obligate marine myxobacterium is the genus Enhygromyxa. This species is truly 
halophilic and was isolated from coasts from all over the world. A NaCl-concentration of 1–2% 
at a pH range of 7.0–8.5 seems to be optimal for growth. Five structures of presumably 
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polyketide, shikimate and terpenoid origin have been isolated and described: the polyketide 
salimabromide (I.6), the enhygrolides A (I.7) and B (I.8), formed by the shikimic acid pathway, 
and the terpenoids salimyxins A (I.9) and B (I.10) (Figure 5). The structure of the enhygrolides 
resembles the ones of cyanobacteria-derived metabolites. Both were tested for their biological 
activity, but only enhygrolide A (I.7) showed some activity against Arthrobacter cristallopoietes with 
an MIC value of 4 µg mL−1. The salimyxins belong to the terpenoid subgroup of incisterols and 
are presumably degraded sterols. Similar to enhygrolide A (I.7), the salimyxins show only 
biological activity against Arthrobacter cristallopoietes with an MIC value of 8 µg mL−1 and 
4 µg mL−1, respectively.4,24 
 
 
Figure 5 Structures of salimabromide (I.6), enhygrolides A (I.7) and B (I.8) and salimyxins A (I.9) and B (I.10). 
 
1.2 Halogenated Natural Products of Marine Origin 
The use and isolation of biologically occurring substances is known for a very long time, but the 
main focus was on terrestrial natural products, due to their easier accessibility. However, since 
the beginning of the 1970s the average number of isolated and characterized marine natural 
products increased steadily and in the year 2007 over 1000 new compounds were described.26 
This effect can be attributed amongst other things to new isolation and cultivation techniques, 
like marine bioprocessing, and remote submersibles, which are able to access new depth in the 
oceans. Data from 2001–2007 show particularly increasing average numbers of isolated new 
compounds from the Caribbean, the China Sea, the Indian Ocean, Japan and the Western 
Pacific (Figure 6b). Also noticeable is the spectacular increase of natural products isolated from 
microorganisms (Figure 6a). Comparison of the data of 2007 with the average of 1965–2005 
6  INTRODUCTION 
 
reveals a rise by 600%. This reflects the augmented interest in bacteria and fungi from marine 
origin. The numbers for the more traditional categories such as sponges and cnidarians remain 
steadily very high.27,26  
 
 
Figure 6 a) Distribution of marine natural products by phylum.26 b) Trends in geographic distribution of collection sources.26 
 
An estimated number of over 15000 marine natural products of all types have been described in 
total and around 15–20% of them (survey of the literature from 1998–2005) are 
organohalogens.28 This is quite surprising, since in 1961 no halogenated substances from marine 
origin were known, except for iodinated tyrosine derivatives, and even in 1973, only 50 of them 
had been discovered.29 Since then, a huge number of marine organohalogens was observed. Due 
to the high halide concentrations in the oceans in contrast to the terrestrial occurrence (Table 1), 
it is not astonishing that most of the halogenated natural products arise from marine organisms. 
They were isolated from a huge number of organisms, such as sponges, cyanobacteria, molluscs, 
sea hares, mussels, bryozoans (moss animals), tunicates, soft corals, symbiotic bacteria, marine 
phytoplankton, macroalgae, marine bacteria and marine fungi.28  
 
Table 1 Distribution of halides/mg kg−1 in the environment.28  
Halide Oceans Sedementary rocks Fungi Wood pulp Plants 
Cl− 19000 10–320  70–2100 200–10000 
Br− 65 1.6–3 100   
I− 0.05 0.3    
F− 1.4 270–740    
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1.2.1 Selected Halogenated Marine Natural Products 
In particular the chloride concentration is extremely high in oceans, which leads to a vast 
number of volatile chlorinated simple alkanes and alkenes. One of them is chloromethane 
(CH3Cl) and interesting is that its natural production, mainly by salt marsh, dwarf the 
anthropogenic contribution. It is also the most frequent occurring organohalogen in the 
atmosphere. Chloroform (CHCl3) is another representative, which is produced, amongst others, 
by green, red and brown seaweeds as well as macro- and microalgae. Studies revealed an increase 
in the CHCl3 production through an increase in light intensity, presumably when photosynthesis 
reached its maximum. Similar to CH3Cl, over 90% of the atmospheric CHCl3 is derived from 
nature.28 Also trichloroethene (TCE), a former dry-cleaning solvent, is produced by over 27 
species of marine algae and the amounts of its emission from the oceans into the atmosphere is 
quite high.30 
Although the availability of bromide is a lot lower than that of chloride, there are multiple 
bromine containing organohalogens, which is a result of the lower reduction potential: E° = 
2.87 V (F−), 1.36 V (Cl−), 1.09 V (Br−), 0.54 V (I−).31 Bormoform (CHBr3) is the major 
contributor of organic bromine in the atmosphere and is invariably produced by macro- and 
microalgae. Around 70% of the worldwide produced CHBr3 stem from macroalgae. Similar to 
CHBr3, iodomethane (CH3I) is produced by marine algae and is often detected in the oceanic 
atmosphere.28  
In general, sea-salt spray is the major source for volatile reactive organohalogens (Cl2, Br2, BrCl, 
HOCl, HOBr) in the atmosphere. These reactive species are subsequently converted to chlorine 
oxide and bromine oxide, which affect the ozone layer and are probably the reason for the 
detected low ozone concentrations over the Dead Sea and the Great Salt Lake.28,32 However, not 
only halomethanes are generated by marine organisms, but a wide variety of metabolites such as 
polyketides, terpenoids, alkaloids, peptides, indols, fatty acids and phenols.33 They are often of 
special interest for the pharmaceutical industry due to their high biological activities, which 
include anti-inflammatory, antibacterial, antituberculosis, antifungal, anticancer, anti-infective, 
antioxidant and antimicrobial activities.34,35  
The sesterterpenoids (C25) neomangicol A (I.11) and B (I.12), for example, were isolated from a 
marine fungus of the genus Fusarium and are probably the first halogenated representatives for 
this class of terpenoids (Figure 7). Both possess an unusual carbon skeleton that is proposed to 
be formed by an atypical terpenoid pathway (“head to tail” isoprene configurations). The 
halogenation pattern is also of interest, since it constitutes of a vinyl dihalogen group. 
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Negmangicol A (I.11) appeared to be active against MCF-7 (human breast carcinoma) and 
CACO-2 (human colon carcinoma) cell lines (IC50 = 4.9 and 5.7 µM, respectively). I.12 however, 
showed antibacterial activity against the Gram-positive bacterium Bacillus subtilus, similar to the 
activity of the antibiotic gentamycin. The halogenation pattern seems to influence the biological 
activity, since their nonhalogenated analog neomangicol C (I.13) does not show any effect at 
all.36 Until today no total synthesis of any neomangicol was reported, but only a synthesis of the 
tetracyclic core of neomangicol C (I.13) by Sarpong.37 
 
 
Figure 7 Structures of neomangicol A (I.11), B (I.12) and C (I.13). 
 
Fluorinated natural products are in general very rare, due to the difficult accessibility of fluoride 
arising from its physical and chemical properties, but marine fluorinated organohaloges are 
especially scarce. In 2003, the first natural organofluorines from a marine source were described, 
which were isolated from the marine sponge Phakellia fusca. The group of Xiao-Hua Xu reported 
five 5-fluorouracil compounds, which are shown in Figure 8. The structures of I.14, I.15 and 
I.18 were new, but the ones of fluorouracil (I.16) and I.17 were known previously.38 Fluorouracil 
(I.16) was synthetically obtained in 195739 and is a prevalent antitumor agent against a variety of 
cancer types and also part of the WHO model list of essential medicines.40  
 
 
Figure 8 Structures of fluorouracil (I.16) and derivatives thereof. 
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Kalihinol A (I.19), a chlorinated representative of the huge family of highly functionalized 
kalihinane diterpenoids, was isolated from the sponge Acanthella in 1984 (Scheme 1).41 Several 
members of this family possess biological activities such as antifungal, antifouling, antimicrobial, 
cytotoxic and anthelminic properties. However, kalihinol A (I.19) is up to now the most potent 
of all tested isocyanoterpenes. I.19 turned out to be remarkably active against the malaria 
transmitting parasite Plasmodium falsiparum (EC50 = 1.2 nM) and shows also an exceptional 
selectivity index (SI = 317), which was defined as the ratio of FM3A cell cytotoxicity to 
Plasmodium falsiparum.42,43,44 A total synthesis with 35 steps was achieved by Miyaoka. At the 
beginning, epoxide I.21 is synthesized in four steps, including a Sharpless asymmetric 
epoxidation. Diol I.23 was afforded by nucleophilic alkylation with Grignard reagent I.22 and 
additional seven steps were required to form the chlorinate tetrahydropyran ring of I.24. Triene 
I.25 for the intramolecular Diels-Alder reaction, to form the decalin system, was achieved in 
seven steps. Deprotection of the TBS-group and oxidation resulted in the ketone, which 
spontaneously underwent the Diels-Alder reaction to generate selectively cis-decalin I.26. This 
was then transferred into trans-decalin I.27 in seven steps, introducing also an azide moiety. In 
the last seven steps, the azide was transformed into an isocyanide and the ketone into a methyl 
and isocanide group.44  
 
 
Scheme 1 Structure and total synthesis of kalihinol A (I.19). 
 
A very interesting structure is the one of obtusallene I (I.28), isolated from the red alga Laurencia 
obtuse in 1982, which was not only determined by NMR spectroscopy, but also verified by X-ray 
analysis.45 Obtusallene I (I.28) belongs to a large family of halogenated C15-acetogenins and 
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possesses the typical bromide substituent in ư-position to the acetogenic oxygen (Figure 9). 
Another typical feature is the bromoallene unit. To date, no total synthesis of I.28 or a 
structurally related member of this family was reported. However, Braddock published a 
possible biosynthesis starting from a linear precursor, involving several electrophilic 
bromination events.46,34 
 
 
Figure 9 Structure of obtusallene I (I.28). 
 
Chlorosulfolipids are known for a long time since they are, together with other toxins, 
responsible for seafood poisoning in humans. However, the mechanism of their biological 
activity is still unknown. They were first isolated from freshwater microalgae (e. g. Ochromonas 
danica and Ochromonas malhamensis) of which they constitute 15% of all lipids. The cytotoxin 
mytilipin A (I.29) is a relatively small representative of the chlorosulfolipids compared to other 
members of this family (Scheme 2). I.29 was isolated in 2001 from 4.3 kg of digestive glands of 
mussels from the genus Mytilus galloprovincialis, collected along the coast of the Emilia Romagna. 
However, it is not sure if the mussels produce I.29 by themselves, or accumulate harmful 
microalgae. Tests to reveal the bioactivity of mytilipin A (I.29) showed antiproliferative activity 
on the J774 (murine monocyte/macrophage), WEHI 164 (murine fibrosarcoma), and P388 
(murine leukemia) cell line as well as inhibition of growth in all investigated cell lines, evaluated 
after 72 h (IC50 of 12.1, 16.3, and 10.4 µg/mL, respectively).47,48,49 Due to its unique structure, the 
polyhalogenated backbone, I.29 is a challenging target for total synthesis. The first synthesis of 
racemic I.29 was published by Carreira in 2009,49 followed by an enantioselective synthesis by 
Yoshimitsu50 and a very concise synthesis (7 or 8 steps, respectively) by Vanderwal.51 The latter 
is depicted in Scheme 2 and commences with a four step synthesis of racemic vinyl epoxide I.31 
from commercially available crotyl alcohol (I.30). At this stage, the epoxide could undergo a 
kinetic resolution to afford enantioenriched material for an enantioselective synthesis. 
Z-selective alkene cross-metathesis using Grubbs cycloadamantyl catalyst I.33 gave vinyl 
epoxide I.34 in only 32% yield but excellent selectivity. Two further steps provided 
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hexachlorinated alcohol I.35, which was treated under conditions reported by Carreira to 
complete the synthesis of I.29.51 
 
 
Scheme 2 Structure and total synthesis by Vanderwal of mytilipin A (I.29). 
 
The class of vicinal bromochlorinated natural products contains over 160 substances, whereby 
many of them are highly bioactive.52 One of them is the tetrahalogenated terpene plocamenone 
(I.36), isolated from the red alga Plocamium angustum (Scheme 3). Its structure was revised several 
times, until it was unequivocally identified as the one depicted.53 The difficulty to elucidate the 
correct molecular structure concerns the whole family of polyhalogenated monoterpenes. NMR 
studies of the noncrystalline terpenes to clarify their structures are challenging as described by 
several studies.54 Moreover, they are often relatively volatile and tend to decompose or 
isomerize, as in the case of isoplocamenone, which isomerizes to plocamenone (I.36) upon 
exposure to light.52 
The most exciting one of the vicinal bromochlorinated natural products is halomon (I.37), 
which was first isolated in 1975 from the red alga Chondrococcus hornemannii and fully described 
and analyzed in 1992 (Scheme 3). The structure elucidation appeared to be very difficult, as 
reported for plocamenone (I.36), but X-ray crystallography and extensive NMR studies 
confirmed the proposed structure. In first biological tests I.37 appeared to be inactive in the 
anti-HIV assay, but highly cytotoxic against human cancer cells. Extended screenings at the NCI 
(National Cancer Institute) revealed that I.37 was “one of the most extreme examples of 
differential cytotoxicity”.55 Most sensitive to halomon (I.37) treatment were brain tumor, renal 
and colon tumor cell lines, compared to the less sensitive melanoma and leukemia cell lines. As a 
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result of this extraordinary activity, the NCI decided to use I.37 in preclinical drug development. 
Although the first results were encouraging, these studies were unfortunately abandoned, since it 
was not possible to gain enough material of I.37. All efforts to isolate enough material from 
natural sources were unsuccessful, probably as a result of seasonal and local deviation of the 
terpene concentration in the algae.55,56,52 Since the natural sources cannot provide sufficient 
amounts of the drug, total synthesis could be a solution to this problem. The first selective 
synthesis of (+)-I.37 was reported by Burns in 2009, who was able to synthesize the target 
molecule in nine steps and 400 mg of I.37 in total. The synthesis starts with the enantioselective 
bromochlorination of allylic alcohol I.38 with the (R,S)-Schiff base I.43. Deoxygenation 
afforded the bromochlorinated myrcene derivative I.40, which was subjected to formal 
1,4-bromohydration conditions. Bromohydrin I.41 was dichlorinated with the (S,R)-Schiff base 
I.43 with excellent results. The final product I.37 was obtained in two further steps in good 
overall yield.52  
 
 
Scheme 3 Structures of plocamenone (I.36) and halomon (I.37) and total synthesis of I.37. 
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One of the most interesting organohalogen is currently salinosporamide A (Marizomib, 
NPI-0052) (I.44), isolated from the obligate marine actinomycete Salinispora tropica (Figure 10). It 
is a high functionalized Ʊ-lactam-ư-lactone with outstanding biological activity. I.44 is an 
irreversible proteasome inhibitor (IC50 value of 1.3 nM) and thus approximately 35 times more 
effective than omuralide (I.45) (IC50 value of 49 nM). Furthermore, I.44 displays high in vitro 
cytotoxicity against several tumor cell lines (IC50 values of 10 nM or less). At the moment it is 
tested in phase I clinical trials against advanced malignancies including multiple myeloma.57  
 
 
Figure 10 Structures of salinosporamide A (I.44) and omuralide (I.45). 
 
Salinosporamide A (I.44) is also a good example to show the influence of the halogen 
substituent on the biological activity. Tests with different substitution patterns, replacing the 
chlorinated ethyl group by simple alkyl groups showed a dramatic decrease in activity. In 
contrast, substitution of the chloride by bromide or iodide did not affect the potency. These 
findings lead to a proposed mechanistic role of the chlorinated ethyl group. The ư-lactone is 
opened by the nucleophilic addition of the hydroxyl group of Thr1OƱ, followed by 
intramolecular SN2-displacement to generate the tetrahydrofuran ring (I.46→I.47) (Scheme 4). 
This reaction sequence results in an irreversible covalent inhibition of the proteasome, a key 
player of the protein degradation pathway, and underlies the elegant way of action of this 
inhibitor.58  
Since this organohalogen I.44 was identified as potential drug lead, several groups of organic 
chemists tried to investigate a total synthesis. In 2004, Corey59 was the first to report an 
enantiospecific synthesis, followed by Danishefsky60 in 2005 and several others in the past few 
years.61  
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Scheme 4 Simplified mechanism of hydrolysis and subsequent rearrangement of I.44 in aqueous solution (R = H) or in the binding pocket of proteasome core particle (R = Thr1OƱ).  
 
1.2.2 Biosynthesis of Halogenated Natural Products 
As shown before, incorporation of halogen atoms profoundly influences the biological activity 
of secondary metabolites. Thus, the exploration of the biosynthesis of those organohalogens is 
an important research field. In general, there are three different types of halogenases that are 
able to catalyze halogenation reactions. The classification was carried out according to the 
chemical nature of active halogen species (Table 2). The primary halogen sources for all 
halogenases are solvated halide anions.62  
 
Table 2 Biohalogenation pathways.  
Electrophilic Radical Nucleophilic 
  
 
XO− X• X− 
Haem-dependent 
haloperoxidases 
Non-haem iron/2-oxoglutarate 
dependent halogenases 
SAM fluorinase 
Vanadate-dependent 
haloperoxidases 
 SAM chlorinase 
Flavin-dependent 
halogenases 
 SAM-dependent halide 
methyl transferase 
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The first type catalyzes electrophilic halogenations by oxidation of a halide anion to an 
electrophilic halonium species “X+”. This gets then transferred to a nucleophilic system, such as 
an alkene or an aromatic compound. The three halogenases use different ways to oxidize X− to 
hypohalous acid HOX or hypo halite XO−, respectively. While the haem- and vanadium-
dependent haloperoxidases (HPO) require H2O2 in combination with a metal co-factor, the 
flavin-dependent halogenases use O2 in the form of a hydroperoxyflavin (FADHOOH) 
intermediate. This is activated by the flavin co-factor FAD (flavin adenine dinucleotide).62 The 
overall stoichiometry of halogenations via haloperoxidases and flavin-dependent halogenases is 
depicted in Scheme 5, equation 1 and 2.63 
A well-known member of the haloperoxidases is the chloroperoxidase (CPO), first isolated as 
haem-dependent CPO in 1966 from the terrestrial fungus Caldariomyces fumago.64 An important 
fact is that the CPO cannot only oxidize Cl−, but also Br− and I− to HOX. In contrast, the 
bromoperoxidase (BPO) utilizes just Br− and I−.63  
 
 
Scheme 5 Overview over the different types of halogenation reactions: (1) electrophilic halogenation via haloperoxidases; (2) electrophilic halogenation via flavin-dependent halogenases; (3) radical halogenation via 2-oxoglutarate (I.50) dependent non-haem iron halogenases; (4) nucleophilic halogenation via SAM-dependent halogenases.  
 
For halogenations in marine environment, especially the vanadium-dependent haloperoxidases 
(V-HPO) are thought to be responsible. A vanadate ion is thereby ligated to a histidine residue 
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of a protein to keep the co-factor trapped in the active site of the enzyme. A proposed catalytic 
cycle for the reaction is depicted in Scheme 6. The resting state of vanadium complex I gets 
activated by H2O2 to generate V(V) peroxide complex II. This complex is then able to oxidize a 
halide ion to a vanadium bound hypohalous acid III. Probably, this active halogenation species 
stays at least in close proximity to the enzyme, since V-HPOs have shown to be more selective 
than Fe-HPOs. In contrast to the heme-dependent HPOs, the oxidation state of the metal 
center stays constant.28,62,63,65 However it has to be noted, that the depicted catalytic cycle is 
speculative, for which reason the protonated state of the complexes is not shown.  
 
 
Scheme 6 Proposed catalytic cycle of a vanadium-dependent haloperoxidases (V-HPO). 
 
The halogenation of inactivated carbon centers proceeds by a radical rebound mechanism. 
Thereby, an Fe(IV) oxido species is generated via binding of O2 to the Fe(II) center followed by 
oxidative decarboxylation of Ư-ketoglutarate to succinate (Scheme 5, equation 3).62,63,65  
Organofluorine compounds are very rare in nature. This observation can be explained by the 
fact that neither H2O2 nor O2 are able to oxidize F− to either F• or F+, as a reason of the high 
reduction potential of fluorine.63 Thus, the halogenases, working best for chlorine, bromine and 
iodine are not able to catalyze fluorinations. The only possibility is to use the nucleophilic F− 
directly as the halogenating agent, but the naked F− is very difficult to generate in aqueous 
media. The only reported enzyme to catalyze a fluorination is FlA (5’-fluoro-5’-
deoxyadenosinesynthase) and also accepts Cl−. SAM (S-adenosyl-L-methionine, I.52) is not a co-
factor in these reactions, but functions as a substrate, unlike to the SAM-dependent halide 
methyl transferases. The formation of the C-F bond proceeds via an SN2-type reaction of F− to 
SAM (I.52), which contains the very good leaving group methionine (Figure 11).62,65 A similar 
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transformation is also known for the SAM chlorinase SalL and the product of both halogenation 
reactions is the corresponding halogenated adenosine derivative. 5’-chloro-5’-deoxyadenosine is 
physiologically used to generate chloroethylmalonyl-CoA, which is then incorporated into 
salinosporamide A (I.44).63 The large amounts of halogenated methanes CH3X (X = Cl, Br, I) 
are produced by SAM-dependent halide methyl transferases, via a nucleophilic attack at the 
methyl group instead of the adenosine part (Figure 11).62  
 
 
Figure 11 Halogenase catalyzed nucleophilic attack on SAM.  
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2 Results and Discussion 
 
In 2013, G. König and co-workers reported on the isolation of the unique structure of the 
natural product salimabromide (I.6) (Figure 12) from a mud sample from the coast of the 
German island Prerow. It turned out to be a novel secondary metabolite of the genome strain 
SWB007 of the obligatory marine myxobacterium Enhygromyxa salina. Due to the fact that only 
minor amounts of the natural product are produced (8 µg L−1) and out of 64 L culture just 
0.5 mg of I.6 could be isolated, only a few tests of its biological activity were performed. 
However, an inhibitory activity against Arthrobacter crystallopoietes (MIC value of 16 µg mL−1) was 
observed.25,24 
 
 
Figure 12 Structure of salimabromide (I.6). 
 
The authors of the isolation paper also suggest that the biosynthesis of salimabromide (I.6) is in 
principle carried out by a polyketide synthase (PKS) III cluster adjacent to at least one 
halogenase. Halogenated metabolites from marine myxobacteria are in general very rare and the 
same holds for pure PKS-derived compounds, which makes the structure of the new natural 
product even more interesting. I.6 consists of an unrivaled tetracyclic core structure, containing 
a dibrominated tetraline subunit and a Ʊ-butyrolactone moiety, which are bridged by a 
cycloheptenone. Moreover, the structure consists of four consecutive stereogenic centers of 
which one is an all carbon quaternary center. Adjacent to this, another all carbon quaternary 
center is positioned. The ethyl side-chain of the benzene ring is rarely found in natural products. 
The structure determination was carried out by extensive NMR analysis and via comparison of 
the experimental and the calculated circular-dichroism (CD) spectroscopic data.1,2 The predicted 
structure was validated in 2017 by Kutateladze, who published studies on “parametric 
corrections to DFT-computed 13C NMR chemical shifts and spin−spin coupling constants”66 
which allow a fast comparison of measured and predicted NMR data.  
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Due to its fascinating new structure and its low natural abundance salimabromide (I.6) 
represents an attractive target for total synthesis. So far, only one toward synthesis was 
published. Menche and Schmalzbauer reported in 2015 the synthesis of the tricyclic core I.55 of 
salimabromide (I.6) in 22 steps (longest linear sequence). Their idea was to synthesize an eight 
membered lactone ring, which should be used to build the Ʊ-lactone and the cycloheptenone 
subsequently (Scheme 7). To generate the eight membered lactone ring I.55, they applied a site-
selective carbonylative lactonization, which surprisingly did not affect the bromine substituents, 
but proceeded in only 31% yield. The side-chain of I.56 was introduced by an aldol reaction and 
the tetraline core was closed by an endo-selective iodocyclization. The chiral quaternary center of 
I.57 was set by an asymmetric Denmark crotylation in 85% yield and 95% ee. The two 
precursors I.58 and I.59 for the synthesis were prepared in five and four steps, respectively.67 
 
 
Scheme 7 Retrosynthetic analysis of salimabromide (I.6) by Menche and Schmalzbauer.  
 
2.1 First Generation Approach 
The aim of this thesis was the development of a total synthesis of salimabromide (I.6) to 
provide some material for detailed biological testings. The retrosynthetic planning hinged on the 
idea to build up the tetraline core by our previously developed fragmentation methodology. This 
provides highly substituted 1-naphthols I.61, which can be further functionalized (Scheme 8).68 
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Scheme 8 Electrocyclic ring-opening and 1,2-chloride migration. 
 
The detailed retrosynthesis of I.6 is depicted in Scheme 9 and started with a double bromination 
of the aromatic ring, followed by an aldol condensation of the ozonolysis product I.64 (Scheme 
9). The furano lactone I.65 was envisaged to be formed by an allylic C‒H activation using the 
methodology developed by C. White.69,70 The double bond of the allyl group at the quaternary 
center should be isomerized71 and the second allylic side chain should be introduced via a 
Michael addition. Precursor I.67 is envisioned to be formed by a dearomatization reaction72 of 
the corresponding naphthol I.68. This would generate a tetralone derivative, which could be 
transformed into the second quaternary center by a gem-dimethylation. Naphthol I.68 was 
expected to be accessible by the fragmentation of I.69.68 
Starting from 5-bromo-1-indanone (I.70), the first steps were the formation of ư-keto ester 
I.71,73 followed by an alkylation74 and a Krapcho decarboxylation75 under strongly acidic 
conditions (Scheme 10). Subsequent bromination with CuBr276 and elimination with DBU77 
afforded indenone I.75, which was cyclopropanated with methyl dichloroacetate (MDA).78 At 
this stage, the first purification by column chromatography was required to afford the 
cyclopropanated indenone I.76 in 50% yield over six steps. The ensuing fragmentation reaction 
(sulfolane, 190 °C) afforded naphthol I.77 in very good yield.68 The palladium-catalyzed Negishi 
cross-coupling of I.77 with diethyl zinc was performed on a 30.3 mmol scale and gave naphthol 
I.78 in excellent yield.79 
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Scheme 9 Retrosynthesis of salimabromide (I.6). 
 
 
 
Scheme 10 Synthesis of chlorinated naphthol I.78. 
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In parallel, we investigated the synthesis of the non-halogenated naphthol I.68 (Scheme 11). The 
beginning of the synthesis was the same as outlined for the halogenated naphthol I.78, but the 
reagent for the cyclopropanation was dimethylsulfonium bromide I.79 this time.80 With this, the 
cyclopropanated product I.80 was obtained in 43% yield over three steps. The fragmentation of 
this substrate turned out to be challenging, since no reaction was observed at 190 °C (Table 3, 
entry 1). The use of neat I.80 or the addition of allyl acohol or allyl amine had no effect on the 
reaction and only starting material was recovered (entries 2–4).81 Running the reaction at 320 °C 
provided the product in very good yield. While the use of a sand-bath to reach such high 
temperatures was quite difficult (entry 6), the handling of a “Luftbad” 82 was very convenient 
(entry 7). Subsequent Negishi cross-coupling afforded the final naphthol I.68.  
 
 
Scheme 11 Synthesis of naphthol I.68. 
 
The ensuing task was to dearomatize the phenolic ring of the naphthol. Our first idea to achieve 
this was to oxidize the naphthols to the 1,4-naphthoquinones and introduce then an allyl or 
vinyl side chain by 1,4-addition. The first step, the oxidation of substrate I.68 with PIFA and 
FeCl3, is depicted in Scheme 12 and gave the corresponding naphthoquinone I.82 in 57% 
yield.83 
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Table 3 Screening of conditions for the fragmentation reaction of I.80.  
 
entry conditions  result  
1 190 °C, sulfolane  no reaction  
2 190 °C, neat  no reaction 
3 110–130 °C, allyl alcohol  no reaction 
4 110–130 °C, diallylamine  no reaction 
5 170 °C, microwave  no reaction 
6 250– >400 °C, sand-bath  I.81, but: 
• temperature difficult to 
control 
• > 400 °C: decomposition 
• poor heat distribution → 
upscale not possible 
7 320 °C, Luftbad I.81 (85%) 
 
 
 
Scheme 12 Oxidation of I.68 to the naphthoquinone I.82. 
 
With I.82 in hands, several 1,4-alkylation reagents and conditions were screened (Table 4), but 
unfortunately, only decomposition and unidentifiable byproducts were observed (entries 1–
5).84,85,86 
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Table 4 Attempted alkylation. 
 
entry reagent conditions result 
1  Sc(OTf)3, (CH2Cl)2, 50 °C,  decomposition 
2  Et2O, 0 °C, 2 h decomposition 
3  CuI, Et2O, −30 °C, 2 h decomposition 
4  TBAF, HMPA, DMF, 23 °C, 30 min 
decomposition 
5  TiCl4, CH2Cl2, −30 °C, 2 h I.82 and unidentifiable byproducts 
 
Since the para-quinone approach turned out to be unsuccessful, a different strategy was 
elaborated. This time, we planned to dearomatize the 1-naphthols by generating the quaternary 
center at the C2-position. To implement this, we went for the ortho-Claisen rearrangements of 
allyl naphthol ethers. We decided to use the chlorinated naphthol I.78 for this reaction, since the 
substituent at the para-position should prevent or at least hinder a subsequent Cope 
rearrangement after the Claisen rearrangement. The allyl ether I.88 for this reaction was 
synthesized by the reaction of 1.78 with allyl bromide and potassium carbonate in 78% yield 
(Scheme 13). 
 
 
Scheme 13 Synthesis of allyl naphthyl ether I.88.  
 
With allyl naphthyl ether I.88 in hands, different conditions were screened for the ortho-Claisen 
rearrangement (Table 5). The reactions were carried out either in sulfolane, mesitylene or neat 
and at 190 or 120 °C, respectively (entries 1–5). The obtained products for all reactions were 
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identified as I.90 and I.91. The para allylated naphthol I.90 must be generated via a tandem 
Claisen-Cope rearrangement, whereupon the chloride must have been eliminated. An 
explanation for this result was found during the analysis of the other product, the tricyclic 
lactone I.91. We propose that its formation is initiated by a thermal Claisen rearrangement 
(Scheme 14), whereupon the molecule undergoes a Cope rearrangement to unstable chloride 
I.92. Hydrogen chloride elimination forms para-quinone methide I.93, which is attacked by the 
adjacent ester to form the lactone moiety.68 Via this unanticipated cascade reaction three of the 
four rings of the final natural product were formed correctly and the only missing cycle was the 
one of the cycloheptenone. Thus, we tried to optimize the reaction in such a manner that the 
lactone formation is favored; however, the best obtained yield of I.91 was only 31% (entry 6). In 
addition, the observation of both products I.90 and I.91 indicate that the chloride at the 
p-position has no effect on the equilibrium of the tandem Claisen-Cope reaction.  
 
Table 5 Various conditions for the envisioned ortho-Claisen rearrangement. 
 
entry conditions result 
1 sulfolane, 120 °C I.90 and I.91 
2 sulfolane, 190 °C I.90 (10%) and I.91 (18%) 
3 mesitylene, 120 °C I.90 
4 neat, 120 °C I.90 and I.91 
5 neat, 190 °C, 5 min I.90 (25%) and I.91 
6 neat, 190 °C, 2 h I.91 (31%) 
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Scheme 14 Proposed mechanism for the formation of lactone I.91. 
 
We turned therefore one more time to a different dearomatization approach and investigated a 
procedure, published by Wang et al. in 2015. Although, they only reported this methodology for 
2-naphthols, we decided to also test it on 1-naphthol I.68 (Scheme 15).87 It was reported that the 
Z/E ratio strongly depends on the quality of the Bu2Mg solution. Older Bu2Mg solutions 
lowered the Z/E ratio of the product, but had no influence on the obtained ee values. Since the 
Z/E ratio is inconsequential for our substrate we did not care about the age of the Bu2Mg 
solution. Nevertheless, the envisaged product I.96 could not be observed.  
 
 
Scheme 15 Attempted intermolecular dearomatization of 1-naphthol I.68. 
 
Our following idea was then to test an intermolecular dearomatization following a procedure of 
You from 2013.72 He reported the use of cinnamyl carbonate I.9788 in combination with DBU, a 
Pd(II) source and chiral Trost ligand (S,S)-L1 for the enantioselective dearomatization of 
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2-naphthols. Subjecting our 1-naphthol I.68 to these conditions gave only traces of the 
envisioned product I.98.  
 
 
Scheme 16 Attempted asymmetric dearomatization via decarboxylative allylation. 
 
Another idea to dearomatize our 1-naphthols was to perform a catalytic asymmetric 
dearomatization (CADA) reaction, according to the intramolecular decarboxylative Tsuji 
allylations.89,90,91,92,93 The allyl carbonates I.99, I.100 and I.102 were prepared with allyl 
chloroformate in excellent yields (Scheme 17A and B). At this point, we also decided to simplify 
the synthesis of the non-halogenated naphthol by simple dehalogenation of chlorinated 
naphthol I.78.  
 
 
Scheme 17 Synthesis of the dearomatization precursors I.199, I.100 and I.102. 
 
With these substrates in hand, various conditions for the CADA reaction were screened. We 
started with the non-halogenated substrate I.102 and a selection of the tested conditions is 
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reported in Table 6. We were pleased to obtain the dearomatized product I.89 in over 80% yield 
(entry 1). Unfortunately, this result could not be obtained on larger scale (entry 2). Both 
reactions were stirred at 23 °C previously to heating to 45 °C, since we initially thought that this 
would give slightly better results. Switching the solvent from THF to toluene afforded the 
product in 66% yield (entry 3). Next, the solvent was changed back to THF, but this time, the 
whole reaction mixture was degassed right after the addition of all components (entries 4–6). 
The measure was taken to remove the generated CO2 from the reaction mixture and to assure 
that the CO2 did not influence the reaction in any way. Monitoring the reaction by TLC showed 
that the decarboxylation of the carbonate I.102 occurred rapidly. The first new spot on TLC 
turned out to be O-allylated naphthol I.103, which was also observed as a side-product for all 
reactions. This could be the explanation for the slightly better yields when the reaction mixture 
was previously stirred at 23 °C for 5 min compared to the results of directly heating to elevated 
temperatures. However, all the listed results were inconsistent and sometimes not reproducible. 
 
Table 6 Screening of conditions for the dearomatization of I.102. 
 
entry solvent T / t comment yield 
1 THF 23 °C / 5 min 
45 °C / 2.5 h 
0.0305 mmol 82% 
2 THF 23 °C / 5 min 
45 °C / 18 h 
0.152 mmol 37% 
3 toluene 23 °C / 5 min 
45 °C / 2.5 h 
- 66% 
4 THF 45 °C / 2 h degassed reaction mixture 50%[a] 
5 THF 45 °C / 40 min degassed reaction mixture 87%[a] 
6 THF 23 °C / 45 min 
45 °C / 15 min 
degassed reaction mixture 58%[a] 
[a] determined by 1H NMR (CDCl3, 400 MHz; mesitylene as internal standard). 
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During parallel studies to investigate this intramolecular Pd-catalyzed dearomatization reaction 
of 1-naphthols further as a general methodology (for further information see Chapter II), a 
1H NMR experiment was undertaken. This clearly revealed that the decarboxylation occurred 
rapidly and that the first generated product is the allyl naphthyl ether, which then undergoes a 
Pd-catalyzed rearrangement toward the dearomatized product.94  
Based on these results, we decided to directly synthesize allyl ether I.103 by allylation of 
naphthol I.101 (Scheme 18). Treatment of I.103 with Pd(PPh3)4 in THF gave - as anticipated - 
the dearomatized product I.104 in 77% yield. This time, the reaction was fully reproducible, 
even on larger scale.  
 
 
Scheme 18 Dearomatization of naphthol I.101. 
 
In parallel to the screening for the dearomatization of I.101 (Table 6), an extensive screening 
was performed for the chlorinated substrate I.100 as well. The final outcome was that the best 
yield for this transformation was achieved in a mixture of toluene and n-hexane in a ratio of 9 : 1 
(Scheme 19). 
 
 
Scheme 19 Dearomatization of I.100.  
 
With the third substrate, the non-halogenated ethyl ester I.99, the dearomatized product I.105 
was received in 69% yield with Pd(PPh3)4 in THF at 45 °C (Table 8, entry 1). The next aim was 
to perform the reaction in an asymmetric fashion. For this purpose and in accordance with the 
literature, we changed the source of palladium to Pd2(dba)3, the solvent to toluene and the 
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reaction temperature to 23 °C. We started the screening of the most common ligands for this 
reaction, which are the (S,S)-DACH-Phenyl Trost ligand (S,S)-L1, the (S)-t-Bu-PHOX ligand 
(S)-L2 and the (S,S)-ANDEN-Phenyl Trost ligand (S,S)-L3 (Scheme 20).95,96,97,98,169  
 
 
Scheme 20 Chiral ligands (S,S)-L1, (S)-L2 and (S,S)-L3. 
 
The best result was observed with (S,S)-L1, affording I.105 (32%) with 56% reisolated 
1-naphthol I.68 (entry 2). The other two ligands gave I.105 in 17% and 25% yield and each time 
over 50% yield of the O-allylated product I.106. Due to the relatively low yields of the 
enantioselective reactions in comparison with the racemic one, we decided to carry on with the 
racemic dearomatization. 
 
Table 7 Screening of conditions for the CADA reaction of allyl carbonate I.99. 
 
entry Pd source ligand solvent T [°C] / t [h] result[a] 
1 Pd(PPh3)4 
(10 mol%) 
- THF (0.03 M) 45 / 3 I.105 (69%)[b],[c] 
2 Pd2(dba)3 
(5 mol%) 
(S,S)-L1 
(10 mol%) 
toluene (0.03 M) 23 / 17.5 I.105 (32%)  
I.68 (56%) 
3 Pd2(dba)3 
(5 mol%) 
(S)-L2 
(10 mol%) 
toluene (0.03 M) 23 / 8.5 I.105 (17%) 
I.106 (52%) 
4 Pd2(dba)3 
(5 mol%) 
(S,S)-L3 
(10 mol%) 
toluene (0.03 M) 23 / 17 I.105 (25%) 
I.106 (50%) 
[a] determined by 1H NMR (CDCl3, 400 MHz; mesitylene as internal standard.; [b] isolated yield; [c] the reaction was carried out on a 0.266 mmol scale. 
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We then turned our attention to the advanced tricyclic lactone I.91 and tested the previously 
established conditions for the dearomatization of this substrate. The first step was again the 
formation of the allyl carbonate with allyl chloroformate to afford I.107 in 80% yield. 
Crystallization from dichloromethane afforded suitable crystals for X-ray crystallography. 
 
 
Scheme 21 Synthesis and crystal structure of carbonate I.107. 
 
We then started to screen for the optimal conditions for the allylic dearomatization of I.107. 
The first reaction with the elaborated conditions of Table 6 resulted in the formation of only 
14% yield of I.108a+b (entry 1). With different ratios of toluene and n-hexane the product was 
obtained as a mixture of isomers (entries 2–4), which were separated by flash column 
chromatography. However, it was not possible to determine the relative stereochemistry of the 
two diastereomers by NMR spectroscopy and suitable crystals for X-ray crystallography were 
not obtained. In entry 5, the substrate I.107 was added dropwise to a solution of Pd(PPh3)4 in 
toluene/n-hexane, but the observed product I.108 contained an isomerized vinyl group. In 
entries 6 and 7, the reaction mixtures were stirred first at 23 °C for a few minutes before they 
were heated to 45 °C. The same procedure was described previously for Table 6. The intention 
was to quantitatively form the allyl ether and then dearomatize it upon heating. The results 
seemed promising, since the product was obtained in 69% yield (combined yield of both 
isomers) also on larger scale (entry 8). Entries 9 and 10 were test reactions, which showed that 
the allyl ether is formed quantitatively at 23 °C.  
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Table 8 Screening of conditions for the CADA reaction of allyl carbonate I.107. 
 
entry solvent 1 solvent 2 T [°C] / t comment result[a] 
1 THF (0.028 M) - 45 / 6 h  I.108a+b 
(14%)  
+ allyl ether 
2 toluene (0.038 M) n-hexane (0.9 M) 45 / 15 min  I.108a (18%) 
I.108b (27%) 
3 toluene (0.038 M) n-hexane (0.38 M) 45 / 15 min 0.0284 mmol I.108a (32%) 
I.108b (43%) 
4 toluene (0.038 M) n-hexane (0.38 M) 45 / 10 min 0.0851 mmol I.108a (23%) 
I.108b (31%) 
5[b] toluene (0.038 M) n-hexane (0.38 M) 45 / 10 min  I.109 
6 toluene (0.038 M) n-hexane (0.38 M) 23 / 7 min  
45 / 10 min 
0.0851 mmol I.108a (28%) 
I.108b (37%) 
7 toluene (0.038 M) n-hexane (0.38 M) 23 / 4 min 
45 / 10 min 
0.255 mmol I.108a (20%) 
I.108b (43%) 
8 toluene (0.038 M) n-hexane (0.38 M) 23 / 4 min 
45 / 45 min 
0.284 mmol I.108a+b 
(69%) 
9 THF (0.028 M) - 23 / 6 h  allyl ether 
10 toluene (0.028 M) - 23 / 6 h  allyl ether 
[a] Yields were determined from crude 1H NMR; [b] Different addition mode: Pd(PPh3)4 was solved in toluene/n-hexane and warmed to 45 °C. The substrate was solved in toluene and added dropwise to the Pd(PPh3)4 solution.  
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The ensuing step was to selectively reduce the styrene subunit of I.108 in the presence of the 
allylic and the vinylic alkene. The intention of this was to bring both terminal double bonds in 
close proximity in order to facilitate a ring-closing metathesis (RCM), which would generate the 
fourth cycle. For the reduction of the tetrasubstituted unsaturated lactone moiety several 
conditions were screened (Table 9). Unfortunately, all attempts for selective 1,4-reduction either 
migrated the vinyl group to give the conjugated product I.109 (entries 1 and 4) or reduced the 
ketone to the corresponding secondary, benzylic alcohol (entry 3).99,100,101 With CuCl and NaBH4 
in diethyl ether, no reaction took place (entry 2).102 
 
Table 9 Screening of conditions for the 1,4-reduction of lactone I.108. 
 
entry metal salt reducing agent solvent T [°C] result 
1 CoCl2•6H2O NaBH4 MeOH 23 decomposition and 
traces of I.109 
2 CuCl NaBH4 Et2O –78 no reaction 
3 CuCl NaBH4 MeOH/THF 7:4 0 ketone was reduced to 
the alcohol 
4 - Mg MeOH 23 I.109 
 
We then changed back to our dearomatized naphthols and continued with the migration of the 
exo-double bond (Table 10). A wide variety of catalysts in combination with several ligands and 
additives were tested at different temperatures. Using the conditions shown in entries 4 and 6,103 
Ư-tetralone I.111 could be isolated as a mixture of double bond isomers in good yield. 
Unfortunately, these results could not be reproduced on larger scale (entries 5 and 7). Next, a 
methodology from the Nishida group was tested where they use Grubbs II in combination with 
vinyloxy-trimethylsilane as catalyst (entry 11).104 With this, the E-isomer of I.111 was afforded in 
75% yield, but at least 20 mol% of the catalyst were required. Since these conditions are not 
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practical on large scale, another migration reaction, developed by Skrydstrup, was elaborated.105 
This methodology reports the use of Pd(dba)2, P(t-Bu)3 and isobutyryl chloride in a ratio of 1:1:1 
to migrate or isomerize double bonds. By using these conditions, product I.111 could be isolated 
in 79% yield together with remaining traces of the starting material I.89 (entry 13).  
 
Table 10 Screening of conditions for the migration of exo-double bond of I.89. 
 
entry conditions T / t comment result 
1 PdCl2(CH3CN)2 (30 mol%), 
benzene 
60 / 22.5 h - I.89 
2 PdCl2(CH3CN)2 (10 mol%), CH2Cl2 45 / 19 h - I.89 
3 RhCl3∙xH2O, EtOH 70 / 6 h - decomposition 
4 [Pd(allyl)Cl]2 (5 mol%), P(o-tol)3 
(10 mol%), AgOTf, CH2Cl2 
23 / 21.5 h 0.0157 mmol I.111 (92%); 
d.r. = 5.6 : 1[a] 
5 [Pd(allyl)Cl]2 (5 mol%), P(o-tol)3 
(10 mol%), AgOTf, CH2Cl2 
23 / 15.5 h 0.0627 mmol I.111 : I.89 = 0.67 : 1 
6 [Pd(allyl)Cl]2 (10 mol%), P(o-tol)3 
(20 mol%), AgOTf, CH2Cl2 
23 / 15.5 h 0.0627 mmol I.111 (80%); 
d.r. = 7.8 : 1[a] 
7 [Pd(allyl)Cl]2 (10 mol%), P(o-tol)3 
(20 mol%), AgOTf, CH2Cl2 
23 / 18 h 0.188 mmol I.89 and traces of 
I.111 
8 KHMDS, THF 23 / 5 min - I.89 and 
decomposition 
9 Grubbs II (10 mol%), MeOH 60 / 23 h - I.89 
10 Grubbs II (10 mol%), 50 / 4.5 h - traces of I.111 
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vinyloxyTMS, toluene 
11 Grubbs II (20 mol%), 
vinyloxyTMS, toluene 
100 / 28 h - I.111 (75%); 
d.r. > 99 : 1[a] 
12 Pd(dba)2 (5 mol%), P(t-Bu)3 
(5 mol%), isobutyryl chloride 
(5 mol%), toluene 
80 / 37 h - I.111 (72%); 
d.r. > 99 : 1;[a] 
remaining I.89 
13 Pd(dba)2 (10 mol%), P(t-Bu)3 
(10 mol%), isobutyryl chloride 
(10 mol%), toluene 
80 / 39 h - I.111 (79%); 
d.r. > 99 : 1;[a] 
remaining I.89 
14 Pd(dba)2 (10 mol%), P(t-Bu)3 
(10 mol%), isobutyryl chloride 
(10 mol%), toluene 
80 / 41 h 1.96 mmol I.111 (84%); 
d.r. > 99 : 1;[a] 
remaining I.89 
[a] d.r. (E/Z) determined by 1H NMR spectroscopy. 
 
Having successfully isomerized the allylic double bond, we concentrated on the introduction of 
the 2-methylallyl group at the C4-position. The idea was to couple the chloride of I.111 via a 
Suzuki-Miyaura cross-coupling with boronic ester I.112, which was prepared according to a 
procedure of Singaram and co-workers.106 In Scheme 22, the screening conditions for the 
coupling are depicted. It was possible to obtain the allylated product I.113 under all reaction 
conditions tested, but unfortunately, the product was co-polar with the starting material I.111 
and thus made the separation and isolation of pure I.113 impossible. In addition, we were not 
able to obtain full conversion of the starting material.  
 
 
Scheme 22 Suzuki-Miyaura cross-coupling to introduce the 2-methylallyl group. 
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An alternative reaction was the Suzuki-Miyaura cross-coupling of I.111 with the commercially 
available allyl boronic acid pinacol ester (Scheme 23). Starting material I.111 and product I.114 
were again co-polar, but after a detailed screen of reaction conditions full conversion of the 
starting material could be achieved. The coupling product I.114 could be isolated in pure form 
and very good yield. This substrate was then selectively oxidized by a Wacker oxidation to 
provide I.115 in 48% yield. Next, the formation of lactone I.117 was investigated. The first 
attempt was a direct Ư-hydroxylation, using LHMDS, O2 and P(OEt)3,107 to obtain the 
thermodynamic product I.116 or the already cyclized lactone I.117, but this failed and only 
decomposition was observed.  
 
 
Scheme 23 Suzuki-Miyaura cross-coupling of I.111, followed by Wacker oxidation and attempted Ư-hydroxylation.  
 
For a stepwise Ư-hydroxylation, the formation TMS enol ether I.118, followed by a Rubottom 
oxidation was envisaged, however even attempts to prepare the TBS enol ether I.119 failed 
under these conditions (Scheme 24).  
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Scheme 24 Attempted stepwise Ư-hydroxylation.  
 
Next, we focused on the formation of the aldehyde moiety. Therefore, the vinyl group of ketone 
I.111 should be dihydroxlated first and then cleaved to yield the corresponding aldehyde I.121. 
Unfortunately, under the shown conditions either no reaction or decomposition occurred (Table 
11).71,108,109 Reasons for the decomposition might be unselective dihydroxylation of both 
alkenes, or a retro-aldol reaction due to the presence of the ketone moiety in ư-position to the 
envisioned aldehyde. Lactonization reactions with the ester group are possible as well.  
 
Table 11 Screening of conditions for the formation of diol I.120 and aldehyde I.121. 
 
entry conditions solvent result 
1 OsO4, K3[Fe(CN)6], K2CO3, DABCO t-BuOH/H2O I.111 
2 OsO4, NMO, DABCO ethylene glycol/H2O decomposition 
3 1) K2[OsO2(OH)4], NMO 
2) NaIO4 
1) H2O/acetone  
2) THF/H2O 
decomposition 
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Another approach to obtain the aldehyde was the ozonolysis of the vinyl group (Scheme 25). 
However, the ozonolysis of I.111 resulted in the formation of naphthol I.78 by a retro-aldol 
reaction, mentioned also for Table 11. To avoid this problem, the ketone was converted to 
tertiary alcohol I.122 and used in another unsuccessful attempt to obtain the aldehyde via 
ozonolysis, but only decomposition was observed.  
At this point, we realized that the ketone moiety vicinal to the quaternary center is the reason 
for many of the side-reactions. Therefore, we decided to introduce the gem-dimethyl group at 
this position first and then investigate the the aldol condensation again. 
 
 
Scheme 25 Ozonolysis of ketone I.111 and tertiary alcohol I.122. 
 
We started our investigations for the conversion of the ketone into a gem-dimethyl group with 
the exhaustive methylation established by Reetz.110 Since previous experiments with this 
methodology were unsuccessful due to the sensibility of the Reetz reagent, the methodology was 
optimized with the literature known test substrate - indanone I.124 (Table 12). During this 
screening we realized that the Reetz reagent is prepared best at 0 °C111 instead of –30 °C and 
that it is slightly sensitive to light. With this in mind a complete conversion of I.124 to I.125 
could be observed (entry 4). 
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Table 12 Screening of conditions for the exhaustive methylation of indanone I.124 as reported by Reetz. 
 
entry reagents T [°C] scale 
[mmol] 
result[a] 
1 TiCl4[b] (2.2 equiv), Me2Zn (2.2 
equiv) 
–30 to 
0 
0.378 I.124 
2 TiCl4[c] (6 equiv), Me2Zn (6 equiv) –30 to 
0 
0.757 ratio I.124 : I.125 = 
3.3 : 1  
3 TiCl4 (6 equiv), Me2Zn (6 equiv) 0 to 23 0.757 ratio I.124 : I.125 = 
0.8 : 1 
4 TiCl4 (6 equiv), Me2Zn (6 equiv) 0 to 23 0.378 I.125 
5 TiCl4 (3 equiv), Me2Zn (6 equiv) 0 to 23 0.378 ratio I.124 : I.125 = 
0.8 : 1 
[a] No yields were measured, since the product I.125 was too volatile. Ratios of starting material to product were determined from crude 1H NMR; [b] Neat TiCl4; [c] 1 M solution of TiCl4 in CH2Cl2.  
 
With the optimized conditions of Table 12 in hands, the direct gem-dimethylation of I.111 was 
performed, but the observed product was identified to be the tricyclic lactone I.127 and not the 
envisioned product I.126. 
 
 
Scheme 26 Attempted exhaustive methylation of ketone I.111. 
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The proposed mechanism for the formation of I.127 is depicted in Scheme 27. The benzylic 
tertiary cation I.129 is trapped by the vicinal methyl group by a [1,2]-shift and the generated 
bis-allylic cation I.130 is in turn trapped by the ester.  
 
Scheme 27 Proposed mechanism for the formation of I.127. 
 
Since Reetz also reported two-step gem-dimethylation reactions starting from tertiary alcohols,110 
we investigated this approach as well (Scheme 28). However, the observed product was again 
the one from the unwanted [1,2]-shift.  
 
 
Scheme 28 Conditions for the methylation of tertiary alcohol I.122. 
 
Another idea was to perform a two-step synthesis for the gem-dimethylation by a procedure of 
Carlier.112 The first step was the formation of tertiary alcohol I.131 (Scheme 29). Afterwards, the 
benzylic alcohol was treated with SOCl2. Carlier and co-workers reported that first a 
chlorosulfite intermediate is generated, which ionizes into a stabilized carbocation/chlorosulfite 
ion pair, which forms subsequently the tertiary chloride under elimination of SO2. Subsequent 
addition of AlMe3 to this crude reaction mixture should then introduce the methyl group. 
However, the only isolated product was the rearomatized Cope rearrangement product I.133 
(Scheme 29A). To prevent this rearrangement, substrate I.122, containing a vinyl instead of an 
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allyl group, was subjected to the same conditions, but only a complex mixture could be observed 
(Scheme 29B).  
 
 
Scheme 29 Attempted stepwise gem-dimethylation of I.131 and I.122 with SOCl2 and AlMe3.  
Inspired by the idea of generating the tertiary chloride as intermediate, we next tried to isolate 
such a halide (Table 13). Unfortunately, only decomposition or the formation of a complex 
mixture could be observed with SOCl2 as reagent (entries 1–3).112 Using MgBr2∙Et2O and TBAB, 
only afforded alkene I.136 (entry 4).113  
 
Table 13 Screening of conditions to convert tertiary alcohol I.122 into tertiary halide I.134 or I.135. 
 
entry reagents solvent result 
1 SOCl2, pyridine CH2Cl2 complex mixture 
2 SOCl2, pyridine - decomposition 
3 SOCl2 - complex mixture 
4 MgBr2·Et2O, TBAB CH2Cl2 I.136  
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Another approach was to form a cyclopropane ring at the position of the ketone, which could 
then be reduced to the gem-dimethyl group. The formation of the alkene I.136 by a Wittig 
olefination was the first step and gave the product in very good yield (Table 14). With this 
alkene, various conditions for the ensuing Simmons-Smith cyclopropanation were screened. 
However, this reaction turned out to be very challenging. With (ClCH2)2Zn, prepared from 
Et2Zn and CH2ICl, no reaction took place at all (entry 1).114,115 Using Et2Zn/CH2I2 instead did 
not change the reaction outcome, even when a large excess of reagents was used (entries 2–4). 
In a publication from 2003, Shi and co-workers report the in situ formation of a 
CF3CO2ZnCH2I complex, which is part of a class of tunable zinc reagents. However, no 
conversion could be observed with this reagent either (entries 5 and 6).116 Another idea was to 
subject the reaction mixture to ultra high pressure (14 kbar), but this was again not successful 
(entry 7). Subsequently, we changed from Et2Zn to Zn/Cu and Zn/Ag couple117,118 (entries 8–
12). However, this time only the starting material and a complex mixture were isolated.  
 
Table 14 Screening of conditions for the Simmons-Smith cyclopropanation of I.136. 
 
entry reagents additive solvent / T [°C] t result 
1 Et2Zn (1.2 equiv), 
CH2ICl (2.4 equiv) 
- CH2Cl2 / 0 to 23 4 h I.136 
2 Et2Zn (2 equiv), CH2I2 
(2.1 equiv) 
- CH2Cl2 / 23 8 h I.136 
3 Et2Zn (2.5 equiv), CH2I2 
(5 equiv) 
- 1,2-dichloroethane 
/ 60 
27 h I.136 
4 Et2Zn (15 equiv), CH2I2 
(30 equiv) 
- CH2Cl2 / 23 27 h I.136 
5 Et2Zn (2 equiv), CH2I2 
(2.1 equiv) 
TFA (2.2 equiv) CH2Cl2 / 0 to 23 2 h I.136 
6 Et2Zn (4 equiv), CH2I2 TFA (4 equiv) CH2Cl2 / 23 5 d I.136 
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(4 equiv) 
7 Et2Zn (4 equiv), CH2I2 
(4 equiv) 
TFA (4 equiv) CH2Cl2 / 20; 
14 kbar 
18 h I.136 
8 Zn/Ag (100 equiv), 
CH2I2 (16 equiv) 
- Et2O / 60 25 h I.136 
9 Zn/Ag (100 equiv), 
CH2I2 (16 equiv) 
- Et2O / 60 2 d I.136 + 
complex 
mixture 
10 Zn/Ag (200 equiv), 
CH2I2 (30 equiv) 
- Et2O / 60 2 d complex 
mixture 
11 Zn/Cu (30 equiv), CH2I2 
(30 equiv) 
I2 (cat.) Et2O / 50 4 d I.136 + 
complex 
mixture 
12 Zn/Cu (30 equiv), CH2I2 
(30 equiv) 
- Et2O / 50 4 d I.136 + 
complex 
mixture 
 
Since the Simmons-Smith cyclopropanation reaction did not give any satisfying results, we 
decided to test a gem-dihalocyclopropanation. However, we were not sure, if the obtained 
product was the desired cyclopropane I.138, since clean purification could not be carried out 
(Scheme 30).119 Attempted dehalogenation with the impure material using either Bu3SnH or 
LiAlH4 was not successful. 
 
Scheme 30 Gem-dihalocyclopropanation of I.136 and attempted reduction to cyclopropane I.137. 
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Since all the methods to install the gem-dimethyl group in a more or less direct way failed, we 
envisaged a quite different approach. The ketone functionality of I.111 was transferred into 
aldehyde I.139 by a Kluge-Wittig reaction and subsequent deprotection (Scheme 31).120  
 
 
Scheme 31 Formation of the aldehyde I.137. 
 
The ensuing step was the alkylation at the Ư-position of aldehyde I.139 to form the second 
quaternary center, which should afterwards be converted into the gem-dimethyl group. We 
started the screening with the most commonly used conditions, by treating I.139 with LHMDS 
and MeI afterwards (entry 1). To our surprise, the obtained product turned out to be ketone 
I.111. Changing to t-BuOK or Cs2CO3 gave either ketone I.111 again (entries 2 and 3), just 
starting material I.139 (entry 4), or a complex mixture (entry 5). With NaH and a large excess of 
MeI (entry 7), product I.140 could be isolated the first time, but with relatively large amounts of 
O-alkylated aldehyde I.141 as side product. Lowering the temperature (entry 8) only resulted in 
the formation of the deformylation product I.111 again. A literature survey revealed that similar 
reactions are known with molecular oxygen.121,122 Therefore, the conditions of entry 7 were 
tested again, but this time the reaction mixture containing solvent, substrate and MeI was 
carefully degassed before it was added to NaH (entry 9). Applying these conditions, I.140 was 
isolated in 69% yield without significant byproducts. An idea to improve the reaction even 
further was to use KH instead of NaH (entries 10 and 11), but unfortunately only I.141 was 
observed. 
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Table 15 Screening of conditions for the alkylation of aldehyde I.139. 
 
entry base solvent / T [°C] result 
1 LHMDS THF / −65 to 23 I.111 
2 t-BuOK THF/t-BuOH / −78 to −15 I.111 
3 t-BuOK THF / 0 to 23 I.111 
4 t-BuOK THF/t-BuOH / −78 I.139 
5 Cs2CO3 1,4-dioxane / 23  complex mixture 
6 NaH[a] THF / 0 to 23 I.111 
7 NaH[b] THF / 0 to 23 I.140 (54%), I.141 (22%) 
8 NaH THF / −35 to 23 I.111 
9[c] NaH THF / 0 to 23 I.140 (69%) 
10[c] KH THF / 0 I.141 
11[c] KH THF / 23 I.141 
[a] NaH (2 equiv) and MeI (2 equiv) were used; [b] NaH (2 equiv) and MeI (10 equiv) were used; [c] the reaction mixture of I.139, MeI and solvent was thoroughly degassed by freeze-pump-thaw.  
 
Therefore, we stayed with the conditions of entry 9 and carried on. The next step was the 
conversion of the aldehyde into a methyl group. Our first idea was to perform a Wolff-Kishner 
reduction (Scheme 32), but only decomposition of the starting material I.140 could be 
observed.123 Another idea was to form thioacetal I.142 from aldehyde I.140 and convert this into 
a methyl group by treatment with Raney nickel. However, thioacetal I.142 could never be 
synthesized.124  
 
 
Scheme 32 Attempted Wolff-Kishner reduction and thioacetal formation of I.140. 
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Since both attempts were not successful, aldehyde I.140 was reduced to alcohol I.143 followed 
by separation of both diastereomers by flash column chromatography (Scheme 33). Subsequent 
tosylation afforded I.144, which was treated with excess LiAlH4 at 60 °C, but even after stirring 
for 18 h only starting material I.144 was observed. Not even the ester moiety was reduced by 
these conditions. 
 
 
Scheme 33 Formation of tosylate I.144 and attempted reduction of the primary tosylate. 
 
A different strategy to introduce the gem-dimethyl group was to perform a Peterson olefination 
with ketone I.111, followed by a Simmons-Smith cyclopropanation and subsequent treatment 
with Raney nickel to get I.137. However, the product of the Peterson olefination with sulfide 
I.145125 could not be obtained (Scheme 34). 
 
 
Scheme 34 Attempted Peterson olefination to form alkene I.146. 
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Lastly, a Barton-McCombie deoxygenation was envisaged to remove the neopentylic hydroxyl 
group. Thus, xanthate I.147 was prepared according to a typical procedure and was provided in 
very good yield (Scheme 35). Subjecting it to the deoxygenation conditions afforded however 
only decomposition.  
 
 
Scheme 35 Attempted Barton-McCombie deoxygenation of I.143. 
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2.2 Second Generation Approach 
2.2.1 Synthesis of a Common Precursor for the Aldol Condensation Approach and the 
[2+2] Cycloaddition Approach 
Since the synthesis of the intermediates I.89 and I.104 was getting more and more unlikely, due 
to serious problems with the introduction of the second quaternary center, the gem-dimethyl 
group, we decided to explore a completely new synthetic approach to reach the core structure. A 
short retrosynthetic analysis is depicted in Scheme 36. The plan was to start with the 6-methoxy-
1-tetralone (I.148) and form the intermediate I.149. Based on this, two approaches for the key 
step were intended (Scheme 36): an Aldol condensation – similar to the previously planned key 
step – and a [2+2] cycloaddition. 
 
 
Scheme 36 Cyclization precursors I.150 and I.151 based on intermediate I.149. 
 
The Aldol condensation with I.150 would give the tricyclic substrate I.152, which has the 
cycloheptenone ring right in place (Scheme 37). Subsequent Ư-hydroxylation next to the 
unsaturated ketone would afford alcohol I.153, which should immediately cyclize to the 
Ʊ-butyrolactone moiety.  
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Scheme 37 Aldol condensation approach.   
The envisaged [2+2] cycloaddition approach is depicted in Scheme 38. Starting from neopentylic 
alcohol I.155, we wanted to use the protocol of Brown and Rasik, who reported ketene-alkene 
[2+2] cycloadditions, promoted by Lewis acids, with in situ generated alkenyl ketenes. Those 
alkenyl ketenes are very reactive and tend to undergo [4+2] cycloadditions with itself. Therefore, 
the alkene substrate has to be used in excess.126 A second challenge for this step was that the 
cycloaddition had to occur from the side of the alcohol. To accomplish this, we wanted to use 
the aluminium alkoxide to coordinate to the ketene (I.157) and thus direct the cycloaddition. 
This should be feasible, since the required Lewis acid for the cycloaddition is AlMe3 or a variant 
thereof. After the addition, the cyclobutanon should be transformed into the lactone I.159 by a 
Baeyer-Villiger oxidation.126 Subsequent ozonolysis of alkene mojety of I.159, followed by 
oxidation of the alcohol would lead to I.160, which then cyclizes to I.154 via an intramolecular 
aldol condensation. 
 
 
Scheme 38 [2+2] Cycloaddition approach.  
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The synthesis of the common intermediate I.149 started with the 1,2-addition of MeMgBr to 
I.148, followed by the elimination of the tertiary alcohol under acidic conditions (Scheme 39).127 
Epoxidation and subsequent Meinwald rearrangement128 afforded -tetralone I.162, which was 
alkylated with KH and MeI.129 For this reaction, careful degassing of the solvent together with 
the substrate was mandatory since otherwise Ư-hydroxylation of the benzylic position took 
place. Interestingly, the alkylation did not work at all with NaH as base. A second 1,2-addition 
of MeMgBr to I.163 - activated by lanthanum(III) chloride bis(lithium chloride) complex 
solution (LaCl3·2LiCl)130 - followed by benzylic oxidation131 and elimination132 of the tertiary 
alcohol afforded I.166 in a very good overall yield and also on large scale. It is important to 
mention that without activation of the ketone functionality of I.163 by the Lewis acid LaCl3, the 
yield dropped significantly on larger scale.  
Via the next three steps, the methoxy group was converted into the ethyl group. For this 
purpose, the methoxy group was first deprotected with BBr3 and then converted to the 
triflate.133 A final Negishi cross-coupling79 of the triflate afforded I.169 in 78% yield over three 
steps. The second quaternary center was then introduced by a two-step sequence of 1,2-addition 
of allylmagnesium bromide and subsequent oxy-Cope rearrangement134 to obtain intermediate 
I.170, which was afterwards isomerized by Skrydstrup’s protocol135 to intermediate I.171.  
For practical reasons, the synthesis of both intermediates I.173 and I.174 was shortened by 
removing the three steps to introduce the ethyl side chain. In our opinion, the reactivity of the 
cyclohexanone part of the molecule does not change significantly if the aromatic part is 
substituted by a methoxy group instead of the ethyl side chain. Therefore, we synthesized 
intermediate I.174 (Scheme 40) in the same way as reported for I.171 (vide infra).  
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Scheme 39 Synthesis of intermediate I.149 and the isomerized intermediate I.171.  
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Scheme 40 Synthesis of intermediate I.173 and the isomerized intermediate I.174.  
 
With these four intermediates in hands, the next steps toward the key steps were envisaged. For 
the Aldol condensation approach an ester at the -position of the ketone was required. 
However, the -acylation turned out to be challenging. The first idea was to introduce the ester 
by a direct acylation with dimethyl carbonate (DMC) (Table 16, entries 1–3). Since only starting 
material or decomposition could be observed, methyl chloroformate (entry 4) and the even 
more reactive Mander’s reagent were used (entries 5–7), but again only starting material could be 
isolated. Interestingly, the use of LHMDS as base (entry 5) resulted in the formation of the TMS 
enol ether I.176, which was stable even during purification by column chromatography. With 
Boc-protected imidazole I.177135 as acylating reagent (entry 8) only the starting material could be 
isolated.   
 
Table 16 Screening of conditions for the direct -acylation. 
 
entry substrate base reagent result 
1 I.174 NaH DMC no reaction 
2 I.174 NaH, KH DMC decomposition 
3 I.171 NaH DMC no reaction 
4 I.171 NaH methyl chloroformate no reaction 
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5 I.171 LHMDS Mander’s reagent I.176 
6 I.171 LDA Mander’s reagent no reaction 
7 I.173 LDA, HMPA Mander’s reagent no reaction 
8 I.174 NaH 
 
no reaction 
 
However, the observation of the stable TMS enol ether I.176 brought us to the idea to test a 
Mukajama Aldol reaction with I.173 (Scheme 41), but again no reaction was observed. Due to 
all these negative results, we assumed that the bulkiness of the adjacent quaternary center 
prevents the attack at the electrophiles. We therefore started to focus on smaller electrophiles, 
such as formaldehyde, which could be oxidized afterwards. However, with aqueous 
formaldehyde and Y(OTf)3, no reaction took place.136  
 
 
Scheme 41 Attempted -acylation via Mukajama Aldol reaction. 
 
Thus, the next variant was to trap the deprotonated ketone I.173 directly with the small 
electrophiles MOMBr and benzotriazole-1-methanol (I.182) (Scheme 42). Unfortunately, no 
reaction was observed. Another idea was to purge the reaction mixture with formaldehyde gas 
that was freshly prepared from paraformaldehyde. However, only I.173 together with a complex 
mixture was obtained. 
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Scheme 42 Attempted formation of -hydroxy ketones. 
 
Our last approach to introduce either an ester or a synthetic equivalent thereof was to perform a 
Reformatsky reaction. From former quenching experiments it was known that halogen atoms 
could be introduced at the Ư-position of the ketone. Deprotonation with LHMDS and the use 
of 1,2-dibromotetrachloroethane as halogen source gave the brominated product I.183 in 
quantitative yield (Scheme 43). With I.183 in hands, several conditions for the alkylation were 
tested. For Zn, only the dehalogenated ketone I.173 was isolated and the use of SmI2137 only led 
to a complex mixture.  
At this point, we stopped our acylation efforts. The result of our attempts was that this 
Ư-position is apparently not reactive enough to attack electrophilic carbon atoms, independent 
of their sizes. However, it turned out that this position can easily be deprotonated and trapped 
with bulky halogen atoms in quantitative yield, which is in contrast to all the other observed 
results. Therefore, the lack of reactivity cannot be explained only by the sterics.  
 
 
Scheme 43 Attempted Reformatsky reaction of I.183.  
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Therefore, we changed our strategy and focused on the [2+2]-cycloaddition approach. Starting 
from vinyl ketone I.171, the ozonolysis afforded ketoaldehyde I.186 which was then reduced in 
a second step to diol I.187 (Scheme 44). Unfortunately, we realized later that ketoaldehyde I.186 
was very sensitive toward further oxidation and even started to decompose during the work-up. 
Since we suspected the benzylic ketone to cause the problem, we reduced it to alcohol I.188 and 
tested the ozonolysis again, but this time decomposition occurred.  
 
 
Scheme 44 Ozonolysis of several vinyl substituted tetralins.   
However, with a few milligram of diol I.187 in hands, the elimination of the benzylic alcohol to 
the alkene was performed. In an attempt to dehydrate I.187 using Amberlyst® at ambient 
temperature, we did not isolate the product I.190, but cyclic ether I.191 in good yield (Scheme 
45).  
 
 
Scheme 45 Attempted elimination of the benzylic alcohol.   
Since our initial attempt to generate I.190 failed, we changed our strategy and went a few steps 
back in the synthesis. From our former route toward the intermediates with the two adjacent 
quaternary centers, we knew that we can overcome the steric repulsion of the gem-dimethylgroup 
by an intramolecular electrocyclization. Due to this, we envisaged to use a [2,3]-Wittig-Still 
rearrangement138 to form the alkene moiety and the primary alcohol together in one step. 
56  RESULTS AND DISKUSSION 
 
Starting from enone I.166, the first step was a Luche reduction to provide the very unstable 
benzylic, allylic alcohol (Scheme 46). To avoid elimination, the alcohol was immediately alkylated 
with tin reagent I.192139 to afford I.193, the precursor for the [2,3]-rearrangement. This crude 
mixture was treated subsequently with n-BuLi and the desired product I.194 was obtained in 
48% yield over three steps. The common side-product of the Wittig-Still reaction, the [1,2] 
rearrangement product, was isolated in minor amounts and could be separated by flash column 
chromatography.  
 
 
Scheme 46 [2,3]-Wittig-Still rearrangement.   
With the substrate for the ketene [2+2] cycloaddition in hand, a variety of reaction conditions 
were screened in accordance to the literature (Table 17).126 The two Lewis acids AlMe2Cl and 
AlMe3 were tested as well as different concentrations of the reaction mixture in CH2Cl2, but only 
remaining starting material, traces of the ester of I.194 and I.195 and some kind of polymer 
were obtained. However, the acid chloride I.195 was used in slight excess in contrast to the 
literature of Brown, but studies of Hugelshofer et al. showed that the cycloaddition also works 
with less ketene.140 We thus guessed that our substrate was not reactive enough to undergo the 
cycloaddition and that the ketene therefore reacts with itself to form a dimer.  
 
Table 17 Screening of conditions for the ketene-alkene [2+2] cycloaddition.  
 
entry conditions result 
1 DIPEA, AlMe2Cl, CH2Cl2, −78 to 23 °C I.194 + ester 
2 DIPEA, AlMe3, CH2Cl2 (0.5 M), −78 to 23 °C I.194 + ester 
3 DIPEA, AlMe3, CH2Cl2 (1 M), −78 to 23 °C I.194 + ester 
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Hereupon, we changed to the more reactive ketene precursor trichloroacetyl chloride (I.201). 
With this, the cycloaddition product could be dehalogenated afterwards upon treatment with Zn 
and functionalized in another step.141 However, we were not sure, if the reaction would tolerate 
the use of a Lewis acid to tether the ketene and decided to test the cycloaddition conditions 
without a Lewis acid. To avoid esterification with the acid chloride, the alcohol moiety was also 
protected with several protecting groups (Table 18).  
 
Table 18 Synthesis of protected alcohols.  
 
entry conditions result 
1 TBSCl, im, DMF, 0 to 23 °C 
 
2 MOMCl, DIPEA, DMAP, CH2Cl2, 0 °C 
 
3 MeI, NaH, DMF, 0 to 23 °C 
 
4 Ac2O, Et3N, DMAP, CH2Cl2, 0 °C 
 
 
The reactive species dichloroketene is generated in situ by dehalogenation of I.201 with Zn/Cu 
couple and in order to avoid dimerization it is crucial to run the reaction under high dilution and 
to add the acid chloride very slowly to the zinc mixture.142 With this in mind, the four substrates 
I.197–I.200 were subjected to these conditions, but no conversion of the starting materials was 
observed (Scheme 47).  
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Scheme 47 Attempted [2+2] cycloaddition by in situ generated dichloroketene.  
 
Since the previous results for the generation of the cyclobutanone were all not successful due to 
the low reactivity of the alkene substrate, we changed from the intermolecular [2+2] 
cycloaddition to an intramolecular version. This would have several advantages, since it is 
known that even very unreactive alkenes and ketenes react by an intramolecular cycloaddition to 
form complex polycyclic compounds. Furthermore, we would be able to control the 
stereoselectivity of the newly formed stereocenters. Our plan was thus to synthesize 
(alkenyloxy)acetic acid I.204 and generate then the corresponding acid chloride I.205 (Scheme 
48). Heating this with Et3N would lead to ketene I.206, which should cyclize to the tetracyclic 
product I.207. The regioselectivity of the addition was proposed to be as depicted for I.207, 
because the partial positive charge of the transition state would be stabilized at the benzylic 
position.143 Unfortunately, the synthesis of acetic acid I.204 was not possible and only starting 
material was observed.  
 
 
Scheme 48 Envisaged synthesis of the tetracyclic compound I.207.  
 
CHAPTER I  59 
 
For this reason, we modified the reaction again, to synthesize an alkoxyamide with which an 
intramolecular keteniminium [2+2] cycloaddition could take place. An advantage of this 
modification would be the positive charge of the keteniminium which makes the reagent more 
electrophilic than ketenes and in addition prevents dimerization.144 The amide precursor I.209 
for the key step was prepared in quantitative yield by nucleophilic substitution with 
2-chloroacetamide I.208 (Table 19). Thereupon, several conditions for the cycloaddition were 
screened. Different equivalents of Tf2O and collidine as well as various reaction temperatures 
and times were tested. Another point was to vary the way how the Tf2O and the collidine were 
added to the reaction mixture. The best result with 70% yield of the envisaged tetracyclic 
product I.207 was obtained when Tf2O and collidine were added at 23 °C to the substrate in 
1,2-dichloroethane and the mixture was then heated to 80 °C (entry 10).  
 
Table 19 Screening of conditions for the thermal intramolecular alkoxyketeniminium [2+2] cycloaddition. 
 
entry conditions comment result 
1 Tf2O (1.1 equiv), collidine (1.2 equiv), DCE, 
23 °C, 4 h, then CCl4/H2O, 100 °C 
addition of Tf2O 
over 45 min 
no reaction 
2 Tf2O (1.1 equiv), collidine (1.2 equiv), DCE, 
80 °C, 24 h, then acetone/H2O, 80 °C 
addition of Tf2O 
over 5 h 
I.207 (36%) 
3 Tf2O (1.1 equiv), collidine (1.2 equiv), DCE, 
80 °C, 24 h, then acetone/H2O, 80 °C 
addition of Tf2O in 
one portion 
I.207 (traces) 
+ 
decomposition 
4 Tf2O (5.0 equiv), collidine (5.0 equiv), DCE, 
80 °C, 2.5 h, then acetone/H2O, 80 °C 
addition of Tf2O in 
one portion 
I.207 (40%) 
5 Tf2O (3.0 equiv), collidine (3.0 equiv), DCE, 
65 °C, 1 h, then acetone/H2O, 65 °C 
addition of Tf2O in 
one portion 
decomposition 
6 Tf2O (2.5 equiv), collidine (2.5 equiv), DCE, addition of Tf2O in I.207 (36%) 
60  RESULTS AND DISKUSSION 
 
55  °C, 30 min, then acetone/H2O, 55 °C one portion 
7 Tf2O (2.5 equiv), collidine (2.5 equiv), DCE, 
60  °C, 1 h, then acetone/H2O, 60 °C 
addition of Tf2O in 
one portion 
I.207 (25%) 
8 Tf2O (5.0 equiv), collidine (5.0 equiv), DCE, 
60 °C, 2.5 h, then acetone/H2O, 60 °C 
addition of Tf2O in 
one portion 
I.207 (traces)  
9[a] Tf2O (5.0 equiv), collidine (5.0 equiv), DCE, 
80 °C, 2 h, then acetone/H2O, 80 °C 
addition of Tf2O in 
one portion 
I.207 (55%) 
10[b] Tf2O (5.0 equiv), collidine (5.0 equiv), DCE, 
80 °C, 2 h, then acetone/H2O, 80 °C 
addition of Tf2O in 
one portion 
I.207 (70%) 
[a] the reaction was performed at 0.0868 mmol scale; [b] the reaction was performed at 0.174 mmol scale.  
 
The mechanism of this thermal intramolecular alkoxyketeniminium [2+2] cycloaddition is 
depicted in Scheme 49. In the first step, the triflated cation I.210 is formed, of which triflic acid 
is subsequently eliminated to form the keteniminium salt I.211. This ketene derivative is attacked 
by the benzylic alkene, resulting in the formation of a benzylic carbocation I.212 which is 
subsequently trapped by the addition of enamine, forming the cyclic iminium ion I.213. The last 
step is the hydrolysis of the iminium toward ketone I.207. Mechanistic studies of Ghosez in 
1983 showed that the reaction proceeds stepwise through a cationic intermediate and not 
concerted.145 However, more recent studies discus also a concerted but highly asynchronous 
cycloaddition. The two mechanisms could also compete and depend on the nature of both the 
alkene and the ketene.146  
 
Scheme 49 Proposed mechanism of the keteniminium [2+2]-cycloaddition. 
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After the successful synthesis of tetracycle I.207, the ensuing step was to open up the cyclic 
ether. Therefore, I.207 was treated with SmI2,147 but hemiketal I.214 was obtained instead of the 
alcohol (Table 20). Therefore, the next aim was to open hemiketal I.214 and trap the primary 
alcohol to prevent the ring closure. The fist idea was to use basic conditions in combination 
with a TBS silyl ether. The screened conditions for this transformation are depicted in Table 20, 
but although various bases, solvents and temperatures were tested, either starting material I.214 
or the protected tertiary alcohol I.216 was isolated. The observation of the latter in quite high 
yields was surprising, since the protection of the tertiary alcohol should not be favored at all. 
However, this result gave us a first hint that the conformation of the hemiketal is way more 
preferred than its corresponding open form.  
 
Table 20 Screening of conditions for the opening of hemiketal I.214. 
 
entry conditions result 
1 TBSCl, imidazole, DMF, 0 to 23 °C no reaction 
2 TBSOTf, Et3N, CH2Cl2, −78 to −35 °C 81% I.216 
3 TBSCl, imidazole, DMAP, DMF, 0 to 23 °C no reaction 
4 TBSCl, t-BuOK, THF, −78 to 23 °C I.216 
5 TBSCl, Et3N, THF, 70 °C no reaction 
 
Since the screening of Table 20 with relatively mild bases was unsuccessful, the attention was 
turned to harsher conditions (Scheme 50). The intention this time was not only to protect the 
primary alcohol, but also form the silyl enol ether of the ketone. As soon as the ketone would be 
protected, the formation of the hemiketal is prohibited and the primary alcohol could be 
protected by the excess of reagents. However, the silyl ether of tertiary alcohol I.216 was again 
the only observed product.  
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Scheme 50 Conditions for the formation of I.217. 
 
A reason for the observations of Table 20 and Scheme 50 might be that, due to the very 
strained, bowl shaped structure of I.214, the primary alcohol points directly to the ketone and 
therefore the equilibrium between the hemiketal and its open form is almost completely on the 
side of the hemiketal. Another factor might be that the primary alcohol is neopentylic and 
therefore sterically quite hindered.  
To overcome at least the problem with the equilibrium of the hemiketal, the idea was to prevent 
its formation during the cleavage of cyclic ether I.207 (Table 21). Therefore, an excess of a 
SmI2/HMPA complex was used to generate both the alkoxide and the enolate at the same time 
and trap both as silyl ether directly. Unfortunately, just starting material or a complex mixture 
was isolated (entries 1 and 2). A complex mixture was also obtained with just SmI2, followed by 
addition of TBSOTf (entry 3). 
 
Table 21 Screening of conditions for the ring opening and twofold protection of I.207.  
 
entry conditions result 
1 SmI2 (2.5 equiv), HMPA (5.0 equiv), TBSOTf, THF, 23 °C no reaction 
2 SmI2 (15 equiv), HMPA (105 equiv), TBSOTf, THF, 23 °C complex mixture 
3 SmI2, TBSOTf, THF, 23 °C complex mixture 
 
Since all the attempts to avoid the formation of the hemiketal or drive its equilibrium to the 
open form by trapping the primary alcohol failed - maybe also due to the sterical hindrance of 
the neopentylic position - a different kind of protecting group was needed. The envisaged key 
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step to build the cycloheptenone affords an aldehyde group at exactly the position of the 
primary alcohol. An aldehyde would be on the one hand small enough for this congested 
position and on the other hand would reduce the number of steps by two. Thus, the hemiketal 
I.214 was exposed to oxidative conditions but no reaction at all could be observed (Scheme 
51A). Another option was to treat hemiketal I.214 with t-butyl carbazate (I.219) under acidic 
conditions to obtain hydrazone I.220, but no conversion of the starting material was observed 
(Scheme 51B).148 
 
 
Scheme 51 Attempted opening of hemiketal I.214. 
 
Although this attempt was unsuccessful, a similar approach came to our mind. Instead of 
subjecting I.214 to oxidative conditions, it was treated with LiAlH4 and in fact, diol I.221 was 
afforded in very good yield and diastereoselectivity (Scheme 52). The proximate reaction was the 
selective protection of the primary alcohol I.222, but the main product was the silylated 
secondary alcohol I.223, presumably due to the sterically hindered neopentylic position.  
To avoid this problem and since ketoaldehyde I.218 is needed anyway, diol I.221 was oxidized 
under Swern conditions to give I.218 in very good yield. 
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Scheme 52 Reduction of hemiketal I.214 to diol I.221 and further transformations. 
 
With dicarbonyl I.218 in hands, several attempts to alkylate the secondary Ư-position of the 
ketone were performed (Scheme 53). First of all, a Pd-catalyzed Ư-vinylation by a procedure of 
Huang et al. was tested,149 but only decomposition was observed. Since alkylations with vinyl 
groups are often difficult the next idea was to use allyl bromide as electrophile. However, the 
product was again not obtained. An aldol addition with acetone and subsequent elimination of 
the tertiary alcohol with DBU was another idea to introduce a vinyl group, which contains a 
methyl group at the C2-position, but the envisioned product could not be isolated.150  
 
 
Scheme 53 Attempted alkylation and aldol addition of ketone I.218.  
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Since the direct alkylation and aldol condensation respectively were not successful, a Mukaiyama 
aldol reaction was envisaged. The product after the first step, the generation of the TMS enol 
ether, was used directly in the next step without any purification (Scheme 54A). TiCl4 and 
acetone were added,151,152,153 but the aldol condensation product I.227 was not obtained. Instead, 
ketoaldehyde I.228 and its aldol condensation product I.229 were isolated. A possible 
explanation could be that the deprotonation with LHMDS occurred at the tertiary Ư-position of 
I.218 instead of the more accessible secondary one (Scheme 54B). Therefore, the cyclobutanone 
ring was opened and the TMS enolate of ketone I.230 was formed, which partially underwent an 
intramolecular aldol condensation to give I.229.  
 
 
Scheme 54 A) Attempted Mukajama aldol addition. B) Proposed mechanism of the formation of I.228 and I.229.  
 
Our last idea was to oxidize the aldehyde moiety of I.218 to the carboxylic acid, to ease the 
differentiation between the two carbonyl groups. Thus, aldehyde I.218 was treated with classical 
Pinnick oxidation conditions. However, the so formed carboxylic acid attacked the 
cyclobutanone and formed again a hemiketal.  
 
 
Scheme 55 Pinnick oxidation of aldehyde I.218.  
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2.2.2 Optimized Synthesis of the Precursor for the Intramolecular 
Alkoxyketeniminium [2+2] Cycloaddition‡ 
Since a major problem with the above reported synthesis was the permanent lack of material 
due to too many steps toward the key step, it was decided to develop in parallel a new synthetic 
route for alcohol I.194. This new route started with a Ba(OH)2 catalyzed aldol condensation of 
m-anisaldehyde (I.234) and pinacolone (I.235).154 Subsequent hydrogenation of the obtained 
enone provided ketone I.237 in good yield (71%, >13 g) over two steps (Scheme 56). Corey-
Chaykovsky epoxidation afforded epoxide I.238 after the next step in very good yield (95%, 
>10 g).155 Screening of conditions for the Friedel-Crafts alkylation revealed that the reaction 
afforded the best yield and regioselectivity in HFIP with a catalytic amount of concentrated 
H2SO4.156 Small amounts of the ortho-Friedel-Crafts product could be isolated as well. 
Unfortunately, the benzylic oxidation of I.239 with DDQ to the alkene I.194 did not afford the 
envisioned product, but cyclic ether I.240, which was also the product of a previous reaction 
(compare Scheme 45). A crystal structure of I.241 was obtained by deprotection of the Friedel-
Crafts adduct.  
 
Scheme 56 Synthesis of alcohol I.239 and subsequent DDQ oxidation. 
                                                 
‡ The experiments of of Chapter 2.2.2 were performed in cooperation with Matthias Schmid. 
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The next idea was therefore to protect the primary alcohol I.239 as TBS ether I.242 and oxidize 
the benzylic position to ketone I.243 (Scheme 57).131,157 Subsequent reduction with LiAlH4 and 
in situ deprotection of the silyl protecting group afforded however not alcohol I.194, but again 
cyclic ether I.240 in quantitative yield.  
 
 
Scheme 57 Benzylic oxidation of I.242 and attempted elimination toward I.194. 
 
We then had another idea, which would also avoid a protection/deprotection sequence. The 
amide mojety for the keteniminium cyclization could also be used as “protecting group” for the 
benzylic oxidation to the alkene (Scheme 58). The first step, the formation of amide I.244, 
occurred in quantitative yield. Subsequent oxidation provided then alkene I.209 in very good 
yield after some screening for the best conditions. It turned out that the reaction worked best in 
1,4-dioxane with six equivalents of DDQ. In toluene or with less or more DDQ, either 
decomposition or incomplete conversion was observed. 
 
 
Scheme 58 Synthesis of precursor I.209 for the [2+2] cycloaddition.  
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3 Conclusion and Outlook 
 
In summary, several approaches toward the total synthesis of the natural product salimabromide 
(I.6) have been investigated in this thesis. The epoxide I.238 was synthesized in three steps from 
the commercially available starting materials I.234 and I.235 (Scheme 59). Subsequent cascade 
reaction consisting of a 1,2-methyl migration followed by Friedel-Crafts alkylation afforded 
bicyclic primary alcohol I.239 in good yield. Due to this elaborate reaction, two adjacent all 
carbon quaternary centers were set in a single step. The synthesis of alkoxyamide I.209 
subsequently proceeded in two steps and set the stage for the keystep. Intramolecular 
keteniminium [2+2] cycloaddition of alkoxyamide I.209 provided the envisaged tetracyclic 
product in 55% yield. To the best of our knowledge, this is the most complex substrate where 
such a keteniminium cycloaddition has been successfully applied. Three ensuing steps gave 
dicarbonyl compound I.218, which proved to be difficult to further functionalize toward 
salimabromide (I.6). Future studies are directed at advancing late-stage ketoaldehyde I.218. 
 
 
Scheme 59 Synthesis of an advanced intermediate for the synthesis of salimabromide (I.6). 
 
To shorten the synthesis the use of elongated amide I.245 will be investigated in the [2+2] 
cycloaddition instead of the alkoxyamide I.209 (Scheme 60). This would have the advantage that 
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– following Baeyer-Villiger oxidation of the cyclobutanone - the thus formed seven-membered 
ring I.255 would simply require an allylic oxidation to establish the tetracyclic core structure of 
salimabromide (I.6).  
In further experiments, the substitution pattern of the aromatic portion of salimabromide (I.6) 
would be introduced. To avoid any additional sterical hindrance during the keteniminium [2+2] 
cycloaddition, bromination is planned to occur at a later stage of the synthesis.  
 
 
Scheme 60 New approach for the keteniminium [2+2] cycloaddition.  
 
During these studies toward salimabromide (I.6), several new and interesting reactions were 
discovered, such as the cascade reaction of allyl naphthyl ether I.88 that provided a tricyclic 
lactone (I.91) (Scheme 61). Further exploration of this reaction could provide rapid access to 
natural products with similar structural motif, such as dioscorealide B (I.247).  
 
 
Scheme 61 Cascade reaction to yield tricyclic lactone I.91.  
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With the Pd-catalyzed intramolecular dearomatization of 1-naphthols another powerful 
transformation was investigated for a new substrate class. This reaction enabled the successful 
installation of an all carbon quaternary center at the C2-position of the former naphthol and was 
capable of proceeding on multi-gram scale (Scheme 62). To date, no such dearomatization by a 
Tsuji allylation is known. As such, it was further investigated in a separate project and is 
presented in Chapter II of this thesis.  
 
 
Scheme 62 Successful dearomatization of a 1-naphthol under Tsuji conditions.  
 
 
 
 
 
 
CHAPTER II 
 
 
 
CATALYTIC ASYMMETRIC DEAROMATIZATION 
(CADA) REACTION 
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4 Introduction  
4.1 Asymmetric Palladium Catalyzed Decarboxylative Allylations 
The formation of new carbon-carbon bonds is one of the most fundamental reactions to create 
complex structures in organic chemistry. Several procedures to form C–C bonds have been 
developed in the past, however, the formation of quaternary centers and especially their 
asymmetric formation is still challenging. In recent years, significant improvement of the 
palladium catalyzed asymmetric allylic alkylation allows the generation of tertiary and quaternary 
centers in a highly asymmetric fashion. In general, there are two types of substrates for this 
reaction: allyl ư-keto carboxylates (Scheme 63) and vinyl carbonates (Scheme 64).158 However, in 
recent years even 2-naphthols turned out to be viable substrates, which undergo a dearomative 
allylation by generating selectively a quaternary center at the C1-position.  
The first palladium catalyzed decarboxylative allylations were independently reported by Tsuji89 
and Saegusa90 in 1980 within two days. However, the first asymmetric version of the so-called 
decarboxylative Tsuji allylation was reported over 20 years later in 2004 by Tunge and Burger 
(Scheme 63).159 They were able to obtain yields up to 94% and ee’s ranging from 54% to 98%, 
using the (R,R)-DACH-phenyl Trost ligand ((R,R)-L1).  
 
 
Scheme 63 First reported asymmetric Tsuji allylation. 
 
Only a few months later, Stoltz published a very similar methodology for an enantioselective 
Tsuji allylation of allyl enol carbonates II.5 and silyl enol ethers II.7 (Scheme 64).98 In contrast 
to Tunge, who was able to control the stereocenter of the ư-position, Stoltz and co-worker 
demonstrated the ability to control the stereochemistry at the Ư-position. A ligand screening 
showed that the PHOX ligands - and especially one with the t-butyl oxazoline - were able to 
improve the ee’s significantly. Using this methodology, Stoltz was able to construct all carbon 
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quaternary stereocenters both intra- and intermolecular in high yields (79–99%) and high ee’s 
(79–92%). The substrate scope covers a variety of 6 to 8 membered rings and 1-tetralones and 
also cyclic enol silanes, for which the use of tetrabutylammonium difluorotriphenylsilicate 
(TBAT) as initiator was essential.  
 
 
Scheme 64 Asymmetric Tsuji allylation by Stoltz and co-workers.  
 
A few months later, Trost also published an enantioselective Tsuji allylation where the 
ANDEN-phenyl Trost ligand ((R,R)-L3) was used (Scheme 65).96 The reaction was performed 
in toluene instead of tetrahydrofuran (THF) and the obtained yields (64–99%) and ee’s (76–
100%) for the substrate scope, which even contains heterocycles, are similar to the ones of 
Stoltz. Notwithstanding the similarity to Stoltz methodology, Trost expanded this methodology 
to the synthesis of tertiary stereocenters and therefore simultaneously overcoming the issue of 
product racemisation and dialkylation.  
 
 
Scheme 65 Asymmetric Tsuji allylation by Trost and co-workers.  
 
Employing the enol carbonate of 1-tetralone II.10 as model substrate for a solvent screening 
gave astonishing results. In toluene and especially in THF substantial amounts of unalkylated 
and dialkylated side products II.12 and II.13 were observed (Scheme 66). Only when the 
reaction was conducted in 1,4-dioxane their formation was almost completely prevented. Trost 
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speculates that the absence of the side products results from the formation of solvent-caged 
contact ion pairs, which are predominantly generated in dioxane compared to other solvents. 
According to this assumption, the equilibrium of the enolate and the product will be minimized, 
if the alkylation reaction between the contact ion pairs is much faster than the diffusion rate of 
the ions or the product out of the solvent cages.96  
 
 
Scheme 66 General scheme for the asymmetric Tsuji allylation using 1-tetralones. 
 
In 2005, Stoltz reported the first example of a very efficient deracemization of Ư-substituted 
ư-ketoesters II.14 by a decarboxylative Tsuji allylation (Scheme 67). In this work, Stoltz and co-
workers explored an enantioconvergent reaction mechanism “in which the same catalyst is 
intimately involved in both the stereoablative (C–C bond-braking) and stereoselective (C–C 
bond-forming) steps.”160 By this, they expanded the scope to a variety of racemic ư-ketoesters 
with Ư-quaternary centers, which could be transformed into their corresponding ketones in up 
to 99% yield and 92% ee.  
 
 
Scheme 67 Enantioconvergent deracemization of ư-ketoesters.  
 
Hamada published in 2010 the first Pd-catalyzed dearomative ipso-Friedel-Crafts allylic alkylation 
for the synthesis of spiro[4.5]cyclohexadienones (Scheme 68). Via this methodology, they were 
able to dearomatize phenol II.16 and obtain spirocycle II.17 as the major diastereomer in 80% 
yield (dr = 9.2:1) and 89% ee.161 Further studies in 2012 confirmed that ligand (R,R)-L3 gives the 
best results.162  
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Scheme 68 Pd-catalyzed asymmetric ipso-Friedel-Crafts allylic alkylation. 
 
In 2011, You published a quite similar reaction for the intramolecular asymmetric formation of 
spirocyclohexadienone derivatives II.19 via the dearomatization of phenols. In contrast to 
Hamada, the reaction is Ir-catalyzed and the phosphoamidite ligand (S,S,S)-L4 is used, which 
provides a wide scope of spirocycles in 60–95% yield and 85–97% ee. Again, the use of Li2CO3 
was crucial for the reaction outcome.163  
 
 
Scheme 69 Ir-catalyzed asymmetric ipso-Friedel-Crafts allylic alkylation. 
 
Notwithstanding the complexity of the spirocyclic products by Hamada and You, the design of 
the phenolic starting materials for the intramolecular dearomatization prevents competing O- 
and ortho-alkylation. In 2013, You overcame this problem and reported the first Pd-catalyzed 
intermolecular asymmetric allylic dearomatization of 2-naphthols (II.20) (Scheme 70). Various 
carbonates (II.21) served as allyl sources in combination with a Pd(II)-catalyst and the Trost-
ligand (R,R)-L1. This time, not Li2CO3 but DBU turned out to be the optimal base concerning 
enantioselectivity and chemoselectivity. The dearomatized products (II.22) with an all carbon 
quaternary center - generated in very good selectivity at the C1-position - were obtained in high 
yields and ee’s. However, the chemoselectivity of the allylation decreased considerably when the 
R2-substituent was a hydrogen atom. Another drawback of this methodology is that the 
naphthols are used in excess with regards to the carbonates (2 equivalents vs. 1 equivalent).72  
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Scheme 70 Pd-catalyzed asymmetric intermolecular allylic dearomatization of 2-naphthols. 
 
One year later You expanded his methodology and was able to obtain very good 
chemoselectivities for the dearomatization of 2-naphthols (II.23) even without a substituent at 
the C3-position. The best chemoselectivities were observed for ester or ketone substituents at 
the C1-position, maybe due to the electron withdrawing effect. However, the ratio of naphthol 
to carbonate is still 2 : 1. In contrast to the previously published methodology, the synthesis of 
the dearomatized substrates is racemic and at elevated temperatures. Interestingly, You also 
published a screening of chiral ligands, showing excellent conversion up to 90% but only 
providing ee’s of 10%.164  
 
 
Scheme 71 Pd-catalyzed asymmetric intermolecular allylic dearomatization of 2-naphthols. 
 
In 2017, You was able to overcome all the former problems of competing O-alkylation, low 
enantioselectivity and unpractical substrate to reagent ratio. An iridium-catalyst was employed, 
which allowed the use of the phosphoramidite ligand (S)-L6 (Scheme 72A) and allylic alcohols 
(II.27) and ethers (II.28) were found to be suitable substrates instead of allyl carbonates. A 
beneficial feature of the use of allylic alcohols and ethers as substrates is the shorter synthesis 
and the reduction of the generated waste. However, a Lewis acid had to be added to activate the 
allylic alcohols and ethers. Screenings showed that Brønsted acids promote the reaction as well 
but with much lower efficiency.165  
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Just a month later, the Zhong group reported almost exactly the same methodology (Scheme 
72B). With a chiral Ir/phosphoramidite complex they were able to dearomatize 2-naphthols 
(II.20) using allylic alcohols (II.30). The major difference between both reactions is that Zhong 
uses the chiral Brønsted acid II.31 to activate the allylic alcohol.166 Interestingly, the same 
Brønsted acid was also tested by You with mediocre success. Another notable difference is the 
used name for the dearomatization reaction: You refers to as catalytic asymmetric 
dearomatization (CADA) reaction and Zhong as asymmetric allylic dearomatization (AADA) 
reaction. To avoid confusion, the author of this thesis decided to just use the term CADA 
reaction.  
 
 
Scheme 72 Catalytic asymmetric dearomatization reactions by You and Zhong.  
 
Notwithstanding the results of You and Zhong, both use 2-naphthols for the allylic 
dearomatization which hinders or even prevents subsequent rearomatization via Cope 
rearrangement. The only publication that examined the intermolecular dearomatization of 
1-naphthols and phenols by a similar methodology was published in 2016 by You. Herein the 
main topic is the arylative dearomatization of 2-naphthols (Scheme 73A). However, they also 
tried to expand the methodology to the dearomatization of 1-naphthol II.34 by generating an all 
carbon quaternary center at the C2-position, but they only could obtain a C4-substituted 
dearomatized product II.35 (Scheme 73B). The only dearomatization took place at a substituted 
C4-position (II.37). A very similar result was observed for phenols.167  
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Scheme 73 Pd-catalyzed intermolecular arylative dearomatization.  
 
 
4.2 Mechanism of the Palladium-Catalyzed Asymmetric Alkylation 
The first investigations toward the mechanism of the Pd-catalyzed Tsuji allylation were cross-
over experiments performed by Stoltz160,168 and Trost.96 Interestingly, Trost’s group observed 
only minimal cross-over between both allyl groups, yet Stoltz observed all possible cross-over 
products in a deuterium labelled experiment (Scheme 74). A possible explanation for the 
different results might be the influence of the ligands on the reaction mechanism.  
Trost proposes that his catalytic system containing the bisphosphine ligand accelerates the 
alkylation reaction in such a way that it exceeds the rate of ion or product diffusion out of the 
solvent–cages formed in 1,4-dioxane. In contrast, Stoltz suggests a similar catalytic cycle as 
Saegusa in 1980,90 which contains two stages for possible scrambling (Scheme 75). This cycle 
would also be consistent with the results that were observed with his catalytic system.  
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Scheme 74 Cross-over experiments performed by the groups of Trost and Stoltz. 
 
 
Scheme 75 Proposed catalytic cycle for the decarboxylative allylic alkylation by Stoltz and Saegusa.  
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A few years later, Trost published another experiment to investigate the scrambling during the 
Tsuji allylation. Trost used a very similar deuterated substrate as Stoltz in combination with the 
different ligands L3, L5 and dppe (1,2-bis(diphenylphosphino)ethane) in 1,4-dioxane to rule out 
the influence of the substrate and the ligand (Scheme 76). Contrary to Trosts previous 
experiment, complete scrambling and thus formation of all six possible products was observed 
this time for all the tested ligands. Therefore he suggests now that the exchange of the ion-pairs 
is faster than the product generation.169  
 
 
Scheme 76 Cross-over experiment of Trost from 2009.   
Trost also discussed the two mechanistic pathways for the recombination of the enolate and the 
π-allylpalladium complex II.61 (Scheme 77). In the inner sphere mechanism, the nucleophile 
coordinates first to the palladium, followed by a reductive elimination to form the product II.63. 
This mechanism is usually favored for “hard nucleophiles” with a pKa>20. The other possibility 
is the outer sphere mechanism where the nucleophile attacks directly the allyl moiety and 
substitutes the palladium in a SN2’ fashion. This pathway is arbitrarily favored by “soft 
nucleophiles” with a pKa<20.169 
 
 
Scheme 77 Inner vs. outer sphere mechanism of the nucleophilic addition to the π-allylpalladium complex II.61.  
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To figure out which pathway is more likely for the decarboxylative Tsuji allylation, (±)-II.64 was 
treated with the usual Trost conditions. The result was an almost perfect kinetic resolution since 
only one enantiomer of the racemate reacted selectively and the other one remained even after 
12 h. Analysis of the configuration of the product II.65 revealed the cis configuration and thus 
retention of configuration. Since ionisations of carbonates generally follow an anti-addition 
mechanism, the observation of the overall retention of configuration strongly indicates an 
“outer sphere” mechanism.169  
 
 
Scheme 78 Palladium-catalyzed decarboxylative allylation of II.64. 
 
In 2012, Stoltz and co-worker published extensive DFT calculations to get a deeper insight into 
the mechanism – inner or outer sphere recombination of the enolate and the π-allylpalladium 
complex – of the asymmetric Tsuji allylation (Scheme 79). They concluded that the inner sphere 
mechanism explains the observed enantioselectivity better than the outer sphere mechanism. 
Their calculations indicate the appearance of a 5-coordinate Pd-species II.70 which undergoes a 
ligand rearrangement to form intermediate II.72. The reductive elimination occurs via an 
unconventional seven-centered transition state II.73 in contrast to the standard three-centered 
carbon-carbon reductive elimination. Although it was not possible to irrevocably determine the 
enantioselective step, all calculations show that the inner sphere pathway is energetically 
preferred over the outer sphere one.170  
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Scheme 79 DFT-calculations for the asymmetric Tsuji-allylation. 
 
You, who published the first Pd-catalyzed intermolecular asymmetric allylic dearomatization72 
performed also mechanistic studies for this reaction (Scheme 80). Treatment of allyl ether II.75 
with Pd(PPh3)4 afforded the dearomatized product II.76 and naphthol II.77 in a ratio of 89 : 11. 
Test reactions revealed that without Pd-catalyst no reaction was observed. Another test reaction 
showed that no back reaction from the dearomatized product II.76 to enol ether II.75 is 
possible. NMR studies of the intermolecular dearomatization displayed the O-allylated naphthol 
to be an intermediate of the reaction which fully converts to the product. Interestingly, the 
O-allylated naphthol II.78 did not react at all with Pd(PPh3)4. This indicates that the induced 
effect of the substituent at the C1-position influences the reversible ionization of the allyl ether. 
However, cross-over experiments with II.78 and a slight excess of the free naphthol II.79 
afforded the dearomatized product II.79 as major product. The result of another cross-over 
experiment proved that the formal rearrangement of the O-allylated naphthol is neither an 
intramolecular nor a contact ion pair process.164  
Based on the results of these experiments, You proposed a catalytic cycle (Scheme 81). At the 
beginning, oxidative addition of Pd(0) to allyl carbonate II.84 generates a π-allylpallydium 
species. This forms by nucleophilic attack of naphthol II either the dearomatized C-alkylated 
species V or the O-alkylated species IV. The O-allyl ether can undergo another oxidative 
addition with Pd(0) to start the catalytic cycle again.164  
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Scheme 80 Mechanistic studies of the Pd-catalyzed allylic dearomatization. 
 
 
 
Scheme 81 Proposed catalytic cycle for the decarboxylative allylic dearomatization by You.  
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5 Results and Discussion 
 
Although the asymmetric Tsuji allylation and CADA reaction was significantly advanced in the 
last years, the allylic dearomatization of 2-substituted 1-naphthols by generating an all carbon 
quaternary center at the C2-position is still unexplored. The most challenging aspect is the 
accessibility of the para-position as the initially dearomatized molecules have the possibility to 
rearomatize by a formal Cope rearrangement, or the allylation occurs at the para-position of the 
aromatic compound. This would lead to the thermodynamically more stable 2,4-disubstituted 
1-naphthols.  
We assumed that if the π-allyl Pd-complex is spatially close enough to the naphthoate, the 
allylation should occur preferentially at the C2-position (Scheme 82). However, the precondition 
for this is to prohibit the ion diffusion. Very mild reaction conditions and low temperatures 
would limit subsequent rearrangement and rearomatization. To fulfill these restrictions, the plan 
of this thesis was to combine the asymmetric allylation methodologies of Trost and Stoltz with 
the CADA reaction of You and Zhang.  
 
 
Scheme 82 General idea for the intramolecular dearomatization of 1-naphthols.  
 
 
5.1 Screening and Optimization of the Intramolecular CADA Reaction of the 
Allyl Carbonate of 1-Naphthols 
We started the screening with the allyl carbonates of 2-substituted 1-naphthols. Subjecting allyl 
carbonate II.89 to Pd(PPh3)4 in various solvents afforded most of the time the dearomatized 
product II.90, but as an inseparable mixture with the diallylated species II.92 (Table 22). 
Naphthol II.34 was always observed as a side-product. This result indicates on the one hand 
                                                 
 The experiments of chapter II were supported by Bernard (Ruben) Andringa. 
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that the Cope rearrangement is not suppressed and that on the other hand ion diffusion out of 
the solvent cages takes place. A second side-product in all reactions was O-allylated II.91, which 
is, as before, in accordance to the reaction mechanism proposed by You (Scheme 81). Another 
interesting fact can be seen by the comparison of entry 3 and 4: surprisingly, the reaction gave 
better results in non-degassed 1,4-dioxane than in degassed one. However, we have no 
explanation for this result.  
 
Table 22 Screening of conditions for the racemic dearomatization reaction of allyl carbonate II.89.  
 
entry catalyst[a] solvent[b] result ratio of 
II.90 : II.92[f] 
1 Pd(PPh3)4 THF II.89 + II.92 (61%)[e] 1 : 0.22 
2 Pd(PPh3)4 n-hexane/toluene (1:10) II.91 - 
3 Pd(PPh3)4 1,4-dioxane[c] II.89 + II.92 (37%)[e] 1 : 0.14 
4 Pd(PPh3)4 1,4-dioxane II.89 + II.92 (15%)[e] 1 : 1.1 
5 Pd(PPh3)4 THF[d] II.89 + II.92 (48%)[e] 1 : 0.20 
6 Pd(PPh3)4 CH2Cl2 II.89 + II.92 (28%)[e] 1 : 1.6 
7 Pd(dba)2/PPh3[g] THF - - 
[a] 10 mol% catalyst were used; [b] solvents were degassed via freeze-pump-thaw; 0.05 M; [c] not degassed; [d] 0.02 M solution; [e] isolated as an inseparable mixture; [f] determined by 1H NMR; [g] Pd(dba)2 (5 mol%) and PPh3 (11 mol%).  
 
To optimize the reaction and thus reduce the amount of side-products, we decided to apply 
chiral ligands since they are often far more optimized than the racemic ones. The most 
commonly used chiral ligands are the P,P-C2-symmetric-coordinating Trost ligands (S,S)-
DACH-phenyl Trost ligand ((S,S)-L1), (S,S)-ANDEN-phenyl Trost ligand ((S,S)-L3) and the 
(S,S)-DACH-naphthyl Trost ligand ((S,S)-L7), the P,N-coordinating PHOX ligand (R)-i-Pr-
PHOX ligand ((R)-L5) (Figure 13) and the N,N-C2-symmetric-coordinating Trost ligand (R,R)-
DACH-pyridyl Trost ligand ((R,R)-L6).  
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Figure 13 Chiral ligands used for the CADA reaction.  
 
The reactions with (S,S)-L3, (R)-L5 and (S,S)-L1 were all screened at 0.083 mmol scale, at a 
concentration of 0.04 M and at 45 °C (Table 23). The resulting ee values of the reactions were 
determined by chiral HPLC of the isolated clean products. One of the most popular Trost 
ligands, the (S,S)-ANDEN-phenyl Trost ligand ((S,S)-L3), resulted only in the formation of allyl 
ether II.91 (entries 1–5). Using the (R)-i-Pr-PHOX ligand afforded the product II.90 in minor 
amounts and negligible ee (entries 6–10). With the (S,S)-DACH-phenyl Trost ligand ((S,S)-L1) 
the yields were still low (entries 11–15) but the obtained ee was up to 70% (entry 12). For the 
two latter ligands, allyl ether II.91 was always observed as the second product.  
 
Table 23 Ligand screening for the CADA reaction of allyl carbonate II.89. 
 
entry ligand[a] solvent[b] result[c] ee [%][d] 
1 (S,S)-L3 THF II.91 - 
2 (S,S)-L3 toluene II.91 - 
3 (S,S)-L3 n-hexane/toluene (1:2) II.91 - 
4 (S,S)-L3 MTBE II.91 - 
5 (S,S)-L3 DME II.91 - 
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6 (R)-L5 THF II.90 (23%) 6 
7 (R)-L5 toluene II.90 (14%) 8 
8 (R)-L5 n-hexane/toluene (1:2) II.90 (trace) - 
9 (R)-L5 MTBE II.90 (trace) - 
10 (R)-L5 DME II.90 (9%) - 
11 (S,S)-L1 THF II.90 (12%) 58 
12 (S,S)-L1 toluene II.90 (18%) 70 
13 (S,S)-L1 n-hexane/toluene (1:2) II.90 (31%) 60 
14 (S,S)-L1 MTBE II.90 (24%) 62 
15 (S,S)-L1 DME II.90 (trace)  - 
[a] 11 mol% ligand were used; [b] solvents were degassed via freeze-pump-thaw; 0.04 M; [c] traces determined by 1H NMR of the crude reaction mixture; [d] determined by chiral HPLC analysis. 
 
Since the (S,S)-L1 ligand seemed to be the best, the influence of different concentrations of 
Pd2(dba)3 was compared (Table 24). As expected, the best ee was obtained with low catalyst 
loading (entry 1) and the best yield with the higher catalyst loading (entry 2). However, with 
100 mol% catalyst, the yield was still just 49% (entry 3). The allyl ether was this time not 
detected as second main product, but presumably the rearomatized Cope product.  
 
Table 24 Screening of different amounts of catalyst.  
 
entry catalyst ligand result ee[a] 
1 Pd2(dba)3 (5 mol%) (S,S)-L1 (11 mol%) II.90 (31%) 60% 
2 Pd2(dba)3 (10 mol%) (S,S)-L1 (22 mol%) II.90 (55%) 50% 
3 Pd2(dba)3 (100 mol%) (S,S)-L1 (200 mol%) II.90 (49%) 32% 
[a] determined by chiral HPLC analysis; the solvents were degassed via freeze-pump-thaw; 0.04 M. 
 
In parallel, the influence of the temperature was studied (Table 25). As expected, the yield 
increased considerably when the reaction was heated to 60 °C and the ee decreased from 60% to 
44% (entry 1 compared to Table 24, entry 1). An interesting observation was made, when the 
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solvents for the reaction were used without degassing (entry 2 compared to Table 24, entry 1). 
Thus, the ee decreased only to 52%, but as before, we have no explanation for this result. The 
reaction was also run at ambient temperature (entry 3), but the product was only isolated in 
minor amounts albeit in 64% ee.  
 
Table 25 Screening the behavior of the CADA reaction at different temperatures.  
 
entry ligand[a] solvent[b] T [°C] result ee [%][c] 
1 (S,S)-L1 n-hexane/toluene (1:2)[d] 60 II.90 (67%) 44 
2 (S,S)-L1 n-hexane/toluene (1:2) 60 II.90 (67%) 52 
3 (S,S)-L1 benzene 23 II.90 (26%) 64 
[a] 11 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] determined by chiral HPLC analysis; [d] solvent was degassed via freeze-pump-thaw.  
 
To improve both the yield and the ee of the CADA reaction of allyl carbonate II.89, another 
solvent screening was performed with ligand (S,S)-L1, but this time with the focus on aromatic 
solvents (Table 26). Benzene as well as chlorobenzene, pyridine, trifluorotoluene and toluene 
were tested and all of them were used without degassing. The best yield (70%) was obtained 
with benzene but the ee was moderate (entry 1). A far better ee (66%) was achieved in toluene, 
although with poor yield (entry 6). Since benzene gave superior yields, this solvent was used to 
test the influence of the additives LiCl and DBU on the reaction outcome (entry 7 and 8). The 
addition of 1 equivalent of LiCl increased the yield from 70% to 83% and left the ee unchanged 
(entry 7). A catalytic amount of DBU increased the ee to 68%, but decreased the yield to 28%. 
Again, II.91 was a side-product for all reactions. 
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Table 26 Screening of aromatic solvents and additives.  
 
entry ligand[a] solvent[b] additive result ee [%][c] 
1 (S,S)-L1 benzene - II.90 (70%) 42 
3 (S,S)-L1 chlorobenzene - II.90 (60%) 42 
4 (S,S)-L1 pyridine - II.90 (24%) 46 
5 (S,S)-L1 trifluorotoluene - II.90 (15%) 46 
6 (S,S)-L1 toluene - II.90 (18%) 66 
7 (S,S)-L1 benzene LiCl (1 equiv) II.90 (83%) 44 
8 (S,S)-L1 benzene DBU (0.1 equiv) II.90 (28%) 68 
[a] 11 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] determined by chiral HPLC analysis; [d] solvent was degassed via freeze-pump-thaw.  
 
Since all the results with ligand (S,S)-L1 gave either good yields or ee but not both at the same 
time the two remaining DACH ligands (R,R)-L6 and (S,S)-L7 were screened for the CADA 
reaction of II.89 (Table 27). Unfortunately (R,R)-L6 did not even fully decarboxylate allyl 
carbonate II.89 (entries 1–3). In contrast to this, the naphthyl ligand (S,S)-L7 afforded in all the 
screened solvents the product II.90 with ee values of around 70%; however, the received yields 
were low (entries 4–7).  
 
Table 27 Screening of further ligands for the CADA reaction of allyl carbonate II.89. 
 
entry ligand[a] solvent[b] result ee [%][c] 
1 (R,R)-L6 benzene II.89, II.91 (trace)[d] - 
2 (R,R)-L6 toluene II.89, II.91 (trace)[d] - 
3 (R,R)-L6 THF II.89, II.91 (trace)[d] - 
4 (S,S)-L7 benzene II.90 (12%) 70 
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5 (S,S)-L7 toluene II.90 (6%) 71 
6 (S,S)-L7 chlorobenzene II.90 (24%) 70 
7 (S,S)-L7 n-hexane/toluene (1:2) II.90 (18%) 69 
[a] 11 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] determined by chiral HPLC analysis; [d] determined by crude 1H NMR.   
Furthermore, we faced problems with the reproducibility of these reactions. Sometimes the 
active catalyst degraded too fast, distinguishable by the formation of a suspension from the 
previous clear solution. Thus, we also investigated the use of the Pd(II)-source Pd(OAc)2 instead 
of Pd2(dba)3. Various solvents were again screened, but the determined yields were all low to 
mediocre and the main product was always the O-allylated naphthol II.91 (Table 28). 
Sometimes, allyl carbonate II.89 did not even fully decarboxylate (entries 9 and 10). As before, 
reactions with degassed solvents (entries 1 and 13) showed lower yields when compared to the 
corresponding non-degassed solvents (entries 2 and 12). However, the poor reproducibility did 
not improve when Pd(OAc)2 was used.  
 
Table 28 Screening of solvents with Pd(OAc)2 as catalyst.  
 
1 ligand[a] solvent[b] result[c] 
1 (S,S)-L1 n-hexane/toluene (1:2)[d] II.90 (8%) + II.91 (40%) 
2 (S,S)-L1 n-hexane/toluene (1:2) II.90 (11%) + II.91 (46%) 
3 (S,S)-L1 benzene II.90 (11%) + II.91 (51%) 
4 (S,S)-L1 chlorobenzene II.90 (12%) + II.91 (71%) 
5 (S,S)-L1 toluene II.90 (17%) + II.91 (83%) 
6 (S,S)-L1 1,4-dioxane II.90 (21%) + II.91 (57%) 
7 (S,S)-L1 1,2-dichloroethane II.90 (9%) + II.91 (72%) 
8 (S,S)-L1 trifluorotoluene II.90 (6%) + II.91 (62%) 
9 (S,S)-L1 CPME[d] II.90 (2%) + II.91 (6%) + II.89 (69%) 
10 (S,S)-L1 DME[d] II.90 (15%) + II.91 (67%) + II.89 (6%) 
11 (S,S)-L1 CH3CN[d] II.90 (8%) + II.91 (70%) 
12 (S,S)-L1 CH2Cl2 II.90 (41%) + II.91 (47%) 
13 (S,S)-L1 CH2Cl2[d] II.90 (20%) + II.91 (62%) 
[a] 10 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] yield was determined by 1H NMR (CDCl3, 400 or 600 MHz, dimethyl sulfone-d6 as internal standard); [d] solvents were degassed via freeze-pump-thaw. 
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In each of the screenings, O-allylated naphthol II.91 was observed as the side or even main 
product. Therefore, we started to think about the reaction mechanism and at which point the 
dearomatized product II.90 and ether II.91 were formed. Were they both formed at the same 
time or was II.91 formed first and then rearranged to II.90? How fast is the decarboxylation of 
the carbonate? To clarify those questions, a 1H NMR experiment was performed (Figure 14). 
The reaction was set up as usual, but after addition of the starting material II.89 to the catalyst 
solution, aliquots were taken out of the reaction mixture after 1, 2, 5, 20 and 40 min and after 
1.5 and 4.5 h. The samples were filtered through a short plug of silica gel, washed with diethyl 
ether and concentrated. Remarkably, II.89 decarboxylated in less than one minute and only 
ether II.91 and very small amounts of product II.90 are visible. The following samples show 
increased signals for II.90 until 20 min and then the relative intensities of II.90 to II.91 do not 
change any more. This led to the conclusion that the decarboxylation is in fact extremely fast 
and II.91 is most likely formed first by O-alkylation. The second step is then the formation of 
the product, presumably via a palladium catalyzed Claisen rearrangement. However, there is no 
explanation why the reaction stopped after a certain time and no further conversion of II.91 to 
II.90 took place.  
Based on these observations and results in combination with the catalytic cycles of Stoltz and 
You we tried to come up with a catalytic cycle for the intramolecular CADA reaction of 
1-naphthol derivatives. Our proposed mechanism is depicted in Scheme 83 and illustrates 
numerous pathways toward the dearomatized product II.90. The first step is the oxidative 
addition of Pd(0) to allyl carbonate II.89 to form the Pd(II)-π-allyl complex I. This complex can 
undergo a cross-over to separate the ion-pair. Both complexes I and II can decarboxylate and 
generate III and IV respectively, which can be transferred into each other by another cross-
over. For the final yield of the reaction it might not be important which decarboxylation 
pathway is the actual one, yet it might influence the ee. The O-Pd(II)-π-allyl complex IV can 
either undergo reductive elimination to O-allylated naphthol II.91, which was detected in almost 
every reaction and can be converted to IV again by oxidative addition of Pd(0). Or complex IV 
can undergo a different reductive elimination to form the dearomatized product II.90 and 
simultaneously regenerate the Pd(0)-species. Additionally, ion pair III could generate the 
product by an SN2’ attack of the naphtholate at the Pd(II)-π-allyl complex.  
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Figure 14 1H NMR experiment (CDCl3, 400 MHz); reaction conditions: Pd2(dba)3 (5 mol%), (S,S)-DACH-phenyl Trost ligand (11 mol%), LiCl (1 equiv), benzene (non-degassed), 45 °C. 
 
Evidence that at least one of the two possible cross-overs take place in the racemic allylic 
dearomatization with Pd(PPh3)4 is the observation of the diallylated side-product II.92 together 
with the completely de-allylated naphthol II.34. Since the second allylation seems to be 
suppressed when using the chiral ligands, the ion-diffusion might be inhibited by them. To gain 
further insights into the mechanism, substituted and/or deuterated allyl carbonates and 
naphthols would have to be synthesized and subjected to various conditions to see if scrambling 
takes place and if an inner- or outer-sphere mechanism is more likely.  
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Scheme 83 Proposed mechanism for the intramolecular CADA reaction of allyl carbonate II.89.  
 
 
5.2 Screening and Optimization of the Intramolecular CADA Reaction of Allyl 
Naphthol Ethers  
As a result of the screenings and the NMR experiment we decided to simplify our reaction 
system in such a way that the allyl ether II.91 was used directly instead of the allyl carbonate 
II.89. Thus, the decarboxylation step would be omitted and the mechanism simplified.  
The screening of the best conditions for the dearomatization of the allyl naphthol started in the 
same way as with the allyl carbonate. First of all, the racemic dearomatization with Pd(PPh3)4 
was tested with various solvents (Table 29). Overall, the yields were slightly better than with the 
carbonate, but still an inseparable mixture of II.90 and II.92 was isolated. Again, the 
comparison of degassed and non-degassed dioxane (entries 2 and 3) showed a better result for 
the non-degassed solvent.  
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Table 29 Screening of conditions for the racemic dearomatization reaction of allyl ether II.91. 
 
entry catalyst[a] solvent[b] result ratio of II.90 : II.92[f] 
1 Pd(PPh3)4 n-hexane/toluene (1:10) II.91 - 
2 Pd(PPh3)4 1,4-dioxane[c] II.90 + II.92 (45%)[e] 1 : 0.24 
3 Pd(PPh3)4 1,4-dioxane II.90 + II.92 (38%)[e] 1 : 0.50 
4 Pd(PPh3)4 THF[d] II.90 + II.92 (47%)[e] 1 : 0.27 
5 Pd(PPh3)4 CH2Cl2 II.90 + II.92 (34%)[e] 1 : 0.92 
6 Pd(dba)2, PPh3[g] THF - - 
[a] 10 mol% catalyst were used; [b] solvents were degassed via freeze-pump-thaw; 0.04 M; [c] not degassed; [d] 0.02 M solution; [e] isolated as an inseparable mixture; [f] determined by 1H NMR spectroscopy; [g] Pd(dba)2 (5 mol%) and PPh3 (11 mol%). 
 
We then changed to chiral ligands and began with the (S,S)-DACH-phenyl Trost ligand 
((S,S)-L1) (Table 30). The ee of all reactions turned out to be independent of the reaction 
conditions and was always around 60% (entries 1–4). The best isolated yield was observed for 
entry 1 with 84%. With the (S,S)-ANDEN-phenyl Trost ligand ((S,S)-L3) no conversion could 
be detected (entries 5 and 6). The (S,S)-DACH-naphthyl Trost ligand ((S,S)-L7) afforded the 
highest ee with 78% but the yields were low (entries 7–10). Additionally to the well-established 
ligands, the (R)-QUINAP ligand (R)-L8 was tested, yet with no success (entry 11). The yield was 
only 19% and no ee at all was detected. All these results are in accordance with the previous ones 
of the allyl carbonate II.89: (S,S)-L1 provides good yields, (S,S)-L7 good ee’s and (S,S)-L3 is not 
able to undergo an oxidative addition to the allyl ether. However, a still ongoing challenge is the 
combination of a good yield and ee in one experiment.  
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Table 30 Screening of conditions for the CADA reaction of allyl naphthol II.91.  
 
entry ligand[a] solvent[b] T [°C] result [%][c] ee [%][d] 
1 (S,S)-L1 benzene 45 II.90: 88 (84) 59 
2 (S,S)-L1 benzene[e] 45 II.90: 84 (76) - 
3 (S,S)-L1 benzene 35 II.90: 69 (68) 60 
4 (S,S)-L1 benzene 23 II.90: 62 (57) 62 
5 (S,S)-L3 benzene 45 II.91 - 
6 (S,S)-L3 1,4-dioxane 45 II.91 - 
7 (S,S)-L7 benzene 45 II.90: 17 (16) 78 
8 (S,S)-L7 benzene[e] 45 II.90: 18 - 
9 (S,S)-L7 1,4-dioxane 45 II.90: 25 (24) 73 
10 (S,S)-L7 1,4-dioxane[e] 45 II.90: 18 - 
11 (R)-L8[f] THF[e] 45 II.90: (19) 0 
[a] 11 mol% ligand was used; [b] solvents were not degassed; 0.05 M; [c] yield was determined by 1H NMR (CDCl3, 400 or 600 MHz, dimethyl sulfone-d6 as internal standard); yield in parentheses refer to isolated yield; [d] determined by chiral HPLC analysis of the isolated product; [e] solvents were degassed via freeze-pump-thaw; [f] 12.5 mol% ligand were used. 
 
Thus, we tried to optimize the ratio of the catalyst to the ligand (Table 31). The best result was 
obtained with 4 mol% catalyst and 8.8 mol% ligand (entry 5), however, the yield was similar to 
the conditions, which were used before and the ee was even lower. Therefore, the screening did 
not lead to optimization of the reaction.  
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Table 31 Screening for different catalyst to ligand ratios.  
 
entry catalyst ligand solvent[a] result [%][b] ee [%][c] 
1 Pd2(dba)3 (5 mol%) (S,S)-L1 (10 mol%) benzene[d] II.90: 72 (76) 53 
2 Pd2(dba)3 (5 mol%) (S,S)-L1 (9 mol%) benzene[d] II.90: traces - 
3 Pd2(dba)3 (5 mol%) (S,S)-L1 (9 mol%) benzene II.90: 36 (33) 60 
4 Pd2(dba)3 (5 mol%) (S,S)-L1 (8 mol%) benzene[d] II.91 - 
5 Pd2(dba)3 (4 mol%) (S,S)-L1 (8.8 mol%) benzene II.90: 85 (87) 49 
6 Pd2(dba)3 (3 mol%) (S,S)-L1 (6.6 mol%) benzene[d] II.90: 76 - 
7 Pd2(dba)3 (3 mol%) (S,S)-L1 (6.6 mol%) benzene II.90: 66 (56) 61 
[a] solvents were not degassed; 0.05 M; [b] yield was determined by 1H NMR (CDCl3, 400 or 600 MHz, dimethyl sulfone-d6 as internal standard); yields in parentheses refer to isolated yields; [c] determined by chiral HPLC analysis of the isolated product; [d] solvents were degassed via freeze-pump-thaw.  
 
In addition to this experiment and due to the fact that reproducibility was still a problem, we 
also investigated other Pd-catalysts such as Pd(OAc)2, Pd(t-Bu3P)2, Pd(dppe)2 and Pd(dmdba)2 
(Table 32). The first three catalysts, Pd(OAc)2, Pd(t-Bu3P)2 and Pd(dppe)2, did not show any 
reactivity and no conversion of the starting material was observed (entries 1–6). Pd(dmdba)2 in 
contrast provided the product in up to 68% yield (entry 9) and 48–60% ee. Changing the ligand 
from (S,S)-L1 to (S,S)-L7 was unsuccessful and no conversion of II.91 took place (entries 14–
16). However, all four catalysts were not able to compete with Pd2(dba)3.  
 
Table 32 Screening of different catalysts and solvents.  
 
entry catalyst[a] ligand[b] solvent[c] result[d] ee [%][d] 
1 Pd(OAc)2 (S,S)-L1 benzene II.91 - 
2 Pd(OAc)2 (S,S)-L1 benzene/CH2Cl2 II.91 - 
3 Pd(OAc)2 (S,S)-L1 CH2Cl2 II.91 - 
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4 Pd(OAc)2 (S,S)-L1 THF II.91 - 
5 Pd(t-Bu3P)2 (S,S)-L1 benzene II.91 - 
6 Pd(dppe)2 (S,S)-L1 benzene II.91 - 
7 Pd(dmdba)2 (S,S)-L1 benzene II.90 (41%) 60 
8 Pd(dmdba)2 (S,S)-L1 benzene[e] II.90 (63%) 60 
9 Pd(dmdba)2 (S,S)-L1 toluene II.90 (68%) 57 
10 Pd(dmdba)2 (S,S)-L1 toluene[e] II.90 (47%) 55 
11 Pd(dmdba)2 (S,S)-L1 1,4-dioxane II.90 (55%) 55 
12 Pd(dmdba)2 (S,S)-L1 THF II.90 (traces) - 
13 Pd(dmdba)2 (S,S)-L1 1,2-dichlorobenzene II.90 (60%) 48 
14 Pd(dmdba)2 (S,S)-L7 benzene II.91 - 
15 Pd(dmdba)2 (S,S)-L7 toluene II.91 - 
16 Pd(dmdba)2 (S,S)-L7 1,4-dioxane II.91 - 
[a] 10 mol% catalyst were used; [b] 11 mol% ligand was used; [c] solvents were not degassed; 0.05 M; [d] determined by chiral HPLC analysis of the isolated product; [e] solvents were degassed via freeze-pump-thaw. dmdba = 3,5,3′,5′-dimethoxydibenzylideneacetone.  
 
 
5.3 Substrate Scope of the Intramolecular CADA Reaction of 1-Naphthols 
Although the screenings did not afford optimal conditions for the intramolecular CADA 
reaction of C2-substituted 1-naphthols, a few substrates with different substitution patterns 
were synthesized. The adopted conditions are depicted in Scheme 84. All reactions were carried 
out at 0.1 mmol scale and as a 0.05 M solution in benzene. The three products I.89, II.95 and 
I.105 could be isolated in very good yields, yet only in very low to moderate ee. For the 
brominated substrate II.96, which was obtained in 83% yield, the ee could not be determined 
due to insufficient separation by HPLC. The crude 1H NMR of tricyclic lactone I.109 showed 
full conversion toward the product, but unfortunately the dba ligand turned out to be co-polar 
with the product I.109 and thus purification and determination of the ee was impossible. A 
similar problem appeared for II.97 and II.98. The crude 1H NMR showed conversion toward 
the products, albeit imperfect, but the dearomatized products and the corresponding starting 
materials appeared to be co-polar. A heterocyclic substrate was tested as well, but the quinoline 
derivative II.99 did not undergo any reaction at all. Last but not least a fluorinated amide was 
subjected to the CADA conditions, but instead of the dearomatized product, the Cope 
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rearrangement product II.100 was observed. Unfortunately, it could not be isolated, since it was 
co-polar with the dba.  
 
 
Scheme 84 Substrate scope of the CADA reaction of 1-naphthols. 
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6 Conclusion and Outlook 
 
In summary, the development of a Pd-catalyzed allylic dearomatization of 2-methyl-1-naphthols 
has been investigated in this thesis. We were able to overcome the challenge of rearomatization 
via subsequent Cope rearrangement by utilizing mild and neutral conditions. Diallylation caused 
by ion diffusion was obviated by the use of more elaborate chiral ligands. Initial screenings with 
allyl carbonate II.89 gave yields up to 83% (Scheme 85), and the reaction was also analyzed by 
NMR spectroscopy. These studies revealed that the decarboxylation reaction occurred rapidly 
and resulted in the in the formation of the O-allylated naphthyl ether, which was then converted 
to the product. Based on this and previous results, a mechanism was proposed for the 
intramolecular CADA reaction of 1-naphthols.  
 
 
Scheme 85 Intramolecular CADA reaction of 1-naphthols.  
 
The second part of the screenings was performed with allyl naphthyl ether II.91 which afforded 
overall slightly higher yields and ee values as compared to the carbonate. However, the observed 
ee values were still moderate. The best ee values (up to 78%) were in general obtained with the 
(S,S)-DACH-naphthyl Trost ligand ((S,S)-L7), yet with poor yields. This proved to be an 
ongoing problem throughout the screenings. We therefore primarily focused on the 
optimization of the yield of the allylation. The best conditions were tested with a few substrates, 
and dearomatized products were obtained in yields of 83–94%. The only drawback was the 
difficult product isolation due to similar polarities of starting material and ligand of the used 
precatalyst.  
Future efforts would involve screenings with (S,S)-DACH-naphthyl Trost ligand ((S,S)-L7) in 
combination with more additives ((chiral) Lewis acids, salts, bases, etc.) to enhance the ee and 
yields. It would also be interesting and helpful to gain deeper insight into the mechanism of the 
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dearomatization reaction. Thus, labeling and cross-over experiments, similar to the ones of 
Trost and Stoltz (see introduction), would be useful. To perform all those experiments in a 
reproducible form, it would be necessary to conduct the experiments in a glove box.  
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7 Introduction† 
 
Within the family of commercially available trihaloethene derivatives, 1,1,2-trichloroethene 
(III.20, TCE, b.p. 87 °C) is by far the most commonly used reagent. Dr. E. Fischer (not 
Hermann Emil Fischer) achieved the first synthesis of III.20 in 1864 by reductive 
dehalogenation of hexachloroethane with hydrogen.171 Since then, TCE (III.20) has gained 
major importance in various industrial applications.172 The ease of preparation of large quantities 
of this non-flammable, volatile organic compound led to a staggering global consumption of 
428.6103 t in 2011. Of this, 84% of the total production volume in the USA were used as an 
intermediate for manufacturing the refrigerant 1,1,1,2-tetrafluoroethane (HFC-134a) and 15% as 
a solvent for metal degreasing.172,173 TCE (III.20) is classified as human carcinogen, and its 
toxicity has been investigated and discussed in detail.173,174 Amongst other factors, the toxicity 
associated with III.20 has led to continuously decreasing production rates in the industry.172,175  
Since the preparation of III.20 has been extensively studied over the years, only a selection of 
approaches will be provided. There are several feedstock chemicals that can be used to 
synthesize TCE (III.20). One such feedstock is acetylene, which is converted to III.20 via a 
chlorination-dehydrochlorination pathway.172 A different approach is the oxychlorination of 
ethene to afford III.20. In this reaction, the chlorine source is hydrogen chloride, which is 
oxidized according to the Deacon process.172,176,177 Tetrachloroethene can also be converted into 
TCE (III.20) via hydrogenolysis with transition metal catalysts.178 
Trihaloethenes in general are versatile C2-building blocks that can be simply modified via 
addition, elimination and transition metal-catalyzed reactions (Figure 15). 
 
 
Figure 15 Overview over the reactivity of trihaloethenes.  
                                                 
† The introduction of chapter III has been adapted from the review “Trihaloethenes as Versatile Building Blocks for Organic Synthesis” - A. S. Grossmann, T. Magauer*, Org. Biomol. Chem. 2016, 14, 5377–5389. 
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An example for an addition reaction was published by Tarrant et al. They prepared fluorine-
containing vinyllithium reagents using III.1. Treatment with a variety of carbonyl compounds 
III.2 afforded the corresponding 1,2-addition products III.3 and III.4 (Scheme 86).179  
 Scheme 86 a) 1,2-Addition of trihalovinyllithium reagents to carbonyl compounds III.2. b) Reaction mechanism for the 1,3-rearrangement of III.5. 
 
The group of Tellier has published fundamental work on Claisen rearrangements of halogenated 
vinyl ether for the synthesis of halogenated acids and esters such as III.10, III.12 and III.14 
(Scheme 87).180,181,182 The requisite halogenated enol ethers are formed by an addition-elmination 
reaction of allylic alkoxides III.9 and halogenated ethylene derivatives III.8, III.11 and III.13. 
Following this strategy, they were able to introduce bromine, fluorine and trifluoromethyl 
groups at the Ư-position of an acid or ester.  
 
Scheme 87 Claisen rearrangements of allyl halovinyl ethers. 
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Mani and Sales discovered an intramolecular 1,3-dipolar cycloaddition one-pot protocol for the 
concise synthesis of benzofuropyrazoles (Scheme 88).183 Starting from salicylaldehyde (III.15), 
the corresponding dichlorovinyl ether was generated and treated with benzenesulfonyl hydrazide 
to form the corresponding hydrazine. Raising the temperature to 50 °C afforded 
aryldiazomethane III.16, which spontaneously cyclized to form chloropyrazole III.17 in 55% 
overall yield. The product could be further functionalized by Buchwald‒Hartwig or Suzuki–
Miyaura cross-coupling reactions.  
 
 
Scheme 88 A one-pot protocol for the synthesis of benzofuropyrazoles.  
 
Since the reactivities of the three C-Cl bonds of TCE (III.20) differ significantly from each 
other, it can be used as versatile reagent for cross-coupling reactions. Hultin exploited the 
unique reactivity of III.20 which enabled the preparation of highly substituted ethene 
derivatives in a controlled fashion (Scheme 89).184 In each case, the first step involves formation 
of a (E)-1,2-dichlorovinyl ether III.21 by an elimination-addition reaction. As depicted in route 
A, deprotonation of the C(2)-H group in III.21 followed by subsequent addition of an 
electrophile allows the preparation of substituted 1,2-dichlorovinyl ether III.26. In route B, the 
C(1)-Cl group of III.21 is able to participate in cross-coupling reactions just as the C(2)-Cl 
group in the ensuing step (route C). The trisubstituted alkene III.25 can be obtained via route C. 
Route D starts from III.22 as well, but the following step involves the deprotonation of C(2)-H 
and replacement with an electrophile. A further cross-coupling reaction of the C(2)-Cl group of 
III.23 then gives rise to the tetrasubstituted alkene III.24. 
However, there are limitations to the reaction pathways depicted in route A and C. While 
Suzuki‒Miyaura cross coupling reactions at the C(1)-Cl group of product III.26 (route A) were 
not stereoselective, Sonogashira cross-couplings proved to be unsuccessful at all. In route C, 
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deprotonation of the C(2)-H group of III.25 was problematic and generation of a 
tetrasubstituted alkene was not possible via this route.184 
 
 
Scheme 89 Reaction sequences for the functionalization of III.20. 
 
The unique reactivity of the trihaloethenes was also used in the total synthesis of natural 
products. One example is Poisson’s total syntheses of (–)-swainsonine (III.34) and 
(+)-6-epicastanospermine (III.35), which started with the preparation of the chiral 
1,2-dichloroenol ether III.28 (Scheme 90).185 Treatment of III.28 with two equivalents of 
n-butyllithium gave rise to the corresponding acetylide, which was treated with allyl iodide to 
afford the ynol ether III.29. After selective reduction of the alkine moiety to the Z-double bond 
using DIBAL-H, a [2+2] cycloaddition with in situ generated dichloroketene took place, yielding 
cyclobutanone III.30. Tamura’s reagent (III.31) was then used for the Beckmann ring 
expansion to yield a dichlorolactam, which was dechlorinated with zinc-copper couple in acidic 
medium. The so formed pyrrolidinone III.32 was converted to the indolizidinone III.33 in 
seven further steps. ()-Swainsonine (III.34) and (+)-6-epicastanospermine (III.35) were 
prepared in eight and four steps, respectively, from this common indolizidinone precursor. 
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Scheme 90 Synthesis of an intermediate for the synthesis of (–)-swainsonine (III.34) and (+)-6-epicastanospermine (III.35). 
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8 Results and Discussion 
 
Prior to this Ph.D. thesis, the synthesis of 2-chloropent-4-enoic acid (III.44) from allyl alcohol 
(III.41) and TCE (III.20) was already investigated in our group. The envisaged product could 
be obtained by utilizing a part of a methodology published by Greene in 1987, who reported the 
synthesis of acetylenic ethers from simple alcohols and TCE (III.20).186 Mechanistically, the 
reaction commenced with the formation of a 1,2-dichlorovinyl ether, via an elimination-addition 
sequence. Such transformations, also referred to as condensation187 or substitution188,189 
reactions, occur readily with TCE (III.20). Seminal studies concerning the mechanism 
were performed by Kende.187 A detailed mechanism, which is based on these findings, 
described by Hultin (Scheme 91).189 
 
 
Scheme 91 Mechanism of the elimination-addition reaction of III.20 using potassium phenolates III.37. 
 
The previous studies continued at this point. By using allyl alcohol (III.41) the reaction did not 
stop at the 1,2-dichlorovinyl ether III.42, but underwent a subsequent Claisen rearrangement via 
a 6-membered transition state according to the Zimmerman-Traxler model. The resulting 
Ư-halogenated acid chloride III.43 was finally hydrolyzed during the work-up (Scheme 92).  
 
 
Scheme 92 General synthesis of 2-chloropent-4-enoic acid (III.44).  
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In this project, we envisaged to investigate a general methodology for the Claisen rearrangement 
of 1,2-dichlorovinyl ethers toward Ư-chloro-4-enoic acids (III.46) (Scheme 93). This approach 
was also extended by the possibility to generate 2,4-dienoic acids (III.47) via formal HCl 
elimination of the Ư-chloro-4-enoic acids (III.46). In addition, the development of a one-pot 
protocol for the preparation of the dienes should be established.  
 
 
Scheme 93 Envisaged reaction pathway for the synthesis of Ư-chlorinated 4-pentenoic acids (III.46) and 2,4-dienoic acids (III.47). 
 
 
8.1 Progress toward α-Chloro-4-enoic Acids 
Due to the previous promising studies, the first intention was to evaluate, if the conditions for 
the preparation of 2-chloropent-4-enoic acids (III.46) tolerate various substitution patterns of 
the allylic alcohols (III.45). Therefore, several substrates were treated with KH (2.4 equiv) at 
low temperatures followed by the addition of TCE (III.20, 1.2 equiv) (Scheme 94). The reaction 
mixture was allowed to warm to 23 °C and was hydrolyzed with saturated aqueous NH4Cl 
solution. The crude 1H NMR spectra of all reactions looked quite promising. Unfortunately, the 
crude reaction products could not be purified by flash column chromatography on silica gel due 
to decomposition. We therefore tested a variety of purification methods, such as 
recrystallization, acid/base extraction, reverse-phase flash column chromatography and flash 
column chromatography on Florisil®. However, all purification approaches were met with 
failure. For this reason, the structure verification of the obtained products was only possible by 
NMR spectroscopy of the crude reaction mixture or subsequent elimination of the chloride. 
Nonetheless, several products could be identified: III.44, III.56, III.57, III.58, III.59, III.60 
and III.61. Interestingly, cinnamyl alcohol (III.50) and crotyl alcohol (III.51) afforded cinnamyl 
ester III.59 and crotyl ester III.58 instead of the corresponding acids. Trans-2-hexenol (III.54) 
gave a mixture of acid III.59 and the corresponding hexenol ester III.60. Despite the drawback 
CHAPTER III  109 
 
concerning the purification we were able to see that the reaction in principal tolerates 
substituents on all positions of the allyl chain.  
 
 
Scheme 94 Claisen rearrangement of various allylic alcohols. 
 
To show an example of a product analysis, the assigned 1H and 13C NMR spectra of the crude 
diastereomeric mixture of acid III.60 and its corresponding ester III.61 are depicted in Figure 
16. The assignment of the peaks was carried out by 2D NMR spectra. The 13C NMR signal at 
174 ppm refers clearly to the carbonyl group of III.60 and the one at 169 ppm to the the 
carbonyl group of ester III.61. In the 1H NMR spectrum, the doublets of 2 and 13 belong to the 
CHCl moieties of the anti-diastereomer of both III.60 and ester III.61. 2* and 13* belong to the 
corresponding syn-isomers. 
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Figure 16 1H and 13C NMR spectra of a diastereomeric mixture of acid III.60 and the corresponding hexenol ester III.61. * indicates the syn-isomer.  
 
During the screening of various allylic alcohols, we observed that for all substrates, except for 
III.41, large amounts of remaining starting material were detected. A possible explanation for 
this might be the incomplete formation of the enol ether. Therefore, we decided to focus on 
one substrate and try to optimize the reaction conditions. The selected substrate was 
trans-2-hexen-1-ol (III.54) and different addition orders as well as various substrate ratios were 
screened (Table 33). However, the results were only moderate. The best d.r. and overall yield, 
determined by 1H NMR, was afforded in entry 1. An excess of TCE (III.20) decreased both the 
yield and the d.r. significantly (entry 2). With an excess of III.54 (entry 4), only ester III.60 
could be identified. 
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Table 33 Screening of conditions for the Claisen rearrangement with trans-2-hexen-1-ol (III.54) as substrate. 
 
entry conditions[a] comment result[b],[c] 
1 KH, III.54, 0 °C to 23 °C,  
then III.20, ‒78 °C to 23 °C 
 III.59 (34%), 
d.r. = 4.3 : 1 
III.60 (26%), 
d.r. = 1.4 : 1 
2 KH, III.54, 0 °C to 23 °C,  
then III.20, ‒78 °C to 23 °C 
ratio III.54 : KH : III.20 = 
1 : 2.4 : 2 
III.59 (8%), 
d.r. = 1.4 : 1 
III.60 (9%), 
d.r. = 0.9 : 1 
3 KH, III.54, 0 °C to 23 °C,  
then mixture added to III.20, ‒78 °C 
to 23 °C 
 III.59 (15%), 
d.r. = 1.2 : 1 
III.60 (13%), 
d.r. = 1 : 1 
4 KH, III.54, 0 °C to 23 °C,  
then III.20, ‒78 °C to 23 °C 
ratio III.54 : KH : III.20 = 
3 : 2.4 : 1.2 
III.60 (39%), 
d.r. = 1 : 1 
5 KH, III.54, 23 °C,  
then III.20, ‒78 °C to 23 °C 
 III.59 (13%) 
III.60 (9%), 
d.r. = 1.2 : 1 
6 KH, III.20, 23 °C,  
then mixture added to III.20, 0 °C 
ratio III.54 : KH : III.20 = 
1 : 1 : 1 
III.60 (30%) 
[a] ratio III.54 : KH : III.20 = 1 : 2.4 : 1.2 unless otherwise noted; [b] the yield was determined by 1H NMR spectroscopy (CDCl3, 400 MHz; mesitylene as internal standard); [c] d.r. = anti : syn. 
 
Since Tellier, who has published similar reactions,180,181,182,190 quenched the enol ether with 
aqueous H2SO4 instead of saturated aqueous NH4Cl, we tested his procedure for our reactions 
(Table 34). Surprisingly, the d.r. of III.60 improved significantly (up to 99:1 in entries 3 and 7). 
Furthermore III.60 was obtained exclusively, even though the yield was still quite low. Longer 
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reaction time at −27 °C (entries 4, 5, 6, 7, 8) or different addition orders of alkoxide and TCE 
(III.20) (entries 1 and 2) did not make any difference. The same result was provided by less 
equivalents of H2SO4 (entriy 7) as well as varied ratios of allyl alcohol (III.54) and TCE (III.20) 
(entries 5 and 6). Another test was to add methanol (entry 8) or hexafluoro-2-propanol (entry 9) 
to generate the corresponding ester directly when the Claisen rearrangement takes place, but 
only III.54 and traces of III.61 were observed. 
 
Table 34 Screening of conditions for the Claisen rearrangement with III.54. 
 
entry conditions[a] comment result[b],[c] 
1 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C, then H2SO4 (10%), 23 °C 
 III.60 (13%), 
d.r. = 19 : 1 
2 KH, III.54, 0 °C to 23 °C, 
then III.20, ‒78 °C to ‒27 °C, 
then H2SO4 (10%), 23 °C 
 III.60 (14%), 
d.r. = 13.3 : 1 
3 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C, 
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 1 : 4 : 1.2 : 1.2  
III.60 (10%), 
d.r. = 99 : 1 
4 1) KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 1.5 h at ‒27 °C, 
then H2SO4 (10%), 23 °C  
 III.60 (25%), 
d.r. = 15.7 : 1 
5 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 45 min at ‒27 °C, 
III.54 : KH : III.20 : H2SO4 
= 1.8 : 2.4 : 1.2 : 1.2 
III.60 (28%), 
d.r. = 15.7 : 1 
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then H2SO4 (10%), 23 °C 
6 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 45 min at ‒27 °C,  
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 2.4 : 2.4 : 1.2 : 1.2 
III.60 (37%), 
d.r. = 13.3 : 1 
7 1) KH, III.54, 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 50 min at ‒27 °C, 
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 1 : 2.4 : 1.2 : 0.55  
III.60 (26%), 
d.r. = 99 : 1 
8 KH, III.54, 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 50 min at ‒27 °C, 
then MeOH, 23 °C 
3 equiv of MeOH III.54 and 
traces of III.20 
9 KH, III.54, 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 50 min at ‒27 °C, 
then HFIP, 23 °C 
3 equiv of HFIP III.54 and 
traces of III.20 
[a] ratio III.54 : KH : III.20 : H2SO4 = 1 : 2.4 : 1.2 : 1.2 unless otherwise noted; [b] the yield was determined by 1H NMR spectroscopy (CDCl3, 400 MHz; mesitylene as internal standard); [c] d.r. = anti : syn. 
 
Even though the obtained d.r. was now excellent, the yield of the reaction remained low and 
large amounts of remaining starting material were still observed after the work-up. Thus, we 
performed a 1H NMR experiment, to examine the dependence of the formation of the enol 
ether on the reaction time (Figure 17). The 1H NMR spectra were measured every 10 °C, 
beginning at −80 °C and increasing the temperature every 15 min until reaching −30 °C. Since 
we assumed the enol ether formation at around −30 °C, the temperature was held there for 2 h 
and every 15 min a 1H NMR spectrum was measured. Afterwards the reaction was gradually 
warmed to −10 °C while monitored by 1H NMR as well. As expected, the formation of the enol 
ether started at −30 °C (singlet at 5.8 ppm). The peak increased during the first 45 min (from 
−30 ° (1) to −30 ° (4)) and remained rather constant. The conclusion of this observation is that 
the formation of the enol ether reaches an equilibrium at −30 °C, which could most likely be 
shifted to the product side by rising the temperature. Unfortunately it is not possible to warm 
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the reaction to considerably higher temperatures, since the Claisen rearrangement is taking place 
between −10 °C and 0 °C. The product of the Claisen rearrangement, an acid chloride, reacts 
rapidly with the present alkoxide to form an ester. Thereby, the alkoxide is removed from the 
equilibrium of the enol ether formation.  
 
 
Figure 17 1H NMR study of the Claisen rearrangement of trans-2-hexen-1-ol (III.54) (400 MHz, THF-d8). 
 
A different strategy to improve the reaction was to prepare dichloroacetylene (DCA, III.38) 
directly instead of generating it in situ. Seminal studies were published about the 
dehydrochlorination of TCE (III.20).188 If III.20 is treated with a strong base, -elimination 
leads to the formation of DCA (III.38).191 A procedure of 1961 reports the passage of a gaseous 
mixture of III.20 in diethyl ether through pyrex tubes, which contain a potassium 
hydroxide/calcium oxide mixture.192 Another synthesis of III.38 was carried out via phase-
transfer catalysis (PTC).191d,193 While Kende reported the use of LHMDS for the deprotonation 
of III.38,194 KH and a catalytic amount of methanol was used by Greene for this transformation 
(Scheme 95).191b  
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A solution of III.38 in diethyl ether proved to be a practical method for the handling of this 
reagent, since a rather stable diethyl ether-DCA (III.38) complex is formed. Pure III.38 is a 
highly explosive and toxic reagent.188,195 
 
 
Scheme 95 Preparation of dichloroacetylene (DCA) (III.38). 
 
Utilizing DCA (III.38), the formation of the enol ether and the subsequent Claisen 
rearrangement was performed with various ratios of III.54 : KH : III.38 (Table 35). However, 
the replacement of III.20 by III.38 did not result in any difference. III.59 and III.60 were 
obtained in the same low to moderate yields as before. With t-BuOK (entry 6) only ester III.60 
was observed in low yield. In another attempt, III.54 was added at 0 °C to a mixture of KH, 
methanol and III.38, but only a diastereomeric mixture of dienes III.61a and III.61b was 
obtained in 33% yield (entry 8). A crystal structure could be obtained of Z-isomer III.62b, 
which confirmed the formation of the dienes (Figure 18).  
 
Table 35 Screening for conditions of the Claisen rearrangement with DCA (III.38).  
 
entry conditions comment result[a],[b] 
1 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 1 : 1.1 : 2 
III.60 (34%), d.r. = 10 : 1 
III.61 (12%), d.r. = 1.5 : 1 
2 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 1 : 1.1 : 3 
III.60 (30%) 
3 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 1 : 0.1 : 3 
III.54 and traces of III.61 
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4 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 3 : 1.5 : 1 
III.61 (56%), d.r. = 1 : 1 
5 KH, III.54, 23 °C, then 
III.38, 23 °C 
ratio III.54 : KH : III.38 
= 2 : 2 : 1 
III.61 (45%), d.r. = 1.1 : 1 
III.62 (18%), d.r. = 1 : 1.4[c] 
6 t-BuOK, III.54, 23 °C, 
then III.38, −30 °C 
ratio III.54 : t-
BuOK : III.38 = 
1.3 : 1 : 1.3 
III.61 (22%), d.r. = 1.3 : 1 
7 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 2 : 2 : 1 
III.60 (11%), d.r. = 6.14 : 1 
III.61 (8%), d.r. = 1 : 1.5 
III.62 (20%), d.r. = 1 : 1[c] 
8 KH, MeOH, 23 °C, then 
III.38, 0 °C, then III.54, 
0 °C (addition over 1.5 h) 
ratio III.54 : KH : III.38 : 
MeOH = 1 : 3 : 1 : 2 
III.62 (33%), d.r. = 1 : 1.3[c] 
[a] the yield was determined by 1H NMR spectroscopy (CDCl3, 400 MHz; mesitylene as internal standard); [b] d.r. = anti : syn; [c] d.r. = E : Z.  
 
 
Figure 18 X-ray structur of Z-diene III.62b.  
 
 
8.2 Progress toward 2,4-Dienoic Acids 
At this point, the screening for the optimal conditions for the enol ether formation and 
subsequent Claisen rearrangement were abandoned. Instead, we focused on the formation of the 
2,4-dienoic acids. This project was initially started to verify the structures of the 
Ư-chloro-4-enoic acids, since these were difficult to isolate in pure form. However, we then 
began to investigate this methodology further, also with the goal to develop a one-pot procedure 
based on the allylic alcohols.  
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For the initial screening, 2-chloropent-4-enoic acid (III.44) was used, due to the fact that its 
formation proceeded rather smoothly. Various bases, such as t-BuOK, DBU, KOTMS and 
NaOH were tested in combination with several solvents (Table 36). The best result was 
obtained for t-BuOK in t-BuOH (entry 1). Only product III.63 was observed in the crude 
1H NMR spectrum, but it turned out that III.63 partially decomposed (polymerization) during 
flash column chromatography on silica gel or Florisil®. Extraction via acid-base treatment failed 
as well. This observation is however not astonishing, since such diens tend to polymerize very 
easily. The commercially available (E)-penta-2,4-dienoic acid (III.63), for instance, contains 
hydroquinone as stabilizer to prevent polymerization.196 For this reason, the conversion of the 
reactions was only monitored by 1H NMR spectroscopy. 
Since the conditions of entry 1 seemed to be most promising, they were used for the subsequent 
screening. 
 
Table 36 Screening of various bases for diene synthesis. 
 
entry base conditions result 
1 t-BuOK (3.5 equiv) t-BuOH, 85 °C, 5 h III.63 
2 t-BuOK (3.5 equiv) t-BuOH, 50 °C, 4 h III.63+ traces of 45 
3 DBU (3.5 equiv) THF, 65 °C, 4 h III.44 
4 KOTMS (3.5 equiv) THF, 85 °C, 4.5 h III.63 : III.44 = 2 : 1[a] 
5 t-BuOK (2.1 equiv) t-BuOH, 85 °C, 4.5 h III.63 : III.44 = 3 : 1[a] 
6 t-BuOK (ca. 10 equiv) t-BuOH, 23 °C, 4.5 h III.63 + traces of III.44 
7 NaOH (3.5 equiv) i-PrOH, 85 °C, 5 h III.63 : III.44 = 6.7 : 1[a] 
[a] ratio determined by 1H NMR spectroscopy. 
 
Using the optimized elimination conditions, the products of the Claisen rearrangement were 
converted into the corresponding dienes (Table 37). However, the obtained dienes often 
decomposed upon purification by flash column chromatography on silica gel, but mass 
spectroscopy and 1H NMR spectroscopy of the crude reaction mixture allowed the 
determination of their structure. The reaction of a mixture of III.60 and III.61 (entry 1) 
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afforded the double bonds isomers III.62a and III.62b with a d.r. of = 1 : 3.5 after column 
chromatography. Acid III.64 (entry 2) was isolated in 60% yield and acid III.65 (entry 3) in 
18%, both after column chromatography. In entry 4, the ester III.58 must have been cleaved by 
the basic conditions to afford both isomers III.66a and III.66b as a mixture of double bond 
isomers (d.r. = 3 : 2).  
 
Table 37 Elimination reaction of various Ư-chloro-4-enoic acids (III.46). 
 
entry substrate product result[a],[b] 
1 
  
d.r. = 1 : 3.5 
2 
  
60% 
3 
  
18% 
4 
  
d.r. = 3 : 2 
[a] d.r. = E : Z was determined by 1H NMR spectroscopy; [b] yield refers to isolated yield. 
 
Since the preparation of 2,4-dienoic acids III.47 over two steps seemed to be promising, 
conditions for a one-pot protocol were screened (Table 38). For the first part of the reaction, 
the Claisen rearrangement, we used our standard conditions with TCE (III.20). For the second 
part, the elimination, various reaction parameter like temperature (entry 1), time (entries 3 and 4) 
and equivalents of t-BuOK (entries 2, 4, 5 and 6) were tested. The ratio of III.63a : III.44 was 
determined by 1H NMR spectroscopy. The best ratio of III.63a : III.44 for the 
t-BuOH/t-BuOK conditions was obtained by heating the mixture with to 85 °C for 5 h (entry 
CHAPTER III  119 
 
2). Traces of Z-diene III.63b were determined for all reactions with t-BuOH/t-BuOK (entries 
1–4 and 6). However, in the end we found out that using NaOH/i-PrOH was superior to all 
other tested conditions (entry 7). The ratio of III.63a : III.44 is 11.5 : 1 and the d.r. of 
III.63a : III.63b is 9 : 1. Therefore the conditions of entry 7 were used for the following one-
pot reactions. 
 
Table 38 Screening of conditions for the one-pot reaction. 
 
entry conditions ratio of III.63a : III.44[a] 
1 1) KH, THF, −50 °C to 23 °C, 2.5 h 
2) t-BuOK (3.5 equiv), 60 °C, 4.5 h 
2.3 : 1; traces of III.63b 
2 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (3.5 equiv), 80 °C, 4 h 
5.3 : 1; traces of III.63b 
3 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (3.5 equiv), 85 °C, 15 h 
3.5 : 1; traces of III.63b 
4 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (4 equiv), 85 °C, 15 h 
2.7 : 1 
5 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (2 equiv), 85 °C, 5 h 
2.3 : 1; traces of III.63b 
6 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (1.5 equiv), 85 °C, 5 h 
3 : 1; traces of III.63b 
7 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) i-PrOH, NaOH (3.5 equiv), 85 °C, 5.5 h 
ratio III.63a : III.44 = 11.5 : 1 
d.r. III.63a : III.63b = 9 : 1 
[a] ratios determined by 1H NMR spectroscopy. 
 
In Table 39, the established one-pot protocol was tested on a few substrates. In entry 1 an 
isomeric mixture of crotyl alcohol (III.51) was used. The diastereomers III.66a and III.66b 
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were isolated with a d.r. of 1 : 0.77. Diene III.64 (entry 2) was isolated in quantitative yield 
without the need of purification. Racemic cyclohexeneol (III.67), used in entry 3, was converted 
into III.68a and III.68b (d.r. = 1 : 1). In entry 4, only 4% of diene III.70 were obtained 
together with remaining allyl alcohol III.69. The product of entry 5 could be obtained, but no 
yield was determined.  
 
Table 39 One-pot reaction.  
 
entry substrate product result[a],[b] 
1 
  
d.r. = 1 : 0.77 
2 
  
III.64 (99%) 
3 
  
d.r. = 1 : 1 
4 
  
III.70 (4%) 
5 
  
III.72 (n. d.) 
[a] yields refer to isolated yields; [b] d.r. = E : Z determined by 1H NMR spectroscopy. 
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9 Conclusion and Outlook 
 
In summary, the Claisen rearrangement of allyl chlorovinyl ethers has been investigated in this 
thesis. We were able to obtain a variety of rearranged products and subsequently converted 
them to the corresponding 2,4-dienoic acids (III.47). A one-pot protocol for this reaction 
sequence, starting from readily available allyl alcohols (III.45), was established as well (Scheme 
96). Using a modified work-up procedure, the diastereomeric ratio of the Ư-chlorinated 
4-pentenoic acids (III.46) could be increased to 99 : 1 (anti : syn).  
 
 
Scheme 96 Synthesis of Ư-chlorinated 4-pentenoic acids (III.46) and 2,4-dienoic acids (III.47).  
 
However, since both carboxylic acid derivatives were very sensitive toward purification, their 
isolation and identification proved very complicated. In addition, the in situ formation of the 
1,2-dichlorovinyl ether was challenging as it proceeded slowly at −30 °C, but did not complete 
until −10 °C whereupon the Claisen rearrangement took place. For this reason, the yields of the 
rearrangement products were relatively low, and sometimes the Ư-chlorinated esters were 
isolated instead of the acids.  
Future experiments have to be dedicated to find an appropriate way to efficiently prepare the 
1,2-dichlorovinyl ethers and to purify the Ư-chlorinated acids and the 2,4-dienoic acids. With 
regard to the 2,4-dienoic acids, allyl alcohols with substituents at the C1-position would be 
beneficial, as such substitution prevents polymerization reactions. However, substrates such as 
3-methylbut-2-en-1-ol (III.49), containing two substituents at the C3-position, would be ideal 
for the Ư-chlorinated acids. The two substituents would generate a quaternary center at the 
ư-position of the Claisen rearrangement product and thus prohibit the elimination of chloride.  
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10 Experimental Part 
10.1 Materials and Methods 
General Experimental Details  
All reactions were performed in flame-dried glassware fitted with rubber septa under a positive 
pressure of argon, unless otherwise noted. Air- and moisture-sensitive liquids were transferred 
via syringe or stainless steel cannula through rubber septa. Solids were added under inert gas 
counter flow or were dissolved in appropriate solvents. Low temperature-reactions were carried 
out in a Dewar vessel filled with a cooling agent: acetone/dry ice (−78 °C), H2O/ice (0 °C). 
Reaction temperatures above room temperature were conducted in a heated oil or water bath. 
The reactions were magnetically stirred and monitored by NMR spectroscopy or analytical thin-
layer chromatography (TLC), using aluminium plates precoated with silica gel (0.25 mm, 60 Å 
pore size, Merck) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized 
by exposure to ultraviolet light (UV), were stained by submersion in aqueous potassium 
permanganate solution (KMnO4), ceric ammonium molybdate solution (CAM) or p-
anisaldehyde solution (ANIS) and were developed by heating with a heat gun. Flash 1 column 
chromatography was performed as described by Still et al.,197 employing silica gel (60 Å, 40–
63 μm, Merck KGaA). Flash‐column chromatography on silica gel using triethylamine 
pretreated silica gel was performed by preparing the silica gel slurry with triethylamine (1% v/v 
in corresponding eluent mixture) and flushing the column with the eluent prior to loading the 
compound on the column. The yields refer to chromatographically and spectroscopically (1H 
and 13C NMR) pure material. 
 
Materials 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled under N2 atmosphere from 
Na/benzophenone prior to use. Dichloromethane (CH2Cl2), triethylamine (Et3N), 
diisopropylamine (DIPA) and Hünig’s base (DIPEA) were distilled under nitrogen atmosphere 
from CaH2 prior to use. Dimethyl sulfoxide (DMSO), acetonitrile (MeCN), benzene, toluene, 
N,N-dimethylformamide (DMF), acetone, n-hexane, 1,4-dioxane,chlorobenzene, 
trifluorotoluene, 1,2-dichloroethane (DCE), Methyl tert-butyl ether (MTBE), Cyclopentyl methyl 
ether (CPME), dimethoxyethane (DME) and methanol (MeOH) were purchased from Acros 
Organics as 'extra dry' reagents and used as received. Potassium hydride (KH) (purchased as a 
30 wt% dispersion in mineral oil from Sigma-Aldrich) was washed three times with dry n-hexane 
124  Experimental Part 
 
and dried under vacuum prior to use. All other reagents and solvents were purchased from 
chemical suppliers (Sigma-Aldrich, Acros Organics, Alfa Aesar, Strem Chemicals, ABCR, 
Carbolution) and were used as received. Solvents for extraction, crystallization and flash column 
chromatography were purchased in technical grade and distilled under reduced pressure prior to 
use. The molarity of n-butyllithium solutions was determined by titration against diphenylacetic 
acid as an indicator (average of three titrations).198 
 
NMR spectroscopy 
NMR spectra were measured on a Bruker Avance III HD 400 MHz spectrometer equipped with 
a CryoProbeTM, Bruker AXR300, Varian VXR400 S, Bruker AMX600 or Bruker Avance HD 
800. Proton chemical shifts are expressed in parts per million (ppm, Ʋ scale) and are referenced 
to residual protium in the NMR solvent (CHCl3: Ʋ 7.26, methanol-d3: Ʋ 4.78, acetone-d5: Ʋ 2.05, 
CDHCl2: Ʋ 5.32). Carbon chemical shifts are expressed in parts per million (Ʋ scale, assigned 
carbon atom) and are referenced to the carbon resonance of the NMR solvent (CDCl3: Ʋ 77.16, 
CD3OD: Ʋ 49.00, acetone-d6: Ʋ 29.84, CD2Cl2: Ʋ 54.00). 1H NMR spectroscopic data are 
reported as follows: Chemical shift in ppm (multiplicity, coupling constants J (Hz), integration 
intensity, assigned proton). The multiplicities are abbreviated with s (singlet), br s (broad singlet), 
d (doublet), t (triplet), q (quartet) and m (multiplet). In case of combined multiplicities, the 
multiplicity with the larger coupling constant is stated first. Except for multiplets, the chemical 
shift of all signals, as well for centrosymmetric multiplets, is reported as the center of the 
resonance range. Additionally to 1H and 13C NMR measurements, 2D NMR techniques such as 
homonuclear correlation spectroscopy (COSY), heteronuclear single quantum coherence 
(HSQC) and heteronuclear multiple bond coherence (HMBC) were used to assist signal 
assignment. For further elucidation of 3D structures of the products, nuclear Overhauser 
enhancement spectroscopy (NOESY) was conducted. Coupling constants J are reported in Hz. 
All raw fid files were processed and the spectra analyzed using the program MestReNOVA 9.1 
from Mestrelab Research S. L. 
 
Mass spectroscopy 
All mass spectra were measured by the analytic section of the Department of Chemistry, 
Ludwig-Maximilians-Universität München. Mass spectra were recorded on the following 
spectrometers (ionization mode in brackets): MAT 95 (EI) and MAT 90 (ESI) from Thermo 
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Finnigan GmbH. Mass spectra were recorded in high-resolution. The used method is reported 
at the relevant section of the experimental section. 
 
IR spectroscopy 
IR spectra were recorded on a PerkinElmer Spectrum BX II FT-IR system. If required, 
substances were dissolved in CH2Cl2 prior to direct application on the ATR unit. Data are 
represented as follows: frequency of absorption (cm−1), and intensity of absorption (vs = very 
stong, s = strong, m = medium, w = weak). 
 
HPLC 
HPLC was performed with HPLC grade solvents. All solvents were degassed by a 
fluoroethylene membrane prior to use.  
Chiral HPLC spectra were recorded on a high performance liquid chromatography (HPLC) 
system from Shimadzu 20A series (DGU-20A3R degasser, LC-20AD Binary Pump VL, SIL-
20AHT autosampler, FCV-14AH thermostated column compartment, SPD-M20A IVDD diode 
array detector), which was computer controlled through Shimadzu LabSolutions Software 
(Version 5.42 SP5). Enantiomeric excess (ee) was calculated by using the following equation; m1 
refers to the integral of the major peak and m2 to the integral of the minor peak: 
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10.2 Experimental Procedures 
10.2.1 Salimabromide 
10.2.1.1 First Generation Approach 
 
5-Bromo-2-methyl-2,3-dihydro-1H-inden-1-one (I.76): 
 
To a suspension of sodium hydride (60% dispersion in mineral oil, 19.9 g, 497 mmol, 
2.00 equiv) and dimethyl carbonate (39.9 mL, 474 mmol, 2.00 equiv) in tetrahydrofuran 
(474 mL) in a 3-necked 1 liter round bottom flask fitted with a reflux condenser, dropping 
funnel and thermometer was added 5-bromo-1-indanone (I.70) (50.0 g, 237 mmol, 1 equiv) in 
tetrahydrofuran (677 mL) at 0 °C over 45 min. The dark brown reaction mixture was stirred at 
0 °C for 30 min, warmed very slowly to 23 °C and heated carefully to 70 °C for 15 h. 
Afterwards, it was cooled to 0 °C and diluted with saturated aqueous ammonium chloride 
solution (200 mL), aqueous hydrogen chloride solution (2 M; 200 mL) and diethyl ether 
(300 mL). The layers were separated and the aqueous layer was extracted with diethyl ether 
(3 × 400 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (300 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered through a short pad of Celite® and the filtrate was concentrated. The crude 
product I.71 was afforded as a dark brown solid and was used without additional purification for 
the next step.  
 
To crude I.71 in dry dimethyl sulfoxide (240 mL) was added potassium carbonate (65.5 g, 
474 mmol, 2.00 equiv) portionwise at 0 °C. After dropwise addition of methyl iodide (29.5 mL, 
474 mmol, 2.00 equiv) the dark green slurry was stirred at 23 °C for 2 h. The excess methyl 
iodide was removed by distillation (23 °C, 50 mbar). The reaction mixture was cooled to 0 °C, 
diluted with saturated aqueous ammonium chloride solution (100 mL), water (100 mL) and ethyl 
acetate (250 mL). The layers were separated and the aqueous layer was extracted with ethyl 
acetate (3 × 400 mL). The combined organic layers were washed with saturated aqueous sodium 
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chloride solution (300 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered through a short pad of Celite® and the filtrate was concentrated. The crude 
product I.72 was afforded as a dark brown solid and was used without additional purification 
for the next step. An analytical pure sample of I.72 was obtained by flash column 
chromatography on silica gel (9% ethyl acetate in hexanes).  
Analytical data for I.72: 
TLC (20% ethyl acetate in hexanes), Rf = 0.40 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.63 (s, 1H), 7.60 (d, J = 7.5 Hz, 1H), 7.51 (d, J = 8.6 Hz, 1H), 
3.69 (s, 1H), 3.64 (s, 3H), 2.95 (d, J = 17.3 Hz, 1H), 1.48 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 202.1, 172.0, 154.2, 133.5, 131.6, 130.9, 129.8, 126.1, 56.1, 52.9, 
39.6, 21.0. 
IR (Diamond-ATR, neat)     : 2953 (w), 1742 (s), 1710 (vs), 1594 (s), 1579 (m), 1428 (m), 
1317 (m), 1266 (s), 1200 (s), 1177 (s), 1095 (m), 1057 (m), 964 (s), 919 (m), 830 (m), 769 (m), 
668 (m), 593 (m) cm−1. 
HRMS (EI) calcd for C12H11O381Br [M]+: 283.9866; found: 283.9875. 
 
Crude I.72 was dissolved in water (82 mL), glacial acetic acid (400 mL) and aqueous hydrogen 
chloride solution (37%, 125 mL, 924 mmol, 3.90 equiv). The reaction mixture was heated to 
100 °C for 16 h. After cooling to 23 °C, the solution was diluted with dichloromethane 
(300 mL) and water (300 mL) and was carefully neutralized by portionwise addition of sodium 
bicarbonate (250 g) and aqueous sodium hydroxide solution (10%, 300 mL). The layers were 
separated and the aqueous layer was extracted with dichloromethane (3 × 400 mL). The 
combined organic layers were dried over sodium sulfate. The dried solution was filtered through 
a short pad of Celite® and the filtrate was concentrated. The crude product I.73 was afforded as 
a dark brown solid and was used without additional purification for the next step. An analytical 
pure sample of I.73 was obtained by flash column chromatography on silica gel (2% ethyl 
acetate in hexanes).  
Analytical data for I.73: 
TLC (20% ethyl acetate in hexanes), Rf = 0.56 (UV, KMnO4). 
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1H NMR (400 MHz, CDCl3) Ʋ: 7.63 – 7.56 (m, 2H), 7.49 (d, J = 8.1 Hz, 1H), 3.37 (dd, J = 18.1, 
8.8 Hz, 1H), 2.70 (dt, J = 12.1, 3.5 Hz, 2H), 1.29 (d, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 208.2, 155.2, 135.3, 131.1, 130.1, 129.9, 125.3, 42.1, 34.7, 16.3. 
IR (Diamond-ATR, neat)     : 2964 (w), 2930 (w), 1707 (vs), 1594 (vs), 1572 (m), 1412 (m), 
1318 (m), 1265 (m), 1199 (m), 1055 (m), 963 (s), 882 (m) 858 (m), 825 (m), 764 (m), 676 (m) cm−1. 
HRMS (EI) calcd for C10H9O81Br [M]+: 225.9811; found: 225.9814. 
 
To crude indanone I.73, dissolved in ethyl acetate (1 L) and chloroform (1 L), was added 
copper(II) bromide (106 g, 474 mmol, 2.00 equiv). The green suspension was stirred with a KPG 
stirrer, while it was heated to 70 °C. After 22 h, it was cooled to 23 °C, filtered through a short 
pad of Celite® and the filtrate was concentrated. The crude product I.74 was used without 
additional purification for the next step. An analytical pure sample of I.74 was obtained by flash 
column chromatography on silica gel (2% ethyl acetate in hexanes).  
Analytical data for I.74: 
TLC (20% ethyl acetate in hexanes), Rf = 0.57 (UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.72 (d, J = 8.2 Hz, 1H), 7.61 (s, 1H), 7.59 (d, J = 8.6 Hz, 1H), 
3.77 (d, J = 18.3 Hz, 1H), 3.47 (d, J = 18.3 Hz, 1H), 1.96 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 199.2, 150.7, 132.1, 131.7, 131.4, 129.8, 127.0, 59.2, 46.1, 26.8. 
IR (Diamond-ATR, neat)     : 1723 (vs), 1596 (s), 1575 (w), 1423 (w), 1320 (m), 1266 (w), 
1210 (w), 1057 (m), 973 (m), 900 (w), 857 (w), 831 (w) cm−1. 
HRMS (EI) calcd for C10H8O79Br2 [M]+: 301.8936; found: 301.8937. 
 
To crude indanone I.74 in benzene (474 mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene 
(106 mL, 711 mmol, 3.00 equiv) at 0 °C. After 5 min, the solution was warmed to 23 °C and was 
stirred for 45 min. The reaction mixture was diluted with saturated aqueous ammonium chloride 
solution (100 mL) and diethyl ether (200 mL). The layers were separated and the aqueous layer 
was extracted with diethyl ether (3 × 300 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (200 mL) and the washed solution was dried over 
sodium sulfate. The dried solution was filtered through a short pad of Celite® and the filtrate 
CHAPTER I  129 
 
was concentrated (>200 mbar). The crude product I.75 was afforded as a yellow-brown oil and 
was used immediately without additional purification for the next step. Note: Indenones undergo 
facile polymerizations and should therefore be used immediately after preparation.  
Note: For safety reasons the cyclopropanation was carried out in two parallel batches. The crude material of both 
batches was subsequently combined and purified together. 
To a stirred solution of lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 137 mL, 
137 mmol, 1.15 equiv) in tetrahydrofuran (119 mL) in a 3-necked 2 liter round bottom flask 
fitted with a reflux condenser, dropping funnel and thermometer, was added methyl 
dichloroacetate (12.9 mL, 125 mmol, 1.05 equiv) over 30 min at −78 °C. After stirring for 
105 min, a solution of crude I.75 in tetrahydrofuran (238 mL) was added over 1.5 h and after 
the addition, the reaction mixture was allowed to warm slowly to 23 °C. After 16 h, the mixture 
was cooled to 0 °C and diluted with saturated aqueous ammonium chloride solution (200 mL) 
and ethyl acetate (300 mL). The layers were separated and the aqueous layer was extracted with 
diethyl ether (3 × 300 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (200 mL) and the washed solution was dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography on silica gel (2 to 3.2% ethyl acetate in hexanes) to obtain I.76 
(38.9 g, 50% over 6 steps, inconsequential mixture of diastereomers) as a yellow solid.  
Analytical data for I.76: 
Note: Traces of the minor diastereomer are visible in the 1H and 13C NMR spectra, but solely the resonances of 
the major diastereomer are listed below. 
TLC (20% ethyl acetate in hexanes), Rf = 0.47 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.67 (s, 1H), 7.54 (s, 2H), 3.86 (s, 3H), 3.71 (s, 1H), 1.51 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 197.3, 165.9, 149.4, 134.5, 132.2, 129.9, 129.8, 125.3, 64.9, 53.9, 
42.8, 37.3, 9.9. 
IR (Diamond-ATR, neat)     : 2954 (w), 1717 (vs), 1597 (s), 1579 (m), 1435 (m), 1356 (w), 
1283 (m), 1260 (s), 1237 (s), 1206 (m), 1162 (m), 1107 (w), 1055 (m), 988 (w), 952 (m), 938 (m), 
889 (m), 836 (m), 788 (w), 777 (w), 738 (m) cm−1. 
HRMS (EI) calcd for C13H10O379Br35Cl [M]+: 327.9496; found: 327.9505. 
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Methyl 7-bromo-1-chloro-4-hydroxy-3-methyl-2-naphthoate (I.77): 
 
Note: The reaction was carried out in two parallel batches. The crude material of both batches was subsequently 
combined and purified together. 
A solution of I.76 (8.90 g, 27.0 mmol, 1 equiv) in sulfolane (54 mL) was heated to 190 °C for 
5.5 h and then cooled to 23 °C. The reaction mixture was diluted with diethyl ether (200 mL) 
and water (200 mL). The layers were separated and the aqueous layer was extracted with diethyl 
ether (3 × 300 mL). The combined organic layers were washed successively with saturated 
aqueous sodium chloride solution (200 mL) and water (3 × 300 mL) and the washed solution 
was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. 
The crude product was purified by flash column chromatography on silica gel (14% ethyl acetate 
in hexanes) to provide I.77 (13.8 g, 77%) as a brown solid.  
Analytical data for I.77: 
TLC (20% ethyl acetate in hexanes), Rf = 0.18 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.18 (s, 1H), 7.94 (d, J = 8.9 Hz, 1H), 7.57 (d, J = 8.9 Hz, 1H), 
5.65 (s, 1H), 4.02 (s, 3H), 2.25 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.5, 148.4, 133.5, 130.6, 130.5, 126.8, 124.2, 123.8, 122.2, 
118.9, 115.0, 53.2, 13.3. 
IR (Diamond-ATR, neat)     : 3330 (w), 2951 (w), 1695 (vs), 1619 (w), 1583 (m), 1558 (w), 
1439 (s), 1378 (m), 1361 (m), 1275 (vs), 1247 (vs), 1177 (m), 1111 (m), 1074 (m), 1053 (m), 962 (m), 
927 (s), 874 (m), 863 (m), 823 (vs), 761 (m), 741 (m) cm−1. 
HRMS (EI) calcd for C13H10O379Br35Cl [M]+: 327.9496; found: 327.9492. 
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Methyl 1-chloro-7-ethyl-4-hydroxy-3-methyl-2-naphthoate (I.78): 
 
Note: The reaction setup has to be flame-dried very carefully, since otherwise the yield decreases significantly.  
To [1,1'-Bis(diphenylphosphino)ferrocene]palladium(II) dichloride (400 mg, 0.546 mmol, 
0.0180 equiv) was added a solution of I.77 (10.0 g, 30.3 mmol, 1 equiv) in 1,4-dioxane (25 mL). 
The red suspension was cooled to 0 °C and a freshly prepared solution of diethylzinc (1 M in 
toluene, 60.1 mL, 60.7 mmol, 2.00 equiv) was added very carefully over 30 min. After the 
addition, the dark red mixture was allowed to warm to 23 °C over 30 min and the beige 
suspension was then heated very carefully to 90 °C. After 3 h, it was cooled to 0 °C and 
methanol (20 mL) was added dropwise. Water (100 mL) and aqueous hydrochloric acid solution 
(2 M, 100 mL) were added, the layers were separated and the aqueous layer was extracted with 
diethyl ether (3 × 200 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (200 mL). The washed solution was dried over sodium sulfate, the 
dried solution was filtered through a short pad of Celite® and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (9% ethyl acetate in 
hexanes) to obtain I.78 (7.82 g, 93%) as a red-brown oil.  
Analytical data for I.78: 
TLC (20% ethyl acetate in hexanes), Rf = 0.31 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.05 (d, J = 8.6 Hz, 1H), 7.97 (q, J = 0.9 Hz, 1H), 7.45 (dd, J = 
8.7, 1.7 Hz, 1H), 5.37 (s, 1H), 4.03 (s, 3H), 2.86 (q, J = 7.6 Hz, 2H), 2.32 (s, 3H), 1.63 (s, 1H), 
1.36 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.6, 148.2, 143.7, 132.7, 130.0, 128.3, 123.9, 122.7, 121.6, 
119.6, 113.1, 52.9, 29.3, 15.6, 13.1. 
IR (Diamond-ATR, neat)     : 3475 (w), 2362 (m), 1715 (s), 1438 (m), 1387 (m), 1293 (m), 
1239 (vs), 1053 (m), 668 (m) cm−1. 
HRMS (EI) calcd for C15H15O335Cl [M]+: 278.0704; found: 278.0699. 
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Ethyl 3-bromo-6a-methyl-6-oxo-1,1a,6,6a-tetrahydrocyclopropa[a]indene-1-carboxylate 
(I.80): 
 
To indanone I.73 (2.00 g, 8.89 mmol, 1 equiv), dissolved in ethyl acetate (39 mL) and 
chloroform (39 mL), was added copper(II) bromide (3.97 g, 17.8 mmol, 2.00 equiv). The green 
suspension was stirred vigorously, while it was heated to 70 °C. After 14 h, it was cooled to 
23 °C, filtered through a short pad of Celite® and the filtrate was concentrated. The crude 
product I.74 was used without additional purification for the next step.  
To crude indanone I.74 in benzene (18 mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene 
(3.98 mL, 26.7 mmol, 3.00 equiv) at 0 °C. After 5 min, the solution was warmed to 23 °C and 
was stirred for 30 min. The reaction mixture was diluted with saturated aqueous ammonium 
chloride solution (30 mL) and diethyl ether (50 mL). The layers were separated and the aqueous 
layer was extracted with diethyl ether (3 × 100 mL). The combined organic layers were washed 
with saturated aqueous sodium chloride solution (100 mL) and the washed solution was dried 
over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product I.75 was afforded as a yellow-brown oil and was used without additional purification 
for the next step. Note: Indenones undergo facile polymerizations and should therefore be used immediately 
after preparation. 
To a suspension of salt I.79199 (2.04 g, 8.89 mmol, 1 equiv) in acetonitrile (11 mL) was added 
1,8-diazabicyclo[5.4.0]undec-7-ene (1.59 mL, 10.7 mmol, 1.20 equiv) dropwise at 0 °C. After 
stirring for 1 h, a solution of the crude indenone I.75 in acetonitrile (33 mL) was added over 
30 min. The reaction mixture was stirred for 21 h during which the temperature warmed to 
23 °C and was then diluted with aqueous hydrogen chloride solution (50 mL) and ethyl acetate 
(50 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 100 mL). The combined organic layers were washed with aqueous hydrogen chloride 
solution (2 M, 50 mL) and saturated aqueous sodium chloride solution (50 mL). The washed 
solution was dried over sodium sulfate and the dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (2 
to 3% ethyl acetate in hexanes) to afford I.80 (1.17 g, 43% over 3 steps) as an orange solid. 
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Analytical data for I.80: 
TLC (20% ethyl acetate in hexanes), Rf = 0.57 (UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.61 (s, 1H), 7.51 (d, J = 8.0 Hz, 1H), 7.45 (d, J = 8.1 Hz, 1H), 
4.17 (q, J = 7.1 Hz, 2H), 3.24 (d, J = 2.6 Hz, 1H), 2.22 (d, J = 2.8 Hz, 1H), 1.58 (s, 3H), 1.26 (t, J 
= 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 201.01, 167.04, 153.48, 131.78, 131.13, 129.58, 128.21, 126.30, 
61.46, 47.52, 38.46, 31.87, 14.38, 8.28. 
IR (Diamond-ATR, neat)     : 2981 (w), 1716 (vs), 1598 (m), 1453 (w), 1383 (w), 1305 (w), 
1268 (w), 1205 (m), 1178 (m), 1106 (w), 1056 (w), 965 (w), 875 (w), 785 (w) cm−1. 
HRMS (EI) calcd for C14H13O379Br [M]+: 308.0043; found: 308.0046. 
 
Ethyl 7-bromo-4-hydroxy-3-methyl-2-naphthoate (I.81): 
 
In a flask with reflux condenser was heated I.80 (3.0 g, 9.7 mmol, 1 equiv) in sulfolane (97 mL) 
in a “Luftbad” (Figure 19) to 320 °C for 4 h. After cooling to 23 °C, the reaction mixture was 
diluted with water (100 mL) and diethyl ether (100 mL). The layers were separated and the 
aqueous layer was extracted with diethyl ether (3 × 150 mL). The combined organic layers were 
washed with water (5 × 150 mL) and saturated aqueous sodium chloride solution (200 mL) and 
the washed solution was dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (20% ethyl acetate in hexanes) to afford I.81 (2.56 g, 85%) as an orange solid.  
Analytical data for I.81: 
TLC (20% ethyl acetate in hexanes), Rf = 0.23 (UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.00 (d, J = 8.8 Hz, 1H), 7.92 (s, 1H), 7.84 (s, 1H), 7.56 (d, J = 
8.6 Hz, 1H), 5.63 (s, 1H), 4.41 (q, J = 7.0 Hz, 2H), 2.53 (s, 3H), 1.43 (t, J = 7.0 Hz, 3H). 
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13C NMR (101 MHz, CDCl3) Ʋ: 168.1, 149.8, 132.7, 130.8, 130.6, 130.4, 124.3, 123.6, 122.5, 
120.5, 116.4, 61.5, 14.5, 12.9. 
IR (Diamond-ATR, neat)     : 3445 (m), 2980 (w), 2935 (w), 1696 (s), 1583 (m), 1567 (m), 
1444 (m), 1372 (s), 1329 (m), 1275 (vs), 1224 (vs), 1211 (vs), 1111 (m), 1046 (vs), 985 (m), 907 (m), 
818 (m), 777 (m) cm−1. 
HRMS (EI) calcd for C14H13O379Br [M]+: 308.0043; found: 308.0040. 
 
Figure 19 Experimental set up for the synthesis of I.81. For safety reasons the whole experimental set up is assembled behind a blast shield. 
 
Ethyl 7-ethyl-4-hydroxy-3-methyl-2-naphthoate (I.68): 
 
Note: The reaction setup has to be flame-dried very carefully, since the yield otherwise decreases significantly.  
To [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride (107 mg, 0.146 mmol, 
0.0180 equiv) was added a solution of I.81 (2.50 g, 8.09 mmol, 1 equiv) in 1,4-dioxane (6.7 mL). 
The red suspension was cooled to 0 °C and diethylzinc solution (15wt% in toluene, 14.6 mL, 
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16.2 mmol, 2.00 equiv) was added dropwise. After stirring for 20 min, the beige suspension was 
heated to 90 °C for 3 h, cooled to 0 °C and carefully treated with methanol (8 mL). Water 
(20 mL) was added, the layers were separated and the aqueous layer was extracted with diethyl 
ether (3 × 30 mL). The combined organic layers were washed with aqueous hydrogen chloride 
solution (2 M, 20 mL) and saturated aqueous sodium chloride solution (40 mL). The washed 
solution was dried over sodium sulfate, the dried solution was filtered through a short pad of 
Celite® and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (9% ethyl acetate in hexanes) to afford I.68 (2.04, 97%) as an 
orange oil.  
Analytical data for I.68: 
TLC (20% ethyl acetate in hexanes), Rf = 0.32 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.05 (d, J = 8.7 Hz, 1H), 7.97 (s, 1H), 7.61 (s, 1H), 7.41 (dd, J = 
8.6, 1.7 Hz, 1H), 5.43 (s, 1H), 4.41 (q, J = 7.1 Hz, 2H), 2.80 (q, J = 7.6 Hz, 2H), 2.57 (s, 3H), 
1.44 (t, J = 7.1 Hz, 3H), 1.32 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.5, 149.6, 142.3, 132.1, 129.7, 128.8, 126.4, 124.4, 123.5, 
121.3, 115.1, 61.1, 29.0, 15.4, 14.5, 12.7. 
IR (Diamond-ATR, neat)     : 3452 (w), 2967 (w), 2932 (w), 1715 (vs), 1601 (m), 1572 (w), 1456 
(m), 1395 (m), 1379 (m), 1290 (s), 1229 (s), 1210 (s), 1112 (s), 1094 (s), 1047 (s), 981 (m), 901 (m), 
930 (m), 780 (m) cm−1. 
HRMS (EI) calcd for C16H18O3 [M]+: 258.1250; found: 258.1247. 
 
Ethyl 7-ethyl-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-2-carboxylate (I.82): 
 
To a solution of I.68 (100 mg, 0.387 mmol, 1 equiv) in acetonitrile (11 mL) and water (6 mL) 
was added [bis(trifluoroacetoxy)iodo]benzene (250 mg, 0.581 mmol, 1.50 equiv) at 0 °C. The ice 
bath was removed after the addition and the reaction mixture was stirred for 2 h at 23 °C. After 
this time, a solution of iron(III) chloride hexahydrate (299 mg, 1.11 mmol, 2.86 equiv) in 
aqueous hydrochloric acid solution (1 M, 2.8 mL) was added. After 16 h, water (20 mL) and ethyl 
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acetate (20 mL) were added, the layers were separated and the aqueous layer was extracted with 
ethyl acetate (3 × 20 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (30 mL). The washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on silica gel (4 to 5% ethyl acetate in hexanes) to obtain I.82 (60.3 mg, 
57%) as a yellow solid.  
Analytical data for I.82: 
TLC (20% ethyl acetate in hexanes), Rf = 0.42 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.02 (d, J = 7.9 Hz, 1H), 7.90 (d, J = 2.2 Hz, 1H), 7.56 (dd, J = 
7.9, 2.2 Hz, 1H), 4.44 (q, J = 7.1 Hz, 2H), 2.79 (q, J = 7.6 Hz, 2H), 2.17 (s, 3H), 1.40 (t, J = 7.1 
Hz, 3H), 1.29 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 184.8, 182.1, 164.8, 151.6, 143.9, 139.7, 133.9, 131.6, 129.8, 
127.1, 125.8, 62.2, 29.3, 15.1, 14.4, 13.9. 
IR (Diamond-ATR, neat)     : 2964 (w), 1732 (m), 1668 (m), 1659 (m), 1602 (m), 1372 (s), 1294 
(vs), 1233 (s), 1203 (m), 1128 (m), 1103 (m), 1051 (m), 1017 (m), 970 (m), 958 (m), 853 (w), 778 (w), 
771 (m), 734 (m), 722 (m), 657 (m) cm−1. 
HRMS (EI) calcd for C16H16O4 [M]+: 272.1043; found: 272.1043.  
 
Methyl 4-(allyloxy)-1-chloro-7-ethyl-3-methyl-2-naphthoate (I.88): 
 
To a solution of I.78 (100 mg, 0.359 mmol, 1 equiv) in dimethylformamide (1.2 mL) were 
successively added potassium carbonate (74.4 mg, 0.538 mmol, 1.50 equiv) and allyl bromide 
(34.2 µL, 47.7 mmol, 1.10 equiv) and the reaction mixture was heated to 65 °C. After 1.5 h, 
water (10 mL) and diethyl ether (15 mL) were added, the layers were separated and the aqueous 
layer was extracted with diethyl ether (3 × 15 mL). The combined organic layers were washed 
with aqueous hydrochloric acid solution (2 M, 30 mL) and saturated aqueous sodium chloride 
solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The residue was purified by flash column 
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chromatography on silica gel (5% ethyl acetate in hexanes) to yield I.88 (103 mg, 90%) as a 
colorless oil.  
Analytical data for I.88: 
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.02 (s, 1H), 8.01 (d, J = 6.6 Hz, 1H), 7.45 (dd, J = 8.6, 0.9 Hz, 
1H), 6.18 (ddt, J = 17.1, 11.6, 5.9 Hz, 1H), 5.50 (d, J = 17.2 Hz, 1H), 5.33 (d, J = 10.4 Hz, 1H), 
4.45 (d, J = 6.6 Hz, 2H), 4.01 (s, 3H), 2.85 (q, J = 7.3 Hz, 2H), 2.37 (s, 3H), 1.34 (t, J = 7.1 Hz, 
3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.2, 152.1, 143.6, 133.6, 133.3, 130.4, 129.0, 127.9, 123.4, 
123.0 (2C), 122.6, 118.0, 75.2, 52.8, 29.3, 15.6, 13.5. 
IR (Diamond-ATR, neat)     : 2965 (w), 287 (w), 1736 (vs), 1598 (w), 1436 (m), 1385 (m), 
1330 (m), 1315 (m), 1280 (m), 1231 (s), 1214 (m), 1170 (m), 1113 (m), 1051 (s), 991 (m), 972 (m), 
937 (m), 877 (m), 833 (m), 757 (w) cm−1. 
HRMS (EI) calcd for C18H19O335Cl [M]+: 318.1017; found: 318.1020. 
 
8-Ethyl-5-hydroxy-4-methyl-1-vinylnaphtho[1,2-c]furan-3(1H)-one (I.91): 
 
A solution of I.88 (1.56 g, 4.90 mmol, 1 equiv) in sulfolane (10 mL) was heated to 190 °C. After 
2 h, water (100 mL) and diethyl ether (100 mL) were added, the layers were separated and the 
aqueous layer was extracted with diethyl ether (3 × 100 mL). The combined organic layers were 
washed successively with water (5 × 100 mL) and saturated aqueous sodium chloride solution 
(100 mL). The washed solution was dried over sodium sulfate, the dried solution was filtered 
and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford I.91 (407.7 mg, 31%) as a 
yellow solid.  
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Note: When the reaction time was shortened to only 5 min, the p-allylated naphthol I.90 was isolated as main 
product in 25% yield.  
Analytical data for I.91: 
TLC (20% ethyl acetate in hexanes), Rf = 0.23 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.22 (d, J = 8.7 Hz, 1H), 7.64 (d, J = 1.0 Hz, 1H), 7.53 (dd, J = 
8.7, 1.7 Hz, 1H), 6.04 (d, J = 7.8 Hz, 1H), 5.92 (ddd, J = 17.0, 9.9, 7.7 Hz, 1H), 5.75 (d, J = 16.8 
Hz, 1H), 5.52 (d, J = 10.3 Hz, 1H), 5.50 (s, 1H), 2.83 (q, J = 7.5 Hz, 2H), 2.70 (s, 3H), 1.32 (t, J 
= 7.6 Hz, 3H).  
13C NMR (101 MHz, CDCl3) Ʋ: 171.4, 150.8, 143.4, 140.0, 134.7, 129.8, 126.6, 125.8, 123.1, 
122.0, 121.7, 121.2, 112.4, 80.7, 29.1, 15.4, 9.2. 
IR (Diamond-ATR, neat)     : 3418 (w), 2966 (w), 1733 (vs), 1582 (w), 1469 (w), 1395 (w), 
1371 (w), 1299 (w), 1262 (w), 1198 (w), 1013 (m), 977 (m), 939 (w), 834 (w) cm−1. 
HRMS (EI) calcd for C17H16O3 [M]+: 268.1094; found: 268.1074. 
 
Analytical data for I.90: 
TLC (20% ethyl acetate in hexanes), Rf = 0.28 (UV, KMnO4). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.06 (d, J = 8.5 Hz, 1H), 7.76 (s, 1H), 7.38 (d, J = 8.5 Hz, 1H), 
6.04 – 5.96 (m, 1H), 5.13 (s, 1H), 5.05 – 5.00 (m, 2H), 3.95 (s, 3H), 3.69 (d, J = 6.7 Hz, 2H), 2.81 
(q, J = 7.6 Hz, 3H), 2.30 (s, 3H), 1.32 (t, J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 170.8, 147.9, 142.2, 136.9, 133.5, 131.6, 127.3, 124.6, 123.4, 
122.9, 121.6, 115.8, 111.7, 52.2, 34.4, 29.4, 15.6, 13.0. 
IR (Diamond-ATR, neat)     : 3472 (w), 2965 (w), 2932 (w), 1728 (vs), 1664 (w), 1601 (m), 
1505 (w), 1437 (m), 1389 (m), 1366 (m), 1282 (m), 1232 (s), 1194 (m), 1175 (m), 1115 (w), 1061 (m), 
991 (w), 914 (w), 832 (w), 754 (w) cm−1. 
HRMS (EI) calcd for C18H20O3 [M]+: 284.1407; found: 284.1410. 
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Ethyl 4-(((allyloxy)carbonyl)oxy)-7-ethyl-3-methyl-2-naphthoate (I.99): 
 
To a solution of I.68 (250 mg, 0.968 mmol, 1 equiv) in tetrahydrofuran (4.8 mL) was added 
pyridine (0.110 mL, 1.35 mmol, 1.40 equiv). After cooling to 0 °C, allyl chloroformate 
(0.123 mL, 1.16 mmol, 1.20 equiv) was added. The reaction mixture was stirred for 5 min at 
0 °C and then 18.5 h at 23 °C. Water (5 mL) and ethyl acetate (5 mL) were added, the layers 
were separated and the aqueous layer was extracted with ethyl acetate (3 × 20 mL). The 
combined organic layers were washed with aqueous hydrogen chloride solution (2 M, 
2 × 20 mL) and saturated aqueous sodium chloride solution (30 mL). The washed solution was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (3% ethyl acetate in 
hexanes) to afford I.99 (178 mg, 54%) as a colorless oil.  
Analytical data for I.99: 
TLC (20% ethyl acetate in hexanes), Rf = 0.50 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.34 (s, 1H), 7.78 (d, J = 8.7 Hz, 1H), 7.69 (s, 1H), 7.47 (d, J = 
8.7 Hz, 1H), 6.04 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.47 (dq, J = 17.2, 1.5 Hz, 1H), 5.36 (dq, J = 
10.4, 1.2 Hz, 1H), 4.80 (dt, J = 5.8, 1.3 Hz, 2H), 4.42 (q, J = 7.1 Hz, 2H), 2.81 (q, J = 7.6 Hz, 
2H), 2.57 (s, 3H), 1.44 (t, J = 7.2 Hz, 3H), 1.32 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.4, 153.2, 145.3, 142.6, 132.0, 131.2, 130.4, 129.5, 129.3, 
127.1, 126.7, 126.0, 120.8, 119.7, 69.5, 61.2, 28.9, 15.4, 14.5, 13.7. 
IR (Diamond-ATR, neat)     : 2968 (w), 1762 (s), 1718 (s), 1604 (w), 1456 (w), 1364 (w), 1287 
(w), 1287 (m), 1231 (vs), 1205 (s), 1169 (m), 1037 (m), 973 (m), 915 (m), 829 (m), 780 (m) cm−1. 
HRMS (EI) calcd for C20H22O5 [M]+: 342.1462; found: 342.1470. 
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Methyl 4-(((allyloxy)carbonyl)oxy)-1-chloro-7-ethyl-3-methyl-2-naphthoate (I.100): 
 
To a solution of I.78 (4.00 g, 14.4 mmol, 1 equiv) in tetrahydrofuran (72 mL) was added 
triethylamine (2.79 mL, 20.1 mmol, 1.40 equiv), the mixture was cooled to 0 °C and allyl 
chloroformate (1.83 mL, 17.2 mmol, 1.20 equiv) was added. After 10 min, saturated aqueous 
ammonium chloride solution (100 mL) was added, the layers were separated and the aqueous 
layer was extracted with ethyl acetate (3 × 100 mL). The combined organic layers were washed 
with saturated aqueous hydrogen chloride solution (100 mL). The washed solution was dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
product I.100 (5.15 g, 99%) was obtained as an orange oil and used without further purification.  
Analytical data for I.100: 
TLC (20% ethyl acetate in hexanes), Rf = 0.43 (UV, KMnO4). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.05 (d, J = 1.8 Hz, 1H), 7.79 (d, J = 8.5 Hz, 1H), 7.49 (dd, J = 
8.7, 1.7 Hz, 1H), 6.24 – 5.78 (m, 1H), 5.46 (dq, J = 16.9, 1.5 Hz, 1H), 5.37 (dq, J = 10.6, 1.3 Hz, 
1H), 4.88 – 4.59 (m, 2H), 4.01 (s, 3H), 2.85 (q, J = 7.6 Hz, 2H), 2.29 (s, 3H), 1.33 (t, J = 7.5 Hz, 
3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 167.6, 152.9, 144.1, 143.8, 132.8, 131.1, 130.2, 129.9, 126.5, 
126.2, 123.3, 123.1, 121.3, 120.0, 69.8, 52.9, 29.3, 15.6, 13.6. 
IR (Diamond-ATR, neat)     : 2361 (m), 1764 (m), 1736 (m), 1437 (w), 1232 (vs), 940 (w), 
668 (w) cm−1. 
HRMS (EI) calcd for C19H20O535Cl [M]+: 362.0916; found: 362.0917. 
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Methyl 7-ethyl-4-hydroxy-3-methyl-2-naphthoate (I.101): 
 
To a solution of I.78 (1.00 g, 3.59 mmol, 1 equiv) in methanol (13.8 mL) were added 
ammonium formate (1.36 g, 21.5 mmol, 6.00 equiv) and Pd/C (10% Pd on activated charcoal, 
382 mg, 0.359 mmol, 0.100 equiv). After 5.5 h, the reaction mixture was filtered through a short 
pad of Celite® and washed successively with diethyl ether (50 mL). Water (50 mL) and aqueous 
hydrochloric acid solution (2 M, 50 mL) were added and the aqueous phase was extracted with 
diethyl ether (3 × 100 mL). The combined organic layers were washed with saturated aqueous 
hydrogen chloride solution (100 mL). The washed solution was dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The product I.101 (865 mg, 99%) 
was obtained as a beige solid and used without further purification.  
Analytical data for I.101: 
TLC (20% ethyl acetate in hexanes), Rf = 0.33 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.05 (d, J = 8.6 Hz, 1H), 7.99 (s, 1H), 7.60 (s, 1H), 7.42 (dd, J = 
8.6, 1.7 Hz, 1H), 5.41 (s, 1H), 3.95 (s, 3H), 2.80 (q, J = 7.6 Hz, 2H), 2.58 (s, 3H), 1.32 (t, J = 7.6 
Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.8, 149.5, 142.3, 132.0, 129.1, 128.9, 126.4, 124.4, 123.7, 
121.3, 115.1, 52.3, 29.0, 15.5, 12.7. 
IR (Diamond-ATR, neat)     : 3501 (m), 2952 (w), 1697 (vs), 1597 (m), 1573 (m), 1436 (m), 
1375 (s), 1326 (m), 1280 (s), 1220 (vs), 1174 (s), 1114 (m), 1065 (m), 1050 (vs), 999 (s), 938 (s), 
899 (s), 838 (s), 775 (vs) cm−1. 
HRMS (EI) calcd for C15H16O3 [M]+: 244.1094; found: 244.1093. 
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Methyl 4-(((allyloxy)carbonyl)oxy)-7-ethyl-3-methyl-2-naphthoate (I.102): 
 
To a solution of I.101 (268 mg, 1.10 mmol, 1 equiv) in tetrahydrofuran (5.5 mL) was added 
triethylamine (0.213 mL, 1.54 mmol, 1.20 equiv), the mixture was cooled to 0 °C and allyl 
chloroformate (0.140 mL, 1.32 mmol, 1.40 equiv) was added. After 5 min, the ice bath was 
removed and after further 10 min, saturated aqueous ammonium chloride solution (40 mL) was 
added, the layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 50 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (50 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. I.102 (358 mg, 99%) was obtained as a yellow oil and 
used without further purification.  
Analytical data for I.102:  
TLC (20% ethyl acetate in hexanes), Rf = 0.49 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.35 (s, 1H), 7.78 (d, J = 8.6 Hz, 1H), 7.69 – 7.61 (m, 1H), 7.47 
(dd, J = 8.7, 1.7 Hz, 1H), 6.04 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.47 (dq, J = 17.2, 1.4 Hz, 1H), 
5.36 (dq, J = 10.5, 1.2 Hz, 1H), 4.80 (dt, J = 5.7, 1.4 Hz, 2H), 3.94 (s, 3H), 2.80 (q, J = 7.6 Hz, 
2H), 2.58 (s, 3H), 1.31 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.7, 153.1, 145.3, 142.6, 131.9, 131.2, 130.4, 129.7, 128.8, 
127.1, 126.7, 126.0, 120.7, 119.7, 69.5, 52.2, 28.9, 15.3, 13.7. 
IR (Diamond-ATR, neat)     : 2965 (w), 1760 (s), 1719 (s), 1605 (w), 1435 (m), 1361 (w), 
1288 (m), 1225 (vs), 1203 (vs), 1165 (s), 1117 (m), 1034 (m), 987 (m), 939 (m), 913 (m), 827 (m), 
778 (m) cm−1. 
HRMS (EI) calcd for C19H20O5 [M]+: 238.1305; found: 328.1305. 
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Methyl 4-(allyloxy)-7-ethyl-3-methyl-2-naphthoate (I.103): 
 
To a solution of I.101 (500 mg, 2.05 mmol, 1 equiv) in dimethylformamide (7 mL) were 
subsequently added potassium carbonate (424 mg, 3.07 mmol, 1.50 equiv) and allyl bromide 
(0.195 mL, 2.25 mmol, 1.10 equiv) and the suspension was heated to 70 °C. After 2 h, saturated 
aqueous ammonium chloride solution (50 mL) was added, the layers were separated and the 
aqueous layer was extracted with diethyl ether (3 × 70 mL). The combined organic layers were 
washed with aqueous hydrochloric acid solution (2 M, 50 mL) and saturated aqueous hydrogen 
chloride solution (50 mL). The washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (2% ethyl acetate in hexanes) to yield I.103 (538 mg, 92%) as a 
colorless oil.  
Analytical data for I.103: 
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.19 (s, 1H), 8.01 (d, J = 8.6 Hz, 1H), 7.65 (d, J = 1.7 Hz, 1H), 
7.44 (dd, J = 8.6, 1.7 Hz, 1H), 6.21 (ddt, J = 17.2, 10.7, 5.5 Hz, 1H), 5.52 (dq, J = 17.2, 1.6 Hz, 
1H), 5.33 (dq, J = 10.4, 1.4 Hz, 1H), 4.47 (dt, J = 5.5, 1.5 Hz, 2H), 3.95 (s, 3H), 2.81 (q, J = 7.6 
Hz, 2H), 2.63 (s, 3H), 1.32 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.5, 153.4, 142.2, 133.9, 132.4, 129.6, 129.5, 128.5, 127.3, 
126.7, 125.8, 122.2, 117.7, 74.8, 52.2, 29.0, 15.5, 13.9. 
IR (Diamond-ATR, neat)     : 2965 (w), 1722 (vs), 1598 (w), 1452 (w), 1435 (m), 1331 (m), 
1284 (s), 1237 (m), 1205 (m), 1111 (m), 1048 (s), 1014 (m), 910 (m), 832 (m), 780 (m) cm−1. 
HRMS (EI) calcd for C18H20O3 [M]+: 284.1407; found: 284.1403. 
 
 
 
 
144  Experimental Part 
 
Methyl 3-allyl-7-ethyl-3-methyl-4-oxo-3,4-dihydronaphthalene-2-carboxylate (I.104): 
 
Tetrakis(triphenylphosphine)palladium(0) (223 mg, 0.189 mmol, 0.100 mmol) was added to a 
Schlenk flask and the flask was purged with argon. I.103 (538 mg, 1.89 mmol, 1 equiv) was 
added and the flask was again purged with argon. The reactants were dissolved in degassed 
tetrahydrofuran (63 mL) and stirred at 45 °C for 1 h. The reaction mixture was filtered through 
a plug of silica gel and rinsed thoroughly with diethyl ether (100 mL). The filtrate was 
concentrated and the residue was purified by flash column chromatography on silica gel (2% 
ethyl acetate and 1% acetic acid in hexanes) to obtain I.104 (416 mg, 77%) as a colorless oil.  
Analytical data for I.104: 
TLC (20% ethyl acetate in hexanes), Rf = 0.51 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.02 (d, J = 7.9 Hz, 1H), 7.72 (s, 1H), 7.34 (dd, J = 8.0, 1.7 Hz, 
1H), 7.22 (d, J = 1.2 Hz, 1H), 5.43 – 5.30 (m, 1H), 4.94 – 4.83 (m, 1H), 4.77 (ddt, J = 10.2, 2.1, 
1.0 Hz, 1H), 3.84 (s, 3H), 3.10 – 2.85 (m, 2H), 2.74 (q, J = 7.6 Hz, 2H), 1.50 (s, 3H), 1.28 (t, J = 
7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 201.8, 166.2, 151.8, 137.3, 135.8, 134.9, 134.1, 130.4, 128.8, 
127.8, 127.6, 117.4, 52.0, 51.5, 43.0, 29.2, 25.1, 15.1. 
IR (Diamond-ATR, neat)     : 2969 (w), 1714 (vs), 1673 (s), 1640 (w), 1599 (m), 1453 (m), 
1374(w), 1281 (m), 1245 (s), 1219 (vs), 1044 (w), 989 (w), 920 (w), 848 (w), 778 (w) cm−1. 
HRMS (EI) calcd for C18H20O3 [M]+: 284.1407; found: 284.1406. 
 
 
 
 
 
CHAPTER I  145 
 
Methyl 3-allyl-1-chloro-7-ethyl-3-methyl-4-oxo-3,4-dihydronaphthalene-2-carboxylate 
(I.89): 
 
Tetrakis(triphenylphosphine)palladium(0) (669 mg, 0.579 mmol, 7.00mol%) was added to a 
Schlenk flask and the flask was purged with argon. I.100 (3.00 g, 8.27 mmol, 1 equiv) was added 
and the flask was again purged with argon. The reactants were dissolved in degassed toluene 
(219 mL) and degassed n-hexanes (22 mL) and stirred at 45 °C for 15 h. The reaction mixture 
was filtered through a plug of silica gel and rinsed thoroughly with diethyl ether (200 mL). The 
filtrate was concentrated and the residue was purified by flash column chromatography on silica 
gel (2% ethyl acetate and 1% acetic acid in hexanes) to obtain I.89 (2.1 g, 80%) as a light yellow 
oil. 
Analytical data for I.89: 
TLC (20% ethyl acetate in hexanes), Rf = 0.44 (UV, KMnO4) 
1H NMR (599 MHz, CDCl3) Ʋ: 8.00 (d, J = 7.8 Hz, 1H), 7.67 (d, J = 1.6 Hz, 1H), 7.34 (dd, J = 
8.2, 1.7 Hz, 1H), 5.74 – 5.32 (m, 1H), 4.99 (dt, J = 17.0, 1.6 Hz, 1H), 4.93 – 4.77 (m, 1H), 3.91 
(s, 3H), 2.76 (p, J = 7.6 Hz, 3H), 2.52 (dd, J = 13.7, 6.5 Hz, 1H), 1.41 (s, 3H), 1.30 (t, J = 7.7 Hz, 
3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 198.4, 166.4, 151.9, 137.9, 134.4, 132.2, 129.7, 127.7, 127.6, 
127.5, 125.4, 118.8, 52.5, 52.3, 44.2, 29.3, 23.7, 15.0. 
IR (Diamond-ATR, neat)     : 2970 (w), 1729 (vs), 1679 (m), 1598 (m), 1453 (w), 1434 (m), 
1284 (m), 1248 (m), 1231 (m), 1195 (m), 1044 (w), 994 (w), 924 (w), 848 (w) 701 (w) cm−1. 
HRMS (EI) calcd for C18H19O335Cl [M]+: 318.1017; found: 318.1016. 
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Ethyl 3-allyl-7-ethyl-3-methyl-4-oxo-3,4-dihydronaphthalene-2-carboxylate (I.105): 
 
A solution of I.99 (91.0 mg, 0.266 mmol, 1 equiv) in degassed tetrahydrofuran (5.3 mL) was 
added to a solution of tetrakis(triphenylphosphane)palladium(0) (31.3 mg, 0.0271 mmol; 
0.102 equiv) in degassed tetrahydrofuran (3.3 mL). The reaction was heated to 45 °C for 3 h, 
cooled to 23 °C and diluted with diethyl ether (5 mL). The reaction mixture was filtered through 
a short plug of silica and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on silica gel (2% ethyl acetate and 1% acetic acid in hexanes) to afford 
I.105 (54 mg, 69%) as a yellow oil. 
Note: During the screening for the optimal reaction conditions, the o-product I.106 was isolated and analyzed.  
Analytical data for I.105: 
TLC (20% ethyl acetate in hexanes), Rf = 0.53 (UV, KMnO4). 
1H NMR (800 MHz, CDCl3) Ʋ: 8.01 (d, J = 7.9 Hz, 1H), 7.72 (s, 1H), 7.33 (dd, J = 7.9, 1.7 Hz, 
1H), 7.23 (d, J = 1.5 Hz, 1H), 5.35 (dddd, J = 16.8, 10.1, 8.2, 6.6 Hz, 1H), 4.89 (ddd, J = 16.9, 
3.4, 1.3 Hz, 1H), 4.77 (ddt, J = 10.3, 1.9, 0.7 Hz, 1H), 4.30 (qd, J = 7.2, 4.0 Hz, 2H), 3.06 (dd, J 
= 13.7, 8.1 Hz, 1H), 2.90 (dd, J = 13.7, 6.5 Hz, 1H), 2.74 (q, J = 7.7 Hz, 2H), 1.51 (s, 3H), 1.38 
(t, J = 7.2 Hz, 3H), 1.28 (t, J = 7.6 Hz, 3H). 
13C NMR (201 MHz, CDCl3) Ʋ: 201.9, 165.8, 151.8, 137.6, 135.9, 134.6, 134.1, 130.3, 128.8, 
127.8, 127.6, 117.4, 60.9, 51.6, 43.0, 29.2, 25.1, 15.2, 14.5. 
IR (Diamond-ATR, neat)     : 2974 (w), 2935 (w), 2360 (w), 1712 (vs), 1674 (s), 1600 (m), 
1456 (w), 1375 (w), 1281 (m), 1245 (m), 1218 (vs), 1045 (w), 990 (w), 920 (w), 848 (w), 777 (w) cm−1. 
HRMS (EI) calcd for C19H22O3 [M]+: 298.1563; found: 298.1567. 
 
Analytical data for I.106:  
TLC (20% ethyl acetate in hexanes), Rf = 0.62 (UV). 
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1H NMR (400 MHz, CDCl3) Ʋ: 8.17 (s, 1H), 8.00 (d, J = 8.6 Hz, 1H), 7.66 (s, 1H), 7.44 (dd, J = 
8.6, 1.7 Hz, 1H), 6.22 (ddt, J = 17.2, 10.8, 5.5 Hz, 1H), 5.52 (dq, J = 17.2, 1.6 Hz, 1H), 5.33 (dq, 
J = 10.4, 1.4 Hz, 1H), 4.47 (dt, J = 5.6, 1.5 Hz, 2H), 4.41 (q, J = 7.1 Hz, 2H), 2.81 (q, J = 7.6 Hz, 
2H), 2.63 (s, 3H), 1.44 (t, J = 7.1 Hz, 3H), 1.33 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.1, 153.3, 142.2, 133.9, 132.4, 130.0, 129.5, 128.4, 127.1, 
126.7, 125.7, 122.2, 117.7, 74.8, 61.1, 29.0, 15.5, 14.5, 13.9. 
IR (Diamond-ATR, neat)     : 2966 (w), 2932 (w), 1715 (vs), 1599 (w), 1568 (w), 1452 (m), 1385 
(m), 1374 (m), 1315 (m), 1281 (vs), 1236 (s), 1201 (vs), 1170 (m), 1110 (m), 1045 (vs), 1009 (s), 992 
(s), 910 (s), 832 (s), 779 (s) cm−1. 
HRMS (EI) calcd for C19H22O3 [M]+: 298.1563; found: 298.1562. 
 
Allyl (8-ethyl-4-methyl-3-oxo-1-vinyl-1,3-dihydronaphtho[1,2-c]furan-5-yl) carbonate 
(I.107): 
 
To a solution of I.91 (500 mg, 1.86 mmol, 1 equiv) in tetrahydrofuran (9.3 mL) was added 
triethylamine (0.363 mL, 2.61 mmol, 1.40 equiv). After 10 min, the reaction mixture was cooled 
to 0 °C and allyl chloroformate (0.238 mL, 2.24 mmol, 1.20 equiv) was added. After 15 min, 
water (100 mL) was added, the layers were separated and the aqueous layer was extracted with 
ethyl acetate (3 × 100 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (70 mL). The washed solution was dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on silica gel (9% ethyl acetate in hexanes) to afford I.107 (528 mg, 
80%) as a light yellow solid.  
Analytical data for I.107: 
TLC (20% ethyl acetate in hexanes), Rf = 0.35 (UV, CAM, KMnO4). 
148  Experimental Part 
 
1H NMR (400 MHz, CDCl3) Ʋ: 7.90 (d, J = 8.7 Hz, 1H), 7.71 (d, J = 0.8 Hz, 1H), 7.57 (dd, J = 
8.7, 1.6 Hz, 1H), 6.10 (d, J = 7.7 Hz, 1H), 6.10 – 5.88 (m, 2H), 5.80 (d, J = 16.7 Hz, 1H), 5.56 
(d, J = 9.9 Hz, 1H), 5.48 (dq, J = 17.2, 1.4 Hz, 1H), 5.39 (dq, J = 10.4, 1.1 Hz, 1H), 4.81 (dt, J = 
5.8, 1.3 Hz, 2H), 2.83 (q, J = 7.6 Hz, 2H), 2.66 (s, 3H), 1.31 (d, J = 7.6 Hz, 3H).  
13C NMR (101 MHz, CDCl3) Ʋ: 170.4, 153.0, 146.1, 145.7, 143.8, 134.0, 131.3, 131.0, 128.5, 
126.7, 124.4, 122.3, 122.3, 122.1, 121.8, 120.1, 80.7, 69.8, 29.1, 15.4, 10.6. 
IR (Diamond-ATR, neat)     : 2921 (w), 1746 (vs), 1610 (w), 1411 (w), 1356 (w), 1304 (w), 
1232 (s), 1196 (m), 1147 (m), 1027 (m), 1013 (m), 972 (m), 938 (m), 924 (m), 886 (m), 840 (m), 
778 (m) cm−1. 
HRMS (EI) calcd for C21H20O5 [M]+: 352.1305; found: 352.1309. 
 
4-Allyl-8-ethyl-4-methyl-1-vinyl-1,4-dihydronaphtho[1,2-c]furan-3,5-dione (I.108): 
 
Tetrakis(triphenylphosphine)palladium(0) (32.8 mg, 0.0284 mmol, 0.100 equiv) was added to a 
Schlenk flask and the flask was purged with argon. I.107 (100 mg, 0.284 mmol, 1 equiv) was 
added and the flask was again purged with argon. The reactants were dissolved in degassed 
toluene (7.5 mL) and degassed n-hexanes (0.75 mL) and stirred at 45 °C for 45 min. The 
reaction mixture was filtered through a plug of silica gel and rinsed thoroughly with diethyl ether 
(100 mL). The filtrate was concentrated and the residue was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to obtain I.108 (60 mg, 69%, mixture 
of diastereomers) as a yellow oil.  
Note: A small sample of the diastereomeric mixture was used to separate the diastereomers by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes).  
Analytical data for the major isomer I.108: 
TLC (20% ethyl acetate in hexanes), Rf = 0.29 (UV, KMnO4). 
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1H NMR (800 MHz, CDCl3) Ʋ: 8.11 (d, J = 8.0 Hz, 1H), 7.43 (dd, J = 8.0, 1.7 Hz, 1H), 7.28 – 
7.26 (m, 1H), 5.89 (ddd, J = 17.0, 10.0, 7.9 Hz, 1H), 5.77 (d, J = 8.4 Hz, 1H), 5.76 (d, J = 17.0 
Hz, 1H), 5.57 (d, J = 10.0 Hz, 1H), 5.33 (dddd, J = 16.8, 10.1, 8.2, 6.6 Hz, 1H), 4.97 (dq, J = 
16.9, 1.3 Hz, 1H), 4.80 (dd, J = 10.1, 1.9 Hz, 1H), 2.96 (dd, J = 13.5, 8.2 Hz, 1H), 2.81 (dd, J = 
13.5, 6.5 Hz, 1H), 2.74 (qd, J = 7.5, 2.9 Hz, 2H), 1.53 (s, 3H), 1.28 (d, J = 7.6 Hz, 3H). 
13C NMR (201 MHz, CDCl3) Ʋ: 200.8, 170.0, 153.0, 151.7, 133.5, 132.8, 132.4, 131.4, 130.7, 
128.9, 128.3, 124.4, 122.5, 118.7, 80.5, 48.6, 42.6, 29.2, 23.1, 15.0. 
IR (Diamond-ATR, neat)     : 2920 (m), 2363 (w), 1756 (vs), 1679 (m), 1600 (m), 1456 (w), 
1378 (w), 1239 (m), 1015 (m), 853 (w), 797 (w) cm−1. 
HRMS (EI) calcd for C20H20O3 [M]+: 308.1407; found: 308.1410. 
 
Analytical data for I.109: 
TLC (20% ethyl acetate in hexanes), Rf = 0.43 (UV, KMnO4). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.14 (d, J = 7.8 Hz, 1H), 7.63 (d, J = 2.1 Hz, 1H), 7.44 (dd, J = 
8.2, 1.6 Hz, 1H), 6.06 (q, J = 7.2 Hz, 1H), 5.40 – 5.31 (m, 1H), 4.96 (dd, J = 17.0, 1.7 Hz, 1H), 
4.81 (dd, J = 10.3, 2.0 Hz, 1H), 2.96 (dd, J = 13.4, 8.0 Hz, 1H), 2.84 (dd, J = 13.8, 6.4 Hz, 1H), 
2.79 (q, J = 7.6 Hz, 2H), 2.11 (d, J = 7.2 Hz, 3H), 1.51 (s, 3H), 1.33 (d, J = 7.7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 200.3, 166.6, 151.6, 146.8, 141.4, 132.9, 132.4, 130.9, 130.5, 
129.4, 128.8, 124.8, 118.7, 111.6, 48.4, 42.4, 29.4, 23.2, 15.3, 12.7. 
IR (Diamond-ATR, neat)     : 2970 (w), 1764 (vs), 1680 (m), 1594 (m), 1452 (w), 1389 (w), 
1315 (w), 1246 (m), 1012 (m), 921 (w), 851 (w), 772 (w) cm−1. 
HRMS (EI) calcd for C20H20O3 [M]+: 308.1407; found: 308.1401. 
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Methyl (E)-1-chloro-7-ethyl-3-methyl-4-oxo-3-(prop-1-en-1-yl)-3,4-dihydronaphthalene-
2-carboxylate (I.111): 
 
To bis(dibenzylidenacetone)palladium(0) (113 mg, 0.0196 mmol, 10.0 mol%) was added 
subsequently a solution of I.89 (625 mg, 1.96 mmol, 1 equiv) in degassed toluene (5.3 mL), 
tri-t-butylphosphine (1 M in toluene, 0.196 mL, 0.196 mmol, 10.0 mol%) and isobutyryl chloride 
(0.078M in degassed toluene, 2.51 mL, 0.196 mmol, 10.0 mol%). The reaction mixture was 
heated to 80 °C for 41 h and then diluted with ethyl acetate (50 mL) and concentrated. The 
residue was purified by flash column chromatography on silica gel (2% ethyl acetate and 1% 
acetic acid in hexanes) to afford I.111 (523 mg, 84%) as a yellow oil. Analytical data for I.111: 
Note: The product I.111 could not be separated from traces of remaining starting material I.89, since both were 
co-polar during column chromatography.  
TLC (20% ethyl acetate in hexanes), Rf = 0.56 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.96 (d, J = 7.9 Hz, 1H), 7.65 (d, J = 1.6 Hz, 1H), 7.33 (dd, J = 
7.9, 1.6 Hz, 1H), 5.67 (dq, J = 15.6, 6.5 Hz, 1H), 5.43 (dq, J = 15.4, 1.6 Hz, 1H), 3.85 (s, 3H), 
2.76 (q, J = 7.6 Hz, 2H), 1.65 (dd, J = 6.5, 1.6 Hz, 3H), 1.52 (s, 3H), 1.29 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 197.0, 166.4, 151.9, 137.8, 134.3, 129.8, 129.7, 128.4, 128.2, 
127.3, 127.3, 125.6, 54.2, 52.4, 29.4, 21.5, 18.2, 15.2. 
IR (Diamond-ATR, neat)     : 2967 (w), 1729 (vs), 1683 (s), 1598 (s), 1447 (m), 1433 (m), 
1373 (w), 1270 (vs), 1230 (s), 1198 (s), 1121 (m), 1061 (m), 1043 (s), 983 (m), 958 (s), 846 (m), 
806 (m), 698 (m) cm−1. 
HRMS (EI) calcd for C18H19O335Cl [M]+: 318.1017; found: 318.1014. 
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Methyl (E)-1-allyl-7-ethyl-3-methyl-4-oxo-3-(prop-1-en-1-yl)-3,4-dihydronaphthalene-2-
carboxylate (I.114): 
 
A mixture of I.111 (88 mg, 0.276 mmol, 1 equiv), cesium carbonate (360 mg, 1.10 mmol, 
4.00 equiv), SPhos-Pd-G2 (19.9 mg, 0.0276 mmol, 0.100 equiv) and SPhos (34.0 mg, 
0.0828 mmol, 0.300 equiv) was dissolved in degassed dioxane (3.9 mL), then allylboronic acid 
pinacol ester (0.207 mL, 1.10 mmol, 4.00 equiv) was added and the reaction mixture was heated 
to 90 °C. After 3.5 h, water (40 mL) was added, the layers were separated and the aqueous phase 
was extracted with ethyl acetate (3 × 60 mL). The combined organic extracts were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (2% ethyl acetate and 1% acetic acid in 
hexanes) to yield I.114 (81 mg, 91%) as a light yellow oil.  
Analytical data for I.114:  
TLC (toluene), Rf = 0.43 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.95 (d, J = 7.9 Hz, 1H), 7.33 – 7.31 (m, 1H), 7.24 (dd, J = 7.9, 
1.6 Hz, 1H), 5.92 (ddt, J = 17.2, 10.2, 6.0 Hz, 1H), 5.63 (dq, J = 15.7, 6.5 Hz, 1H), 5.45 (dq, J = 
15.4, 1.6 Hz, 1H), 5.16 (dd, J = 17.2, 1.7 Hz, 1H), 5.11 (dd, J = 10.2, 1.6 Hz, 1H), 3.79 (s, 3H), 
3.34 (qdt, J = 16.0, 5.9, 1.7 Hz, 2H), 2.72 (q, J = 7.6 Hz, 2H), 1.65 (dd, J = 6.5, 1.6 Hz, 3H), 1.49 
(s, 3H), 1.26 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 199.1, 168.8, 151.2, 138.8, 136.6, 135.3, 130.9, 130.8, 128.6, 
128.1, 127.6, 127.5, 125.2, 117.1, 52.3, 51.8, 34.6, 29.5, 21.5, 18.3, 15.2. 
IR (Diamond-ATR, neat)     : 2967 (w), 2875 (w), 1724 (vs), 1682 (s), 1601 (m), 1449 (w), 
1433 (w), 1373 (w), 1285 (m), 1237 (s), 1195 (m), 1061 (w), 1021 (w), 983 (w), 963 (w), 916 (w), 
846 (w) cm−1. 
HRMS (EI) calcd for C21H24O3 [M]+: 324.1720; found: 324.1724. 
 
 
152  Experimental Part 
 
Methyl (E)-7-ethyl-3-methyl-4-oxo-1-(2-oxopropyl)-3-(prop-1-en-1-yl)-3,4-dihydron 
aphthalene-2-carboxylate (I.115): 
 
A suspension of I.114 (60.0 mg, 0.185 mmol, 1 equiv), palladium(II) chloride (6.56 mg, 
0.0370 mmol, 0.200 equiv) and copper(I) chloride (20.1 mg, 0.203 mmol, 1.10 equiv) in water 
(0.6 mL) and dimethylformamide (10.5 mL) was sparged with oxygen gas for 1 min. An oxygen 
balloon stayed attached and after 24 h, the reaction mixture was diluted with aqueous 
hydrochloric acid solution (2 M, 50 mL). The layers were separated and the aqueous phase was 
extracted with ethyl acetate (3 × 50 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to yield I.115 
(30 mg, 48%) as a yellow oil.  
Analytical data for I.115:  
TLC (20% ethyl acetate in hexanes), Rf =0.20 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.97 (d, J = 7.9 Hz, 1H), 7.27 (dd, J = 8.1, 1.7 Hz, 1H), 7.13 (d, 
J = 1.5 Hz, 1H), 5.66 (dq, J = 15.4, 6.4 Hz, 1H), 5.47 (dq, J = 15.5, 1.6 Hz, 1H), 3.80 (s, 3H), 
3.76 – 3.61 (m, 2H), 2.70 (q, J = 7.6 Hz, 2H), 2.19 (s, 3H), 1.65 (dd, J = 6.5, 1.6 Hz, 3H), 1.53 (s, 
3H), 1.24 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 205.8, 198.6, 168.5, 151.7, 140.5, 136.5, 130.5, 129.1, 128.4, 
128.4, 127.9, 127.2, 124.6, 52.5, 52.1, 46.0, 29.4, 29.1, 21.6, 18.3, 15.2. 
IR (Diamond-ATR, neat)     : 2966 (w), 1717 (vs), 1679 (s), 1600 (s), 1432 (m), 1358 (w), 1286 
(s), 1237 (vs), 1196 (m), 1159 (m), 1064 (w), 1033 (m), 981 (m), 964 (m), 913 (w), 847 (w) cm−1. 
HRMS (EI) calcd for C21H24O4 [M]+: 340.1669; found: 340.1670. 
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Methyl (E)-1-chloro-7-ethyl-4-hydroxy-3,4-dimethyl-3-(prop-1-en-1-yl)-3,4-dihydro 
naphthalene-2-carboxylate (I.122): 
 
To a solution of I.111 (250 mg, 0.784 mmol, 1 equiv) in tetrahydrofuran (9 mL) was added 
methylmagnesium chloride solution (3 M in tetrahydrofuran, 1.57 mL, 4.71 mmol, 6 equiv) at 
0 °C. The reaction mixture was allowed to warm to 23 °C and after 4 h, saturated aqueous 
sodium bicarbonate solution (30 mL) was added. The layers were separated and the aqueous 
phase was extracted with ethyl acetate (3 × 50 mL). The combined organic extracts were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash column chromatography on silica gel (9% ethyl acetate in hexanes) 
to yield I.122 (255 mg, quant., 1:1.3 mixture of diastereomers) as a colorless oil.  
Analytical data for I.122:  
Note: The singals, which could be assigned to the major diastereomer, are marked with ‡. Signals in the 
13C NMR which could only be assigned by cross-coupling in the HMBC are marked with an asterisk. Due to 
severe signal broadening in the 13C NMR spectra some signals are missing.  
TLC (20% ethyl acetate in hexanes), Rf = 0.39 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.58 – 7.41 (m, 4H), 7.25 – 7.16 (m, 2H), 5.86 – 5.61 (m, 3H), 
5.42 (d, J = 15.7 Hz, 1H), 3.82 (s, 3H)‡, 3.80 (s, 3H), 2.67 (q, J = 7.6 Hz, 4H), 1.98 (s, 1H)‡, 1.86 
(s, 1H), 1.78 – 1.69 (m, 3H), 1.65 (dd, J = 6.5, 1.6 Hz, 3H)‡, 1.46 (s, 3H), 1.40 (s, 3H)‡, 1.32 – 
1.21 (m, 12H). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.5, 167.3‡, 143.7, 143.5‡, 141.4*, 139.6, 136.9, 136.0, 130.6, 
130.0, 129.9, 129.9, 129.7, 129.2, 128.8, 128.6, 128.3, 125.1, 125.1, 124.1, 124.0‡, 75.8, 75.2‡, 
52.1‡, 52.1, 50.2, 49.4, 28.7 (2C), 25.6*, 23.8*, 18.6, 18.4, 16.7, 15.6, 15.5.  
IR (Diamond-ATR, neat)     : 3522 (w), 2966 (w), 1728 (vs), 1624 (w), 1606 (w), 1433 (m), 
1370 (m), 1370 (vs), 1196 (m), 1169 (m), 1145 (s), 1090 (m), 1041 (s), 965 (m), 931 (m), 838 (m), 
766 (w) cm−1. 
HRMS (EI) calcd for C19H23O335Cl [M]+: 334.1330; found: 334.1339. 
 
154  Experimental Part 
 
10-Chloro-8-ethyl-3,5,5-trimethyl-3,5-dihydro-1H-benzo[g]isochromen-1-one (I.127): 
 
To titanium(IV) chloride (1 M in dichloromethane, 0.941 mL, 0.941 mmol, 6.00 equiv) in a 
Schlenk tube, which was wrapped in aluminum foil, was added dimethylzinc (15wt% in toluene, 
0.784 mL, 0.941 mmol, 6.00 equiv) over 5 min at 0 °C. After 25 min, a solution of I.111 
(50.0 mg, 0.157 mmol, 1 equiv) in dichloromethane (1.6 mL) was added over 5 min. The 
reaction mixture was stirred for 8 h at 0 °C before saturated aqueous ammonium chloride 
solution (10 mL) was added. The layers were separated and the aqueous phase was extracted 
with ethyl acetate (3 × 10 mL). The combined organic extracts were dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated. The residue was purified by 
flash column chromatography on silica gel (2% ethyl acetate and 1% acetic acid in hexanes) to 
yield I.127 (29 mg, 61%) as a light yellow oil.  
Analytical data for I.127:  
TLC (20% ethyl acetate in hexanes), Rf = 0.23 (UV, CAM, KMnO4). 
1H NMR (599 MHz, CDCl3) Ʋ: 7.85 (d, J = 1.9 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 7.24 (dd, J = 
8.0, 1.9 Hz, 1H), 5.94 (d, J = 2.9 Hz, 1H), 5.03 (qd, J = 6.8, 3.2 Hz, 1H), 2.69 (q, J = 7.7 Hz, 
2H), 1.48 (s, 3H), 1.47 (d, J = 7.0 Hz, 3H), 1.43 (s, 3H), 1.26 (t, J = 7.7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 163.6, 143.1, 143.0, 142.6, 136.8, 130.7, 130.2, 127.6, 123.8, 
123.3, 117.9, 74.5, 38.3, 28.9, 28.6, 27.2, 22.1, 15.6. 
IR (Diamond-ATR, neat)     : 2967 (m), 1729 (vs), 1556 (m), 1463 (m), 1379 (m), 1379 (m), 
1286 (m), 1210 (m), 1159 (m), 895 (w), 835 (w), 835 (w), 786 (w) cm−1. 
HRMS (EI) calcd for C18H19O235Cl [M]+: 302.7975; found: 302.1071. 
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Ethyl 3-allyl-7-ethyl-4-hydroxy-3,4-dimethyl-3,4-dihydronaphthalene-2-carboxylate 
(I.131): 
 
To a solution of I.105 (10.0 mg, 0.0335 mmol, 1 equiv) in dry tetrahydrofurane (0.4 mL) was 
added methylmagnesium bromide solution (1 M in dibutylether, 0.268 mL, 0.268 mmol, 
8.00 equiv) at 0 °C. After 5 min, the reaction mixture was warmed to 23 °C and stirred for 4 h. 
Water (2 mL), saturated aqueous sodium bicarbonate solution (5 mL) and ethyl acetate (10 mL) 
were added, the layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 20 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (30 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (9% ethyl acetate in hexanes) to afford I.131 (9.06 mg, 86%) as a 
yellow oil.  
Analytical data for I.131:  
TLC (20% ethyl acetate in hexanes), Rf = 0.48 (UV, KMnO4). 
1H NMR (200 MHz, CDCl3) Ʋ: 7.48 (d, J = 7.8 Hz, 1H), 7.30 (s, 1H), 7.28 – 7.09 (m, 1H), 6.99 
(d, J = 1.9 Hz, 1H), 5.85 (dtd, J = 17.3, 8.8, 6.1 Hz, 1H), 4.96 – 4.80 (m, 2H), 4.24 (qd, J = 7.3, 
2.8 Hz, 2H), 2.64 (q, J = 7.6 Hz, 2H), 2.54 – 2.24 (m, 2H), 1.47 (s, 3H), 1.44 – 1.16 (m, 9H). 
IR (Diamond-ATR, neat)     : 3541 (w), 2976 (m), 1710 (vs), 1455 (w), 1367 (m), 1283 (m), 
1218 (vs), 1184 (m), 1043 (s), 918 (m), 837 (m), 776 (w) cm−1. 
HRMS (EI) calcd for C20H25O3 [M−H]−: 313.1809; found: 313.1794. 
 
 
 
 
 
156  Experimental Part 
 
Ethyl 1-allyl-7-ethyl-3,4-dimethyl-2-naphthoate (I.133): 
 
To I.131 (9.06 mg, 0.0288 mmol, 1 equiv) was added thionly chloride (5.23 µL, 0.720 mmol, 
2.50 equiv) at 0 °C. After 2 h, all volatiles were removed under reduced pressure, the remaining 
mixture was cooled to −78 °C, diluted with dichloromethane (0.11 mL) and trimethylaluminum 
(2 M in toluene, 28.8 µL, 0.0576 mmol, 2.00 equiv) was added. The reaction mixture was warmed 
to 23 °C over 18 h, diluted with aqueous hydrochloric acid chloride solution (2 M, 10 mL), the 
layers were separated and the aqueous layer was extracted with dichloromethane (3 × 15 mL). 
The combined organic layers were dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The residue was purified by flash column chromatography on silica 
gel (9% ethyl acetate in hexanes) to yield I.133 (2.4 mg, 28%) as a light yellow oil.  
Analytical data for I.133:  
TLC (20% ethyl acetate in hexanes), Rf = 0.55 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.98 (d, J = 8.8 Hz, 1H), 7.80 (s, 1H), 7.39 (dd, J = 8.7, 1.6 Hz, 
1H), 6.02 (ddt, J = 17.4, 9.6, 6.0 Hz, 1H), 5.06 (dd, J = 6.3, 1.6 Hz, 1H), 5.03 (t, J = 1.5 Hz, 1H), 
4.44 (q, J = 7.2 Hz, 2H), 3.75 (d, J = 6.6 Hz, 2H), 2.81 (q, J = 7.6 Hz, 2H), 2.59 (s, 3H), 2.38 (s, 
3H), 1.41 (t, J = 7.1 Hz, 3H), 1.31 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 171.2, 141.1, 136.7, 134.0, 131.8, 131.2, 130.4, 129.3, 127.5 (2C), 
124.6, 123.1, 116.0, 61.3, 34.8, 29.2, 17.7, 15.7, 14.9, 14.4. 
IR (Diamond-ATR, neat)     : 2965 (w), 2932 (w), 1725 (vs), 1590 (w), 1453 (w), 1378 (w), 
1288 (w), 1243 (m), 1216 (m), 1168 (m), 1095 (w), 1052 (m), 1022 (w), 911 (w), 820 (w) cm−1. 
HRMS (EI) calcd for C20H24O2 [M]+: 296.1771; found: 296.1775.  
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Methyl (E)-1-chloro-7-ethyl-3-methyl-4-methylene-3-(prop-1-en-1-yl)-3,4-dihydronaph-
thalene-2-carboxylate (I.136): 
 
A solution of I.122 (10.0 mg, 0.0299 mmol, 1 equiv) in dichloromethane (1.5 mL) was treated 
with magnesium bromide diethyl etherate (46.3 mg, 0.179 mmol, 6.00 equiv) and 
tetrabutylammonium bromide (57.8 mg, 0.179 mmol, 6.00 equiv) at 0 °C. After 10 min, the 
reaction mixture was warmed to 23 °C. After 5 h, saturated aqueous sodium bicarbonate 
solution (15 mL) was added, the layers were separated and the aqueous phase was extracted with 
ethyl acetate (3 × 15 mL). The combined organic extracts were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash 
column chromatography on silica gel (20% ethyl acetate in hexanes) to yield I.136 (2.6 mg, 28%) 
as a yellow oil. For the detailed analytical data see the experiment below. 
 
Methyl (E)-1-chloro-7-ethyl-3-methyl-4-methylene-3-(prop-1-en-1-yl)-3,4-dihydronaph-
thalene-2-carboxylate (I.136): 
 
To a solution of methyltriphenylphosphonium bromide (1.03 g, 2.89 mmol, 2.00 equiv) in 
tetrahydrofuran (14 mL) was added potassium tert-butoxide (324 mg, 2.89 mmol, 2.00 equiv). 
After 1.5 h, the reaction mixture was cooled to 0 °C, a solution of I.111 (460 mg, 1.44 mmol, 
1 equiv) in tetrahydrofuran (9 mL) was added and the reaction mixture was allowed to warm to 
23 °C. After 4 h, water (70 mL) was added, the layers were separated and the aqueous phase was 
extracted with ethyl acetate (3 × 70 mL). The combined organic extracts were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to yield I.136 
(455 mg, 99%) as a yellow oil.  
Analytical data for I.136:  
158  Experimental Part 
 
TLC (20% ethyl acetate in hexanes), Rf = 0.56 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.48 (d, J = 1.7 Hz, 1H), 7.45 (d, J = 7.8 Hz, 1H), 7.16 (dd, J = 
7.9, 1.8 Hz, 1H), 5.67 – 5.56 (m, 2H), 5.44 (s, 1H), 5.18 (s, 1H), 3.80 (s, 3H), 2.68 (q, J = 7.6 Hz, 
2H), 1.77 – 1.66 (m, 3H), 1.42 (s, 3H), 1.26 (t, J = 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.5, 148.3, 144.8, 136.8, 133.3, 132.2, 129.4, 128.8, 128.3, 
125.8, 125.3, 124.7, 112.7, 52.1, 47.3, 28.9, 23.7, 18.2, 15.6. 
IR (Diamond-ATR, neat)     : 2966 (w), 1755 (vs), 1602 (w), 1485 (w), 1432 (m), 1264 (s), 
1235 (s), 1193 (m), 1154 (m), 1091 (w), 1043 (m), 962 (m), 898 (m), 836 (m), 737 (m) cm−1. 
HRMS (EI) calcd for C19H21O235Cl [M]+: 316.1225; found: 316.1222. 
 
Methyl (E)-2,2-dibromo-4'-chloro-6'-ethyl-2'-methyl-2'-(prop-1-en-1-yl)-2'H-spiro[cyclo-
propane-1,1'-naphthalene]-3'-carboxylate (I.137): 
 
To the substrate I.136 (40.0 mg, 0.126 mmol, 1 equiv) in dichloromethane (0.5 mL) were added 
bromoform (13.2 µL, 0.152 mmol, 1.20 equiv) and benzyltriethlammonium chloride (2.88 mg, 
0.0126 mmol, 0.100 equiv). An aqueous solution of sodium hydroxide (50wt%, 20.2 µL, 
0.253 mmol, 2.00 equiv) was added and the flask was wrapped in aluminum foil. After 2 d, water 
(10 mL) was added, the layers were separated and the aqueous phase was extracted with ethyl 
acetate (3 × 15 mL). The combined organic extracts were dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated.  
Note: The residue could only be partially purified by flash column chromatography on silica gel for which reason 
no yield and no NMR and IR data are given.  
Analytical data for I.137:  
TLC (20% ethyl acetate in hexanes), Rf = 0.54 (UV). 
HRMS (EI) calcd for C20H21O279Br235Cl [M]+: 485.9591; found: 485.9575. 
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Methyl 1-chloro-7-ethyl-4-(methoxymethylene)-3-methyl-3-((E)-prop-1-en-1-yl)-3,4-
dihydronaphthalene-2-carboxylate (I.141): 
 
To a suspension of (methoxymethyl)triphenylphosphonium chloride (1.19 g, 3.48 mmol, 
3.70 equiv) in tetrahydrofuran (4.7 mL) was added n-butyllithium (2.36 M in hexanes, 1.24 mL, 
2.92 mmol, 3.10 equiv) over 5 min at 0 °C. After the addition, the reaction mixture was warmed 
to 23 °C, stirred at this temperature for 20 min and cooled back to 0 °C. A solution of I.111 
(300 mg, 0.941 mmol, 1 equiv) in tetrahydrofuran (4.7 mL) was added and the reaction mixture 
was warmed to 23 °C. After 2 h, saturated aqueous ammonium chloride solution (15 mL) was 
added and the layers were separated. The aqueous phase was extracted with ethyl acetate 
(3 × 20 mL) and the combined organic extracts were washed with saturated aqueous sodium 
chloride solution (15 mL). The washed organic solution was dried over sodium sulfate and the 
dried solution was filtered and concentrated. The residue was purified by flash column 
chromatography on silica gel (2% ethyl acetate in hexanes) to afford I.141 (265 mg, 81%, 
inconsequential 1:1 mixture of diastereomers) as a light yellow oil.  
Analytical data for I.141:  
Note: Singals marked with an asterisk belong to the same diastereomer.  
TLC (20% ethyl acetate in hexanes), Rf = 0.47 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.81 (d, J = 8.0 Hz, 1H)*, 7.48 (d, J = 1.9 Hz, 1H)*, 7.46 (d, J = 
1.9 Hz, 1H), 7.20 (d, J = 7.9 Hz, 1H), 7.15 (dd, J = 8.0, 1.9 Hz, 1H)*, 7.07 (dd, J = 8.0, 1.9 Hz, 
1H), 6.43 (s, 1H), 6.14 (s, 1H)*, 5.73 – 5.63 (m, 1H), 5.62 – 5.57 (m, 1H+1H*), 5.46 (dq, J = 
15.4, 6.4 Hz, 1H), 3.80 (s, 3H), 3.78 (s, 3H)*, 3.70 (s, 3H)*, 3.66 (s, 3H), 2.64 (qd, J = 7.6, 5.4 
Hz, 2H+2H*), 1.75 – 1.67 (m, 3H)*, 1.64 (dd, J = 6.4, 1.6 Hz, 3H), 1.54 (s, 3H), 1.38 (s, 3H)*, 
1.24 (td, J = 7.6, 3.6 Hz, 3H+3H*). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.6, 167.5*, 146.8, 145.9*, 142.8, 142.7*, 136.6, 136.6*, 134.6, 
133.3*, 131.8, 129.3*, 129.1, 128.9*, 128.7*, 128.7*, 128.5, 128.5*, 128.0, 125.9*, 124.9, 124.7*, 
123.4, 123.0, 116.6, 116.4*, 60.8*, 60.7, 52.0, 52.0*, 45.6, 45.3*, 28.9, 28.7*, 24.0*, 23.0, 18.2*, 
18.0, 15.6*, 15.6. 
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IR (Diamond-ATR, neat)     : 2965 (m), 1748 (vs), 1641 (s), 1432 (m), 1260 (s), 1239 (s), 
1145 (m), 1103 (m), 1043 (m), 977 (m), 833 (m) cm−1. 
HRMS (EI) calcd for C20H23O335Cl [M]+: 346.1330; found: 346.1330. 
 
Methyl (E)-1-chloro-7-ethyl-4-formyl-3-methyl-3-(prop-1-en-1-yl)-3,4-dihydronaphtha-
lene-2-carboxylate (I.139): 
 
To I.141 (265 mg, 0.764 mmol, 1 equiv) in diethyl ether (13 mL) was added perchloric acid (70% 
in water, 0.395 mL, 4.56 mmol, 6.00 equiv) and the reaction mixture was vigorously stirred for 
19 h. After diluting with diethyl ether (15 mL) and water (15 mL), sodium bicarbonate (400 mg) 
was added carefully. The layers were separated and the aqueous phase was extracted with diethyl 
ether (3 × 20 mL). The combined organic extracts were washed with saturated sodium chloride 
solution (15 mL), dried over sodium sulfate and the dried solution was filtered and concentrated. 
The residue was purified by flash column chromatography on Davisil© (2% ethyl acetate in 
hexanes) to yield I.139 (202 mg, 79%, inconsequential mixture of diastereomers) as a colorless 
oil.  
Analytical data for I.139:  
Note: The singals, which could be assigned to the major diastereomer, are marked with an asterisk.  
TLC (20% ethyl acetate in hexanes), Rf = 0.47 (UV, CAM, KMnO4). 
1H NMR (599 MHz, C6D6) Ʋ: 9.62 (d, J = 4.5 Hz, 1H), 9.54 (d, J = 4.5 Hz, 1H)*, 7.63 (d, J = 
11.9 Hz, 1H+1H*), 6.88 – 6.63 (m, 2H+2H*), 5.77 – 5.59 (m, 1H), 5.51 (dqd, J = 15.3, 6.5, 2.4 
Hz, 1H+1H*), 5.33 (dd, J = 15.6, 2.1 Hz, 1H*), 3.44 (app d, J = 4.06 Hz, 3H+3H*), 3.23 (d, J = 
4.7 Hz, 1H)*, 3.18 (d, J = 4.9 Hz, 1H), 2.31 (dq, J = 19.5, 7.5 Hz, 2H+2H*), 1.41 (dd, J = 6.7, 
1.6 Hz, 3H), 1.29 – 1.25 (m, 9H*), 0.99 (t, J = 7.7 Hz, 3H), 0.96 (t, J = 7.7 Hz, 3H)*. 
13C NMR (151 MHz, C6D6) Ʋ: 198.0, 197.6*, 166.7*, 145.2, 145.1*, 136.5, 135.1*, 133.3, 131.4, 
131.1, 130.6, 130.1, 129.8, 129.3, 129.2, 128.6, 128.5, 125.9, 125.5, 63.0, 62.3*, 51.7*, 51.6, 43.8, 
42.8*, 28.9, 28.8*, 23.0, 21.6*, 18.1, 17.9*, 15.5, 15.4*. 
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IR (Diamond-ATR, neat)     : 2967 (w), 1724 (vs), 1603 (w), 1434 (w), 1266 (s), 1203 (w), 
1046 (w), 964 (w), 834 (w) cm−1. 
HRMS (EI) calcd for C19H21O335Cl [M]+: 332.1174; found: 332.1155. 
 
Methyl (E)-1-chloro-7-ethyl-4-formyl-3,4-dimethyl-3-(prop-1-en-1-yl)-3,4-dihydro 
naphthalene-2-carboxylate (I.140): 
 
To sodium hydride (60% dispersion in mineral oil, 32.9 mg, 0.823 mmol, 2.00 equiv) was added 
a degassed solution of I.139 (137 mg, 0.412 mmol, 1 equiv) and methyl iodide (0.256 mL, 
4.12 mmol, 10.0 equiv) in tetrahydrofuran (5.9 mL) at 0 °C. The solution was allowed to warm 
to 23 °C and after 5.5 h, saturated aqueous ammonium chloride solution (10 mL) was added. 
The layers were separated and the aqueous phase was extracted with ethyl acetate (3 × 20 mL). 
The combined organic extracts were dried over sodium sulfate, the dried solution was filtered 
and the filtrate was concentrated. The residue was purified by flash column chromatography on 
silica gel (toluene) to obtain I.140 (98 mg, 69%) as a light yellow oil.  
Analytical data for I.140:  
TLC (20% ethyl acetate in hexanes), Rf = 0.45 (UV, CAM, KMnO4). 
1H NMR (800 MHz, C6D6) Ʋ: 9.82 (s, 1H), 7.68 (d, J = 1.9 Hz, 1H), 6.87 (d, J = 7.9 Hz, 1H), 
6.83 (dd, J = 7.9, 1.9 Hz, 1H), 5.50 – 5.30 (m, 2H), 3.43 (s, 3H), 2.33 (q, J = 7.6 Hz, 2H), 1.35 (s, 
3H), 1.34 – 1.30 (m, 3H), 1.24 (s, 3H), 1.00 (t, J = 7.6 Hz, 3H). 
13C NMR (201 MHz, C6D6) Ʋ: 199.8, 166.7, 144.5, 141.5, 136.1, 133.2, 131.1, 130.3, 129.9, 
127.3, 127.1, 125.9, 56.2, 51.6, 46.2, 28.7, 18.1, 18.0, 15.4, 14.0. 
IR (Diamond-ATR, neat)     : 2969 (w), 2362 (w), 1731 (vs), 1605 (w), 1434 (w), 1373 (w), 
1268 (m), 1154 (w), 1102 (w), 1042 (w), 968 (w), 890 (w), 816 (w) cm−1. 
HRMS (EI) calcd for C20H23O335Cl [M]+: 346.1330; found: 346.1341. 
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Methyl (E)-1-chloro-7-ethyl-4-(hydroxymethyl)-3,4-dimethyl-3-(prop-1-en-1-yl)-3,4-
dihydronaphthalene-2-carboxylate (I.143): 
 
To a solution of I.140 (15.0 mg, 0.0432 mmol, 1 equiv) in methanol (0.4 mL) was added sodium 
borohydride (2.45 mg, 0.0649 mmol, 1.50 equiv) at 0 °C. After 25 min, saturated aqueous 
ammonium chloride solution (10 mL) was added. The layers were separated and the aqueous 
phase was extracted with ethyl acetate (3 × 15 mL). The combined organic extracts were dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash column chromatography on silica gel (11% ethyl acetate in 
hexanes) to obtain I.143 (12 mg, 80%, major isomer) as a colorless oil.  
Analytical data for I.143:  
Note: Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked with 
an asterisk. The relative stereochemistry was assigned by NOE correlations of I.147.  
TLC (20% ethyl acetate in hexanes), Rf = 0.21 (UV, CAM, ANIS, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.53 (d, J = 1.7 Hz, 1H), 7.23 (d, J = 7.9 Hz, 1H), 7.18 (dd, J = 
7.9, 1.9 Hz, 1H), 5.50 (dt, J = 18.0, 6.4 Hz, 1H), 5.34 (d, J = 15.6 Hz, 1H), 3.90 (dd, J = 10.9, 3.9 
Hz, 1H), 3.82 (s, 3H), 3.51 (t, J = 9.8 Hz, 1H), 2.67 (q, J = 7.6 Hz, 2H), 1.60 (dd, J = 6.3, 1.5 Hz, 
3H), 1.30 (s, 3H), 1.26 (t, J = 7.6 Hz, 3H), 1.21 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.6, 143.3, 135.9, 131.0, 129.9, 129.2, 127.9*, 127.4*, 126.0, 
125.4, 66.0, 52.2, 46.5, 45.8, 29.9, 28.6, 18.3, 16.4*, 16.4, 15.5. 
IR (Diamond-ATR, neat)     : 3430 (w), 2964 (m), 1731 (vs), 1629 (w), 1607 (w), 1433 (m), 
1375 (w), 1268 (vs), 1196 (w), 1151 (m), 1040 (s), 968 (m), 890 (w), 833 (w), 723 (w) cm−1. 
HRMS (EI) calcd for C20H25O335Cl [M]+: 348.1487; found: 348.1492. 
 
 
CHAPTER I  163 
 
Methyl (E)-1-chloro-7-ethyl-3,4-dimethyl-3-(prop-1-en-1-yl)-4-((tosyloxy)methyl)-3,4-
dihydronaphthalene-2-carboxylate (I.144): 
 
To I.143 (14.0 mg, 0.0401 mmol, 1 equiv) and p-toluenesulfonyl chloride (23.0 mg, 0.120 mmol, 
3.00 equiv) was added pyridine (0.3 mL). After stirring for 48 h, the reaction mixture was diluted 
with saturated aqueous ammonium chloride solution (15 mL), the layers were separated and the 
aqueous phase was extracted with ethyl acetate (3 × 20 mL). The combined organic extracts 
were dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. 
The residue was purified by flash column chromatography on silica gel (14% ethyl acetate in 
hexanes) to afford I.144 (14.8 mg, 73%) as a colorless oil.  
Analytical data for I.144:  
Note: Due to severe signal broadening in the NMR spectra some signals are missing or possess inaccurate 
integrals. Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked 
with an asterisk. 
TLC (20% ethyl acetate in hexanes), Rf = 0.31 (UV, ANIS, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.29 (s, 1H), 7.21 – 7.10 (m, 4H), 5.44 (dq, J = 15.4, 6.4 Hz, 
1H), 5.20 (s, 1H), 4.08 (s, 2H), 3.77 (s, 3H), 2.66 (q, J = 7.6 Hz, 2H), 2.41 (s, 3H), 1.55 (d, J = 4.9 
Hz, 3H), 1.27 (t, J = 7.6 Hz, 6H), 1.16 (s, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 167.2, 144.5, 143.3, 135.1*, 132.2, 129.8, 129.3, 129.1, 128.1, 
127.8, 125.0, 72.6, 52.1, 46.6*, 44.1, 29.9*, 28.6, 21.8, 18.2, 16.7, 15.5. 
IR (Diamond-ATR, neat)     : 2965 (w), 1729 (s), 1628 (w), 1451 (w), 1434 (w), 1361 (m), 
1269 (m), 1189 (s), 1176 (vs), 1097 (m), 1041 (m), 979 (s), 912 (m), 830 (s), 813 (s), 731 (m), 
666 (s) cm−1. 
HRMS (EI) calcd for C27H31O535ClS [M]+: 502.1575; found: 502.1574. 
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Methyl (E)-1-chloro-7-ethyl-3,4-dimethyl-4-((((methylthio)carbonothioyl)oxy)methyl)-3-
(prop-1-en-1-yl)-3,4-dihydronaphthalene-2-carboxylate (I.147): 
 
To a solution of I.143 (12.0 mg, 0.0344 mmol, 1 equiv) in tetrahydrofuran (0.26 mL) was added 
sodium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 0.172 mL, 0.172 mmol, 5.00 equiv) at 
−78 °C. After 30 min, carbon disulfide (0.0415 mL, 0.688 mmol, 20.0 equiv) was added and the 
reaction was allowed to warm to −65 °C. After another 30 min, methyl iodide (0.0428 mL, 
0.688 mmol, 20.0 equiv) was added and the reaction mixture was stirred for 75 min. Saturated 
aqueous ammonium chloride solution (15 mL) was added, the layers were separated and the 
aqueous phase was extracted with ethyl acetate (3 × 20 mL). The combined organic extracts 
were dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. 
The residue was purified by flash column chromatography on silica gel (5% ethyl acetate in 
hexanes) to obtain I.147 (12.6 mg, 83%) as a colorless oil. 
Analytical data for I.147:  
Note: Due to severe signal broadening in the NMR spectra some signals are missing or possess inaccurate 
integrals. Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked 
with an asterisk. 
TLC (20% ethyl acetate in hexanes), Rf = 0.50 (UV, ANIS, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.58 – 7.44 (m, 1H), 7.18 (d, J = 1.2 Hz, 2H), 5.64 – 5.37 (m, 
2H), 4.75 (s, 2H), 3.81 (s, 3H), 2.67 (q, J = 7.8 Hz, 2H), 2.45 (s, 3H), 1.65 (d, J = 6.1 Hz, 3H), 
1.36 (s, 3H), 1.31 – 1.18 (m, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 215.5, 167.4, 143.4, 137.3*, 135.8*, 130.2, 129.7, 129.5, 128.2, 
125.3, 77.0*, 52.1, 47.2*, 44.7, 28.6, 18.9, 18.4, 17.2, 15.5, 10.6*.  
IR (Diamond-ATR, neat)     : 2964 (w), 1730 (vs), 1607 (w), 1488 (w), 1449 (w), 1432 (m), 
1375 (w), 1268 (s), 1253 (s), 1209 (s), 1153 (m), 1067 (vs), 1041 (m), 967 (m), 911 (w), 832 (w), 
731 (w) cm−1. 
HRMS (EI) calcd for C22H27O335ClS2 [M]+: 438.1085; found: 438.1077. 
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The relative stereochemistry was assigned by NOE correlations.  
 
 
 
 
 
10.2.1.2 Second Generation Approach 
 
6-Methoxy-1-methyl-3,4-dihydronaphthalen-2(1H)-one (I.162): 
 
To I.148 (10.0 g, 56.7 mmol, 1 equiv) in tetrahydrofuran (100 mL) was added methylmagnesium 
bromide solution (3 M in diethyl ether, 28.4 mL, 85.1 mmol, 1.50 equiv) at 0 °C. The ice bath 
was removed after the addition and the reaction mixture was stirred for 17 h. Finally, it was 
cooled to 0 °C and aqueous hydrochloric acid solution (2 M, 200 mL) was added until pH=2. 
The reaction was stirred for further 5 h, diluted with water (100 mL) and the layers were 
separated. The aqueous phase was extracted with diethyl ether (3 × 200 mL). The combined 
organic extracts were washed with saturated aqueous sodium chloride solution (200 mL), the 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The residue was used without further purification. An analytical pure sample 
of I.161 was obtained by flash column chromatography on silica gel (2% ethyl acetate in 
hexanes).  
Analytical data for I.161:  
TLC (20% ethyl acetate in hexanes), Rf = 0.63 (KMnO4, ANIS). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.16 (d, J = 8.2 Hz, 1H), 6.88 – 6.62 (m, 2H), 5.73 (ddd, J = 6.0, 
3.8, 1.6 Hz, 1H), 3.81 (s, 3H), 2.75 (t, J = 8.0 Hz, 2H), 2.29 – 2.16 (m, 2H), 2.03 (q, J = 1.6 Hz, 
3H). 
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13C NMR (101 MHz, CDCl3) Ʋ: 158.5, 138.3, 131.9, 129.2, 124.0, 123.0, 113.7, 110.9, 55.4, 29.0, 
23.3, 19.5. 
IR (Diamond-ATR, neat)     : 2932 (w), 1605 (m), 1496 (s), 1427 (m), 1302 (m), 1249 (vs), 
1141 (s), 1032 (s), 867 (m), 819 (s), 674 (m) cm−1. 
HRMS (EI) calcd for C12H14O [M]+: 174.1039; found: 174.1041.  
 
To a solution of crude I.161 in dichloromethane (283 mL) and trifluoroethanol (71 mL) were 
added 3-chloroperoxybenzoic acid (75% in water, 16.3 g, 70.9 mmol, 1.25 equiv) and p-
toluenesulfonic acid monohydrate (13.5 g, 70.9 mmol, 1.25 equiv) subsequently at 0 °C. After 
stirring for 20 min, saturated aqueous sodium bicarbonate solution (200 mL) and 
dichloromethane (200 mL) were added, the layers were separated and the aqueous layer was 
extracted with dichloromethane (3 × 200 mL). The combined organic layers were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (6% ethyl acetate in hexanes) 
to obtain I.162 (4.76 g, 44% over 2 steps) as a yellow oil.  
Analytical data for I.162:  
TLC (20% ethyl acetate in hexanes), Rf = 0.45 (KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.11 (d, J = 8.3 Hz, 1H), 6.83 – 6.76 (m, 2H), 3.81 (s, 3H), 3.47 
(qd, J = 6.9, 0.9 Hz, 1H), 3.15 – 2.91 (m, 2H), 2.62 (dt, J = 17.5, 5.9 Hz, 1H), 2.48 (ddd, J = 
17.5, 9.0, 6.1 Hz, 1H), 1.45 (d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 212.5, 158.5, 138.1, 130.1, 127.3, 113.3, 112.3, 55.4, 46.8, 37.3, 
28.4, 14.6. 
IR (Diamond-ATR, neat)     : 2937 (w), 1713 (vs), 1610 (m), 1579 (w), 1497 (s), 1454 (m), 
1261 (s), 1160 (m), 1037 (m), 864 (w) cm−1. 
HRMS (EI) calcd for C12H14O2 [M]+: 190.0988; found: 190.0994.  
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6-Methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one (I.163): 
 
To a suspension of freshly washed potassium hydride (4.55 g, 114 mmol, 1.20 equiv) in degassed 
tetrahydrofuran (40 mL) was added a degassed solution of I.162 (18.0 g, 94.6 mmol, 1 equiv) in 
tetrahydrofuran (500 mL) over 25 min at 0 °C. After 20 min, the ice bath was removed and the 
reaction mixture was stirred at 23 °C. After 1 h, it was cooled back to 0 °C, methyl iodide 
(11.8 mL, 189 mmol, 2.00 equiv) was added and the ice bath was removed after the addition. 
After 25 min at 23 °C, the mixture was again cooled to 0 °C, saturated aqueous ammonium 
chloride solution (200 mL) and ethyl acetate (100 mL) were added, the layers were separated and 
the aqueous layer was extracted with ethyl acetate (3 × 200 mL). The combined organic layers 
were dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. 
The crude product was purified by flash column chromatography on silica gel (6% ethyl acetate 
in hexanes) to afford I.163 (13.6 g, 71%) as a yellow oil.  
Analytical data for I.163:  
TLC (20% ethyl acetate in hexanes), Rf = 0.39 (KMnO4, ANIS, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.29 (s, 1H), 6.84 (ddd, J = 8.7, 2.8, 0.7 Hz, 1H), 6.73 (d, J = 2.6 
Hz, 1H), 3.83 (s, 3H), 3.09 (t, J = 6.9 Hz, 2H), 2.79 – 2.63 (m, 2H), 1.44 (s, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 215.0, 158.1, 136.6, 135.8, 127.4, 113.3, 112.9, 55.4, 47.4, 37.3, 
28.9, 27.2 (2C). 
IR (Diamond-ATR, neat)     : 2968 (w), 1709 (vs), 1609 (m), 1500 (s), 1464 (m), 1307 (m), 
1265 (s), 1228 (m), 1138 (m), 1035 (s), 814 (m) cm−1. 
HRMS (EI) calcd for C13H16O2 [M]+: 204.1145; found: 204.1133. 
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6-Methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-ol (I.164): 
 
To a solution of I.163 (2.74 g, 13.4 mmol, 1 equiv) in tetrahydrofuran (13 mL) was added 
lanthanum(III) chloride bis(lithium chloride) complex solution200 (0.3 M in tetrahydrofuran, 
44.7 mL, 13.4 mmol, 1 equiv). After 1 h, the solution was cooled to 0 °C and methylmagnesium 
bromide solution (3 M in diethyl ether, 6.71 mL, 20.1 mmol, 1.50 equiv) was added dropwise 
over 20 min (syringe pump). After 20 min, saturated aqueous ammonium chloride solution 
(50 mL) and diethyl ether (50 mL) were added, the layers were separated and the aqueous layer 
was extracted with diethyl ether (3 × 50 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (20 mL) and the washed solution was dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (14% ethyl acetate in 
hexanes) to obtain I.164 (2.83 g, 96%) as a colorless oil.  
Analytical data for I.164:  
TLC (20% ethyl acetate in hexanes), Rf = 0.23 (ANIS). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.27 (d, J = 8.7 Hz, 1H), 6.75 (dd, J = 8.7, 2.8 Hz, 1H), 6.60 (d, 
J = 2.7 Hz, 1H), 3.78 (s, 3H), 2.98 (dt, J = 17.6, 7.1 Hz, 1H), 2.81 (dt, J = 17.5, 6.8 Hz, 1H), 2.04 
– 1.79 (m, 2H), 1.32 (s, 3H), 1.27 (s, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.4, 137.4, 135.5, 128.1, 113.0, 112.8, 73.7, 55.3, 41.5, 32.8, 
27.1, 27.0, 25.4, 24.3. 
IR (Diamond-ATR, neat)     : 3470 (w), 2969 (m), 1608 (m), 1499 (vs), 1464 (m), 1373 (w), 
1315 (m), 1237 (s), 1084 (m), 1037 (s), 911 (m), 818 (s) cm−1. 
HRMS (EI) calcd for C14H20O2 [M]+: 220.1458; found: 220.1452.  
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3-Hydroxy-7-methoxy-3,4,4-trimethyl-3,4-dihydronaphthalen-1(2H)-one (I.165): 
 
To a solution of I.164 (843 mg, 3.83 mmol, 1 equiv) in dry acetone (7.7 mL) was added 
cobalt(II) acetylacetonate (197 mg, 0.765 mmol, 0.200 equiv). To the resulting purple suspension 
was added dropwise tert-butyl hydroperoxide (5.5 M in decane, 2.78 mL, 15.3 mmol, 4.00 equiv). 
After 2 d, saturated aqueous ammonium chloride solution (20 mL) and ethyl acetate (20 mL) 
were added. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 20 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (20 mL) and the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (25% ethyl acetate in hexanes) to afford I.165 (854 mg, 95%) as a 
green oil.  
Analytical data for I.165:  
TLC (20% ethyl acetate in hexanes), Rf = 0.056 (ANIS, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.50 (d, J = 3.0 Hz, 1H), 7.41 (d, J = 8.7 Hz, 1H), 7.14 (dd, J = 
8.7, 3.0 Hz, 1H), 3.84 (s, 3H), 2.89 (s, 2H), 1.44 (s, 3H), 1.38 (s, 3H), 1.33 (s, 3H).  
13C NMR (101 MHz, CDCl3) Ʋ: 196.8, 158.2, 143.5, 131.8, 127.8, 122.6, 109.1, 75.7, 55.7, 55.6, 
50.0, 42.5, 24.7, 24.6. 
IR (Diamond-ATR, neat)     : 3483 (m), 2975 (m), 1677 (vs), 1608 (s), 1493 (s), 1418 (m), 
1325 (s), 1291 (vs), 1262 (s), 1087 (m), 1032 (s), 883 (w), 830 (w), 705 (w) cm−1. 
HRMS (EI) calcd for C14H18O3 [M]+: 234.1250; found: 234.1249.  
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7-Methoxy-3,4,4-trimethylnaphthalen-1(4H)-one (I.166): 
 
A mixture of I.165 (270 mg, 1.15 mmol, 1 equiv) in acetic acid (11.5 mL) and sulfuric acid (97%, 
30 µL) was heated to 100 °C for 10 min. After cooling to 23 °C, the reaction mixture was 
diluted with water (30 mL) and dichloromethane (50 mL). Sodium bicarbonate was slowly added 
until pH=7. The layers were separated and the aqueous layer was extracted with 
dichloromethane (3 × 30 mL). The combined organic layers were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography on silica gel (25% ethyl acetate in hexanes) to obtain I.166 
(220 mg, 88%) as a yellow solid.  
Analytical data for I.166:  
TLC (60% ethyl acetate in hexanes), Rf = 0.50 (KMnO4, UV). 
1H NMR (800 MHz, CDCl3) Ʋ: 7.63 (d, J = 3.0 Hz, 1H), 7.50 (d, J = 8.8 Hz, 1H), 7.16 (dd, J = 
8.7, 3.0 Hz, 1H), 6.32 (q, J = 1.3 Hz, 1H), 3.88 (s, 3H), 2.14 (d, J = 1.3 Hz, 3H), 1.48 (s, 6H). 
13C NMR (201 MHz, CDCl3) Ʋ: 184.5, 165.9, 158.2, 144.1, 131.7, 127.9, 126.6, 121.4, 107.6, 
55.7, 40.3, 28.7 (2C), 20.3. 
IR (Diamond-ATR, neat)     : 2975 (w), 1657 (vs), 1608 (m), 1497 (s), 1425 (s), 1296 (s), 
1230 (w), 1032 (w), 870 (w) cm−1. 
HRMS (EI) calcd for C14H16O2 [M]+: 216.1145; found: 216.1145.  
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5,5,6-Trimethyl-8-oxo-5,8-dihydronaphthalen-2-yl trifluoromethanesulfonate (I.168): 
 
To a solution of I.166 (200 mg, 0.925 mmol, 1 equiv) in dichloromethane (4.6 mL) was added 
dropwise boron tribromide (1 M, in dichloromethane, 4.62 mL, 4.62 mmol, 5 equiv) at −78 °C. 
The reaction mixture was allowed to warm to 0 °C over 2 h and methanol (3 mL) was added 
dropwise. Water (40 mL) was added, the layers were separated and the aqueous layer was 
extracted with dichloromethane (3 × 20 mL). The combined organic layers were dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product I.167 was used in the next step without further purification.  
To a solution of crude I.167 in dichloromethane (4.6 mL) was added triethylamine at −78 °C 
and the mixture was stirred for 5 min before trifluoromethanesulfonic anhydride (0.230 mL, 
1.39 mmol, 1.50 equiv) was added over 10 min. The reaction was allowed to warm to 23 °C over 
3 h and saturated aqueous sodium bicarbonate solution (15 mL) and dichloromethane (20 mL) 
were added. The layers were separated and the aqueous layer was extracted with 
dichloromethane (3 × 20 mL). The combined organic layers were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography on silica gel (14% ethyl acetate in hexanes) to afford I.168 
(302 mg, 98% over 2 steps) as a yellow solid.  
Analytical data for I.168:  
TLC (33% ethyl acetate in hexanes), Rf = 0.26 (KMnO4, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.05 (d, J = 2.9 Hz, 1H), 7.69 (d, J = 8.8 Hz, 1H), 7.47 (dd, J = 
8.8, 2.9 Hz, 1H), 6.36 (t, J = 1.3 Hz, 1H), 2.17 (d, J = 1.3 Hz, 3H), 1.53 (s, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 182.5, 166.2, 151.1, 148.4, 132.8, 129.2, 126.4, 125.3, 118.9 (q, J 
= 320.3 Hz) 118.8, 40.7, 28.7 (2C), 20.5. 
IR (Diamond-ATR, neat)     : 2980 (w), 1660 (s), 1579 (w), 1486 (w), 1421 (s), 1314 (m), 
1290 (m), 1204 (vs), 1137 (vs), 1109 (m), 918 (vs), 875 (m), 841 (s), 811 (s), 767 (m) cm−1.  
HRMS (EI) calcd for C14H13O4F3S [M]+: 334.0481; found: 334.0490.  
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7-Ethyl-3,4,4-trimethylnaphthalen-1(4H)-one (I.169): 
 
Note: The reaction setup has to be flame-dried very carefully, since the yield otherwise decreases significantly.  
To [1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloride (41.1 mg, 0.0562 mmol, 
0.0180 equiv) was added a solution of I.168 (1.04 g, 3.12 mmol, 1 equiv) in 1,4-dioxane 
(2.6 mL). The red suspension was cooled to 0 °C and diethylzinc solution (15wt% in toluene, 
4.27 mL, 6.25 mmol, 2.00 equiv) was added dropwise. After stirring for 10 min, the yellow 
solution was heated to 90 °C for 70 min, cooled to 0 °C and treated with methanol (5 mL). 
Water (15 mL) was added, the layers were separated and the aqueous layer was extracted with 
diethyl ether (3 × 20 mL). The combined organic layers were washed with aqueous hydrogen 
chloride solution (2 M, 20 mL) and saturated aqueous sodium chloride solution (20 mL). The 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The crude product was purified by flash column chromatography on silica gel 
(17% ethyl acetate in hexanes) to obtain I.169 (590 mg, 88%) as a yellow oil.  
Analytical data for I.169:  
TLC (20% ethyl acetate in hexanes), Rf = 0.35 (KMnO4, UV). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.01 (d, J = 2.1 Hz, 1H), 7.50 (d, J = 8.2 Hz, 1H), 7.42 (dd, J = 
8.2, 2.2 Hz, 1H), 6.32 (d, J = 1.5 Hz, 1H), 2.71 (q, J = 7.6 Hz, 2H), 2.13 (d, J = 1.1 Hz, 3H), 1.49 
(s, 6H), 1.27 (t, J = 7.7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 184.9, 165.6, 148.8, 142.6, 132.5, 130.4, 126.8, 126.5, 125.2, 
40.4, 28.7, 28.5, 20.3, 15.5. 
IR (Diamond-ATR, neat)     : 2971 (m), 2873 (w), 1657 (vs), 1610 (m), 1462 (w), 1427 (m), 
1307 (m), 1270 (w), 1117 (w), 1011 (w), 876 (m), 837 (w) cm−1. 
HRMS (EI) calcd for C15H18O2 [M]+: 214.1352; found: 214.1351.  
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3-Allyl-7-ethyl-3,4,4-trimethyl-3,4-dihydronaphthalen-1(2H)-one (I.149): 
 
To a solution of I.169 (590 mg, 2.75 mmol, 1 equiv) in tetrahydrofuran (5.5 mL) was added 
dropwise allylmagnesium bromide solution (1 M in diethyl ether, 4.13 mL, 4.13 mmol, 
1.50 equiv) at 0 °C. After 1 h, it was cooled back to 0 °C and saturated aqueous sodium 
bicarbonate solution (10 mL) and dichloromethane (10 mL) were added. The layers were 
separated and the aqueous layer was extracted with dichloromethane (3 × 15 mL). The 
combined organic layers were dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The crude product I.170 was used without further purification.  
A mixture of 18-crown-6 (1.45 g, 5.50 mmol, 2.00 equiv) and potassium tert-butoxide (617 mg, 
5.50 mmol, 2.00 equiv) in tetrahydrofuran (46 mL) was stirred at 0 °C for 1 h. A solution of 
crude I.170 in tetrahydrofuran (10 mL) was added over 10 min and after complete addition, the 
reaction mixture was allowed to warm to 23 °C. After 2 h, saturated aqueous sodium 
bicarbonate solution (40 mL) and dichloromethane (40 mL) were added. The layers were 
separated and the aqueous layer was extracted with dichloromethane (3 × 40 mL). The 
combined organic layers were dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (2% ethyl acetate in hexanes) to obtain I.149 (270 mg, 38% over 2 steps) as a yellow oil.  
Analytical data for I.149:  
TLC (20% ethyl acetate in hexanes), Rf = 0.59 (KMnO4, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.84 (s, 1H), 7.38 (s, 2H), 5.78 (ddt, J = 15.0, 10.1, 7.5 Hz, 1H), 
5.08 (dd, J = 10.1, 2.0 Hz, 1H), 4.98 (d, J = 17.0 Hz, 1H), 2.66 (q, J = 7.6 Hz, 2H), 2.60 (s, 2H), 
2.17 – 2.13 (m, 2H), 1.35 (s, 3H), 1.34 (s, 3H), 1.25 (t, J = 7.6 Hz, 3H), 0.99 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 198.4, 149.9, 142.1, 134.5, 134.2, 131.3, 126.4, 125.7, 118.6, 
46.1, 41.2, 40.9, 40.4, 28.3, 20.9, 15.4. 
IR (Diamond-ATR, neat)     : 2969 (s), 1683 (vs), 1639 (w), 1611 (m), 1456 (m), 1376 (m), 
1296 (m), 1263 (m), 1093 (m), 999 (m), 913 (m), 835 (m) cm−1. 
HRMS (EI) calcd for C18H24O [M]+: 256.1822; found: 256.1820. 
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(E)-7-Ethyl-3,4,4-trimethyl-3-(prop-1-en-1-yl)-3,4-dihydronaphthalen-1(2H)-one (I.171): 
 
To bis(dibenzylidenacetone)palladium(0) (66.1 mg, 0.115 mmol, 10.0 mol%) was added 
subsequently a solution of I.149 (295 mg, 1.15  mmol, 1 equiv) in degassed toluene (3.3 mL), 
tri-t-butylphosphine (1 M in toluene, 0.115 mL, 0.115 mmol, 10.0 mol%) and isobutyryl chloride 
(0.078M in degassed toluene, 1.47 mL, 0.115 mmol, 10.0 mol%). The reaction mixture was 
heated to 80 °C for 2 d, diluted afterwards with ethyl acetate (30 mL) and concentrated. The 
residue was purified by flash column chromatography on silica gel (20% ethyl acetate in 
hexanes) to afford I.171 (272 mg, 92%) as a yellow oil.  
Analytical data for I.171:  
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (KMnO4, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.86 (d, J = 1.9 Hz, 1H), 7.40 – 7.33 (m, 2H), 5.61 (d, J = 15.7 
Hz, 1H), 5.47 (dq, J = 15.6, 6.2 Hz, 1H), 2.83 (d, J = 17.3 Hz, 1H), 2.66 (q, J = 7.6 Hz, 2H), 2.53 
(d, J = 17.4 Hz, 1H), 1.67 (d, J = 6.2 Hz, 3H), 1.33 (s, 3H), 1.28 (s, 3H), 1.24 (t, J = 7.6 Hz, 3H), 
1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 198.6, 149.7, 142.0, 135.9, 134.1, 130.9, 126.4, 125.8, 124.5, 
48.1, 43.5, 40.6, 28.3, 26.8, 24.5, 21.7, 18.5, 15.4. 
IR (Diamond-ATR, neat)     : 2968 (m), 2936 (w), 1683 (vs), 1611 (w), 1491 (w), 1452 (w), 
1376 (w), 1290 (w), 1264 (w), 1096 (w), 975 (w), 834 (w) cm−1. 
HRMS (EI) calcd for C18H24O [M]+: 256.1822; found: 256.1821.  
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3-Allyl-7-methoxy-3,4,4-trimethyl-3,4-dihydronaphthalen-1(2H)-one (I.173): 
 
To a solution of I.166 (5.75 g, 26.6 mmol, 1 equiv) in tetrahydrofuran (53 mL) was added 
allylmagnesium bromide solution (1 M in diethyl ether, 39.9 mL, 39.9 mmol, 1.50 equiv) over 
30 min (syringe pump) at 0 °C and the reaction mixture was allowed to warm to 23 °C. After 
1 h, it was cooled back to 0 °C and saturated aqueous sodium bicarbonate solution (60 mL) and 
dichloromethane (60 mL) were added. The layers were separated and the aqueous layer was 
extracted with dichloromethane (3 × 100 mL). The combined organic layers were dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product I.172 was used without further purification.  
A mixture of 18-crown-6 (14.1 g, 53.2 mmol, 2.00 equiv) and potassium tert-butoxide (5.97 g, 
53.2 mmol, 2.00 equiv) in tetrahydrofuran (445 mL) was stirred at 0 °C for 1 h. A solution of 
crude I.172 in tetrahydrofuran (95 mL) was added over 10 min and after the addition, the 
reaction mixture was allowed to warm to 23 °C. After 4.5 h, saturated aqueous sodium 
bicarbonate solution (200 mL) and dichloromethane (200 mL) were added. The layers were 
separated and the aqueous layer was extracted with dichloromethane (3 × 200 mL). The 
combined organic layers were dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (5% ethyl acetate in hexanes) to yield I.173 (5.31 g, 77% over 2 steps) as a dark orange 
oil.  
Analytical data for I.173:  
Note: Severe signal broadening was observed in the NMR spectra recorded at room temperature. Better resolved 
spectra could be obtained at 50 °C; however, some carbon atoms are still not visible in the 13C NMR spectrum.  
TLC (20% ethyl acetate in hexanes), Rf = 0.50 (KMnO4, UV). 
1H NMR (400 MHz, 50 °C, CDCl3) Ʋ: 7.51 (d, J = 3.0 Hz, 1H), 7.37 (dd, J = 8.7, 0.4 Hz, 1H), 
7.11 (dd, J = 8.7, 3.0 Hz, 1H), 5.79 (ddt, J = 17.3, 10.1, 7.5 Hz, 1H), 5.08 (ddt, J = 10.1, 1.9, 0.9 
Hz, 1H), 4.99 (dd, J = 16.9, 1.6 Hz, 1H), 3.85 (s, 3H), 2.61 (d, J = 4.6 Hz, 2H), 2.27 – 2.08 (m, 
2H), 1.35 (s, 3H), 1.34 (s, 3H), 1.00 (s, 3H). 
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13C NMR (101 MHz, 50 °C, CDCl3) Ʋ: 197.5, 157.9, 144.9, 134.4, 132.4, 127.5, 122.1, 118.2, 
108.9, 55.4, 46.1, 40.9, 40.4, 29.6, 25.6*, 24.6*, 20.8. 
IR (Diamond-ATR, neat)     : 2973 (m), 2360 (w), 1684 (vs), 1608 (m), 1492 (s), 1417 (w), 
1324 (m), 1290 (m), 1232 (m), 1033 (m), 828 (w) cm−1. 
HRMS (EI) calcd for C17H22O2 [M]+: 258.1614; found: 258.1612.  
 
(E)-7-Methoxy-3,4,4-trimethyl-3-(prop-1-en-1-yl)-3,4-dihydronaphthalen-1(2H)-one 
(I.174): 
 
To bis(dibenzylidenacetone)palladium(0) (5.34 mg, 0.00929 mmol, 10.0 mol%) was added 
subsequently a solution of I.173 (24 mg, 0.0929 mmol, 1 equiv) in degassed toluene (0.34 mL), 
tri-t-butylphosphine (1 M in toluene, 9.29 µL, 0.00929 mmol, 10.0 mol%) and isobutyryl chloride 
(0.078 M in degassed toluene, 0.119 mL, 0.00929 mmol, 10.0 mol%). The reaction mixture was 
heated to 80 °C for 2 d, diluted afterwards with ethyl acetate (15 mL) and concentrated. The 
residue was purified by flash column chromatography on silica gel (5% ethyl acetate and 1% 
acetic acid in hexanes) to afford I.174 (22 mg, 92%) as a yellow oil.  
Analytical data for I.174:  
Note: Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked with 
an asterisk.  
TLC (20% ethyl acetate in hexanes), Rf = 0.50 (KMnO4, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.50 (d, J = 3.0 Hz, 1H), 7.35 (d, J = 8.7 Hz, 1H), 7.11 (dd, J = 
8.7, 3.0 Hz, 1H), 5.61 (d, J = 15.7 Hz, 1H), 5.47 (dq, J = 15.6, 6.2 Hz, 1H), 3.84 (s, 3H), 2.83 (d, 
J = 16.9 Hz, 1H), 2.55 (d, J = 17.4 Hz, 1H), 1.67 (d, J = 6.1 Hz, 3H), 1.32 (s, 3H), 1.27 (s, 3H), 
1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 198.2, 157.8, 144.9, 135.8, 131.9, 127.8, 124.5, 122.3, 108.8, 
55.6, 48.0, 43.6, 40.4, 27.0*, 24.8*, 21.7, 18.5. 
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IR (Diamond-ATR, neat)     : 2970 (m), 1681 (vs), 1607 (m), 1490 (s), 1416 (m), 1376 (w), 
1323 (m), 1283 (s), 1231 (s), 1032 (s), 975 (m), 828 (m), 703 (w) cm−1. 
HRMS (EI) calcd for C17H22O2 [M]+: 258.1614; found: 258.1607.  
 
(E)-((7-Ethyl-3,4,4-trimethyl-3-(prop-1-en-1-yl)-3,4-dihydronaphthalen-1-
yl)oxy)trimethylsilane (I.176): 
 
To a solution of lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 58.5 µL, 0.0585 mmol, 
1.50 equiv) was added I.171 (10.0 mg, 0.0390 mmol, 1 equiv) in tetrahydrofuran (0.3 mL) at 
−78 °C. Methyl cyanoformate (6.19 µL, 0.0780 mmol, 2.00 equiv) was added after stirring for 
1.5 h and the reaction was allowed to warm to 23 °C. After 20 h, the reaction mixture was 
diluted with saturated aqueous sodium bicarbonate solution (10 mL), the layers were separated 
and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic 
layers were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (3% 
ethyl acetate in hexanes) to yield I.176 (4.1 mg, 32%) as a colorless oil.  
Analytical data for I.176:  
TLC (20% ethyl acetate in hexanes), Rf = 0.73 (UV, CAM, KMnO4) 
1H NMR (800 MHz, CDCl3) Ʋ: 7.15 (d, J = 7.8 Hz, 1H), 7.05 (dd, J = 7.8, 2.0 Hz, 1H), 5.50 (d, 
J = 15.8 Hz, 1H), 5.45 (dq, J = 15.5, 5.9 Hz, 1H), 4.86 (s, 1H), 2.64 (q, J = 7.6 Hz, 2H), 1.65 (d, J 
= 5.6 Hz, 3H), 1.24 (t, J = 7.6 Hz, 3H), 1.20 (s, 3H), 1.14 (s, 3H), 1.06 (s, 3H), 0.27 (s, 9H). 
13C NMR (201 MHz, CDCl3) Ʋ: 146.1, 143.2, 141.4, 135.9, 131.3, 127.5, 124.3, 123.1, 121.6, 
115.6, 44.0, 40.4, 28.6, 24.3, 23.5, 20.4, 18.3, 15.5, 0.5. 
HRMS (EI) calcd for C21H32O128Si [M]+: 328.2217; found: 328.2217.  
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3-Allyl-2-bromo-7-methoxy-3,4,4-trimethyl-3,4-dihydronaphthalen-1(2H)-one (I.183): 
 
To a solution of I.173 (100 mg, 0.387 mmol, 1 equiv) in tetrahydrofuran (1.5 mL) was added 
lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 0.581 mL, 0.581 mmol, 1.50 equiv) at 
−78 °C. The mixture was stirred for 30 min and a solution of 1,2-dibromo-1,1,2,2-
tetrachloroethane (189 mg, 0.581 mmol, 1.50 equiv) in tetrahydrofuran (2.5 mL) was added. The 
reaction was allowed to warm to 23 °C over 17 h and a saturated aqueous ammonium chloride 
solution (15 mL) was added. The layers were separated and the aqueous layer was extracted with 
ethyl acetate (3 × 20 mL). The combined organic layers were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography on silica gel (5% ethyl acetate in hexanes) to yield I.183 (130 mg, 
quant.) as a light yellow oil.  
Note: Since the reaction afforded an inseparable mixture of isomers no NMR spectra of purified I.183 are 
reported.  
Analytical data for I.183:  
TLC (14% ethyl acetate in hexanes), Rf = 0.39 (ANIS, UV). 
IR (Diamond-ATR, neat)     : 3076 (w), 2978 (m), 2837 (w), 1699 (s), 1609 (s), 1496 (vs), 
1464 (m), 1333 (s), 1287 (vs), 1247 (s), 1176 (w), 1031 (s), 920 (m), 832 (m), 720 (m) cm−1. 
HRMS (EI) calcd for C17H20O279Br [M−H]−: 335.0652; found: 335.0646. 
 
6-Ethyl-1,1,2-trimethyl-4-oxo-1,2,3,4-tetrahydronaphthalene-2-carbaldehyde (I.186): 
 
A solution of I.171 (154 mg, 0.601 mmol, 1 equiv) in dichloromethane (25 mL) was cooled to 
−78 °C and a stream of ozone was bubbled through the reaction mixture for 10 min. 
Afterwards, a stream of oxygen was bubbled through the blue reaction mixture for 5 min. After 
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10 min, dimethyl sulfide (0.222 mL, 3.00 mmol, 5.00 equiv) was added. The reaction mixture 
was allowed to warm to 23 °C over 4 h, diluted with dichloromethane (20 mL) and 
concentrated. The crude product was purified by flash column chromatography on silica gel 
(14.3% ethyl acetate in hexanes) to provide I.186 (97.6 mg, 67%) as a colorless oil. The product 
was immediately used for the next reaction due to its instability. For the same reason it was not 
possible to obtain clean analytical data, since the product started to decompose immediately 
after the purification.  
 
8-Ethyl-4,5,5-trimethyl-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepine (I.191): 
 
To a solution of I.186 (9.00 mg, 0.0368 mmol, 1 equiv) in ethanol (1 mL) was added sodium 
borohydride (5.57 mg, 0.0147 mmol, 4.00 equiv). After 2.5 h, water (10 mL) and ethyl acetate 
(10 mL) were added, the layers were separated and the aqueous layer was extracted with ethyl 
acetate (3 × 10 mL). The combined organic layers were dried over sodium sulfate, the dried 
solution was filtered and the filtrate was concentrated. The crude product I.187 was used 
without further purification.  
To a solution of crude I.187 in dichloromethane (5 mL) was added Amberlyst® (23.1 mg, 
0.0736 mmol, 2.00 equiv). After 100 min, the reaction mixture was filtered through sodium 
sulfate, the filtercake was thoroughly rinsed with dichloromethane and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (5% 
ethyl acetate in hexanes) to provide I.191 (6.5 mg, 77%) as a colorless oil.  
Analytical data for I.191:  
TLC (25% ethyl acetate in hexanes), Rf = 31 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.25 (d, J = 4.6 Hz, 1H), 7.10 (dd, J = 8.0, 1.9 Hz, 1H), 6.88 (d, 
J = 1.9 Hz, 1H), 4.75 (d, J = 5.0 Hz, 1H), 4.08 (d, J = 8.8 Hz, 1H), 3.48 (d, J = 8.8 Hz, 1H), 2.59 
(q, J = 7.6 Hz, 2H), 2.24 (d, J = 11.5 Hz, 1H), 1.84 (dd, J = 11.5, 5.1 Hz, 1H), 1.35 (s, 3H), 1.28 
(s, 3H), 1.26 – 1.17 (m, 6H). 
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13C NMR (101 MHz, CDCl3) Ʋ: 142.2, 142.0, 138.2, 128.1, 127.4, 126.1, 79.0, 75.1, 46.8, 42.1, 
40.0, 29.4, 28.3, 24.0, 19.7, 15.5. 
IR (Diamond-ATR, neat)     : 2965 (m), 2934 (m), 2878 (w), 1497 (w), 1452 (m), 1374 (w), 1260 
(w), 1242 (w), 1152 (w), 1073 (w), 1034 (vs), 962 (m), 909 (m), 884 (m), 829 (m), 731 (m) cm−1. 
HRMS (EI) calcd for C16H22O [M]+: 230.1665; found: 230.1662. 
 
(E)-7-Methoxy-3,4,4-trimethyl-3-(prop-1-en-1-yl)-1,2,3,4-tetrahydronaphthalen-1-ol 
(I.188): 
 
To a solution of I.174 (35.0 mg, 0.135 mmol, 1 equiv) in methanol (0.5 mL) was added sodium 
borohydride (10.2 mg, 0.271 mmol, 2.00 equiv) at 0 °C. The mixture was allowed to warm to 
23 °C and after 1.5 h, saturated aqueous ammonium chloride solution (10 mL) was added. The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The 
combined organic layers were dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated. The crude product I.188 was filtered through a short plug of silica gel 
and used without further purification.  
 
(6-Methoxy-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methanol (I:194): 
 
To a solution of I.166 (870 mg, 4.02 mmol, 1 equiv) in methanol (34 mL) were added cerium(III) 
chloride heptahydrate (1.65 g, 4.42 mmol, 1.10 equiv) and sodium borohydride (228 mg, 
6.03 mmol, 1.50 equiv) respectively at 0 °C. After 1 h, the mixture was diluted with pH7 buffer 
solution (20 mL) and dichloromethane (20 mL).The layers were separated and the aqueous layer 
was extracted with dichloromethane (3 × 20 mL). The combined organic layers were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
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product was used immediately without further purification. Note: The product is very sensitive toward 
acidic conditions wand was found to undergo facile elimination. Therefore it was used immediately in the next 
step.  
To washed potassium hydride (242 mg, 6.03 mmol, 1.50 equiv) was added a solution of the 
crude alcohol in tetrahydrofuran (60 mL) at 0 °C. After 10 min, a solution of 
tributyl(iodomethyl)stannane201 (1.91 g, 4.42 mmol, 1.10 equiv) in tetrahydrofuran (15 mL) was 
added. After 105 min, the mixture was diluted with pH7 buffer solution (30 mL) and 
dichloromethane (30 mL).The layers were separated and the aqueous layer was extracted with 
dichloromethane (3 × 30 mL). The combined organic layers were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The crude product I.193 was used 
immediately without further purification. 
To a solution of crude I.193 in tetrahydrofuran (80 mL) was added n-butyllithium (2.51 M in 
hexanes, 2.08 mL, 5.23 mmol, 1.30 equiv) dropwise over 5 min at −78 °C. The reaction was 
allowed to warm to −45 °C over 2 h and was diluted with saturated aqueous ammonium 
chloride solution (30 mL) and water (20 mL). The layers were separated, the aqueous layer was 
extracted with ethyl acetate (3 × 40 mL) and the combined organic layers were dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (17% ethyl acetate in 
hexanes) to obtain I.194 (250 mg, 48% over 3 steps) as a yellow oil.  
Analytical data for I.194:  
TLC (25% ethyl acetate in hexanes), Rf = 0.26 (KMnO4, CAM, UV). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.18 (d, J = 8.5 Hz, 1H), 6.73 (dd, J = 8.5, 2.8 Hz, 1H), 6.59 (d, 
J = 2.8 Hz, 1H), 6.46 (d, J = 9.6 Hz, 1H), 5.68 (d, J = 9.6 Hz, 1H), 3.79 (s, 3H), 3.62 (d, J = 10.8 
Hz, 1H), 3.39 (d, J = 10.8 Hz, 1H), 1.29 (s, 4H), 1.13 (s, 3H), 1.09 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.9, 137.3, 135.5, 133.3, 127.3, 125.2, 112.9, 112.2, 67.8, 55.3, 
43.0, 38.6, 25.8, 21.6, 17.7. 
IR (Diamond-ATR, neat)     : 3409 (m), 2969 (m), 2877 (w), 1746 (w), 1602 (m), 1490 (m), 
1309 (m), 1259 (vs), 1154 (w), 1035 (vs), 777 (w) cm−1. 
HRMS (EI) calcd for C15H20O2 [M]+: 232.1458; found: 232.1458.  
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(6-Methoxy-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methyl acetate (I.200): 
 
To a solution of I.194 (10.0 mg, 0.0430 mmol, 1 equiv) in dichloromethane (0.43 mL) were 
added triethylamine (17.9 µL, 0.129 mmol, 3.00 equiv), acetic anhydride (10.5 µl, 0.112 mmol, 
2.60 equiv) and 4-dimethylaminopyridine (0.526 mg, 0.00430 mmol, 0.100 equiv) at 0 °C. After 
30 min, the reaction mixture was diluted with saturated aqueous sodium bicarbonate solution 
(10 mL), the layers were separated and the aqueous layer was extracted with dichloromethane 
(3 × 10 mL). The combined organic layers were dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to afford I.200 (10.2 mg, 86%) as a 
colorless oil.  
Analytical data for I.200:  
TLC (20% ethyl acetate in hexanes), Rf = 0.31 (UV, CAM). 
1H NMR (599 MHz, CDCl3) Ʋ: 7.18 (d, J = 8.3 Hz, 1H), 6.72 (dd, J = 8.3, 2.8 Hz, 1H), 6.58 (d, 
J = 2.7 Hz, 1H), 6.39 (d, J = 9.7 Hz, 1H), 5.67 (d, J = 9.5 Hz, 1H), 4.01 (q, J = 10.7 Hz, 2H), 
3.78 (s, 3H), 1.94 (s, 3H), 1.27 (s, 3H), 1.18 (s, 3H), 1.07 (s, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 171.4, 158.0, 136.8, 135.1, 133.2, 126.7, 125.2, 112.8, 112.2, 
68.6, 55.4, 41.4, 39.0, 24.7, 22.5, 21.0, 17.8. 
IR (Diamond-ATR, neat)     : 2971 (m), 1738 (s), 1603 (m), 1491 (m), 1375 (m), 1260 (s), 
1237 (vs), 1154 (m), 1034 (s), 856 (s), 777 (s) cm−1. 
HRMS (EI) calcd for C17H22O3 [M]+: 274.1563; found: 274.1564. 
 
 
 
 
 
CHAPTER I  183 
 
6-Methoxy-2-((methoxymethoxy)methyl)-1,1,2-trimethyl-1,2-dihydronaphthalene (I.198): 
 
To a solution of I.194 (20.0 mg, 0.0861 mmol, 1 equiv) in dichloromethane (0.43 mL) were 
added N,N-diisopropylethylamine (59.6 µL, 0.344 mmol, 4.00 equiv), 4-dimethylaminopyridine 
(1.05 mg, 0.008641 mmol, 0.100 equiv) and chloromethyl methyl ether (22.9 µL, 0.301 mmol, 
3.50 equiv) respectively at 0 °C. The reaction mixture was allowed to warm to 23 °C and after 
4 h, saturated aqueous ammonium chloride solution (10 mL) was added. The layers were 
separated, the aqueous layer was extracted with diethyl ether (3 × 10 mL) and the combined 
organic layers were washed with saturated aqueous sodium chloride solution (10 mL). The 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The crude product was purified by flash column chromatography on silica gel 
(5% ethyl acetate in hexanes) to provide I.198 (22.3 mg, 94%) as a colorless oil.  
Analytical data for I.198:  
TLC (20% ethyl acetate in hexanes), Rf = 0.43 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.18 (dd, J = 8.4, 0.6 Hz, 1H), 6.72 (dd, J = 8.5, 2.8 Hz, 1H), 
6.58 (d, J = 2.8 Hz, 1H), 6.37 (d, J = 9.6 Hz, 1H), 5.77 (d, J = 9.6 Hz, 1H), 4.59 – 4.52 (m, 2H), 
3.79 (s, 3H), 3.45 (s, 2H), 3.32 (s, 3H), 1.22 (s, 3H), 1.19 (s, 3H), 1.10 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 158.0, 137.0, 136.6, 133.5, 125.7, 125.2, 112.5, 112.1, 97.0, 72.3, 
55.3, 55.3, 42.0, 39.1, 24.3, 22.9, 17.9. 
IR (Diamond-ATR, neat)     : 2968 (w), 2931 (w), 1602 (w), 1464 (w), 1309 (w), 1260 (m), 
1149 (m), 1105 (m), 1037 (vs), 916 (w), 854 (w), 776 (w) cm−1. 
HRMS (EI) calcd for C17H24O3 [M]+: 276.1720; found: 276.1715.  
 
 
 
 
184  Experimental Part 
 
tert-Butyl((6-methoxy-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methoxy)dimethyl-
silane (I.197): 
 
To a solution of I.194 (20.0 mg, 0.0861 mmol, 1 equiv) in dimethylformamide (0.21 mL) were 
added imidazole (11.7 mg, 0.172 mmol, 2.00 equiv) and tert-butyldimethylsilyl chloride (19.5 mg, 
0.129 mmol, 1.50 equiv) at 0 °C and the reaction was allowed to warm to 23 °C. After 20 h, 
saturated aqueous ammonium chloride solution (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with diethyl ether (3 × 10 mL) and the combined 
organic layers were washed with saturated aqueous sodium chloride solution (10 mL). The 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The crude product was purified by flash column chromatography on silica gel 
(5% ethyl acetate in hexanes) to obtain I.197 (20.2 mg, 68%) as a colorless oil.  
Analytical data for I.197:  
TLC (20% ethyl acetate in hexanes), Rf = 0.68 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.17 (dd, J = 8.4, 0.6 Hz, 1H), 6.71 (dd, J = 8.5, 2.8 Hz, 1H), 
6.56 (d, J = 2.8 Hz, 1H), 6.33 (d, J = 9.6 Hz, 1H), 5.71 (d, J = 9.6 Hz, 1H), 3.79 (s, 3H), 3.51 (s, 
2H), 1.21 (d, J = 3.6 Hz, 6H), 1.02 (s, 3H), 0.86 (s, 9H), -0.03 (d, J = 2.4 Hz, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.8, 137.5, 137.1, 133.7, 125.6, 125.1, 112.4, 111.9, 67.0, 55.3, 
43.1, 39.0, 26.0, 24.5, 23.2, 18.4, 17.6, -5.4, -5.4. 
IR (Diamond-ATR, neat)     : 2955 (m), 2928 (m), 2855 (w), 1602 (w), 1463 (m), 1360 (w), 
1309 (w), 1259 (s), 1072 (s), 1038 (s), 1005 (m), 849 (vs), 835 (vs), 773 (vs), 668 (m) cm−1.  
HRMS (EI) calcd for C21H34O2Si [M]+: 346.2323; found: 346.2322.  
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6-Methoxy-2-(methoxymethyl)-1,1,2-trimethyl-1,2-dihydronaphthalene (I.199): 
 
To a solution of I.194 (20.0 mg, 0.0861 mmol, 1 equiv) in dimethylformamide (0.43 mL) was 
added sodium hydride (60% dispersion in mineral oil, 6.89 mg, 0.172 mmol, 2.00 equiv) at 0 °C. 
After 15 min, methyl iodide (9.65 mL, 0.155 mmol, 1.80 equiv) was added and the mixture was 
allowed to warm to 23 °C over 2.5 h. Saturated aqueous ammonium chloride solution (10 mL) 
was added and the layers were separated. The aqueous layer was extracted with ethyl acetate 
(3 × 10 mL) and the combined organic layers were dried over sodium sulfate. The dried solution 
was filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to provide I.199 (17 mg, 80%) as a 
colorless oil.  
Analytical data for I.199:  
TLC (20% ethyl acetate in hexanes), Rf = 0.61 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.18 (d, J = 8.4 Hz, 1H), 6.72 (dd, J = 8.5, 2.8 Hz, 1H), 6.59 (d, 
J = 2.7 Hz, 1H), 6.37 (d, J = 9.6 Hz, 1H), 5.75 (d, J = 9.6 Hz, 1H), 3.79 (s, 3H), 3.33 – 3.22 (m, 
5H), 1.22 (s, 3H), 1.18 (s, 3H), 1.09 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.9, 137.0, 136.9, 133.5, 125.5, 125.2, 112.5, 112.0, 77.4, 59.5, 
55.3, 42.2, 39.1, 24.4, 22.8, 17.8. 
IR (Diamond-ATR, neat)     : 2970 (m), 2932 (m), 1886 (m), 1602 (m), 1572 (m), 1489 (m), 
1464 (m), 1361 (w), 1309 (m), 1282 (m), 1261 (vs), 1194 (m), 1154 (m), 1105 (vs), 1089 (s), 1037 (s), 
982 (w), 871 (w), 777 (m) cm−1. 
HRMS (EI) calcd for C16H22O2 [M]+: 246.1620; found: 246.1614. 
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N,N-Diethyl-2-((6-methoxy-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methoxy)acet-
amide (I.209): 
 
To a solution of I.194 (100 mg, 0.430 mmol, 1 equiv) in 1,2-dimethoxyethane (2.2 mL) was 
added sodium hydride (60% dispersion in mineral oil, 51.6 mg, 1.29 mmol, 3.00 equiv) at 0 °C 
and after 20 min 2-chloro-N,N-diethylacetamide (I.208) (88.7 µL, 0.646 mmol, 1.50 equiv). The 
reaction was allowed to warm slowly to 23 °C over 17 h and diluted with saturated aqueous 
ammonium chloride solution (10 mL) and water (5 mL). The layers were separated, the aqueous 
layer was extracted with ethyl acetate (3 × 15 mL) and the combined organic layers were dried 
over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (33% ethyl acetate in 
hexanes) to afford I.209 (144 mg, 97%) as a colorless oil.  
Analytical data for I.209:  
TLC (33% ethyl acetate in hexanes), Rf = 0.17 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.16 (d, J = 8.4 Hz, 1H), 6.70 (dd, J = 8.5, 2.8 Hz, 1H), 6.56 (d, 
J = 2.7 Hz, 1H), 6.34 (d, J = 9.6 Hz, 1H), 5.78 (d, J = 9.7 Hz, 1H), 4.04 (q, J = 13.2 Hz, 2H), 
3.78 (s, 3H), 3.47 – 3.25 (m, 6H), 1.26 – 1.04 (m, 15H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.5, 157.9, 136.9, 136.7, 133.4, 125.6, 125.2, 112.4, 112.0, 
76.0, 71.3, 55.3, 42.3, 41.1, 39.8, 39.0, 24.3, 22.8, 17.9, 14.4, 12.9. 
IR (Diamond-ATR, neat)     : 2971 (m), 2935 (m), 2874 (w), 1645 (vs), 1603 (m), 1572 (w), 
1464 (m), 1431 (m), 1381 (w), 1362 (w), 1309 (m), 1261 (vs), 1222 (m), 1153 (m), 1102 (m), 1088 
(m), 1036 (m), 947 (w), 871 (w), 791 (w), 779 (w), 734 (w) cm−1. 
HRMS (EI) calcd for C21H31O3N [M]+: 345.2298; found: 345.2295.  
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7-Methoxy-3,4,4-trimethyl-2a,3,4,8b-tetrahydro-1,3-(epoxymethano)cyclobuta[a]-
naphthalen-2(1H)-one (I.207): 
 
To a solution of I.209 (60.0 mg, 0.174 mmol, 1 equiv) in 1,2-dichloroethane (6 mL) were added 
2,4,6-collidine (11.7 µL, 0.868 mmol, 5.00 equiv) and trifluoromethanesulfonic anhydride (1 M in 
dichloromethane, 0.868 mL, 0.868 mmol, 5.00 equiv) and the reaction mixture was heated to 
80 °C. After 75 min, potassium carbonate (120 mg, 0.868 mmol, 5.00 equiv), acetone (6 mL) and 
water (6 mL) were added and the mixture was heated to 70 °C. After 2 h, aqueous hydrochloric 
acid solution (2 M, 20 mL) was added and the aqueous phase was extracted with diethyl ether 
(3 × 20 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (20 mL) and the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (14% ethyl acetate in hexanes) to yield I.207 (33 mg, 70%) as a 
yellow oil.  
Analytical data for I.207:  
TLC (25% ethyl acetate in hexanes), Rf = 0.41 (CAM, ANIS, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.36 (d, J = 8.7 Hz, 1H), 6.83 (dd, J = 8.7, 2.8 Hz, 1H), 6.69 (d, 
J = 2.8 Hz, 1H), 4.66 (dd, J = 6.7, 4.3 Hz, 1H), 4.05 (dt, J = 12.1, 0.9 Hz, 1H), 3.80 (s, 3H), 3.50 
(d, J = 12.1 Hz, 1H), 3.41 (tt, J = 6.1, 0.7 Hz, 1H), 3.27 (dd, J = 6.0, 4.3 Hz, 1H), 1.41 (s, 3H), 
1.08 (s, 3H), 1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 204.8, 158.0, 139.1, 130.3, 126.3, 113.7, 113.6, 93.0, 71.9, 64.2, 
55.3, 45.9, 38.1, 35.8, 30.9, 21.5, 20.8. 
IR (Diamond-ATR, neat)     : 2975 (m), 2865 (w), 1780 (vs), 1610 (m), 1501 (m), 1465 (m), 
1316 (w), 1260 (m), 1249 (m), 1153 (w), 1053 (m), 1037 (m), 908 (m), 818 (m) cm−1. 
HRMS (EI) calcd for C17H20O3 [M]+: 272.1407; found: 272.1406.  
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7-Methoxy-3a,4,4-trimethyl-3,3a,4,8b-tetrahydro-1H-benzo[f]cyclobuta[cd]isobenzo-
furan-1a(1a1H)-ol (I.214): 
 
To a degassed solution of I.207 (12.0 mg, 0.0441 mmol, 1 equiv) in tetrahydrofuran (1.2 mL) 
and methanol (0.6 mL) was added dropwise a solution of samarium(II) iodide (0.1 M in 
tetrahydrofuran, 3.52 mL, 0.352 mmol, 8.00 equiv) at 0 °C. After 1 h, water (10 mL) and 
aqueous hydrochloric acid solution (2 M, 10 mL) were added and the aqueous phase was 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by flash column chromatography on silica gel (33% ethyl acetate in hexanes) to afford 
I.214 (12 mg, quant.) as a colorless oil.  
Analytical data for I.214:  
TLC (33% ethyl acetate in hexanes), Rf = 0.26 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.24 (d, J = 8.8 Hz, 1H), 6.73 (dd, J = 8.7, 2.8 Hz, 1H), 6.58 (d, 
J = 2.7 Hz, 1H), 3.78 (s, 3H), 3.68 (d, J = 8.9 Hz, 1H), 3.51 (d, J = 8.9 Hz, 1H), 3.34 (td, J = 
10.4, 5.0 Hz, 1H), 3.05 (ddd, J = 12.9, 11.2, 1.7 Hz, 1H), 2.75 – 2.66 (m, 2H), 2.23 (dd, J = 13.0, 
5.1 Hz, 1H), 1.28 (s, 6H), 1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.8, 139.4, 136.8, 126.1, 112.8, 112.3, 106.4, 76.7, 55.3, 53.6, 
46.6, 44.2, 37.9, 29.5, 23.6, 22.2, 21.9. 
IR (Diamond-ATR, neat)     : 3391 (w), 2971 (m), 1608 (m), 1575 (w), 1502 (m), 1424 (w), 
1364 (w), 1284 (s), 1254 (s), 1216 (w), 1158 (m), 1125 (w), 1037 (vs), 867 (m), 815 (m), 728 (m) 
cm−1. 
HRMS (EI) calcd for C17H22O3 [M]+: 274.1563; found: 274.1572.  
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tert-Butyl((7-methoxy-3a,4,4-trimethyl-3,3a,4,8b-tetrahydro-1H-benzo[f]cyclobuta[cd] 
isobenzofuran-1a(1a1H)-yl)oxy)dimethylsilane (I.216): 
 
To a solution of I.214 (4.70 mg, 0.0171 mmol, 1 equiv) in dichloromethane (1.1 mL) were added 
triethylamine (47.6 µL, 0.343 mmol, 20.0 equiv) and tert-butyldimethylsilyl 
trifluoromethanesulfonate (39.3 µL, 0.171 mmol, 10.0 equiv) at −78 °C and the reaction was 
allowed to warm to −35 °C over 2.5 h. The reaction mixture was diluted with saturated aqueous 
sodium bicarbonate solution (10 mL), the layers were separated and the aqueous layer was 
extracted with diethyl ether (3 × 10 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (10 mL) and the washed solution was dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) 
to yield I.216 (5.4 mg, 81%) as a colorless oil.  
Analytical data for I.216:  
TLC (33% ethyl acetate in hexanes), Rf = 0.75 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.2 (d, J = 8.7 Hz, 1H), 6.7 (dd, J = 8.6, 2.8 Hz, 1H), 6.6 (d, J = 
2.8 Hz, 1H), 3.8 (s, 3H), 3.6 (d, J = 8.6 Hz, 1H), 3.5 (d, J = 8.7 Hz, 1H), 3.3 (td, J = 10.0, 4.0 Hz, 
1H), 2.9 (t, J = 11.3 Hz, 1H), 2.8 (d, J = 9.4 Hz, 1H), 2.3 (dd, J = 12.0, 4.0 Hz, 1H), 1.3 (s, 6H), 
1.0 (s, 3H), 0.9 (s, 9H), 0.1 (s, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.8, 140.4, 137.2, 125.8, 112.9, 111.8, 107.4, 78.5, 56.2, 55.2, 
47.8, 45.6, 38.5, 28.8, 25.9, 25.3, 22.3, 22.0, 17.9, -3.2, -3.5. 
IR (Diamond-ATR, neat)     : 2957 (s), 2930 (s), 2857 (m), 1700 (w), 1608 (w), 1576 (w), 
1499 (m), 1472 (m), 1464 (m), 1390 (m), 1290 (s), 1253 (s), 1214 (w), 1160 (m), 1140 (m), 1101 (m), 
1040 (vs), 962 (m), 902 (m), 836 (s), 780 (s) cm−1. 
HRMS (EI) calcd for C23H36O3Si [M]+: 388.2428; found: 388.2427.  
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3-(Hydroxymethyl)-7-methoxy-3,4,4-trimethyl-1,2,2a,3,4,8b-hexahydrocyclobuta[a] 
naphthalen-2-ol (I.221): 
 
To a solution of I.214 (12.0 mg, 0.0437 mmol, 1 equiv) in diethyl ether (3 mL) was added 
lithium aluminum hydride (16.6 mg, 0.437 mmol, 10.0 equiv) at 0 °C and the reaction mixture 
was allowed to warm slowly to 23 °C. After 4 h, the reaction mixture was diluted with saturated 
aqueous ammonium chloride solution (15 mL), the layers were separated and the aqueous layer 
was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (10 mL) and the washed solution was dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (33% ethyl acetate in 
hexanes) to yield I.221 (12 mg, 99%, d.r. = 30:1) as a colorless oil.  
Analytical data for I.221:  
TLC (50% ethyl acetate in hexanes), Rf = 0.20 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.09 (d, J = 8.5 Hz, 1H), 6.66 (dd, J = 8.6, 2.8 Hz, 1H), 6.59 (d, 
J = 2.7 Hz, 1H), 4.52 (dt, J = 9.7, 8.1 Hz, 1H), 3.77 (s, 3H), 3.55 – 3.44 (m, 2H), 3.35 (s, 2H), 
3.12 (q, J = 8.9 Hz, 1H), 3.03 (dt, J = 12.0, 6.0 Hz, 1H), 2.90 (dtd, J = 11.3, 8.0, 3.3 Hz, 1H), 
2.00 (q, J = 10.1 Hz, 1H), 1.31 (s, 3H), 1.18 (s, 3H), 1.02 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 158.2, 140.7, 137.0, 124.9, 112.3, 111.1, 65.5, 65.1, 55.3, 49.8, 
42.9, 41.1, 40.1, 27.9, 27.3, 21.5, 18.7. 
IR (Diamond-ATR, neat)     : 3217 (m), 2970 (m), 2934 (m), 1606 (m), 1576 (w), 1495 (m), 
1465 (m), 1365 (w), 1310 (m), 1247 (s), 1198 (m), 1112 (m), 1031 (vs), 849 (m), 808 (m), 735 (s), 
703 (m) cm−1.  
HRMS (ESI) calcd for C17H24O3 [M]+: 276.1720; found: 276.1726.  
The relative stereochemistry was assigned by NOE correlations.  
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3-(((tert-Butyldimethylsilyl)oxy)methyl)-7-methoxy-3,4,4-trimethyl-1,2,2a,3,4,8b-hexa-
hydrocyclobuta[a]naphthalen-2-ol (I.222) and (2-((tert-butyldimethylsilyl)oxy)-7-
methoxy-3,4,4-trimethyl-1,2,2a,3,4,8b-hexahydrocyclobuta[a]naphthalen-3-yl)methanol 
(I.223): 
 
To a solution of I.221 (8.50 mg, 0.0308 mmol, 1 equiv) in dimethylformamide (0.15 mL) were 
added imidazole (4.19 mg, 0.0615 mmol, 2.00 equiv), tert-butyldimethylsilyl chloride (4.64 mg, 
0.0308 mmol, 1 equiv) and 4-dimethylaminopyridine (0.376 mg, 0.00308 mmol, 0.100 equiv) 
subsequently. After 4 h, the reaction mixture was diluted with saturated aqueous ammonium 
chloride solution (5 mL), the layers were separated and the aqueous layer was extracted with 
ethyl acetate (3 × 10 mL). The combined organic layers were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography on silica gel (9% ethyl acetate in hexanes) to afford I.223 (2.8 mg, 
23%) and I.222 (1 mg, 8%) as a colorless oils.  
Analytical data for I.223:  
TLC (33% ethyl acetate in hexanes), Rf = 0.60 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.10 (d, J = 8.6 Hz, 1H), 6.66 (dd, J = 8.5, 2.7 Hz, 1H), 6.55 (d, 
J = 2.7 Hz, 1H), 4.84 (d, J = 11.6 Hz, 1H), 4.64 (q, J = 8.6 Hz, 1H), 3.76 (s, 3H), 3.43 (d, J = 
12.4 Hz, 1H), 3.22 (t, J = 12.0 Hz, 1H), 3.14 (q, J = 9.0 Hz, 1H), 3.00 (td, J = 8.8, 3.0 Hz, 1H), 
2.87 (ddt, J = 12.4, 8.1, 4.0 Hz, 1H), 2.13 (q, J = 10.1 Hz, 1H), 1.32 (s, 3H), 1.14 (s, 3H), 1.00 (s, 
3H), 0.92 (s, 9H), 0.14 (app d, J = 9.3 Hz, 6H).  
13C NMR (101 MHz, CDCl3) Ʋ: 158.1, 140.3, 137.3, 124.9, 112.1, 110.9, 66.4, 64.1, 55.3, 50.4, 
43.2, 40.8, 40.1, 27.9, 27.5, 25.8, 21.4, 18.8, 18.2, -4.9, -5.2. 
IR (Diamond-ATR, neat)     : 3424 (w), 2956 (m), 1607 (w), 1576 (w), 1496 (m), 1472 (m), 
1253 (s), 1198 (m), 1116 (m), 1077 (m), 1038 (s), 983 (w), 870 (m), 838 (vs), 782 (m) cm−1.  
HRMS (ESI) calcd for C23H38O3Si [M]+: 390.2585; found: 390.2597.  
The relative stereochemistry and the position of the TBS protecting 
group were assigned by NOE correlations.  
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Analytical data for I.222:  
Note: Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked with 
an asterisk.  
TLC (33% ethyl acetate in hexanes), Rf = 0.51 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.08 (d, J = 8.5 Hz, 1H), 6.66 (dd, J = 8.6, 2.8 Hz, 1H), 6.59 (d, 
J = 2.8 Hz, 1H), 5.98 (d, J = 11.7 Hz, 1H), 4.52 – 4.33 (m, 1H), 3.78 (s, 3H), 3.53 – 3.39 (m, 
2H), 3.09 (q, J = 8.7 Hz, 1H), 3.02 (td, J = 8.6, 3.5 Hz, 1H), 2.95 – 2.84 (m, 1H), 1.90 (q, J = 
10.1 Hz, 1H), 1.31 (s, 3H), 1.15 (s, 3H), 1.02 (s, 3H), 0.86 (s, 9H), 0.05 (s, 3H), 0.01 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 158.1*, 140.7, 137.0, 124.9, 112.3, 111.2, 65.9, 65.5, 55.3, 49.9, 
43.2, 41.8, 40.1, 28.3, 27.2, 25.9 (3C), 21.6, 19.0, 18.4, -5.4 (2C). 
IR (Diamond-ATR, neat)     : 3373 (w), 2930 (m), 2363 (w), 1653 (w), 1607 (w), 1559 (w), 
1457 (m), 1252 (m), 1128 (m), 1038 (s), 839 (vs), 781 (m) cm−1.  
HRMS (ESI) calcd for C23H38O3Si [M]+: 390.2585; found: 390.2590.  
The relative stereochemistry and the position of the TBS protecting 
group were assigned by NOE correlations. 
 
 
7-Methoxy-3,4,4-trimethyl-2-oxo-1,2,2a,3,4,8b-hexahydrocyclobuta[a]naphthalene-3-
carbaldehyde (I.218): 
 
To a solution of oxalyl chloride (2 M in dichloromethane, 151 µL, 0.302 mmol, 2.20 equiv) in 
dichloromethane (1.5 mL) was added dimethyl sulfoxide (47.9 µL, 0.674 mmol, 4.90 equiv) at 
−78 °C. After stirring for 3 min, a solution of I.221 (38.0 mg, 0.137 mmol, 1 equiv) 
dichloromethane (1 mL) was added and after further 25 min triethylamine (191 µL, 1.37 mmol, 
10.0 equiv) was added. The reaction mixture was stirred for 10 min at −78 °C and was then 
directly warmed to 23 °C. After 10 min, saturated aqueous sodium bicarbonate solution (10 mL) 
was added, the layers were separated and the aqueous layer was extracted with dichloromethane 
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(3 × 10 mL). The combined organic layers were dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes, triethylamine pretreated silica gel) to 
obtain I.218 (35.5 mg, 95%) as a colorless oil.  
Analytical data for I.218:  
Note: Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked with 
an asterisk. 
TLC (20% ethyl acetate in hexanes), Rf = 0.18 (ANIS). 
1H NMR (400 MHz, C6D6) Ʋ: 9.12 (br s, 1H), 6.89 (d, J = 8.5 Hz, 1H), 6.68 – 6.59 (m, 2H), 3.31 
(s, 3H), 3.24 (br s, 1H), 3.08 (ddd, J = 17.2, 9.6, 3.8 Hz, 1H), 2.95 (tdt, J = 9.6, 6.0, 1.1 Hz, 1H), 
2.83 (ddd, J = 10.3, 3.7, 2.8 Hz, 1H), 1.05 (s, 3H), 1.01 (s, 3H), 0.73 (s, 3H). 
13C NMR (101 MHz, C6D6) Ʋ: 206.7, 202.2, 159.2, 140.3, 135.5, 125.4, 113.4, 112.3, 63.9, 55.9, 
54.7, 53.1, 39.7, 26.3, 25.9, 21.7*, 16.3. 
IR (Diamond-ATR, neat)     : 2973 (w), 2933 (w), 2728 (w), 1774 (vs), 1718 (s), 1607 (m), 
1574 (w), 1494 (m), 1465 (m), 1388 (m), 1298 (m), 1249 (s), 1155 (m), 1087 (m), 1034 (s), 854 (w), 
820 (w) cm−1. 
HRMS (ESI) calcd for C17H20O3 [M]+: 272.1412; found: 272.1409. 
 
3-Acetyl-6-methoxy-1,1,2-trimethyl-1,2-dihydronaphthalene-2-carbaldehyde (I.228) and 
7-methoxy-3a,4,4-trimethyl-3a,4-dihydro-1H-cyclopenta[b]naphthalen-1-one (I.229): 
 
To a solution of I.218 (5.00 mg, 0.0184 mmol, 1 equiv) in tetrahydrofuran (0.2 mL) was added 
lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 22.0 µL, 0.0220 mmol, 1.20 equiv) at 
−78 °C. After 1 h, freshly distilled trimethylsilyl chloride (over CaH2, 3.52 µL, 0.0275 mmol, 
1.50 equiv) was added and the mixture was allowed to warm to 23 °C. After 3 h, 
dichloromethane (5 mL) was added, the reaction mixture was filtered through a small plug of 
Celite® and the filtrate was concentrated. The residue was used without further purification. 
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To acetone (2.03 µL, 0.0276 mmol, 1.50 equiv) in dichloromethane (0.1 mL) was added 
titanium(IV) chloride (3.04 µL, 0.0276 mmol, 1.50 equiv) followed by the addition of a solution 
of crude product in dichloromethane (0.3 mL) at −78 °C. The reaction mixture was allowed to 
warm to 23 °C over 17 h. pH7 Buffer solution (10 mL) and diethyl ether (10 mL) were added, 
the layers were separated and the aqueous layer was extracted with diethyl ether (3 × 10 mL). 
The combined organic layers were washed with saturated aqueous sodium chloride solution 
(10 mL) and the washed solution was dried over sodium sulfate. The dried solution was filtered 
and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to provide trace amounts of I.228 
and I.229 as colorless oils.  
Analytical data for I.228:  
TLC (20% ethyl acetate in hexanes), Rf = 0.14 (UV, CAM, KMnO4). 
1H NMR (400 MHz, C6D6) Ʋ: 9.90 (s, 1H), 6.91 (d, J = 8.6 Hz, 1H), 6.89 (s, 1H), 6.69 (dd, J = 
8.5, 2.8 Hz, 1H), 6.55 (d, J = 2.7 Hz, 1H), 3.33 (s, 3H), 1.90 (s, 3H), 1.26 (s, 3H), 1.18 (s, 3H), 
1.02 (s, 3H). 
13C NMR (101 MHz, C6D6) Ʋ: 200.4, 196.6, 158.6, 142.4, 138.5, 137.6, 131.3, 125.8, 116.7, 
115.0, 54.9, 53.8, 40.7, 26.4, 25.0, 20.3, 14.6. 
IR (Diamond-ATR, neat)     : 2965 (w), 2934 (w), 1775 (m), 1719 (m), 1652 (m), 1606 (m), 1570 
(m), 1495 (m), 1464 (m), 1370 (m), 1259 (s), 1236 (s), 1195 (m), 1146 (m), 1091 (m), 1035 (vs), 928 
(m), 905 (m), 816 (m), 736 (m) cm−1. 
HRMS (ESI) calcd for C17H20O3 [M]+: 272.1407; found: 272.1407. 
 
Analytical data for I.229:  
TLC (20% ethyl acetate in hexanes), Rf = 0.26 (UV, CAM, KMnO4). 
1H NMR (400 MHz, C6D6) Ʋ: 7.20 (s, 1H), 6.99 (d, J = 8.5 Hz, 1H), 6.86 (dd, J = 6.0, 1.1 Hz, 
1H), 6.78 (dd, J = 8.5, 2.8 Hz, 1H), 6.63 (d, J = 2.8 Hz, 1H), 6.24 (d, J = 6.0 Hz, 1H), 3.27 (s, 
3H), 1.08 (s, 3H), 0.76 (s, 3H), 0.69 (s, 3H). 
13C NMR (101 MHz, C6D6) Ʋ: 194.6, 162.4, 158.9, 143.1, 139.3, 136.4, 133.0, 126.1, 124.4, 
115.9, 115.0, 54.9, 49.9, 39.6, 26.3, 20.4, 20.3. 
CHAPTER I  195 
 
IR (Diamond-ATR, neat)     : 2966 (w), 2929 (w), 1689 (vs), 1645 (vs), 1605 (m), 1566 (m), 1482 
(w), 1465 (w), 1372 (w), 1322 (w), 1249 (m), 1229 (vs), 1205 (w), 1146 (w), 1082 (w), 1057 (w), 1036 
(m), 853 (w), 816 (s), 709 (w) cm−1. 
HRMS (ESI) calcd for C17H18O3 [M]+: 254.1301; found: 254.1301.  
 
1a-Hydroxy-7-methoxy-3a,4,4-trimethyl-1,1a,1a1,3a,4,8b-hexahydro-3H-benzo[f]cyclo-
buta[cd]isobenzofuran-3-one (I.233): 
 
A suspension of I.218 (5.00 mg, 0.0184 mmol, 1 equiv) in tert-butanol (0.54 mL) and water 
(0.3 mL) was treated with 2-methyl-2-butene (2 M in tetrahydrofuran, 0.367 mL, 0.734 mmol, 
40.0 equiv) at 0 °C. Sodium dihydrogen phosphate (22.0 mg, 0.184 mmol, 10.0 equiv) and 
sodium chlorite (16.6 mg, 0.184 mmol, 10.0 equiv) were added and the ice bath was removed. 
After 2.5 h, saturated aqueous sodium thiosulfate solution (10 mL), water (2 mL) and 
dichloromethane (5 mL) were added and the layers were separated. The aqueous layer was 
extracted with dichloromethane (3 × 10 mL). The combined organic layers were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (33% ethyl acetate in 
hexanes) to yield I.233 (4.6 mg, 87%) as a white amorphous solid.  
Analytical data for I.233:  
TLC (50% ethyl acetate in hexanes), Rf = 0.42 (CAM, ANIS, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.23 (d, J = 8.7 Hz, 1H), 6.72 (ddd, J = 8.7, 2.8, 0.9 Hz, 1H), 
6.60 (dd, J = 2.8, 1.1 Hz, 1H), 3.76 (s, 3H), 3.48 (td, J = 10.1, 2.7 Hz, 2H), 3.15 (dt, J = 9.5, 0.8 
Hz, 1H), 3.02 (dd, J = 12.5, 10.2 Hz, 1H), 2.56 (ddd, J = 12.5, 2.8, 1.1 Hz, 1H), 1.63 (s, 3H), 1.42 
(s, 3H), 1.06 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 179.5, 158.5, 137.9, 136.7, 125.6, 113.7, 112.2, 102.6, 55.3, 51.3, 
50.7, 43.3, 38.4, 27.8, 25.7, 20.4, 19.9. 
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IR (Diamond-ATR, neat)     : 3362 (m), 2971 (m), 1768 (s), 1743 (s), 1608 (m), 1574 (w), 
1499 (m), 1466 (m), 1366 (w), 1318 (w), 1298 (m), 1286 (m), 1253 (vs), 1222 (s), 1161 (s), 1101 (w), 
1074 (m), 1036 (m), 1018 (s), 950 (w), 908 (m), 875 (w), 784 (w) cm−1. 
HRMS (ESI) calcd for C17H20O4 [M]+: 288.1356; found: 288.1360. 
 
1-(3-Methoxyphenyl)-4,4-dimethylpentan-3-one (I.236): 
 
A mixture of m-anisaldehyde (I.234) (8.95 mL, 73.4 mmol, 1 equiv), pinacolone (I.235) 
(13.8 mL, 110 mmol, 1.50 equiv) and barium hydroxide (1.89 g, 11.0 mmol, 0.150 equiv) in 
ethanol (37 mL) was heated to 90 °C. After 2 h, the reaction mixture was concentrated, the 
residue was dissolved in ethyl acetate (460 mL) and filtered through a short pad of Celite®. To 
this solution was added Pd/C (10% Pd on activated charcoal, 0.781 g, 0.734 mmol, 
0.0100 mmol) and the resulting suspension was sparged with hydrogen gas for 20 min. Stirring 
under hydrogen atmosphere was continued for 15 h, then Celite® was added and the mixture 
was filtered through a pad of Celite®. The filtrate was concentrated and the crude residue was 
purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) to yield 
I.236 (13.3 g, 82% over 2 steps) as a colorless oil.  
Analytical data for I.236:  
TLC (20% ethyl acetate in hexanes), Rf = 0.54 (ANIS). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.23 – 7.16 (m, 1H), 6.78 (dt, J = 7.7, 1.2 Hz, 1H), 6.76 – 6.72 
(m, 2H), 3.79 (s, 3H), 2.88 – 2.76 (m, 4H), 1.11 (s, 9H). 
13C NMR (101 MHz, CDCl3) Ʋ: 215.0, 159.7, 143.3, 129.5, 120.8, 114.2, 111.4, 55.2, 44.2, 38.5, 
30.2, 26.4. 
IR (Diamond-ATR, neat)     : 3315 (m), 3297 (m), 3256 (m), 3183 (m), 3106 (m), 2957 (m), 
2835 (m), 2707 (m), 2617 (m), 2125 (w), 1703 (w), 1651 (m), 1584 (s), 1517 (s), 1476 (vs), 1394 (s), 
1364 (s), 1317 (w), 1226 (s), 1151 (vs), 1125 (s), 1099 (s), 1025 (s), 978 (s), 928 (s), 787 (s), 762 (s), 
723 (s) cm−1.  
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HRMS (ESI) calcd for C14H20O2 [M]+: 220.1458; found: 220.1459. 
 
2-(tert-Butyl)-2-(3-methoxyphenethyl)oxirane (I.238): 
 
A suspension of sodium hydride (60% dispersion in mineral oil, 3.92 g, 98.0 mmol, 2.00 equiv) 
in dimethyl sulfoxide (49 mL) was heated to 70 °C until gas evolution ceased. After 70 min, the 
reaction mixture was cooled to 23 °C, diluted with tetrahydrofuran (49 mL) and cooled to 0 °C. 
A solution of trimethylsulfonium iodide (12.0 g, 58.8 mmol, 1.20 equiv) in dimethyl sulfoxide 
(45 mL) was added and after stirring for 20 min, I.237 (10.8 g, 49.0 mmol, 1 equiv) was added 
slowly. The mixture was allowed to warm to 23 °C over 3 h, cooled back to 0 °C and diluted 
with water (200 mL).The layers were separated and the aqueous layer was extracted with diethyl 
ether (3 × 200 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (200 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on silica gel (5% ethyl acetate in hexanes) to obtain I.238 (10.9 g, 95%) 
as a colorless oil.  
Analytical data for I.238:  
TLC (20% ethyl acetate in hexanes), Rf = 0.54 (CAM, ANIS). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.23 – 7.17 (m, 1H), 6.80 – 6.76 (m, 1H), 6.76 – 6.70 (m, 2H), 
3.80 (s, 3H), 2.78 (dd, J = 4.2, 0.8 Hz, 1H), 2.67 (d, J = 4.2 Hz, 1H), 2.54 (ddd, J = 13.5, 11.5, 
5.1 Hz, 1H), 2.44 (ddd, J = 13.5, 11.6, 5.8 Hz, 1H), 2.13 (ddd, J = 14.6, 11.6, 5.8 Hz, 1H), 2.02 
(ddd, J = 14.6, 11.7, 5.1 Hz, 1H), 0.97 (s, 9H). 
13C NMR (101 MHz, CDCl3) Ʋ: 159.8, 144.0, 129.5, 120.8, 114.3, 111.2, 63.5, 55.3, 48.1, 34.1, 
31.4, 30.8, 26.2.  
IR (Diamond-ATR, neat)     : 2958 (m), 2872 (w), 2835 (w), 1602 (s), 1585 (s), 1490 (s), 1465 (s), 
1455 (s), 1436 (m), 1394 (w), 1364 (w), 1284 (w), 1261 (vs), 1166 (s), 1153 (vs), 1055 (s), 1039 (vs), 
910 (m), 836 (m), 777 (vs), 745 (m), 696 (vs) cm−1.  
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HRMS (ESI) calcd for C15H22O2 [M]+: 234.1614; found: 234.1621.  
 
(6-Methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanol (I.239): 
 
To a solution of I.238 (234 mg, 1.00 mmol, 1 equiv) in hexafluoro-2-propanol (10 mL) was 
added sulfuric acid (40 µL). After 5 min, the reaction mixture was cooled to 0 °C and saturated 
aqueous sodium bicarbonate solution (10 mL), saturated aqueous sodium chloride solution 
(10 mL) and diethyl ether (20 mL) were added. The layers were separated and the aqueous layer 
was extracted with diethyl ether (3 × 20 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (20 mL). The washed solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (11% ethyl acetate in 
hexanes) to afford I.239 (143 mg, 61%) as a yellow oil.  
Note: During the screening for the optimal reaction conditions, the o-product I.248 was isolated and analyzed.  
Analytical data for I.239:  
TLC (20% ethyl acetate in hexanes), Rf = 0.13 (CAM, ANIS). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.25 (d, J = 8.9 Hz, 1H), 6.74 (dd, J = 8.7, 2.9 Hz, 1H), 6.58 (d, 
J = 2.7 Hz, 1H), 3.78 (s, 3H), 3.60 – 3.49 (m, 2H), 2.88 – 2.68 (m, 2H), 1.87 – 1.65 (m, 2H), 1.21 
(app d, J = 10.9 Hz, 6H), 0.99 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 157.0, 138.3, 136.7, 128.0, 112.9, 112.6, 67.3, 55.2, 39.2, 38.7, 
27.9, 27.2, 26.6, 25.4, 19.1. 
IR (Diamond-ATR, neat)     : 3358 (m), 2973 (m), 2956 (m), 2929 (m), 1609 (s), 1500 (s) 
1459 (s), 1448 (s), 1432 (m), 1361 (m), 1317 (s), 1246 (s), 1232 (s), 1198 (m), 1164 (m), 1084 (m), 
1047 (s), 1033 (vs), 1022 (vs), 993 (s), 948 (m), 889 (m), 848 (s), 823 (vs), 754 (m), 714 (m) cm−1.  
HRMS (ESI) calcd for C15H22O2 [M]+: 234.1614; found: 234.1617. 
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Analytical data for I.248:  
TLC (20% ethyl acetate in hexanes), Rf = 0.29 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.08 (t, J = 7.8 Hz, 1H), 6.74 – 6.68 (m, 2H), 3.80 (s, 3H), 3.59 
(s, 2H), 2.92 – 2.70 (m, 3H), 1.80 – 1.61 (m, 2H), 1.33 (app d, J = 9.0 Hz, 6H), 0.99 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 159.5, 138.1, 133.9, 126.1, 122.1, 109.5, 66.9, 55.2, 40.5, 39.3, 
27.2, 26.9, 23.5, 21.9, 18.9. 
IR (Diamond-ATR, neat)     : 3384 (w), 2969 (m), 2938 (m), 1576 (m), 1452 (s), 1436 (s), 
1362 (m), 1248 (vs), 1191 (m), 1109 (m), 1074 (s), 1058 (s), 1022 (vs), 1005 (s), 953 (m), 880 (m), 
811 (m), 779 (s), 754 (s), 740 (vs).  
HRMS (ESI) calcd for C15H22O2 [M]+: 234.1614; found: 234.1616. 
 
6-(Hydroxymethyl)-5,5,6-trimethyl-5,6,7,8-tetrahydronaphthalen-2-ol (I.241): 
 
To a solution I.239 (234 mg, 1 mmol, 1 equiv) in dichloromethane (5 mL) at −78 °C was added 
dropwise a solution of boron tribromide (1 M in dichloromethane, 5.00 mL, 5.00 mmol, 
5.00 equiv). The reaction mixture was allowed to warm to 23 °C over 2.5 h, cooled back to 0 °C 
and excess boron tribromide was carefully quenched by addition of methanol (1 mL). Water 
(40 mL) was added, the layers were separated and the aqueous layer was extracted with 
dichloromethane (3 × 20 mL). The combined organic layers were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The crude product was purified by 
flash column chromatography on silica gel (33% ethyl acetate in hexanes) to provide I.241 
(197 mg, 89%) as an orange solid.  
Analytical data for I.241:  
TLC (50% ethyl acetate in hexanes), Rf = 0.38 (CAM). 
1H NMR (400 MHz, Acetone-d6) Ʋ: 7.93 (s, 1H), 7.16 (d, J = 8.6 Hz, 1H), 6.61 (dd, J = 8.6, 2.6 
Hz, 1H), 6.48 (d, J = 2.7 Hz, 1H), 3.58 (t, J = 5.1 Hz, 1H), 3.49 (dd, J = 10.5, 5.0 Hz, 1H), 3.43 
(dd, J = 10.5, 5.4 Hz, 1H), 2.76 (ddd, J = 17.4, 8.8, 6.3 Hz, 1H), 2.62 (dt, J = 17.4, 6.1 Hz, 1H), 
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1.81 (dt, J = 13.4, 6.2 Hz, 1H), 1.63 (ddd, J = 13.3, 8.7, 6.3 Hz, 1H), 1.19 (s, 3H), 1.16 (s, 3H), 
0.96 (s, 3H). 
13C NMR (101 MHz, Acetone-d6) Ʋ: 155.3, 137.9, 137.3, 128.5, 115.2, 114.3, 66.5, 39.8, 39.1, 
28.3, 27.8, 26.9, 25.5, 19.4. 
IR (Diamond-ATR, neat)     : 3379 (m), 3166 (m), 2970 (m), 2931 (m), 1616 (m), 1585 (m), 
1499 (m), 1456 (m), 1432 (m), 1352 (m), 1293 (m), 1258 (s), 1232 (s), 1159 (m), 1137 (m), 1091 (m), 
1020 (vs), 940 (m), 931 (m), 896 (m), 867 (m), 807 (vs), 738 (m) cm−1. 
HRMS (EI) calcd for C14H20O2 [M]+: 220.1458; found: 220.1457 
 
tert-Butyl((6-methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methoxy) 
dimethylsilane (I.242): 
 
To a solution of I.239 (100 mg, 0.427 mmol, 1 equiv) in dimethylformamide (1.3 mL) were 
added imidazole (58.1 mg, 0.853 mmol, 2.00 equiv) and tert-butyldimethylsilyl chloride (96.5 mg, 
0.640 mmol, 1.50 equiv) at 0 °C. After 6 h, the reaction mixture was diluted with saturated 
aqueous ammonium chloride solution (10 mL), the layers were separated and the aqueous layer 
was extracted with ethyl acetate (3 × 15 mL). The combined organic layers were dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (5% ethyl acetate in hexanes) 
to yield I.242 (144 mg, 97%) as a colorless oil.  
Analytical data for I.242:  
TLC (20% ethyl acetate in hexanes), Rf = 0.66 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.26 (d, J = 8.5 Hz, 1H), 6.74 (dd, J = 8.8, 2.7 Hz, 1H), 6.58 (d, 
J = 2.8 Hz, 1H), 3.79 (s, 3H), 3.44 (d, J = 1.9 Hz, 2H), 2.86 – 2.65 (m, 2H), 1.82 (dt, J = 12.7, 6.1 
Hz, 1H), 1.67 – 1.54 (m, 1H), 1.23 (s, 3H), 1.19 (s, 3H), 0.95 (s, 3H), 0.91 (s, 9H), 0.03 (app d, J 
= 6.5 Hz, 6H). 
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13C NMR (101 MHz, CDCl3) Ʋ: 156.9, 138.8, 137.2, 128.0, 112.9, 112.4, 67.0, 55.2, 39.4, 38.6, 
28.3, 27.4, 26.7, 26.0, 25.3, 19.4, 18.3, -5.4, -5.4. 
IR (Diamond-ATR, neat)     : 2954 (m), 2928 (m), 2856 (m), 1718 (w), 1610 (w), 1499 (m), 
1463 (m), 1362 (w), 1318 (w), 1251 (s), 1235 (m), 1203 (w), 1117 (m), 1075 (s), 1040 (s), 1006 (m), 
835 (vs), 810 (s), 773 (vs), 666 (m) cm−1.  
HRMS (ESI) calcd for C21H36O2Si [M]+: 348.2479; found: 348.2496.  
 
3-(((tert-Butyldimethylsilyl)oxy)methyl)-7-methoxy-3,4,4-trimethyl-3,4-dihydro-
naphthalen-1(2H)-one (I.243): 
 
To a solution of I.242 (1.29 g, 3.70 mmol, 1 equiv) in acetone (7 mL) was added cobalt(II) 
acetylacetonate (190 mg, 0.74 mmol, 0.200 equiv). To the resulting purple suspension was added 
dropwise tert-butyl hydroperoxide (5.5 M in decane, 2.69 mL, 14.8 mmol, 4.00 equiv). After 
2.5 d, saturated aqueous sodium chloride solution (15 mL) and ethyl acetate (20 mL) were 
added. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3 × 20 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (20 mL) and the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to afford I.243 (855 mg, 64%) as a 
yellow oil.  
 
Analytical data for I.243:  
Note: Signals in the 13C NMR which could only be assigned by cross-coupling in the HMBC are marked with 
an asterisk. 
TLC (20% ethyl acetate in hexanes), Rf = 0.53 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.47 (d, J = 3.0 Hz, 1H), 7.33 (d, J = 8.7 Hz, 1H), 7.08 (dd, J = 
8.7, 3.0 Hz, 1H), 3.83 (s, 3H), 3.53 (d, J = 10.0 Hz, 1H), 3.45 (d, J = 9.9 Hz, 1H), 2.78 (d, J = 
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17.4 Hz, 1H), 2.53 (d, J = 17.4 Hz, 1H), 1.33 (app d, J = 4.6 Hz, 6H), 0.98 (s, 3H), 0.81 (s, 9H), -
0.06 (d, J = 9.6 Hz, 6H). 
13C NMR (101 MHz, CDCl3) Ʋ: 198.0, 157.7, 145.3, 132.6, 127.3, 122.1, 108.5, 67.9, 55.6, 45.0, 
43.1, 39.3, 26.9*, 25.9, 24.8*, 19.8, 18.3, -5.6, -5.7. 
IR (Diamond-ATR, neat)     : 2956 (m), 2929 (m), 2856 (m), 1684 (m), 1608 (m), 1493 (m), 
1464 (m), 1416 (m), 1322 (m), 1282 (m), 1249 (m), 1181 (w), 1114 (m), 1078 (m), 1034 (m), 1006 
(w), 836 (vs), 775 (s), 669 (w) cm−1.  
HRMS (ESI) calcd for C21H35O3Si [M+H]+: 363.2350; found: 363.2351.  
 
8-Methoxy-4,5,5-trimethyl-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepine (I.240): 
 
To a solution of I.243 (100 mg, 0.276 mmol, 1 equiv) in tetrahydrofuran (9.2 mL) was added 
lithium aluminum hydride (126 mg, 3.31 mmol, 12.0 equiv) at 0 °C. The reaction was allowed to 
warm to 23 °C and after 80 min, the mixture was cooled back to 0 °C. An aqueous hydrochloric 
acid solution (2 M, 3 mL) was added very carefully followed by addition of concentrated aqueous 
hydrochloric acid solution (37%, 3 mL). The reaction mixture was allowed to warm to 23 °C 
and after 5 h, ethyl acetate (10 mL) was added. The layers were separated and the aqueous layer 
was extracted with ethyl acetate (3 × 20 mL). The combined organic layers were dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (9% ethyl acetate in hexanes) 
to yield I.240 (64 mg, quant.) as a colorless solid.  
Analytical data for I.240:  
TLC (33% ethyl acetate in hexanes), Rf = 0.45 (CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.26 (d, J = 8.5 Hz, 1H), 6.82 (dd, J = 8.7, 2.7 Hz, 1H), 6.60 (d, 
J = 2.7 Hz, 1H), 4.73 (d, J = 5.0 Hz, 1H), 4.10 (d, J = 8.7 Hz, 1H), 3.78 (s, 3H), 3.50 (d, J = 8.6 
Hz, 1H), 2.26 (d, J = 11.3 Hz, 1H), 1.85 (dd, J = 11.5, 5.0 Hz, 1H), 1.35 (s, 3H), 1.28 (s, 3H), 
1.22 (s, 3H).  
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13C NMR (101 MHz, CDCl3) Ʋ: 157.6, 139.5, 136.9, 128.5, 114.5, 111.3, 79.0, 75.1, 55.3, 46.8, 
41.8, 39.9, 29.4, 24.1, 19.6. 
IR (Diamond-ATR, neat)     : 2963 (m), 2937 (m), 2877 (m), 1607 (m), 1578 (w), 1504 (m), 
1452 (m), 1392 (w), 1334 (w), 1314 (m), 1265 (m), 1240 (vs), 1171 (m), 1154 (m), 1119 (w), 1074 
(w), 1035 (vs), 1026 (vs), 991 (w), 964 (w), 907 (m), 856 (s), 822 (m), 807 (m), 680 (w) cm−1.  
HRMS (EI) calcd for C15H20O2 [M]+: 232.1458; found: 232.1462.  
 
N,N-Diethyl-2-((6-methoxy-1,1,2-trimethyl-1,2,3,4-tetrahydronaphthalen-2-yl)methoxy) 
acetamide (I.244): 
 
To a solution of I.239 (125 mg, 0.533 mmol, 1 equiv) in 1,2-dimethoxyethane (2.7 mL) was 
added sodium hydride (60% dispersion in mineral oil, 53.3 mg, 1.60 mmol, 3.00 equiv) at 0 °C 
and after 20 min 2-chloro-N,N-diethylacetamide (I.208) (110 µL, 0.800 mmol, 1.50 equiv). The 
reaction was allowed to warm slowly to 23 °C over 20 h and was diluted with saturated aqueous 
ammonium chloride solution (10 mL) and water (5 mL). The layers were separated, the aqueous 
layer was extracted with ethyl acetate (3 × 15 mL) and the combined organic layers were dried 
over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (20 to 33% ethyl acetate in 
hexanes) to afford I.244 (185 mg, quant.) as a yellow oil.  
Analytical data for I.244:  
TLC (50% ethyl acetate in hexanes), Rf = 0.38 (ANIS, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.22 (d, J = 8.8 Hz, 1H), 6.71 (dd, J = 8.7, 2.9 Hz, 1H), 6.56 (d, 
J = 2.8 Hz, 1H), 4.09 (d, J = 0.8 Hz, 2H), 3.76 (s, 3H), 3.43 – 3.29 (m, 6H), 2.81 (ddd, J = 17.6, 
8.6, 6.4 Hz, 1H), 2.71 (dt, J = 17.4, 6.1 Hz, 1H), 1.85 (dt, J = 13.4, 6.1 Hz, 1H), 1.69 (ddd, J = 
13.4, 8.7, 6.3 Hz, 1H), 1.23 – 1.15 (m, 9H), 1.11 (t, J = 7.1 Hz, 3H), 1.03 (s, 3H). 
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13C NMR (101 MHz, CDCl3) Ʋ: 168.5, 157.0, 138.3, 136.7, 127.9, 112.9, 112.5, 76.3, 71.3, 55.2, 
41.0, 39.8, 38.9, 38.7, 27.9, 27.6, 26.5, 25.3, 19.7, 14.4, 12.9. 
IR (Diamond-ATR, neat)     : 2969 (m), 2935 (m), 1643 (vs), 1608 (m), 1576 (w), 1499 (s), 
1461 (s), 1434 (m), 1381 (m), 1364 (m), 1316 (m), 1289 (m), 1263 (s), 1234 (s), 1204 (m), 1164 (m), 
1089 (vs), 1036 (vs), 968 (w), 892 (w), 846 (m), 801 (m), 733 (w) cm−1.  
HRMS (EI) calcd for C21H33O3N [M]+: 347.2455; found: 347.2460. 
 
N,N-Diethyl-2-((6-methoxy-1,1,2-trimethyl-1,2-dihydronaphthalen-2-yl)methoxy) 
acetamide (I.209): 
 
To I.244 (2.00 g, 5.76 mmol, 1 equiv) in 1,4-dioxane (58 mL) was added 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (7.84 g, 34.5 mmol, 6.00 equiv) and the reaction mixture was heated 
to 95 °C. After 16 h, saturated aqueous sodium bicarbonate solution (50 mL) was added and the 
layers were separated. The aqueous layer was extracted with diethyl ether (3 × 200 mL), the 
combined organic layers were washed with saturated aqueous sodium chloride solution 
(200 mL) and the washed solution was dried over sodium sulfate. The dried solution was filtered 
and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (33% ethyl acetate in hexanes) to yield I.209 (1.78 g, 90%) as an 
orange oil.  
For the analytical data see the experimental procedure vide infra.  
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10.2.2 CADA Reaction 
10.2.2.1 Synthesis of Precursors 
 
For the synthesis of I.68, I.77, I.78, I.81 and I.91 see the experimental part of salimabromide. 
 For the synthesis of II.101, II.103 see J. M. Hammann, T. A. Unzner, T. Magauer, Chem. Eur. J. 
2014, 20, 6733–6738.  
For the synthesis of II.102 see T. A. Unzner, A. Grossmann, T. Magauer, Angew. Chem. Int. Ed. 
2016, 55, 9763–9767. 
For the synthesis of II.104 see A. J. Brockway, M. González-López, J. C. Fettinger, J. T. Shaw, J. 
Org. Chem. 2011, 76, 3515–3518. 
 
 
2-Methylnaphthalen-1-ol (I.34): 
 
To a solution of 1-hydroxy-2-naphthoic acid (II.105) (4.5 g, 24 mmol, 1 equiv) in 
tetrahydrofuran (150 mL) was added triethylamine (8.7 mL, 62 mmol, 2.6 equiv). The reaction 
mixture was cooled to 0 °C and stirred for 2 h. Ethyl chloroformate (6.0 mL, 62 mmol, 
2.6 equiv) was added dropwise. After 1 h, the suspension was filtered and the residue was 
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washed with tetrahydrofuran (10 mL). The filtrate was concentrated and redissolved in 
tetrahydrofuran (45 mL). The resulting solution was added to a stirred mixture of sodium 
borohydride (7.3 g, 0.19 mol, 8.0 equiv) in water (45 mL) at 0 °C. The resulting yellow mixture 
was allowed to stir for 2.5 h before aqueous hydrogen chloride solution (2 M; 10 mL) was added 
carefully until gas evolution ceased. The mixture was partitioned between water (50 mL) and 
ethyl acetate (50 mL). The aqueous layer was extracted with ethyl acetate (3 × 50 mL). The 
combined organic layers were washed with saturated aqueous sodium chloride solution (50 mL) 
and the washed solution was dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The residue was purified by flash column chromatography on silica gel 
(20% diethyl ether in hexanes) to afford II.34 (3.5 g, 86% over 2 steps) as colorless crystals. 
The obtained analytical data were in full agreement with those reported in the literature.202 
 
Allyl (2-methylnaphthalen-1-yl) carbonate (I.89): 
 
To a solution of 2-methylnaphthalen-1-ol (II.34) (1.90 mmol, 300 mg, 1 equiv) and methyl 
chloroformate (22.0 µL, 2.10 mmol, 1.10 equiv) in dichloromethane was added triethylamine 
(30.0 µL, 2.10 mmol, 1.10 equiv) at 0 °C. After 5 min, the reaction mixture was allowed to warm 
to 23 °C and was stirred for 1 h. The resulting mixture was treated with water (25 mL) and was 
partitioned between water (20 mL) and dichloromethane (20 mL). The aqueous layer was 
extracted with dichloromethane (3 × 15 mL). The combined organic layers were washed with 
aqueous sodium chloride solution (50 mL) and the washed solution was dried over sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (10% diethyl ether in hexanes) to afford 
II.89 (405 mg, 88%) as a colorless oil. 
Analytical data for II.89:  
TLC (20% diethyl ether in hexanes), Rf = 0.45 (ANIS, UV). 
1H NMR (599 MHz, CDCl3) Ʋ: 7.87 (d, J = 8.4, 1.0 Hz, 1H), 7.83 (d, J = 8.2, 0.9 Hz, 1H), 7.69 
(d, J = 8.4 Hz, 1H), 7.52 (td, J = 8.3, 6.8, 1.3 Hz, 1H), 7.46 (td, J = 8.1, 6.8, 1.2 Hz, 1H), 7.35 (d, 
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J = 8.5 Hz, 1H), 6.05 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.47 (dq, J = 17.2, 1.5 Hz, 1H), 5.36 (dq, 
J = 10.4, 1.2 Hz, 1H), 4.80 (dt, J = 5.8, 1.4 Hz, 2H), 2.40 (s, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 153.3, 144.5, 133.3, 131.4, 128.9, 128.0, 127.2, 126.9, 126.7, 
126.3, 125.8, 120.7, 119.6, 69.5, 16.3. 
IR (Diamond-ATR, neat)     : 3052 (w), 3018 (w), 2865 (w), 1759 (s), 1603 (w), 1608 (w), 1360 
(w), 1267 (m), 1225 (vs), 1178 (s), 1339 (m), 1090 (w), 944 (m), 810 (m), 781 (w), 743 (w) cm−1. 
HRMS (EI) calcd for C15H14O3 [M]+: 242.0937; found: 242.0940. 
 
 
10.2.2.2 Synthesis of Allyl Naphthol Ether 
General Procedure for the Allylation of Naphthols:  
To a solution of naphthol (1 equiv) in dimethylformamide (0.3 m) were subsequently added 
potassium carbonate (1.50 equiv) and allyl bromide (1.10 equiv) and the suspension was heated 
to 65 °C. After 1.5–2 h, saturated aqueous ammonium chloride solution was added, the layers 
were separated and the aqueous layer was extracted with diethyl ether (3 ×). The combined 
organic layers were washed with aqueous hydrochloric acid solution (2 M) and saturated aqueous 
sodium chloride solution. The washed solution was dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel. 
 
Following the general procedure except for heating the reaction for 17.5 h, 
naphthol II.34 (3.0 g, 19 mmol) provided the allyl ether II.91 (2.0 g, 53%) as a 
light yellow oil after flash column chromatography on silica gel (2% ethyl acetate 
in hexanes). 
Analytical data for II.91:  
TLC (20% diethyl ether in hexanes), Rf = 0.40 (ANIS, UV). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.05 (ddt, J = 7.8, 1.4, 0.7 Hz, 1H), 7.55 (td, J = 7.5, 1.4 Hz, 
1H), 7.35 (td, J = 7.5, 1.2 Hz, 1H), 7.23 (dd, J = 7.7, 1.1 Hz, 1H), 6.59 (d, J = 9.8 Hz, 1H), 6.10 
(d, J = 9.7 Hz, 1H), 5.58 (ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.01 (ddt, J = 17.0, 2.0, 1.4 Hz, 1H), 
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4.93 (ddt, J = 10.1, 1.9, 0.9 Hz, 1H), 2.67 (ddt, J = 13.6, 7.4, 1.1 Hz, 1H), 2.29 (ddt, J = 13.6, 7.2, 
1.3 Hz, 1H), 1.27 (s, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 203.1, 139.6, 138.5, 134.5, 133.5, 129.4, 128.0, 127.4, 127.1, 
124.0, 118.2, 49.3, 44.6, 24.8. 
IR (Diamond-ATR, neat)     : 2928 (w), 1673 (vs), 1642 (m), 1598 (s), 1449 (w), 13.20 (m), 
1268 (m), 1233 (m), 985 (m), 919 (m), 792 (vs), 693.2 (m) cm−1. 
HRMS (EI) calcd for C14H14O [M]+: 198.1039; found: 198.1043. 
 
Following the general procedure, naphthol I.68 (300 mg, 1.16 mmol) 
provided the allyl ether I.106 (274 mg, 79%) as a light yellow oil after 
flash column chromatography on silica gel (2% ethyl acetate in hexanes). 
For the analytical data see the experimental procedure for salimabromide. 
 
Following the general procedure, naphthol II.104 (100 mg, 0.495 mmol) 
provided the allyl ether II.105 (108 mg, 90%) as a colorless oil after flash 
column chromatography on silica gel (5% ethyl acetate in hexanes). 
Analytical data for II.105:  
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (UV, CAM). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.31 – 8.26 (m, 1H), 7.89 – 7.82 (m, 2H), 7.62 (dt, J = 8.7, 0.6 
Hz, 1H), 7.61 – 7.51 (m, 2H), 6.23 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.49 (dq, J = 17.2, 1.6 Hz, 
1H), 5.33 (dq, J = 10.4, 1.3 Hz, 1H), 4.67 (dt, J = 5.7, 1.4 Hz, 2H), 3.97 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 166.9, 157.1, 136.9, 133.9, 129.0, 128.5, 128.0, 126.8, 126.7, 
123.9, 123.9, 119.7, 118.1, 77.0, 52.4. 
IR (Diamond-ATR, neat)     : 3070 (w), 2950 (w), 1723 (vs), 1626 (w), 1598 (w), 1570 (w), 1504 
(w), 1464 (w), 1435 (m), 1393 (w), 1342 (s), 1278 (s), 1237 (s), 1204 (m), 1152 (m), 1132 (s), 1081 
(s), 980 (m), 929 (w), 828 (w), 768 (s) cm−1. 
HRMS (EI) calcd for C15H14O3 [M]+: 242.0937; found: 242.0939. 
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Following the general procedure, naphthol I.81 (100 mg, 0.323 mmol) 
provided the allyl ether II.106 (89 mg, 79%) as a light yellow solid after 
flash column chromatography on silica gel (5% ethyl acetate in hexanes). 
Analytical data for II.106:  
TLC (20% ethyl acetate in hexanes), Rf = 0.64 (UV, CAM). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.11 (s, 1H), 8.03 (d, J = 2.0 Hz, 1H), 7.95 (d, J = 9.2 Hz, 1H), 
7.62 (dd, J = 9.0, 1.9 Hz, 1H), 6.18 (ddt, J = 17.9, 10.6, 5.5 Hz, 1H), 5.51 (dq, J = 17.0, 1.6 Hz, 
1H), 5.33 (dd, J = 10.5, 1.6 Hz, 1H), 4.45 (d, J = 5.5 Hz, 2H), 4.42 (q, J = 7.2 Hz, 2H), 2.61 (s, 
3H), 1.44 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 167.6, 153.6, 133.5, 133.2, 131.4, 131.4, 130.9, 128.5, 127.3, 
126.2, 124.2, 120.3, 118.0, 75.0, 61.4, 14.5, 14.0. 
IR (Diamond-ATR, neat)     : 2981 (w), 2930 (w), 1719 (vs), 1583 (w), 1564 (w), 1446 (w), 1382 
(w), 1346 (m), 1317 (m), 1273 (vs), 1235 (m), 1209 (m), 1192 (m), 1165 (w), 1108 (m), 1048 (s), 1011 
(w), 993 (w), 905 (m), 824 (m), 778 (w) cm−1. 
HRMS (EI) calcd for C17H17O379Br [M]+: 348.0356; found: 348.0355. 
 
Following the general procedure, naphthol I.78 (100 mg, 0.359 mmol) 
provided the allyl ether I.88 (103 mg, 90%) as a colorless oil after flash 
column chromatography on silica gel (5% ethyl acetate in hexanes). For the 
analytical data see the experimental procedure for salimabromide.  
 
Following the general procedure, naphthol II.102 (180 mg, 0.718 mmol) 
provided the allyl ether II.107 (185 mg, 89%) as a yellow oil without further 
purification.  
 
Analytical data for II.107:  
TLC (9% ethyl acetate in hexanes), Rf = 0.32 (UV, KMnO4). 
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1H NMR (400 MHz, CDCl3) Ʋ: 8.25 (dd, J = 6.1, 3.5 Hz, 1H), 8.10 (dd, J = 6.2, 3.5 Hz, 1H), 
7.59 (dd, J = 6.4, 3.2 Hz, 2H), 6.18 (ddt, J = 17.2, 10.5, 5.5 Hz, 1H), 5.51 (dq, J = 17.1, 1.6 Hz, 
1H), 5.34 (dq, J = 10.5, 1.3 Hz, 1H), 4.46 (dt, J = 5.5, 1.5 Hz, 2H), 4.02 (s, 3H), 2.39 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.0, 152.0, 133.4, 133.3, 130.2, 129.4, 127.8, 127.3, 125.2, 
124.0, 123.9, 122.5, 118.1, 75.1, 52.9, 13.6. 
IR (Diamond-ATR, neat)     : 2951 (w), 1735 (vs), 1592 (w), 1436 (m), 1385 (m), 1331 (s), 1280 
(vs), 1239 (s), 1213 (s), 1171 (m), 1103 (m), 1051 (s), 972 (m), 924 (s), 863 (w), 764 (s) cm−1. 
HRMS (EI) calcd for C16H15O335Cl [M]+: 290.0704; found: 290.0707.  
 
Following the general procedure, naphthol I.77 (200 mg, 0.607 mmol) 
provided the allyl ether II.108 (208 mg, 93%) as a light yellow oil after flash 
column chromatography on silica gel (5% ethyl acetate in hexanes).  
Analytical data for II.108:  
TLC (20% ethyl acetate in hexanes), Rf = 0.55 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.39 (d, J = 1.9 Hz, 1H), 7.94 (d, J = 8.9 Hz, 1H), 7.63 (dd, J = 
8.9, 1.9 Hz, 1H), 6.14 (ddt, J = 17.2, 10.7, 5.5 Hz, 1H), 5.48 (dd, J = 17.1, 1.6 Hz, 1H), 5.33 (dd, 
J = 10.4, 1.4 Hz, 1H), 4.43 (dt, J = 5.5, 1.4 Hz, 2H), 4.01 (s, 3H), 2.35 (s, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 167.6, 152.1, 134.4, 133.1, 131.2, 131.2, 128.0, 127.4, 124.6, 
124.4, 122.7, 122.0, 118.3, 75.3, 52.9, 13.6. 
IR (Diamond-ATR, neat)     : 2950 (w), 1735 (vs), 1584 (m), 1436 (m), 1405 (w), 1384 (w), 1346 
(w), 1315 (s), 1267 (s), 1230 (s), 1205 (m), 1169 (m), 1111 (m), 1075 (m), 1051 (s), 958 (m), 931 (s), 
872 (w), 824 (m) cm−1. 
HRMS (EI) calcd for C16H14O379Br35Cl [M]+: 367.9809; found: 367.9808.  
 
Following the general procedure, naphthol I.91 (50 mg, 0.186 mmol) 
provided the allyl ether II.109 (32 mg, 55%) as a white solid after flash 
column chromatography on silica gel (5% ethyl acetate in hexanes).  
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Analytical data for II.109:  
TLC (20% ethyl acetate in hexanes), Rf = 0.61 (UV, CAM). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.15 (d, J = 8.7 Hz, 1H), 8.03 (d, J = 1.5 Hz, 1H), 7.55 (dd, J = 
8.5, 1.8 Hz, 1H), 6.20 (ddd, J = 17.3, 10.7, 5.4 Hz, 1H), 6.15 (q, J = 7.2 Hz, 1H), 5.51 (dq, J = 
17.0, 1.6 Hz, 1H), 5.34 (dt, J = 10.5, 1.7 Hz, 1H), 4.49 (dd, J = 5.7, 1.4 Hz, 2H), 2.88 (q, J = 7.6 
Hz, 2H), 2.72 (s, 3H), 2.15 (d, J = 7.2 Hz, 3H), 1.37 (t, J = 7.7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 167.7, 154.4, 147.1, 144.1, 133.4, 132.7, 130.4, 129.9, 126.7, 
124.0, 123.7, 123.2, 122.7, 118.2, 108.5, 75.2, 29.4, 15.7, 12.5, 11.2. 
IR (Diamond-ATR, neat)     : 2983 (w), 2925 (w), 1738 (s), 1464 (w), 1447 (w), 1373 (m), 1300 
(w), 1236 (vs), 1114 (w), 1097 (w), 1045 (s), 1013 (w), 918 (w), 846 (w), 734 (w) cm−1. 
HRMS (EI) calcd for C20H20O3 [M]+: 308.1407; found: 308.1408. 
 
Following the general procedure, naphthol II.103 (60 mg, 0.237 mmol) 
provided the allyl ether II.110 (56 mg, 80%) as a light pink oil after flash column 
chromatography on silica gel (5% ethyl acetate in hexanes).  
Analytical data for II.110:  
TLC (20% ethyl acetate in hexanes), Rf = 0.58 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.19 (d, J = 8.5 Hz, 1H), 8.06 (d, J = 8.3 Hz, 1H), 7.76 (t, J = 
7.6 Hz, 1H), 7.64 (t, J = 7.6 Hz, 1H), 6.19 (ddt, J = 16.1, 10.6, 5.4 Hz, 1H), 6.01 (ddt, J = 16.4, 
10.2, 5.9 Hz, 1H), 5.55 (dd, J = 17.2, 1.7 Hz, 1H), 5.39 (d, J = 10.5 Hz, 1H), 5.05 (dd, J = 19.5, 
13.7 Hz, 2H), 4.65 (d, J = 5.2 Hz, 2H), 3.74 (d, J = 5.8 Hz, 2H). 
13C NMR (101 MHz, CDCl3) Ʋ: 163.1, 147.9 (q, J = 32.5 Hz) 147.3, 135.9, 132.7, 130.6, 130.3, 
128.5, 124.7, 122.9, 122.1, 122.1 (q, J = 276.7 Hz), 118.4, 116.4, 76.2, 29.8 (t, J = 2.6 Hz). 
IR (Diamond-ATR, neat)     : 3083 (w), 2984 (w), 2874 (w), 1640 (w), 1566 (w), 1493 (w), 1382 
(m), 1353 (m), 1342 (s), 4283 (m), 1250 (w), 1182 (s), 1122 (vs), 1107 (vs), 1002 (s), 964 (m), 919 
(m), 768 (vs), 726 (s) cm−1. 
HRMS (EI) calcd for C16H15ONF3 [M+H]+: 294.1100; found: 294.1109. 
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Following the general procedure, naphthol II.101 (60 mg, 0.230 mmol) 
provided the allyl ether II.111 (75 mg, quant.) as a yellow oil after flash 
column chromatography on silica gel (20% ethyl acetate in hexanes). 
Analytical data for II.111:  
TLC (20% ethyl acetate in hexanes), Rf = 0.17 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.93 (dt, J = 8.6, 1.0 Hz, 1H), 7.89 (dd, J = 8.5, 1.0 Hz, 1H), 
7.44 (ddd, J = 8.5, 7.7, 5.4 Hz, 1H), 7.38 (d, J = 8.6 Hz, 1H), 7.18 (ddd, J = 10.5, 7.7, 1.0 Hz, 
1H), 6.11 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.45 (dq, J = 17.2, 1.6 Hz, 1H), 5.26 (dq, J = 10.5, 1.4 
Hz, 1H), 4.64 (dd, J = 33.0, 5.5 Hz, 2H), 3.85 (q, J = 7.2 Hz, 1H), 3.38 (dd, J = 13.6, 6.9 Hz, 
1H), 3.21 (dq, J = 24.8, 7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H), 1.03 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 168.7, 160.0 (d, J = 252.0 Hz), 150.3 (d, J = 4.1 Hz), 133.6, 
130.0 (d, J = 4.6 Hz), 127.6 (d, J = 1.4 Hz), 126.3 (d, J = 8.4 Hz), 125.3 (d, J = 1.4 Hz), 125.2 (d, 
J = 17.1 Hz), 118.6 (d, J = 4.2 Hz), 117.7, 117.1 (d, J = 5.5 Hz), 110.6 (d, J = 19.8 Hz), 76.3, 
43.2, 39.3, 14.2, 13.0. 
HRMS (EI) calcd for C18H20O2NF [M]+: 301.1473; found: 301.1480. 
 
 
10.2.2.3 Screenings for the CADA Reaction  
General Procedure for the Racemic Dearomatization with Pd(PPh3)4: 
A Schlenk tube was charged with tetrakis(triphenylphosphine)palladium(0) (0.100 equiv) and 
purged with argon three times. The substrate II.91 or II.89 (1 equiv) was added as a 0.05 M 
solution in the indicated solvent and the reaction mixture was heated to 45°C in a preheated oil 
bath. After TLC indicated no further conversion, the crude mixture was diluted with diethyl 
ether, filtered through a small plug of silica gel and the filtrate was concentrated. The residue 
was purified by flash column chromatography on silica gel.  
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entry catalyst[a] solvent[b] result 
with II.89 
ratio of 
II.90 : II.92[f] 
result 
with II.91 
ratio of 
II.90 : II.92[f] 
1 Pd(PPh3)4 THF II.89 + 
II.92 
(61%)[e] 
1 : 0.22 - - 
2 Pd(PPh3)4 n-hexane/ 
toluene (1:10) 
II.91 - II.91 - 
3 Pd(PPh3)4 1,4-dioxane[c] II.89 + 
II.92 
(37%)[e] 
1 : 0.14 II.90 + 
II.92 
(45%)[e] 
1 : 0.24 
4 Pd(PPh3)4 1,4-dioxane II.89 + 
II.92 
(15%)[e] 
1 : 1.1 II.90 + 
II.92 
(38%)[e] 
1 : 0.50 
5 Pd(PPh3)4 THF[d] II.89 + 
II.92 
(48%)[e] 
1 : 0.20 II.90 + 
II.92 
(47%)[e] 
1 : 0.27 
6 Pd(PPh3)4 CH2Cl2 II.89 + 
II.92 
(28%)[e] 
1 : 1.6 II.90 + 
II.92 
(34%)[e] 
1 : 0.92 
[a] 10 mol% catalyst were used; [b] solvents were degassed via freeze-pump-thaw; 0.04 M; [c] not degassed; [d] 0.02 M solution; [e] isolated as an inseparable mixture; [f] determined by 1H NMR spectroscopy.  
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General Procedure for the Racemic Dearomatization with Pd(dba)2/PPh3: 
 
A Schlenk tube was charged with bis(dibenzylideneacetone)palladium (II) (0.102 equiv) and 
triphenylphosphine (0.5 equiv) and purged with argon three times. The substrate II.91 or II.89 
(1 equiv) was added as a 0.05 M solution in degassed tetrahydrofuran and the reaction mixture 
was heated to 45°C in a preheated oil bath. After TLC indicated no further conversion, the 
crude mixture was diluted with diethyl ether, filtered through a small plug of silica gel and the 
filtrate was concentrated.  
 
 
General Procedures for the CADA Reaction: 
For the screening with chiral ligands to obtain enantiomerically enriched material, the 
experiments were carried out using procedures A–H and the following HPLC parameters for 
the determination of the ee:  
Chiral HPLC:  Retention time II.90a: 7.07 min 
 Retention time II.90b: 7.60 min 
Column: CHIRALCEL® 5 μm OB-H column 
Flow rate: 1 mL/min 
Mobile phase: 100% n-heptane 
Temperature: 40 °C 
Wavelength: 230 nm 
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Analytical data for II.90:  
TLC (20% diethyl ether in hexanes), Rf = 0.40 (ANIS, UV). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.05 (ddt, J = 7.8, 1.4, 0.7 Hz, 1H), 7.55 (td, J = 7.5, 1.4 Hz, 
1H), 7.35 (td, J = 7.5, 1.2 Hz, 1H), 7.23 (dd, J = 7.7, 1.1 Hz, 1H), 6.59 (d, J = 9.8 Hz, 1H), 6.10 
(d, J = 9.7 Hz, 1H), 5.58 (ddt, J = 17.3, 10.1, 7.3 Hz, 1H), 5.01 (ddt, J = 17.0, 2.0, 1.4 Hz, 1H), 
4.93 (ddt, J = 10.1, 1.9, 0.9 Hz, 1H), 2.67 (ddt, J = 13.6, 7.4, 1.1 Hz, 1H), 2.29 (ddt, J = 13.6, 7.2, 
1.3 Hz, 1H), 1.27 (s, 3H). 
13C NMR (151 MHz, CDCl3) Ʋ: 203.09, 139.62, 138.49, 134.45, 133.49, 129.35, 127.95, 127.42, 
127.10, 124.01, 118.15, 49.30, 44.64, 24.78. 
IR (Diamond-ATR, neat)     : 2928 (w), 1673 (vs), 1642 (m), 1598 (s), 1449 (w), 13.20 (m), 1268 
(m), 1233 (m), 985 (m), 919 (m), 792 (vs), 693.2 (m) cm−1. 
HRMS (EI) calcd for C14H14O [M]+: 198.1039; found: 198.1043. 
 
 
 
Procedure A: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with tris(dibenzylideneacetone)dipalladium(0) (3.78 mg, 4.13 µmol, 0.050 equiv) and a 
chiral ligand (0.11 equiv) and was afterwards purged with argon one time. (Degassed) solvent 
was added and the catalyst was stirred at 23 °C for 30 min. A solution of the allyl carbonate 
II.89 (20.0 mg, 82.6 mmol, 1 equiv) in the (degassed) solvent was added and the reaction was 
heated to 45 °C in a preheated oil bath. After TLC indicated no further conversion, the crude 
mixture was diluted with diethyl ether, filtered through a small plug of silica gel and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel (5% 
diethyl ether in hexanes). The ee of the clean product II.90 was analyzed by chiral HPLC. 
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entry ligand solvent[a] result[b] ee [%] 
1 (S,S)-L3 THF II.91 - 
2 (S,S)-L3 toluene II.91 - 
3 (S,S)-L3 n-hexane/toluene (1:2) II.91 - 
4 (S,S)-L3 MTBE II.91 - 
5 (S,S)-L3 DME II.91 - 
6 (R)-L5 THF II.90 (23%) 6 
7 (R)-L5 toluene II.90 (14%) 8 
8 (R)-L5 n-hexane/toluene (1:2) II.90 (trace) - 
9 (R)-L5 MTBE II.90 (trace) - 
10 (R)-L5 DME II.90 (9%) - 
11 (S,S)-L1 THF II.90 (12%) 58 
12 (S,S)-L1 toluene II.90 (18%) 70 
13 (S,S)-L1 n-hexane/toluene (1:2) II.90 (31%) 60 
14 (S,S)-L1 MTBE II.90 (24%) 62 
15 (S,S)-L1 DME II.90 (trace)  - 
16 (S,S)-L1 benzene[c] II.90 (70%) 42 
17 (S,S)-L1 chlorobenzene[c] II.90 (60%) 42 
18 (S,S)-L1 pyridine[c] II.90 (24%) 46 
19 (S,S)-L1 trifluorotoluene[c] II.90 (15%) 46 
20 (S,S)-L1 toluene[c] II.90 (18%) 66 
21 (R,R)-L6 benzene[c] 33 + 35 (trace)[d] - 
22 (R,R)-L6 toluene[c] 33 + 35 (trace)[d] - 
23 (R,R)-L6 THF[c] 33 + 35 (trace)[d] - 
24 (S,S)-L7 benzene[c] II.89, II.91 (trace)[d] 70 
25 (S,S)-L7 toluene[c] II.89, II.91 (trace)[d] 71 
26 (S,S)-L7 chlorobenzene[c] II.89, II.91 (trace)[d] 70 
27 (S,S)-L7 n-hexane/toluene (1:2) [c] II.90 (12%) 69 
[a] solvents were degassed via freeze-pump-thaw; [b] refer to isolated yields; [c] solvents were not degassed; [d] determined by crude 1H NMR.  
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Procedure B: The reaction was carried out at a concentration of 0.04 M. A Schlenk tube was 
charged with tris(dibenzylideneacetone) dipalladium(0) and a chiral ligand and was afterwards 
purged with argon one time. A degassed solvent mixture of n-hexane/toluene (1:2) was added 
and the catalyst was stirred at 23 °C for 30 min. A solution of the allyl carbonate II.89 (20.0 mg, 
82.6 mmol, 1 equiv) in the degassed solvent mixture of n-hexane/toluene (1:2) was added and 
the reaction was heated to 45 °C in a preheated oil bath. After TLC indicated no further 
conversion, the crude mixture was diluted with diethyl ether, filtered through a small plug of 
silica gel and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (5% diethyl ether in hexanes). The ee of the clean product II.90 
was analyzed by chiral HPLC. 
 
entry catalyst ligand result ee[a] 
1 Pd2(dba)3 (5 mol%) (S,S)-L1 (11 mol%) II.90 (31%) 60% 
2 Pd2(dba)3 (10 mol%) (S,S)-L1 (22 mol%) II.90 (55%) 50% 
3 Pd2(dba)3 (100 mol%) (S,S)-L1 (200 mol%) II.90 (49%) 32% 
[a] determined by chiral HPLC analysis; the solvents were degassed via freeze-pump-thaw; 0.04 M. 
 
 
Procedure C: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with tris(dibenzylideneacetone) dipalladium(0) (3.78 mg, 4.13 µmol, 0.050 equiv) and 
the (S,S)-DACH-phenyl Trost ligand ((S,S)-L1) (6.27 mg, 9.08 µmol, 0.110 equiv) and was 
afterwards purged with argon one time. (Degassed) solvent was added and the catalyst was 
stirred at 23 °C for 30 min. A solution of the allyl carbonate II.89 (20.0 mg, 82.6 mmol, 1 equiv) 
in the (degassed) solvent was added, followed by subsequent addition of the additive. The 
reaction was heated to 45 °C in a preheated oil bath. After TLC indicated no further conversion, 
the crude mixture was diluted with diethyl ether, filtered through a small plug of silica gel and 
the filtrate was concentrated. The residue was purified by flash column chromatography on silica 
gel (5% diethyl ether in hexanes). 
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entry ligand[a] solvent[b] additive result ee [%][c] 
1 (S,S)-L1 benzene LiCl (1 equiv) II.90 (83%) 44 
2 (S,S)-L1 benzene DBU (0.1 equiv) II.90 (28%) 68 
[a] 11 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] determined by chiral HPLC analysis. 
 
 
Procedure D: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with tris(dibenzylideneacetone) dipalladium(0) (3.78 mg, 4.13 µmol, 0.050 equiv) and 
the (S,S)-DACH-phenyl Trost ligand ((S,S)-L1) (6.27 mg, 9.08 µmol, 0.110 equiv) and was 
afterwards purged with argon one time. (Degassed) solvent was added and the catalyst was 
stirred at 23 °C for 30 min. A solution of the allyl carbonate II.89 (20.0 mg, 82.6 mmol, 1 equiv) 
in the (degassed) solvent was added and the reaction was stirred at the indicated temperature. 
After TLC indicated no further conversion, the crude mixture was diluted with diethyl ether, 
filtered through a small plug of silica gel and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel (5% diethyl ether in hexanes).  
 
entry ligand[a] solvent[b] T [°C] result ee [%][c] 
1 (S,S)-L1 n-hexane/toluene (1:2)[d] 60 II.90 (67%) 44 
2 (S,S)-L1 n-hexane/toluene (1:2) 60 II.90 (67%) 52 
3 (S,S)-L1 benzene 23 II.90 (26%) 64 
[a] 11 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] determined by chiral HPLC analysis; [d] solvent was degassed via freeze-pump-thaw.  
 
 
Procedure E: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with palladium(II) acetate (1.85 mg, 8.26 µmol, 0.100 equiv) and the (S,S)-DACH-
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phenyl Trost ligand ((S,S)-L1) (5.70 mg, 8.26 µmol, 0.100 equiv) and was afterwards purged with 
argon one time. (Degassed) solvent was added and the catalyst was stirred at 23 °C for 30 min. 
A solution of the allyl carbonate II.89 (20.0 mg, 82.6 mmol, 1 equiv) in the (degassed) solvent 
was added and the reaction was heated to 45 °C in a preheated oil bath. After TLC indicated no 
further conversion, the crude mixture was diluted with diethyl ether, filtered through a small 
plug of silica gel and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (5% diethyl ether in hexanes).  
 
1 ligand[a] solvent[b] result[c] 
1 (S,S)-L1 n-hexane/toluene (1:2)[d] II.90 (8%) + II.91 (40%) 
2 (S,S)-L1 n-hexane/toluene (1:2) II.90 (11%) + II.91 (46%) 
3 (S,S)-L1 benzene II.90 (11%) + II.91 (51%) 
4 (S,S)-L1 chlorobenzene II.90 (12%) + II.91 (71%) 
5 (S,S)-L1 toluene II.90 (17%) + II.91 (83%) 
6 (S,S)-L1 1,4-dioxane II.90 (21%) + II.91 (57%) 
7 (S,S)-L1 1,2-dichloroethane II.90 (9%) + II.91 (72%) 
8 (S,S)-L1 trifluorotoluene II.90 (6%) + II.91 (62%) 
9 (S,S)-L1 CPME[d] II.90 (2%) + II.91 (6%) + II.89 (69%) 
10 (S,S)-L1 DME[d] II.90 (15%) + II.91 (67%) + II.89 (6%) 
11 (S,S)-L1 CH3CN[d] II.90 (8%) + II.91 (70%) 
12 (S,S)-L1 CH2Cl2 II.90 (41%) + II.91 (47%) 
13 (S,S)-L1 CH2Cl2[d] II.90 (20%) + II.91 (62%) 
[a] 10 mol% ligand were used; [b] solvents were not degassed; 0.05 M; [c] yield was determined by 1H NMR (CDCl3, 400 or 600 MHz, dimethyl sulfone-d6 as internal standard); [d] solvents were degassed via freeze-pump-thaw. 
 
 
Procedure F: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with tris(dibenzylideneacetone)dipalladium(0) (4.62 mg, 5.04 µmol, 0.050 equiv) and a 
chiral ligand (0.11 equiv) and was afterwards purged with argon one time. (Degassed) solvent 
was added and the catalyst was stirred at 23 °C for 30 min. A solution of the allyl naphthol ether 
II.91 (20.0 mg, 0.101 mmol, 1 equiv) in the (degassed) solvent was added and the reaction was 
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stirred at the indicated temperature. After TLC indicated no further conversion, the crude 
mixture was diluted with diethyl ether, filtered through a small plug of silica gel and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel (5% 
diethyl ether in hexanes). The ee of the clean product II.90 was analyzed by chiral HPLC. 
 
entry ligand[a] solvent[b] T [°C] result [%][c] ee [%][d] 
1 (S,S)-L1 benzene 45 II.90: 88 (84) 59 
2 (S,S)-L1 benzene[e] 45 II.90: 84 (76) - 
3 (S,S)-L1 benzene 35 II.90: 69 (68) 60 
4 (S,S)-L1 benzene 23 II.90: 62 (57) 62 
5 (S,S)-L3 benzene 45 II.91 - 
6 (S,S)-L3 1,4-dioxane 45 II.91 - 
7 (S,S)-L7 benzene 45 II.90: 17 (16) 78 
8 (S,S)-L7 benzene[e] 45 II.90: 18 - 
9 (S,S)-L7 1,4-dioxane 45 II.90: 25 (24) 73 
10 (S,S)-L7 1,4-dioxane[e] 45 II.90: 18 - 
11 (R)-L8[f] THF[e] 45 II.90: (19) 0 
[a] 11 mol% ligand was used; [b] solvents were not degassed; 0.05 M; [c] yield was determined by 1H NMR (CDCl3, 400 or 600 MHz, dimethyl sulfone-d6 as internal standard); yield in parentheses refer to isolated yield; [d] determined by chiral HPLC analysis of the isolated product; [e] solvents were degassed via freeze-pump-thaw; [f] 12.5 mol% ligand were used. 
 
 
Procedure G: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with tris(dibenzylideneacetone)dipalladium(0) and the (S,S)-DACH-phenyl Trost ligand 
((S,S)-L1) and was afterwards purged with argon one time. (Degassed) benzene was added and 
the catalyst was stirred at 23 °C for 30 min. A solution of the allyl naphthol ether II.91 (20.0 mg, 
0.101 mmol, 1 equiv) in the (degassed) benzene was added and the reaction was heated to 45 °C 
in a preheated oil bath. After TLC indicated no further conversion, the crude mixture was 
diluted with diethyl ether, filtered through a small plug of silica gel and the filtrate was 
concentrated. The residue was purified by flash column chromatography on silica gel (5% 
diethyl ether in hexanes). The ee of the clean product II.90 was analyzed by chiral HPLC. 
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entry catalyst ligand solvent[a] result [%][b] ee [%][c] 
1 Pd2(dba)3 (5 mol%) (S,S)-L1 (10 mol%) benzene[d] II.90: 72 (76) 53 
2 Pd2(dba)3 (5 mol%) (S,S)-L1 (9 mol%) benzene[d] II.90: traces - 
3 Pd2(dba)3 (5 mol%) (S,S)-L1 (9 mol%) benzene II.90: 36 (33) 60 
4 Pd2(dba)3 (5 mol%) (S,S)-L1 (8 mol%) benzene[d] II.91 - 
5 Pd2(dba)3 (4 mol%) (S,S)-L1 (8.8 mol%) benzene II.90: 85 (87) 49 
6 Pd2(dba)3 (3 mol%) (S,S)-L1 (6.6 mol%) benzene[d] II.90: 76 - 
7 Pd2(dba)3 (3 mol%) (S,S)-L1 (6.6 mol%) benzene II.90: 66 (56) 61 
[a] solvents were not degassed; 0.05 M; [b] yield was determined by 1H NMR (CDCl3, 400 or 600 MHz, dimethyl sulfone-d6 as internal standard); yields in parentheses refer to isolated yields; [c] determined by chiral HPLC analysis of the isolated product; [d] solvents were degassed via freeze-pump-thaw.  
 
 
Procedure H: The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was 
charged with the catalyst (0.100 equiv) and the chiral ligand (0.110 equiv) and was afterwards 
purged with argon one time. (Degassed) solvent was added and the catalyst was stirred at 23 °C 
for 30 min. A solution of the allyl naphthol ether II.91 (20.0 mg, 0.101 mmol, 1 equiv) in the 
(degassed) solvent was added and the reaction was heated to 45 °C in a preheated oil bath. After 
TLC indicated no further conversion, the crude mixture was diluted with diethyl ether, filtered 
through a small plug of silica gel and the filtrate was concentrated. The residue was purified by 
flash column chromatography on silica gel (5% diethyl ether in hexanes). The ee of the clean 
product II.90 was analyzed by chiral HPLC. 
 
entry catalyst[a] ligand[b] solvent[c] result[d] ee [%][d] 
1 Pd(OAc)2 (S,S)-L1 benzene II.91 - 
2 Pd(OAc)2 (S,S)-L1 benzene/CH2Cl2 II.91 - 
3 Pd(OAc)2 (S,S)-L1 CH2Cl2 II.91 - 
4 Pd(OAc)2 (S,S)-L1 THF II.91 - 
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5 Pd(t-Bu3P)2 (S,S)-L1 benzene II.91 - 
6 Pd(dppe)2 (S,S)-L1 benzene II.91 - 
7 Pd(dmdba)2 (S,S)-L1 benzene II.90 (41%) 60 
8 Pd(dmdba)2 (S,S)-L1 benzene[e] II.90 (63%) 60 
9 Pd(dmdba)2 (S,S)-L1 toluene II.90 (68%) 57 
10 Pd(dmdba)2 (S,S)-L1 toluene[e] II.90 (47%) 55 
11 Pd(dmdba)2 (S,S)-L1 1,4-dioxane II.90 (55%) 55 
12 Pd(dmdba)2 (S,S)-L1 THF II.90 (traces) - 
13 Pd(dmdba)2 (S,S)-L1 1,2-dichlorobenzene II.90 (60%) 48 
14 Pd(dmdba)2 (S,S)-L7 benzene II.91 - 
15 Pd(dmdba)2 (S,S)-L7 toluene II.91 - 
16 Pd(dmdba)2 (S,S)-L7 1,4-dioxane II.91 - 
[a] 10 mol% catalyst were used; [b] 11 mol% ligand was used; [c] solvents were not degassed; 0.05 M; [d] determined by chiral HPLC analysis of the isolated product; [e] solvents were degassed via freeze-pump-thaw. dmdba = 3,5,3′,5′-dimethoxydibenzylideneacetone.  
 
 
10.2.2.4 Substrate Scope 
General Procedure for the Substrate Scope: 
The reaction was carried out at a concentration of 0.05 M. A Schlenk tube was charged with 
tris(dibenzylideneacetone)dipalladium(0) (0.0500 equiv) and the (S,S)-DACH-phenyl Trost 
ligand ((S,S)-L1) (0.110 equiv) and was afterwards purged with argon one time. Benzene was 
added and the catalyst was stirred at 23 °C for 30 min. A solution of the substrate (0.101 mmol, 
1 equiv) in benzene was added and the reaction was heated to 45 °C in a preheated oil bath. 
After TLC indicated no further conversion, the crude mixture was diluted with diethyl ether, 
filtered through a small plug of silica gel and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel. The ee of the clean substrate was 
analyzed by chiral HPLC. 
 
Following the general procedure, allylated naphthol I.106 (30.1 mg, 
0.101 mmol) provided the ketone I.105 (28.4 mg, 94%) as a colorless oil 
after flash column chromatography on silica gel (5% diethyl ether in 
hexanes). 
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Analytical data for I.105:  
TLC (33% ethyl acetate in hexanes), Rf = 0.69 (UV, CAM, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 8.01 (d, J = 7.9 Hz, 1H), 7.71 (s, 1H), 7.35 – 7.31 (m, 1H), 7.23 
(d, J = 1.7 Hz, 1H), 5.42 – 5.28 (m, 1H), 4.89 (ddt, J = 17.0, 2.5, 1.4 Hz, 1H), 4.77 (ddt, J = 10.1, 
2.0, 1.0 Hz, 1H), 4.30 (qd, J = 7.1, 1.1 Hz, 2H), 3.06 (ddt, J = 13.6, 8.1, 1.1 Hz, 1H), 2.90 (ddt, J 
= 13.6, 6.6, 1.3 Hz, 1H), 2.73 (q, J = 7.6 Hz, 2H), 1.51 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H), 1.28 (t, J 
= 7.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 201.8, 165.8, 151.7, 137.6, 135.9, 134.6, 134.1, 130.3, 128.8, 
127.8, 127.6, 117.4, 60.9, 51.6, 43.0, 29.2, 25.1, 15.1, 14.5. 
IR (Diamond-ATR, neat)     : 2971 (w), 1933 (w), 1709 (s), 1672 (s), 1599 (m), 1452 (w), 
1374 (w), 1279 (m), 1243 (m), 1215 (vs), 1094 (w), 1043 (m), 982 (m), 919 (m), 847 (m), 776 (m), 702 
(m) cm−1. 
HRMS (EI) calcd for C19H22O3 [M]+: 298.1563; found: 298.1568. 
Chiral HPLC:  Retention time I.105a: 5.82 min 
 Retention time I.105b: 7.90 min 
Column: CHIRALCEL® 5 μm OB-H column 
Flow rate: 1 mL/min 
Mobile phase: n-heptane:MTBE = 90:10 (v/v) 
Temperature: 40 °C 
Wavelength: 230 nm 
 
 
Following the general procedure, allylated naphthol II.107 (29.4 mg, 
0.101 mmol) provided the ketone II.95 (25.7 mg, 88%) as a colorless oil after 
flash column chromatography on silica gel (5% diethyl ether in hexanes). 
Analytical data for II.95:  
TLC (33% ethyl acetate in hexanes), Rf = 0.65 (UV, CAM, KMnO4). 
1H NMR (599 MHz, CDCl3) Ʋ: 8.06 (dd, J = 7.7, 1.6 Hz, 1H), 7.86 (d, J = 7.4 Hz, 1H), 7.70 (td, 
J = 7.7, 1.6 Hz, 1H), 7.53 – 7.48 (m, 1H), 5.58 – 5.49 (m, 1H), 4.99 (dd, J = 17.0, 1.6 Hz, 1H), 
4.91 – 4.85 (m, 1H), 3.91 (s, 3H), 2.79 – 2.73 (m, 1H), 2.58 – 2.51 (m, 1H), 1.42 (s, 3H). 
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13C NMR (151 MHz, CDCl3) Ʋ: 198.8, 166.5, 137.9, 134.8, 134.5, 132.2, 130.2, 129.8, 127.6, 
127.3, 126.2, 119.1, 52.8, 52.5, 44.4, 23.6. 
IR (Diamond-ATR, neat)     : 3076 (w), 2952 (w), 1728 (vs), 1681 (s), 1594 (m), 1452 (m), 1434 
(m), 1312 (m), 1282 (vs), 1258 (s), 1246 (s), 1224 (s), 1194 (m), 1111 (m), 1044 (m), 988 (m), 949 
(m), 924 (m), 848 (m), 766 (s), 695 (m) cm−1. 
HRMS (EI) calcd for C16H15O335Cl [M]+: 290.0704; found: 290.0709. 
Chiral HPLC:  Retention time II.95a: 12.33 min 
 Retention time II.95b: 21.26 min 
Column: CHIRALCEL® 5 μm OD-H column 
Flow rate: 1 mL/min 
Mobile phase: n-heptane:MTBE = 95:5 (v/v) 
Temperature: 40 °C 
Wavelength: 230 nm 
 
 
Following the general procedure, allylated naphthol I.88 (30.9 mg, 
0.101 mmol) provided the ketone I.89 (28.1 mg, 88%) as a colorless oil 
after flash column chromatography on silica gel (5% diethyl ether in 
hexanes).  
For the analytical data, except the ones of the chiral HPLC, see the experimental procedure for 
salimabromide. 
Analytical data for I.89:  
Chiral HPLC:  Retention time I.89a: 10.01 min 
 Retention time I.89b: 12.56 min 
Column: CHIRALCEL® 5 μm OD-H column 
Flow rate: 1 mL/min 
Mobile phase: n-heptane:MTBE = 95:5 (v/v) 
Temperature: 40 °C 
Wavelength: 254 nm 
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Following the general procedure, allylated naphthol II.106 (34.9 mg, 
0.101 mmol) provided the ketone II.96 (28.9 mg, 83%) as a light yellow oil 
after flash column chromatography on silica gel (5% diethyl ether in 
hexanes). 
Analytical data for II.96:  
TLC (33% ethyl acetate in hexanes), Rf = 0.55 (CAM, UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.93 (d, J = 8.3 Hz, 1H), 7.63 (s, 1H), 7.61 (dd, J = 8.3, 1.9 Hz, 
1H), 7.57 (d, J = 1.9 Hz, 1H), 5.34 (dddd, J = 16.9, 10.1, 8.0, 6.7 Hz, 1H), 4.89 (dq, J = 17.0, 1.4 
Hz, 1H), 4.79 (ddt, J = 10.1, 2.0, 1.0 Hz, 1H), 4.30 (qd, J = 7.1, 1.0 Hz, 2H), 3.06 (ddt, J = 13.5, 
8.0, 1.0 Hz, 1H), 2.88 (ddt, J = 13.6, 6.7, 1.3 Hz, 1H), 1.51 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3) Ʋ: 201.3, 165.4, 139.3, 137.2, 133.6, 133.5, 132.7, 132.0, 129.8, 
129.0, 128.3, 117.9, 61.1, 51.9, 43.1, 24.9, 14.4. 
IR (Diamond-ATR, neat)     : 2980 (w), 2361 (w), 2333 (w), 1714 (vs), 1678 (s), 1636 (w), 1583 
(m), 1560 (m), 1457 (w), 1374 (w), 1269 (s), 1243 (m), 1213 (s), 1045 (m), 983 (w), 921 (w), 777 (w) 
cm−1. 
HRMS (EI) calcd for C17H17O379Br [M]+: 348.0356; found: 348.0351. 
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10.2.3 Claisen Rearrangement of Allyl Chlorovinyl Ether 
10.2.3.1 Synthesis of Precursors 
 
For the synthesis of III.55 see H. Liu, A. Chatterjee, D. C. Tully, P. B. Alper, B. Bursulaya, J. 
Guo, D. Woodmansee, D. Mutnick, D. S. Karanewsky, Y. He, Inhibitors of Chatepsin S, PCT 
Int. Appl. 2005/034848 A2, 21 April 2005 and T. Miura, T. Tanaka, K. Hiraga, S. G. Stewart, M. 
Murakami, J. Am. Chem. Soc. 2013, 135, 13652–13655. 
 
 
10.2.3.2 Screenings for the Synthesis of α-Chloro-4-enoic Acids 
General Procedures for the Claisen Reaction: 
For the screenings to obtain Ư-chloro-4-enoic acids, the experiments were carried out using 
procedures A–D.  
 
 
Procedure A: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol (1 equiv) in tetrahydrofuran (0.75 M) was added 
at 0 °C. After 35 min, the reaction was cooled to the indicated temperature, trichloroethene 
(III.20) (1.2 equiv) in tetrahydrofuran (0.8 M) was added over 15 min and the reaction was 
allowed to warm to 23 °C. After 19 h, saturated aqueous ammonium chloride solution was 
added, the layers were separated and the aqueous layer was extracted with diethyl ether (3 ×). 
The combined organic layers were washed with saturated aqueous sodium chloride solution, the 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The crude product was analyzed by 1H NMR spectroscopy.  
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entry substrate T  result 
1 
 
−70 to 23 °C 
 
2 
 
−70 to 23 °C 
 
3 
 
−70 to 23 °C - 
4 
 
−70 to 23 °C 
 
5 
 
−85 to 23 °C 
 
6 
 
−50 to 23 °C 
 
7 
 
−50 to 23°C - 
8 
 
−50 to 23 °C 
 
9 
 
−50 to 23 °C - 
 
Following the general procedure, allyl alcohol (III.41) provided Ư-chlorinated acid 
III.44. 
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The obtained analytical data for III.44 were in full agreement with those reported in the 
literature.203  
Following the general procedure, 2-methylbut-3-en-2-ol (III.48) provided 
Ư-chlorinated acid III.56.  
The structure was unambiguously identified by converting III.56 into the corresponding dienoic 
acid III.65 (vide supra). 
 
Following the general procedure, cinnamyl alcohol (III.50) provided 
dienoic ester III.57.  
Analytical data for III.57: 
Note: Since purification was only partially possible, the structure was determined by impure material. 
TLC (20% diethyl ether in hexanes), Rf = 0.86 (UV, KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 7.93 (dd, J = 17.6, 10.8 Hz, 1H), 7.41 – 7.29 (m, 10), 6.68 (d, J = 
15.9 Hz, 1H), 6.33 (dt, J = 15.7, 6.4 Hz, 1H), 5.85 (s, 1H), 5.61 (d, J = 10.8 Hz, 1H), 5.32 (d, J = 
17.6 Hz, 1H), 4.82 (d, J = 6.4 Hz, 2H). 
13C NMR (101 MHz, CDCl3) Ʋ: 166.0, 156.4, 139.6, 136.5, 134.3, 133.9, 129.2, 128.8, 128.8, 
128.4, 128.2, 126.8, 125.6, 123.6, 118.1, 65.0. 
IR (Diamond-ATR, neat)     : 3027 (w), 2924 (w), 1711 (m), 1621 (w), 1583 (m), 1447 (w), 1375 
(w), 1344 (w), 1276 (m), 1154 (vs), 1110 (w), 1001 (w), 964 (m), 869 (w), 692 (m) cm−1. 
HRMS (EI) calcd for C20H18O2 [M]+: 290.1301; found: 290.1302 
 
Following the general procedure, a diastereomeric mixture of crotyl alcohol 
(III.51) provided Ư-chlorinated ester III.58.  
The structure was unambiguously identified by converting III.58 into the corresponding dienoic 
acids III.66a and III.66b (vide supra). 
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Following the general procedure, 2-methylprop-2-en-1-ol (III.52) provided 
Ư-chlorinated acid III.59.  
The structure was unambiguously identified by converting III.59 into the corresponding dienoic 
acid III.64 (vide supra). 
 
Following the general procedure, (E)-hex-2-en-1-ol 
(III.54) provided acid III.60 and ester III.61 as a 1.4 : 1 
mixture.  
The structure of acid III.60 was unambiguously identified by converting the mixture III.60 and 
III.61 into the corresponding dienoic acids III.62a and III.62b (vide supra). The NMR spectrum 
of the reaction mixture was discussed in Chapter III.8.1.  
 
 
Procedure B1: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol III.54 in tetrahydrofuran (0.75 M) was added at 
0 °C and the reaction was warmed to 23 °C. After 30 min, the reaction was cooled to the 
indicated temperature, trichloroethene (III.20) in tetrahydrofuran (0.8 M) was added over 
10 min and the reaction was allowed to warm to 23 °C. After 19 h, water and aqueous 
hydrochloric acid solution (2 M) were added, the layers were separated and the aqueous layer was 
extracted with ethyl acetate (3 ×) and dichloromethane (1 ×). The combined organic layers were 
washed with saturated aqueous sodium chloride solution, the washed solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The crude 
product was analyzed by 1H NMR spectroscopy. 
Procedure B2: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol III.54 (1 equiv) in tetrahydrofuran (0.75 M) was 
added at 0 °C and the reaction was warmed to 23 °C. After 30 min, the reaction mixture was 
added to a cooled solution of trichloroethene (III.20) in tetrahydrofuran (0.8 M) and the 
reaction was allowed to warm to 23 °C. After 19 h, water and aqueous hydrochloric acid 
solution (2 M) were added, the layers were separated and the aqueous layer was extracted with 
ethyl acetate (3 ×) and dichloromethane (1 ×). The combined organic layers were washed with 
saturated aqueous sodium chloride solution, the washed solution was dried over sodium sulfate, 
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the dried solution was filtered and the filtrate was concentrated. The crude product was analyzed 
by 1H NMR spectroscopy. 
 
entry conditions[a] comment result[b],[c] 
1 KH, III.54, 0 °C to 23 °C,  
then III.20, ‒78 °C to 23 °C 
 III.59 (34%), 
d.r. = 4.3 : 1 
III.60 (26%), 
d.r. = 1.4 : 1 
2 KH, III.54, 0 °C to 23 °C,  
then III.20, ‒78 °C to 23 °C 
ratio III.54 : KH : III.20 = 
1 : 2.4 : 2 
III.59 (8%), 
d.r. = 1.4 : 1 
III.60 (9%), 
d.r. = 0.9 : 1 
3 KH, III.54, 0 °C to 23 °C,  
then mixture added to III.20, ‒78 °C 
to 23 °C 
 III.59 (15%), 
d.r. = 1.2 : 1 
III.60 (13%), 
d.r. = 1 : 1 
4 KH, III.54, 0 °C to 23 °C,  
then III.20, ‒78 °C to 23 °C 
ratio III.54 : KH : III.20 = 
3 : 2.4 : 1.2 
III.60 (39%), 
d.r. = 1 : 1 
5 KH, III.54, 23 °C,  
then III.20, ‒78 °C to 23 °C 
 III.59 (13%) 
III.60 (9%), 
d.r. = 1.2 : 1 
6 KH, III.20, 23 °C,  
then mixture added to III.20, 0 °C 
ratio III.54 : KH : III.20 = 
1 : 1 : 1 
III.60 (30%) 
[a] ratio III.54 : KH : III.20 = 1 : 2.4 : 1.2 unless otherwise noted; [b] the yield was determined by 1H NMR spectroscopy (CDCl3, 400 MHz; mesitylene as internal standard); [c] d.r. = anti : syn.  
 
Procedure C1: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol III.54 (1 equiv) in tetrahydrofuran (0.75 M) was 
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added at 0 °C and the reaction was warmed to 23 °C. After 30 min, the reaction was cooled to 
the indicated temperature, trichloroethene (III.20) (1.2 equiv) in tetrahydrofuran (0.8 M) was 
added over 10 min and the reaction was allowed to warm to −27 °C. After 2.5 h at this 
temperature, aqueous H2SO4 (10%, 1.2 equiv) was added and the reaction was warmed to 23 °. 
After 4.5 h, water and aqueous hydrochloric acid solution (2 M) were added, the layers were 
separated and the aqueous layer was extracted with ethyl acetate (3 ×) and dichloromethane 
(1 ×). The combined organic layers were washed with saturated aqueous sodium chloride 
solution, the washed solution was dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The crude product was analyzed by 1H NMR spectroscopy. 
Procedure C2: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol III.54 in tetrahydrofuran (0.75 M) was added at 
0 °C and the reaction was warmed to 23 °C. After 30 min, the reaction mixture was added to a 
−78 °C cold solution of trichloroethene (III.20) in tetrahydrofuran (0.8 M) and the reaction was 
allowed to warm to −27 °C. After the indicated time at this temperature, aqueous H2SO4 (10%) 
or dry methanol (3.0 equiv) or hexafluoroisopropanol (3.0 equiv) was added and the reaction 
was warmed to 23 °. After 2–6 h, water and aqueous hydrochloric acid solution (2 M) were 
added, the layers were separated and the aqueous layer was extracted with ethyl acetate (3 ×) and 
dichloromethane (1 ×). The combined organic layers were washed with saturated aqueous 
sodium chloride solution, the washed solution was dried over sodium sulfate, the dried solution 
was filtered and the filtrate was concentrated. The crude product was analyzed by 1H NMR 
spectroscopy. 
 
entry conditions[a] comment result[b],[c] 
1 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C, then H2SO4 (10%), 23 °C 
 III.60 (13%), 
d.r. = 19 : 1 
2 KH, III.54, 0 °C to 23 °C, 
then III.20, ‒78 °C to ‒27 °C, 
then H2SO4 (10%), 23 °C 
 III.60 (14%), 
d.r. = 13.3 : 1 
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3 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C, 
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 1 : 4 : 1.2 : 1.2  
III.60 (10%), 
d.r. = 99 : 1 
4 1) KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 1.5 h at ‒27 °C, 
then H2SO4 (10%), 23 °C  
 III.60 (25%), 
d.r. = 15.7 : 1 
5 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 45 min at ‒27 °C, 
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 1.8 : 2.4 : 1.2 : 1.2 
III.60 (28%), 
d.r. = 15.7 : 1 
6 KH, III.54, 0 °C to 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 45 min at ‒27 °C,  
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 2.4 : 2.4 : 1.2 : 1.2 
III.60 (37%), 
d.r. = 13.3 : 1 
7 1) KH, III.54, 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 50 min at ‒27 °C, 
then H2SO4 (10%), 23 °C 
III.54 : KH : III.20 : H2SO4 
= 1 : 2.4 : 1.2 : 0.55  
III.60 (26%), 
d.r. = 99 : 1 
8 KH, III.54, 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 50 min at ‒27 °C, 
then MeOH, 23 °C 
3 equiv of MeOH III.54 and 
traces of III.20 
9 KH, III.54, 23 °C, 
then mixture added to III.20, ‒78 °C to ‒27 °C; 50 min at ‒27 °C, 
then HFIP, 23 °C 
3 equiv of HFIP III.54 and 
traces of III.20 
[a] ratio III.54 : KH : III.20 : H2SO4 = 1 : 2.4 : 1.2 : 1.2 unless otherwise noted; [b] the yield was determined by 1H NMR spectroscopy (CDCl3, 400 MHz; mesitylene as internal standard); [c] d.r. = anti : syn. 
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Note: Dichloroacetylene (DCA, III.38) is highly toxic and explosive! All reactions were carried out behind a 
blast shield.  
Trichloroethene (III.20) (0.692 mL, 7.69 mmol, 1 equiv) and methanol (11.2 µL, 0.192 mmol, 
0.0250 equiv) were added to a suspension of washed potassium hydride (401 mg, 10.0 mmol, 
1.30 equiv) in tetrahydrofuran (7 mL). The reaction mixture was stirred for 1 h until gas 
evolution ceased. Stirring was stopped and the brown-grey supernatant was used immediately. It 
was assumed that the concentration of III.38 is approximately 1 M.204 
 
Procedure D1: A Schlenk tube was charged with washed potassium hydride or potassium 
tert-butoxide and tetrahydrofuran (1 M). A solution of allyl alcohol III.54 in tetrahydrofuran 
(0.75 M) was added at 23 °C. After 30 min, the reaction was cooled to the indicated temperature, 
a solution of dichloroacetylene III.38 (1 M in tetrahydrofuran) was added and the reaction was 
allowed to warm to 23 °C. After 3–6 h, saturated aqueous ammonium chloride solution and 
aqueous hydrochloric acid solution (2 M) were added, the layers were separated and the aqueous 
layer was extracted with ethyl acetate (3 ×) and dichloromethane (1 ×). The combined organic 
layers were washed with saturated aqueous sodium chloride solution, the washed solution was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
crude product was analyzed by 1H NMR spectroscopy. 
Procedure D2: A Schlenk tube was charged with washed potassium hydride (3 equiv), 
tetrahydrofuran (1 M) and methanol (2 equiv). After 30 min, the reaction mixture was cooled to 
0 °C and a solution of dichloroacetylene III.38 (1 M in tetrahydrofuran, 1 equiv) was added. 
After 15 min, allylic alcohol III.54 (1 equiv) was added over 1.5 h (syringe pump) at 0 °C. After 
3 h, saturated aqueous ammonium chloride solution and aqueous hydrochloric acid solution 
(2 M) were added, the layers were separated and the aqueous layer was extracted with ethyl 
acetate (3 ×) and dichloromethane (1 ×). The combined organic layers were washed with 
saturated aqueous sodium chloride solution, the washed solution was dried over sodium sulfate, 
the dried solution was filtered and the filtrate was concentrated. The crude product was analyzed 
by 1H NMR spectroscopy. For analytical data of the isomeric mixture of III.62a and III.62b 
vide supra.  
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entry conditions comment result[a],[b] 
1 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 1 : 1.1 : 2 
III.60 (34%), d.r. = 10 : 1 
III.61 (12%), d.r. = 1.5 : 1 
2 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 1 : 1.1 : 3 
III.60 (30%) 
3 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 1 : 0.1 : 3 
III.54 and traces of III.61 
4 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 3 : 1.5 : 1 
III.61 (56%), d.r. = 1 : 1 
5 KH, III.54, 23 °C, then 
III.38, 23 °C 
ratio III.54 : KH : III.38 
= 2 : 2 : 1 
III.61 (45%), d.r. = 1.1 : 1 
III.62 (18%), d.r. = 1 : 1.4[c] 
6 t-BuOK, III.54, 23 °C, 
then III.38, −30 °C 
ratio III.54 : t-
BuOK : III.38 = 
1.3 : 1 : 1.3 
III.61 (22%), d.r. = 1.3 : 1 
7 KH, III.54, 23 °C, then 
III.38, −30 °C 
ratio III.54 : KH : III.38 
= 2 : 2 : 1 
III.60 (11%), d.r. = 6.14 : 1 
III.61 (8%), d.r. = 1 : 1.5 
III.62 (20%), d.r. = 1 : 1[c] 
8 KH, MeOH, 23 °C, then 
III.38, 0 °C, then III.54, 
0 °C (addition over 1.5 h) 
ratio III.54 : KH : III.38 : 
MeOH = 1 : 3 : 1 : 2 
III.62 (33%), d.r. = 1 : 1.3[c] 
[a] the yield was determined by 1H NMR spectroscopy (CDCl3, 400 MHz; mesitylene as internal standard); [b] d.r. = anti : syn; [c] d.r. = E : Z.  
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10.2.3.3 Screenings for the Synthesis of 2,4-Dienoic Acids 
General Procedures for the Elimination Reaction 
The screenings for the synthesis of 2,4-dienoic acids from Ư-chloro-4-enoic acids were carried 
out according to the procedures A-B. 
 
Procedure A: A solution of III.44 (1 equiv) in the indicated solvent (0.28 M) was added to the 
base in a pressure tube and the reaction mixture was heated to the indicated temperature. After 
the indicated time, water and aqueous hydrochloric acid solution (2 M or 37%) were added, the 
layers were separated and the aqueous layer was extracted with ethyl acetate (3 ×). The 
combined organic layers were washed with saturated aqueous sodium chloride solution, the 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The crude product was analyzed by 1H NMR spectroscopy.  
The obtained analytical data for III.63 were in full agreement with those reported in the 
literature.205 
 
entry base conditions result 
1 t-BuOK (3.5 equiv) t-BuOH, 85 °C, 5 h III.63 
2 t-BuOK (3.5 equiv) t-BuOH, 50 °C, 4 h III.63+ traces of 45 
3 DBU (3.5 equiv) THF, 65 °C, 4 h III.44 
4 KOTMS (3.5 equiv) THF, 85 °C, 4.5 h III.63 : III.44 = 2 : 1[a] 
5 t-BuOK (2.1 equiv) t-BuOH, 85 °C, 4.5 h III.63 : III.44 = 3 : 1[a] 
6 t-BuOK (ca. 10 equiv) t-BuOH, 23 °C, 4.5 h III.63 + traces of III.44 
7 NaOH (3.5 equiv) i-PrOH, 85 °C, 5 h III.63 : III.44 = 6.7 : 1[a] 
[a] ratio determined by 1H NMR spectroscopy. 
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Procedure B: A solution of III.46 (1 equiv) in the tert-butanol (0.28 M) was added to potassium 
tert-butoxide (3.5 equiv) in a pressure tube and the reaction mixture was heated to 85 °C. After 
4 h, water and aqueous hydrochloric acid solution (37%) were added, the layers were separated 
and the aqueous layer was extracted with ethyl acetate (3 ×). The combined organic layers were 
washed with saturated aqueous sodium chloride solution, the washed solution was dried over 
sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The residue was 
purified by flash column chromatography on silica gel. The d.r. of the product was analyzed by 
1H NMR spectroscopy. 
 
Following the general procedure, a mixture of Ư-chlorinated acid 
III.60 and ester III.61 provided a mixture of dienes III.62a and 
III.62b (d.r. = 1 : 3.5) as a light brown solid without purification. 
Analytical data for III62a and III.62b: 
Note: Since purification was not possible, the structure was determined by impure material. Signals marked with 
an asterisk belong to the Z-isomer III.62b.   
TLC (20% diethyl ether in hexanes), Rf = 0.41 (smear, KMnO4). 
1H NMR (599 MHz, CDCl3) Ʋ. 11.43 (s, 1H), 7.70 (ddd, J = 17.7, 11.1, 0.8 Hz, 1H)*, 6.34 (dd, J 
= 17.4, 10.7 Hz, 0.3H), 5.79 (s, 0.2H), 5.73 (s, 1H)*, 5.67 (d, J = 17.4 Hz, 0.3H), 5.65 (d, J = 17.7 
Hz, 1H)*, 5.48 (dt, J = 11.1, 1.4 Hz, 1H)*, 5.42 (d, J = 10.7 Hz, 0.3H), 2.80 – 2.74 (m, 0.5H), 
2.39 – 2.32 (m, 2H)*, 1.56 (dq, J = 15.1, 7.5 Hz, 2H)*, 1.52 (td, J = 14.7, 7.1 Hz, 1H), 0.97 (t, J = 
7.4 Hz, 1.5H), 0.96 (t, J = 7.4 Hz, 3H)*.  
13C NMR (151 MHz, CDCl3) Ʋ. 171.8, 171.5, 159.6, 157.6, 139.1, 133.1, 121.0, 120.2, 118.7, 
116.5, 35.9, 29.2, 23.1, 22.4, 14.5, 14.1. 
IR (Diamond-ATR, neat)     : 2958 (m), 2929 (m), 2872 (m), 1676 (s), 1621 (m), 1585 (m), 1456 
(w), 1438 (w), 1400 (w), 1248 (s), 1183 (s), 1051 (s), 999 (s), 937 (s), 894 (s), 764 (m), 718 (s) cm−1. 
HRMS (EI) calcd for C20H18O2 [M]+: 140.0832; found: 140.0837. 
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Following the general procedure, Ư-chlorinated acid III.59 (50.0 mg, 0.336 mmol) 
provided diene III.64 (22.6 mg, 60%) as a white solid after flash column 
chromatography on silica gel (14% ethyl acetate in hexanes).  
The obtained analytical data were in full agreement with those reported in the literature.206 
 
Following the general procedure Ư-chlorinated acid III.56 (23.0 mg, 
0.141 mmol) provided diene III.65 (3.2 mg, 18%) as a beige solid after flash 
column chromatography on silica gel (11% ethyl acetate and 1% acetic acid in hexanes). 
The obtained analytical data were in full agreement with those reported in the literature.207 
 
Following the general procedure, Ư-chlorinated ester III.58 provided 
a mixture of dienes III.66a and III.66b (d.r. = 3 : 2) as a brown oil 
without purification.  
The obtained analytical data of the crude reaction mixture were in full agreement with those 
reported in the literature.208 
 
 
General Procedures for the One-Pot Reaction 
The screenings for the synthesis of 2,4-dienoic acids from allylic alcohols were carried out 
according to the procedures A-B. 
 
Procedure A: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol (III.41) (1 equiv) in tetrahydrofuran (0.75 M) 
was added at 0 °C. After 35 min, the reaction was cooled to −50 °C, trichloroethene (III.20) 
(1.2 equiv) in tetrahydrofuran (0.8 M) was added and the reaction was allowed to warm to 23 °C. 
After 2 h, tert-butanol (0.28 M) or iso-propanol (0.28 M) and potassium tert-butoxide or sodium 
hydroxide (3.5 equiv) were added and the reaction mixture was heated to 85 °C. After the 
indicated time, water and aqueous hydrochloric acid solution (37%) were added, the layers were 
separated and the aqueous layer was extracted with ethyl acetate (3 ×). The combined organic 
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layers were washed with saturated aqueous sodium chloride solution, the washed solution was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
crude product was analyzed by 1H NMR spectroscopy. 
 
entry conditions ratio of III.63a : III.44[a] 
1 1) KH, THF, −50 °C to 23 °C, 2.5 h 
2) t-BuOK (3.5 equiv), 60 °C, 4.5 h 
2.3 : 1; traces of III.63b 
2 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (3.5 equiv), 80 °C, 4 h 
5.3 : 1; traces of III.63b 
3 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (3.5 equiv), 85 °C, 15 h 
3.5 : 1; traces of III.63b 
4 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (4 equiv), 85 °C, 15 h 
2.7 : 1 
5 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (2 equiv), 85 °C, 5 h 
2.3 : 1; traces of III.63b 
6 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) t-BuOH, t-BuOK (1.5 equiv), 85 °C, 5 h 
3 : 1; traces of III.63b 
7 1) KH, THF, −50 °C to 23 °C, 1.5 h 
2) i-PrOH, NaOH (3.5 equiv), 85 °C, 5.5 h 
ratio III.63a : III.44 = 11.5 : 1 
d.r. III.63a : III.63b = 9 : 1 
[a] ratios determined by 1H NMR spectroscopy. 
 
 
 
Procedure B: A Schlenk tube was charged with washed potassium hydride (2.4 equiv) and 
tetrahydrofuran (1 M). A solution of allyl alcohol (1 equiv) in tetrahydrofuran (0.75 M) was added 
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at 0 °C. After 35 min, the reaction was cooled to −50 °C, trichloroethene (III.20) (1.2 equiv) in 
tetrahydrofuran (0.8 M) was added and the reaction was allowed to warm to 23 °C. After 1.5 h, 
iso-propanol (0.28 M) and sodium hydroxide (3.5 equiv) were added and the reaction mixture was 
heated to 85 °C. After 5 h, water and aqueous hydrochloric acid solution (2 M) were added, the 
layers were separated and the aqueous layer was extracted with ethyl acetate (3 ×). The 
combined organic layers were washed with saturated aqueous sodium chloride solution, the 
washed solution was dried over sodium sulfate, the dried solution was filtered and the filtrate 
was concentrated. The residue was purified by flash column chromatography on silica gel. The 
dr of the substrate was analyzed by 1H NMR spectroscopy. 
 
Following the general procedure, crotyl alcohol (III.51) (48.6 mg, 
0.674 mmol) provided a mixture of dienes III.66a and III.66b 
(40.0 mg, 53%, d.r. = 1 : 0.77) as a brown solid without purification.  
The obtained analytical data were in full agreement with those reported in the literature.208 
 
Following the general procedure, 2-methyl-2-propen-1-ol (III.52) (71.7 mg, 
0.994 mmol) provided diene III.64 (110 mg, 99%) as a brown solid without 
purification.  
The obtained analytical data were in full agreement with those reported in the literature.206 
 
Following the general procedure, 2-cyclohexenol (III.67) (55.6 mg, 
0.566 mmol) provided a mixture of dienes III.68a and III.68b 
(24.0 mg, 31%, d.r. = 1:1) as a white solid after flash column 
chromatography on silica gel (9% ethyl acetate and 1% acetic acid in hexanes). 
Analytical data for III.68a and III.68b:  
Note: Asterisks denote the signals of the E-isomer III.68b, but not all signals could be assigned.  
TLC (20% diethyl ether in hexanes), Rf = 0.26 (KMnO4). 
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1H NMR (400 MHz, CDCl3) Ʋ: 10.43 (s, 2H), 7.46 (d, J = 10.2 Hz, 1H), 6.28 (dq, J = 8.9, 4.1 
Hz, 2H), 6.14 (d, J = 9.8 Hz, 1H)*, 5.59 (s, 1H)*, 5.50 (s, 1H), 3.01 – 2.92 (m, 2H)*, 2.47 – 2.36 
(m, 2H), 2.22 (dd, J = 13.9, 6.0 Hz, 4H), 1.76 (dp, J = 25.6, 6.1 Hz, 4H). 
13C NMR (101 MHz, CDCl3) Ʋ: 173.0*, 172.3, 156.6*, 155.3, 139.5, 139.2*, 130.3*, 125.3, 
114.5*, 112.5, 32.9, 26.6*, 26.3, 25.7*, 22.7, 21.9*. 
IR (Diamond-ATR, neat)     : 2923 (m), 1681 (s), 1614 (s), 1587 (s), 1420 (m), 1391 (w), 1338 
(w), 1258 (s), 1242 (s), 1187 (s), 1131 (m), 1049 (m), 918 (s), 871 (vs), 691 (s) cm−1. 
HRMS (EI) calcd for C8H10O2 [M]+: 138.0675; found: 138.0681.  
 
Following the general procedure, 2-methylenecyclohexan-1-ol (III.69) (104 mg, 
0.931 mmol) provided the diene III.70 (6.00 mg, 4%) as a beige solid after flash 
column chromatography on silica gel (17% to 50% ethyl acetate in hexanes). 
The obtained analytical data were in full agreement with those reported in the literature.209 
 
Following the general procedure, cyclohex-1-en-1-ylmethanol (III.71) (57.1 mg, 
0.509 mmol) provided the diene III.72 after flash column chromatography on silica 
gel (9% to 50% ethyl acetate in hexanes).  
Analytical data for III.72: 
TLC (17% diethyl ether in hexanes), Rf = 0.30 (KMnO4). 
1H NMR (400 MHz, CDCl3) Ʋ: 11.28 (s, 1H), 5.86 (s, 1H), 5.02 (s, 1H), 4.80 (s, 1H), 2.93 (t, J = 
4.9 Hz, 2H), 2.34 (t, J = 4.6 Hz, 2H), 1.69 (dt, J = 6.7, 3.1 Hz, 4H). 
13C NMR (101 MHz, CDCl3) Ʋ: 172.2, 164.0, 149.6, 112.4, 111.6, 35.5, 30.1, 26.5, 26.0. 
IR (Diamond-ATR, neat)     : 2933 (m), 2859 (m), 1682 (vs), 1632 (s), 1440 (w), 1411 (w), 1295 
(m), 1226 (s), 1163 (w), 902 (m), 882 (w), 689 (w) cm−1. 
HRMS (EI) calcd for C9H12O2 [M]+: 152.0832; found: 152.0829. 
The relative stereochemistry was assigned by NOE correlations. 
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11 Appendix 
11.1 X‐Ray Crystallographic Data 
The data collections were performed either on an Oxford Diffraction Xcalibur diffractometer, on a Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoK ‐radiation (  = 0.71073 Å, graphite monochromator). The CrysAlisPro software (version 1.171.33.41)[S8] was applied for the integration, scaling and multi‐scan absorption correction of the data. The structures were solved by direct methods with SIR9711 and refined by least‐squares methods against F2 with SHELXL‐97.12 All non‐hydrogen atoms were refined anisotropically. The hydrogen atoms were placed in ideal geometry riding on their parent atoms. Further details are summarized in the tables at the different sections. 
 
Single-crystal X-ray analysis of compound I.107: 
 
 
net formula C21H20O5 Mr/g mol−1 352.37 crystal size/mm 0.100 × 0.090 × 0.010 T/K 100(2) radiation MoK  diffractometer 'Bruker D8Venture' crystal system monoclinic space group 'C 2/c' a/Å 30.2456(18) b/Å 7.6603(4) c/Å 18.2737(11) 
/° 90 
/° 122.731(2) 
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/° 90 V/Å3 3561.6(4) Z 8 calc. density/g cm−3 1.314 
/mm−1 0.094 absorption correction multi-scan transmission factor range 0.8940–0.9580 refls. measured 18840 Rint 0.0480 
mean σ(I)/I 0.0356 
θ range 3.202–25.38 observed refls. 2358 x, y (weighting scheme) 0.0393, 2.6371 hydrogen refinement constr refls in refinement 3250 parameters 237 restraints 0 R(Fobs) 0.0402 Rw(F2) 0.0956 S 1.058 shift/errormax 0.001 max electron density/e Å−3 0.223 min electron density/e Å−3 −0.210  
Single-crystal X-ray analysis of compound I.165: 
 
 net formula C14H18O3 Mr/g mol−1 234.28 crystal size/mm 0.090 × 0.040 × 0.030 T/K 100.(2) radiation MoK  
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diffractometer 'Bruker D8 Venture TXS' crystal system monoclinic space group 'P 1 21/n 1' a/Å 7.0271(3) b/Å 17.0529(7) c/Å 10.0184(4) 
/° 90 
/° 91.650(2) 
/° 90 V/Å3 1200.03(9) Z 4 calc. density/g cm−3 1.297 
/mm−1 0.090 absorption correction Multi-Scan transmission factor range 0.9017–0.9705 refls. measured 18124 Rint 0.0421 
mean σ(I)/I 0.0268 
θ range 3.137–26.365 observed refls. 2013 x, y (weighting scheme) 0.0528, 1.1304 hydrogen refinement H(C) constr, H(O) restr refls in refinement 2450 parameters 162 restraints 1 R(Fobs) 0.0561 Rw(F2) 0.1404 S 1.116 shift/errormax 0.001 max electron density/e Å−3 0.496 min electron density/e Å−3 −0.358  
Single-crystal X-ray analysis of compound I.166: 
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net formula C14H16O2 Mr/g mol−1 216.27 crystal size/mm 0.090 × 0.070 × 0.030 T/K 100.(2) radiation MoK  diffractometer 'Bruker D8 Venture TXS' crystal system orthorhombic space group 'P n m a' a/Å 15.3960(5) b/Å 7.0864(2) c/Å 10.4521(3) 
/° 90 
/° 90 
/° 90 V/Å3 1140.35(6) Z 4 calc. density/g cm−3 1.260 
/mm−1 0.083 absorption correction Multi-Scan transmission factor range 0.9123–0.9705 refls. measured 12854 Rint 0.0310 
mean σ(I)/I 0.0191 
θ range 3.287–28.272 observed refls. 1332 x, y (weighting scheme) 0.0630, 0.3244 hydrogen refinement constr refls in refinement 1533 parameters 97 restraints 0 R(Fobs) 0.0394 Rw(F2) 0.1145 S 1.065 shift/errormax 0.001 max electron density/e Å−3 0.402 min electron density/e Å−3 −0.210  
Single-crystal X-ray analysis of compound I.241: 
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net formula C14H20O2 Mr/g mol−1 220.30 crystal size/mm 0.070 × 0.060 × 0.030 T/K 103.(2) radiation MoK  diffractometer 'Bruker D8 Venture TXS' crystal system monoclinic space group 'P 1 21/n 1' a/Å 13.2972(7) b/Å 11.6884(6) c/Å 15.5919(8) 
/° 90 
/° 99.159(2) 
/° 90 V/Å3 2392.4(2) Z 8 calc. density/g cm−3 1.223 
/mm−1 0.080 absorption correction Multi-Scan transmission factor range 0.9360–0.9705 refls. measured 17874 Rint 0.0507 
mean σ(I)/I 0.0434 
θ range 3.169–25.350 observed refls. 3246 x, y (weighting scheme) 0.0440, 1.2903 hydrogen refinement mixed 
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refls in refinement 4368 parameters 371 restraints 27 R(Fobs) 0.0493 Rw(F2) 0.1200 S 1.032 shift/errormax 0.001 max electron density/e Å−3 0.241 min electron density/e Å−3 −0.239  
Single-crystal X-ray analysis of compound III.62b: 
 
 
net formula C8H12O2 Mr/g mol−1 140.180 crystal size/mm 0.254 × 0.112 × 0.059 T/K 123(2) radiation MoK  diffractometer 'Oxford XCalibur' crystal system triclinic space group P1bar a/Å 7.4344(7) b/Å 9.1982(7) c/Å 12.4795(13) 
/° 81.541(7) 
/° 81.300(8) 
/° 68.583(8) V/Å3 781.39(12) Z 4 calc. density/g cm−3 1.19161(18) 
/mm−1 0.084 absorption correction 'multi-scan' 
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transmission factor range 0.90603–1.00000 refls. measured 3969 Rint 0.0224 
mean σ(I)/I 0.0669 
θ range 4.21–25.34 observed refls. 1881 x, y (weighting scheme) 0.0459, 0.0586 hydrogen refinement mixed refls in refinement 2817 parameters 191 restraints 0 R(Fobs) 0.0537 Rw(F2) 0.1267 S 1.025 shift/errormax 0.001 max electron density/e Å−3 0.193 min electron density/e Å−3 −0.228  
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11.2 NMR Spectra of Chapter I 
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11.3 NMR Spectra of Chapter II 
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11.4 NMR Spectra of Chapter III 
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11.5 Chiral HPLC Data 
Chiral HPLC of racemic II.90: 
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Example of a chiral HPLC analysis of II.90 synthesized with (S,S)-DACH-naphthyl Trost ligand ((S,S)-L7): 
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Chiral HPLC of I.105 : 
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Chiral HPLC of II.95: 
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Chiral HPLC of I.89: 
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